data_2mst_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mst _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.5 pt -114.77 174.84 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.123 -0.986 . . . . 0.0 110.881 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.7 t80 -121.93 157.7 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.495 -0.753 . . . . 0.0 109.422 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -149.72 153.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.009 . . . . 0.0 110.479 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -141.1 176.37 21.68 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 87.1 15.38 62.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.449 HD13 ' N ' ' A' ' 152' ' ' PHE . 15.4 mt -47.63 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 115' ' ' GLY . 2.2 t -57.52 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 110.66 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 120' ' ' THR . 15.6 m -89.06 154.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.496 -0.753 . . . . 0.0 110.867 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 62.26 -35.28 0.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.739 -0.601 . . . . 0.0 111.082 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 118' ' ' VAL . 62.2 m -43.63 128.65 5.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 110.13 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 15.3 t -117.69 158.58 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 110.248 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.4 t -37.5 -51.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.57 -0.706 . . . . 0.0 110.848 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -41.11 -26.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.556 -0.715 . . . . 0.0 109.441 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.514 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 1.6 m-20 -74.14 -55.76 5.71 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.728 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.528 ' CG2' HD23 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.6 -48.06 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.328 -0.857 . . . . 0.0 109.241 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 8.6 ttpp -47.53 -60.77 2.3 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.448 -0.783 . . . . 0.0 109.673 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -63.94 -33.51 75.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 7.1 t80 -57.77 -60.7 3.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.56 -0.712 . . . . 0.0 110.439 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 97.3 m-85 -80.43 -16.4 54.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.8 tt0 -56.64 -36.45 69.52 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.382 -1.449 . . . . 0.0 107.957 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.2 pt20 -73.75 -17.21 61.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 3.6 m-30 -86.31 -28.29 23.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.426 0.632 . . . . 0.0 109.608 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -165.83 -165.73 23.66 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -52.41 59.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.298 -1.119 . . . . 0.0 110.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 55.34 90.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.087 0.946 . . . . 0.0 110.913 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -92.83 -26.57 17.61 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -130.73 140.61 50.34 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.007 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -154.91 98.78 2.07 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 4.2 ptp -116.57 163.47 16.05 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.948 0.88 . . . . 0.0 112.461 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.528 HD23 ' CG2' ' A' ' 125' ' ' VAL . 89.2 mt -137.26 133.01 34.56 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.496 ' HA ' ' CE ' ' A' ' 141' ' ' MET . 2.6 mmt -107.19 125.05 50.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.933 -1.105 . . . . 0.0 110.577 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 27.0 m-85 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.478 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.3 p90 -147.02 137.29 23.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -1.134 . . . . 0.0 109.992 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -114.71 159.56 13.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 139' ' ' MET . 30.8 m-85 -115.04 109.85 18.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -1.1 . . . . 0.0 109.372 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -104.66 -178.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.892 -1.13 . . . . 0.0 109.008 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 30.8 m -164.81 104.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.038 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' A' ' 111' ' ' ILE . 2.0 p90 -128.37 107.81 10.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 0.0 109.23 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -39.31 -26.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.793 . . . . 0.0 111.138 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 162' ' ' ILE . 2.3 m -56.48 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.777 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.6 tt0 -58.32 -38.61 77.45 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.693 -1.255 . . . . 0.0 109.463 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 6.6 t0 -40.37 -63.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 110.389 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 159' ' ' SER . 1.3 tp -57.99 -45.06 88.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.98 -1.075 . . . . 0.0 108.82 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 157' ' ' PHE . 35.5 t -47.42 -39.82 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -51.17 -56.58 12.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.716 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 167' ' ' CYS . 5.9 tttp -84.8 -60.83 1.94 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.285 -0.884 . . . . 0.0 110.863 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 172' ' ' HIS . 4.3 p -41.34 -25.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.097 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.9 t -75.62 -38.3 59.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.152 -0.968 . . . . 0.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 165' ' ' LYS . 4.4 mt-10 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.512 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.568 ' CE1' HG22 ' A' ' 166' ' ' VAL . 18.6 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.082 0.468 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -141.32 99.41 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 109.988 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.59 ' CG2' ' CB ' ' A' ' 177' ' ' LYS . 0.5 OUTLIER -92.06 81.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.958 -1.089 . . . . 0.0 110.159 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 69.4 m-80 64.47 -53.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 111.287 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.1 p30 -147.75 7.45 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 111.191 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.59 ' CB ' ' CG2' ' A' ' 174' ' ' ILE . 0.3 OUTLIER -124.64 172.17 9.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.797 -1.19 . . . . 0.0 111.415 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 23.7 mmt -113.05 57.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.65 -0.656 . . . . 0.0 109.894 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 114' ' ' GLY . 15.4 m -56.88 -166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.822 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -136.34 162.88 31.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.715 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.562 ' HB3' ' CD2' ' A' ' 172' ' ' HIS . 41.4 t -144.1 130.81 20.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.72 173.38 9.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.431 ' HD2' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -95.59 156.23 16.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.275 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 110.58 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 5.7 ptpt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.576 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 5.1 pt -102.33 163.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.473 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 154' ' ' PHE . 64.7 t80 -125.73 137.22 53.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.854 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -130.06 149.41 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -147.27 177.43 25.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.436 ' C ' HG13 ' A' ' 179' ' ' VAL . . . 75.83 11.1 84.86 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.545 ' CA ' HG13 ' A' ' 179' ' ' VAL . 1.1 pp -87.53 97.19 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.196 -1.179 . . . . 0.0 110.458 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.0 t -52.91 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.3 t -78.28 -153.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.403 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.65 -17.34 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.776 -0.577 . . . . 0.0 111.169 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.537 ' H ' ' C ' ' A' ' 118' ' ' VAL . 40.7 m -91.41 143.62 26.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.735 -1.228 . . . . 0.0 110.695 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 11.8 t -127.98 151.16 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.682 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 140' ' ' LEU . 2.4 t -41.75 -51.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.158 -0.964 . . . . 0.0 110.178 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.526 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 mt-10 -42.79 -26.01 0.11 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.584 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 66.0 m-20 -76.37 -57.37 3.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 110.094 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 140' ' ' LEU . 1.3 t -67.34 -47.53 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HA ' ' CB ' ' A' ' 138' ' ' ALA . 6.0 ttpp -48.4 -58.23 4.92 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.818 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.584 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -66.83 -32.49 73.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 109.697 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -59.21 -55.96 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.496 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 66.9 m-85 -83.66 -15.94 46.96 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.06 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 46.0 tt0 -56.41 -37.76 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.423 -1.423 . . . . 0.0 108.163 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -74.59 -15.93 60.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 4.9 m-30 -88.16 -32.79 18.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.44 168.18 36.56 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.522 ' CE ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -46.87 -40.02 13.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -1.17 . . . . 0.0 111.118 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.1 t 44.59 92.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.863 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -25.06 21.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 141.25 39.86 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.425 0.631 . . . . 0.0 109.604 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -149.45 95.21 2.32 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.437 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 6.4 ttp -101.07 164.78 11.64 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.873 0.844 . . . . 0.0 111.823 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.597 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 72.8 mt -143.93 133.59 23.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.7 OUTLIER -108.27 99.09 8.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.855 -1.153 . . . . 0.0 110.8 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.597 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.551 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 38.2 p90 -146.68 136.56 23.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.77 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.472 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -111.25 157.34 15.02 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.645 -1.265 . . . . 0.0 110.26 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 112' ' ' PHE . 24.4 m-85 -121.83 109.41 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -1.068 . . . . 0.0 109.363 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -104.59 179.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.047 . . . . 0.0 109.342 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 155' ' ' VAL . 98.8 m -161.94 107.28 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.984 -1.486 . . . . 0.0 112.535 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -131.32 106.24 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.8 . . . . 0.0 108.915 177.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.522 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 5.0 mm-40 -39.33 -27.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 0.0 110.822 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 162' ' ' ILE . 3.4 m -55.58 85.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.129 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -62.94 -38.33 90.59 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.738 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.57 -67.38 0.23 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 110.137 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.532 HG21 ' N ' ' A' ' 163' ' ' VAL . 0.7 OUTLIER -58.17 -40.23 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.119 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.609 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 18.2 t -57.23 -34.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 160' ' ' GLU . 1.4 tt0 -55.34 -53.08 60.62 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.255 0.55 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.6 tttt -88.59 -59.51 2.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.267 -0.896 . . . . 0.0 110.829 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.82 -26.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 7.9 t -73.64 -45.67 51.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.591 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' LYS . 29.1 tt0 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.4 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.323 0.582 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 1.1 pt-20 -72.36 89.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.58 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' A' ' 177' ' ' LYS . 16.4 tt -89.27 91.75 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 3.4 m-20 65.73 -55.32 0.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.791 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.3 p30 -158.19 18.74 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.648 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 174' ' ' ILE . 2.2 tptt -131.66 169.24 16.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 110.664 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 178' ' ' MET . 0.8 OUTLIER -112.4 33.57 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.267 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.545 HG13 ' CA ' ' A' ' 116' ' ' LEU . 18.0 m -37.96 159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.514 0.673 . . . . 0.0 111.315 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' OE2' ' HE2' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -99.06 141.37 31.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.761 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 167' ' ' CYS . 38.5 m -113.33 127.8 56.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 110.759 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.449 ' HE2' ' OE2' ' A' ' 180' ' ' GLU . 1.4 mmmt -125.77 170.32 11.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -0.846 . . . . 0.0 109.678 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -108.52 169.79 8.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.076 -1.015 . . . . 0.0 110.329 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.403 -0.811 . . . . 0.0 109.838 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.507 ' CB ' ' OG1' ' A' ' 156' ' ' THR . 27.1 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.065 0.459 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.571 HG22 ' CE1' ' A' ' 157' ' ' PHE . 1.1 pp -94.61 171.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.459 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 27.9 t80 -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -147.14 160.79 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -144.17 168.76 26.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 90.01 17.15 54.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 141' ' ' MET . 7.0 mt -44.81 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.361 -1.082 . . . . 0.0 110.032 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.47 ' HB3' ' OG1' ' A' ' 120' ' ' THR . 11.3 t -45.66 171.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 120' ' ' THR . 2.7 t -70.81 149.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.526 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 65.08 -42.24 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.438 0.637 . . . . 0.0 109.996 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.578 ' H ' ' C ' ' A' ' 118' ' ' VAL . 6.1 m -38.76 120.91 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.572 . . . . 0.0 110.436 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 14.8 t -119.86 170.4 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.396 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 124' ' ' ASP . 1.9 t -38.48 -46.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.423 -0.798 . . . . 0.0 110.226 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.504 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 2.9 tt0 -40.95 -27.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.465 -0.772 . . . . 0.0 109.072 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.581 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 8.1 t70 -77.75 -59.41 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.356 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.461 ' HB ' HD13 ' A' ' 140' ' ' LEU . 1.4 t -62.74 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.798 . . . . 0.0 109.904 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 18.4 tttt -56.83 -56.72 17.91 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.581 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -64.0 -26.23 68.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.125 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 173' ' ' GLU . 19.8 t80 -79.4 -57.76 3.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.515 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 53.5 m-85 -77.38 -14.88 59.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.719 -1.238 . . . . 0.0 111.798 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -53.01 -41.68 64.91 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.152 -1.592 . . . . 0.0 108.859 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -70.49 -18.14 62.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 25.3 m-85 -83.23 -31.04 27.23 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -165.13 156.52 28.54 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -39.22 -38.85 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.983 . . . . 0.0 110.5 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 45.24 91.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.87 -25.63 23.18 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.74 137.6 43.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -147.08 93.96 2.34 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 2.8 ttm -101.01 162.86 12.59 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.954 0.883 . . . . 0.0 111.949 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 13.1 mt -142.82 132.2 23.5 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 21.5 mmm -112.76 113.54 25.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.962 -1.086 . . . . 0.0 110.823 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 13.3 m-85 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 0.0 110.093 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 7.8 p90 -146.41 142.96 28.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 109.864 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.525 ' HA3' ' CD2' ' A' ' 140' ' ' LEU . . . -109.69 154.77 16.4 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.236 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 112' ' ' PHE . 21.5 m-85 -119.64 108.72 14.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -1.04 . . . . 0.0 109.262 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 138' ' ' ALA . 1.3 t -104.76 178.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.06 . . . . 0.0 109.225 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.507 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 86.0 m -161.26 109.82 1.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.09 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -136.19 110.2 8.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -39.7 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.405 -0.809 . . . . 0.0 110.763 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.8 OUTLIER -55.29 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -68.2 -38.53 82.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 109.094 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 8.0 t70 -43.02 -57.26 2.95 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.664 -0.647 . . . . 0.0 110.032 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.571 HG21 ' N ' ' A' ' 163' ' ' VAL . 3.9 tp -64.01 -39.86 86.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.963 -1.085 . . . . 0.0 108.945 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.593 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 37.5 t -55.21 -39.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 2.7 tt0 -46.96 -59.45 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.798 -0.564 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 0.4 OUTLIER -90.96 -47.54 7.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.121 -0.987 . . . . 0.0 111.834 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 3.6 p -50.37 -23.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.861 -1.15 . . . . 0.0 110.073 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 61.7 m -83.63 -0.64 51.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.758 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.489 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.428 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -155.24 108.24 2.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.554 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.513 ' CG2' ' OD2' ' A' ' 124' ' ' ASP . 1.6 mt -109.32 96.11 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.753 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 1.9 m-20 66.56 -55.91 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.436 -0.79 . . . . 0.0 110.429 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -164.86 21.49 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.701 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 117' ' ' SER . 1.4 tptt -122.11 159.14 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.58 43.2 1.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 109.877 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.503 HG22 ' CD1' ' A' ' 174' ' ' ILE . 33.6 m -53.98 -174.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -137.3 152.7 50.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 109.819 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.9 t -130.78 143.19 50.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 110.487 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 10.7 mtmt -134.93 178.01 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.813 . . . . 0.0 109.857 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -101.23 158.64 15.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 110.511 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 26.0 pttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.116 0.484 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.02 177.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.445 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.703 ' CD1' ' CE2' ' A' ' 154' ' ' PHE . 3.8 t80 -130.13 154.42 47.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 109.498 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.485 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -142.34 151.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.352 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.09 174.33 26.93 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.412 ' C ' HG13 ' A' ' 179' ' ' VAL . . . 85.72 0.63 87.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.482 ' O ' ' HA3' ' A' ' 151' ' ' GLY . 0.6 OUTLIER -80.33 95.91 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 110.33 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 116' ' ' LEU . 68.0 m -53.41 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.632 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.4 t -81.28 -154.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.785 -1.197 . . . . 0.0 110.196 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.566 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.45 -17.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.712 -0.617 . . . . 0.0 111.081 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.3 m -91.18 172.81 8.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.806 -1.183 . . . . 0.0 110.469 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.7 t -150.89 144.16 24.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.761 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.531 HG22 ' CB ' ' A' ' 140' ' ' LEU . 1.5 t -37.57 -47.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.603 -0.686 . . . . 0.0 110.638 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 122' ' ' VAL . 1.4 tt0 -43.33 -26.05 0.17 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.216 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 24.7 m-20 -74.75 -56.23 5.01 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.404 0.621 . . . . 0.0 109.685 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 128' ' ' TYR . 2.0 t -63.05 -49.42 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.525 ' HA ' ' CB ' ' A' ' 138' ' ' ALA . 12.7 tttt -47.16 -65.71 0.52 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 110.058 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.544 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -58.93 -31.73 68.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 13.5 t80 -61.37 -68.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.453 ' CD2' HG23 ' A' ' 155' ' ' VAL . 73.1 m-85 -69.93 -15.87 63.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 110.911 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.535 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 23.0 tt0 -55.38 -37.82 68.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.75 -1.219 . . . . 0.0 108.124 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.561 ' CG ' ' CD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -73.5 -18.1 61.14 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.561 ' CD1' ' CG ' ' A' ' 131' ' ' GLN . 5.9 m-30 -89.98 -30.15 17.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.563 0.696 . . . . 0.0 109.442 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -160.45 161.93 32.98 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 15.1 ptpt -45.13 -41.05 7.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.1 t 49.92 92.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.944 0.878 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -90.36 -30.08 17.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.487 ' O ' HG11 ' A' ' 155' ' ' VAL . 14.3 m-20 -132.66 136.67 46.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 126' ' ' LYS . . . -144.94 92.32 2.26 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 5.0 ttm -91.85 165.79 13.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.883 0.849 . . . . 0.0 112.113 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.531 ' CB ' HG22 ' A' ' 122' ' ' VAL . 5.2 tp -154.73 161.28 41.59 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.584 ' HB2' ' CE1' ' A' ' 152' ' ' PHE . 7.5 mmt -143.12 158.23 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.009 -1.057 . . . . 0.0 110.576 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.506 ' CE1' HD22 ' A' ' 140' ' ' LEU . 54.7 m-85 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.387 -0.821 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 141' ' ' MET . 5.0 p90 -150.57 141.39 22.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -1.067 . . . . 0.0 109.115 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -135.07 178.01 18.89 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.771 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.703 ' CE2' ' CD1' ' A' ' 112' ' ' PHE . 88.0 m-85 -140.98 122.8 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.56 ' CB ' HD12 ' A' ' 111' ' ' ILE . 1.2 t -110.65 -172.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.439 -1.304 . . . . 0.0 109.691 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 18.6 m -158.54 102.62 1.72 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.006 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -126.12 111.55 14.79 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.281 177.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' GLU . 78.8 tt0 -41.69 -24.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 111.28 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -61.02 71.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.123 -0.986 . . . . 0.0 110.527 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.3 tt0 -51.86 -37.84 53.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.901 -1.124 . . . . 0.0 109.227 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -41.68 -59.66 1.58 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.965 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER -58.56 -47.7 87.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.59 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.578 ' N ' ' CG2' ' A' ' 162' ' ' ILE . 42.7 t -45.91 -45.19 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -42.54 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 167' ' ' CYS . 25.2 tttt -90.28 -57.93 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 111.422 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.574 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 4.1 p -42.35 -23.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 111.082 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 163' ' ' VAL . 84.6 m -87.27 -15.19 38.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 110.413 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.392 -179.916 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.574 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.347 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.6 OUTLIER 61.89 77.5 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 15.3 tt -96.46 98.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.273 -0.892 . . . . 0.0 110.002 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.2 m-20 65.33 -54.75 0.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 111.042 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -160.7 18.45 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.855 -179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.1 tptt -130.58 159.33 37.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.067 -1.02 . . . . 0.0 111.443 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.449 ' O ' ' C ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -102.22 29.69 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 108.897 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 174' ' ' ILE . 6.6 m -35.27 152.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.489 0.661 . . . . 0.0 111.34 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.502 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 5.1 tt0 -106.0 148.47 27.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -0.773 . . . . 0.0 109.682 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.502 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 87.9 m -110.65 140.45 44.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.989 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.481 ' CG ' ' OE2' ' A' ' 180' ' ' GLU . 21.2 mmmt -128.57 167.32 17.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 109.855 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -92.73 152.64 19.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.422 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 110.128 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 3.5 pttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -122.36 173.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 24.7 t80 -132.96 151.17 52.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.242 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.1 OUTLIER -141.1 146.95 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.374 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.4 158.57 26.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.38 -6.8 36.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 117' ' ' SER . 1.2 mp -68.28 96.24 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 110.037 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.01 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.4 t -89.53 -165.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.97 -1.081 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER 63.63 -11.54 0.1 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.681 -0.637 . . . . 0.0 110.509 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.557 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.4 m -90.43 -175.9 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.97 -1.081 . . . . 0.0 110.84 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 6.2 t -176.99 153.49 1.0 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.443 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -40.55 -51.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.522 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.9 -26.18 0.13 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.24 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.565 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 53.8 m-20 -77.27 -58.5 3.24 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.409 HG12 HG23 ' A' ' 155' ' ' VAL . 1.7 t -64.9 -48.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.38 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.532 ' HA ' ' CB ' ' A' ' 138' ' ' ALA . 3.2 tttt -49.03 -64.36 0.83 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.739 . . . . 0.0 110.523 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.565 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 6.1 p-80 -59.87 -32.26 70.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.112 -0.993 . . . . 0.0 110.013 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 63.6 t80 -62.93 -65.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.379 -0.826 . . . . 0.0 110.487 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 79.2 m-85 -72.77 -13.7 61.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 111.149 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.711 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 1.1 tp10 -57.55 -37.34 72.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.449 -1.407 . . . . 0.0 108.282 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.5 pt20 -76.43 -12.44 60.05 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.447 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.522 ' CA ' HD11 ' A' ' 162' ' ' ILE . 4.3 m-30 -88.26 -30.64 19.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.731 -0.606 . . . . 0.0 110.764 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -173.88 62.92 0.12 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 118.36 -1.876 . . . . 0.0 111.292 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 2.6 tptt 58.97 -68.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.458 -1.025 . . . . 0.0 111.521 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 130' ' ' GLU . 1.1 t 63.99 91.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.88 -29.27 27.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -129.95 139.38 51.1 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 126' ' ' LYS . . . -152.61 95.8 2.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 108.7 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.495 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.9 ttt -101.8 162.69 12.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.727 0.775 . . . . 0.0 111.462 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.499 ' O ' ' HG2' ' A' ' 141' ' ' MET . 53.7 tp -144.35 160.54 40.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.771 -0.581 . . . . 0.0 109.995 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -144.72 159.01 43.55 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.477 -0.764 . . . . 0.0 110.902 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.542 -0.724 . . . . 0.0 109.238 178.885 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 12.4 p90 -146.24 142.94 28.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 109.498 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.55 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -125.53 150.51 17.4 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.55 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 34.0 m-85 -112.48 113.43 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.459 -1.024 . . . . 0.0 108.41 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -110.77 -178.58 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -178.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.515 ' N ' HD12 ' A' ' 111' ' ' ILE . 27.6 m -159.09 103.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.811 -1.18 . . . . 0.0 111.26 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.617 ' CE2' ' CD1' ' A' ' 111' ' ' ILE . 2.0 p90 -126.54 106.92 9.77 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.85 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.9 mt-10 -40.25 -37.7 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 0.0 111.187 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.508 ' O ' HG21 ' A' ' 162' ' ' ILE . 58.7 m -46.54 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.535 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -64.02 -37.98 89.42 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.08 -1.013 . . . . 0.0 109.492 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 4.9 t0 -40.57 -64.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.186 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.7 OUTLIER -60.34 -44.92 96.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.97 -1.081 . . . . 0.0 108.693 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.547 ' N ' ' CG2' ' A' ' 162' ' ' ILE . 15.5 t -51.17 -41.7 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -48.25 -58.53 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 111.184 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 167' ' ' CYS . 12.0 tttt -90.47 -58.21 2.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.0 111.272 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.576 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 2.0 p -39.83 -26.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.762 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.504 ' N ' HG11 ' A' ' 166' ' ' VAL . 68.5 m -82.73 -31.96 28.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.954 -1.091 . . . . 0.0 110.15 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.137 -0.977 . . . . 0.0 110.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.576 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.252 0.549 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 5.1 tt0 -153.95 107.0 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 110.061 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.516 ' CD1' ' CG2' ' A' ' 179' ' ' VAL . 1.3 mp -113.42 102.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER 67.56 -56.24 0.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.557 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -168.97 25.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.99 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -130.74 151.81 50.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 0.0 111.14 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -90.36 46.9 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.54 -0.725 . . . . 0.0 109.607 179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.516 ' CG2' ' CD1' ' A' ' 174' ' ' ILE . 20.3 m -54.77 -160.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.74 . . . . 0.0 110.802 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -150.51 142.41 23.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.402 -0.811 . . . . 0.0 109.919 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 167' ' ' CYS . 16.8 t -112.66 156.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.176 -0.953 . . . . 0.0 110.582 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 167' ' ' CYS . 51.2 mttt -138.78 -178.77 5.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 0.0 110.177 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -102.9 161.13 14.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 110.216 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.015 0.436 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.57 HG22 ' CE1' ' A' ' 157' ' ' PHE . 1.5 pt -110.3 169.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 7.9 t80 -125.01 158.39 33.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -150.16 142.84 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.383 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -134.43 150.84 20.15 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 151' ' ' GLY . . . 103.34 2.0 47.59 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 153' ' ' GLY . 2.5 mt -63.62 98.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -1.175 . . . . 0.0 110.022 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -39.61 156.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.63 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.573 HG11 ' N ' ' A' ' 119' ' ' ASN . 2.4 t -62.75 -62.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 110.383 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.573 ' N ' HG11 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -44.58 -19.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.736 0.779 . . . . 0.0 108.914 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 142' ' ' PHE . 2.9 m -68.18 157.8 34.61 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.826 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 7.8 t -148.44 150.47 33.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.097 -1.002 . . . . 0.0 110.405 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 140' ' ' LEU . 3.2 t -35.77 -53.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.764 -0.585 . . . . 0.0 111.097 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.536 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.5 mt-10 -41.02 -26.38 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.385 -0.822 . . . . 0.0 109.45 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.546 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 43.8 t0 -73.43 -59.44 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.526 0.679 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.505 HG21 ' CG1' ' A' ' 174' ' ' ILE . 2.4 t -68.71 -52.91 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.773 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.8 ttmt -41.04 -60.98 1.07 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.711 -0.618 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.879 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.478 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -65.59 -64.31 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 111.011 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 28.2 m-85 -74.03 -16.75 61.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.657 -1.277 . . . . 0.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.499 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 4.5 tt0 -55.6 -37.98 68.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.036 -1.466 . . . . 0.0 108.173 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.3 pt20 -72.59 -18.06 61.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 162' ' ' ILE . 16.0 m-85 -84.84 -37.09 21.12 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -154.76 159.01 28.69 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -42.42 -43.25 3.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.16 . . . . 0.0 110.365 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 48.1 89.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 122.02 0.914 . . . . 0.0 110.94 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -89.18 -24.9 22.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -126.57 137.91 53.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.91 101.23 1.61 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -112.9 157.61 21.23 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.861 0.839 . . . . 0.0 112.758 -177.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.529 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 1.3 mp -138.12 142.45 40.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.885 -0.509 . . . . 0.0 110.258 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.522 ' HG3' ' CE2' ' A' ' 152' ' ' PHE . 2.2 mmt -118.5 145.78 45.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 120' ' ' THR . 28.5 m-85 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 0.0 110.178 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.522 ' CE2' ' HG3' ' A' ' 141' ' ' MET . 50.1 p90 -149.91 135.13 18.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -1.219 . . . . 0.0 109.855 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.49 ' N ' ' CD1' ' A' ' 116' ' ' LEU . . . -128.0 166.92 20.45 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.148 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 139' ' ' MET . 64.6 m-85 -122.99 109.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -1.095 . . . . 0.0 109.03 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -99.81 177.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 120.948 -1.095 . . . . 0.0 109.172 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 91.5 m -165.03 109.86 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.127 -1.429 . . . . 0.0 112.461 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.57 ' CE1' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -118.88 135.03 54.78 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.2 177.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.07 54.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.89 96.64 2.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 110.115 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.461 ' HA ' HG22 ' A' ' 163' ' ' VAL . 10.5 tt0 -49.71 -38.33 32.74 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -41.95 -47.33 4.32 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.254 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.566 HG23 ' CE2' ' A' ' 157' ' ' PHE . 20.1 mm -68.5 -42.6 83.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 11.8 t -63.28 -40.61 89.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -56.29 -47.11 79.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 110.621 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 168' ' ' GLU . 19.2 ttmt -90.25 -65.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.356 -0.84 . . . . 0.0 111.167 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 1.0 OUTLIER -41.42 -25.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 110.175 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 41.2 t -76.51 -36.15 57.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.374 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 87.3 mt-10 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.64 -0.663 . . . . 0.0 110.105 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.507 ' NE2' ' HA ' ' A' ' 166' ' ' VAL . 34.3 m-70 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.229 0.538 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 46.47 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.556 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 1.0 OUTLIER -93.44 100.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.602 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 124' ' ' ASP . 2.6 m-20 65.58 -55.85 0.34 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.358 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.3 OUTLIER -168.66 28.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.414 -0.804 . . . . 0.0 109.537 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.5 tptt -132.51 158.02 43.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.483 -0.761 . . . . 0.0 110.769 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.78 55.17 0.86 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.859 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 174' ' ' ILE . 33.4 m -59.32 130.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.4 OUTLIER -70.65 148.01 48.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.328 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 166' ' ' VAL . 3.0 t -125.08 140.8 52.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.04 -174.34 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -109.82 150.28 28.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.106 179.83 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.522 ' CB ' ' OG1' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.58 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 3.3 pt -110.81 167.93 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 111.138 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -119.29 155.01 32.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.278 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -148.39 146.97 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 110.556 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.41 -170.33 12.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.472 ' O ' HG11 ' A' ' 179' ' ' VAL . . . 65.45 23.31 70.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' SER . 1.1 mt -84.15 93.91 8.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -1.109 . . . . 0.0 110.343 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 99.2 p -52.66 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.787 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.582 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.5 t -85.22 -165.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER 63.11 -10.28 0.1 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.626 -0.671 . . . . 0.0 110.358 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -88.7 -177.27 5.51 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.117 -0.99 . . . . 0.0 110.781 -178.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 12.1 t -178.8 153.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.878 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -38.42 -50.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.738 . . . . 0.0 110.735 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.477 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.67 -26.17 0.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.197 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.585 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.7 m-20 -76.58 -57.72 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 0.0 110.062 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.446 HG11 ' N ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -64.12 -47.83 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.549 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -51.13 -62.62 1.51 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 110.653 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.585 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -57.62 -26.53 61.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -78.48 -64.19 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 0.0 111.891 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 52.1 m-85 -70.91 -13.42 62.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.927 -1.108 . . . . 0.0 112.283 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.658 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -53.99 -41.39 67.86 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 119.893 -1.755 . . . . 0.0 109.115 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.9 pt20 -73.66 -14.86 61.23 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 16.2 m-85 -82.36 -31.11 29.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.725 -0.609 . . . . 0.0 110.051 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 157' ' ' PHE . . . -174.44 60.24 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.055 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 4.3 tptt 59.71 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.31 -1.112 . . . . 0.0 110.831 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.658 ' HB ' ' HA ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER 63.58 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 111.315 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -89.64 -23.15 21.98 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -133.29 137.67 46.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.502 0.668 . . . . 0.0 109.449 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -153.76 96.02 1.95 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.546 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 4.3 ttm -101.49 165.98 10.96 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.0 111.972 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 2.6 tp -143.57 151.08 39.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.636 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 3.0 mmt -128.11 130.87 48.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.772 -1.205 . . . . 0.0 111.253 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 10.4 m-85 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.515 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 25.0 p90 -145.62 136.0 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.924 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -120.82 158.12 15.76 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.68 107.38 12.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -1.017 . . . . 0.0 109.246 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -102.7 179.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.947 -1.096 . . . . 0.0 109.08 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 62.9 m -163.35 106.62 1.01 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.184 -1.406 . . . . 0.0 111.915 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.618 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.5 OUTLIER -125.09 105.64 9.32 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.494 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -39.76 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.576 -0.703 . . . . 0.0 110.623 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.4 OUTLIER -57.73 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.326 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -57.28 -39.08 74.97 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.651 -1.281 . . . . 0.0 109.559 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 160' ' ' GLU . 3.7 m-20 -40.65 -64.88 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 159' ' ' SER . 4.1 tp -57.25 -41.87 78.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.908 -1.12 . . . . 0.0 109.038 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.618 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 26.3 t -53.77 -37.56 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.7 OUTLIER -52.26 -56.72 12.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.809 -0.557 . . . . 0.0 110.975 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.9 tttp -85.87 -59.53 2.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.215 -0.928 . . . . 0.0 110.663 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 3.9 p -40.94 -26.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.488 -0.758 . . . . 0.0 109.834 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 11.1 t -75.29 -38.34 60.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.872 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.7 tt0 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.537 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 1.2 m80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.298 0.571 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 4.0 mt-10 -65.84 100.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.542 HG23 ' CB ' ' A' ' 177' ' ' LYS . 1.8 tp -78.1 -178.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.828 -1.17 . . . . 0.0 109.386 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.508 ' N ' HG21 ' A' ' 174' ' ' ILE . 16.3 m-80 -34.56 -30.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.551 -0.718 . . . . 0.0 111.649 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.2 p30 -164.93 30.02 0.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.542 ' CB ' HG23 ' A' ' 174' ' ' ILE . 1.3 tptp -145.99 -166.25 2.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 110.967 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.451 ' O ' ' C ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -131.22 38.9 3.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 174' ' ' ILE . 27.6 m -35.6 153.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.461 0.648 . . . . 0.0 111.257 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -98.03 156.06 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 6.8 p -134.56 153.78 51.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 4.2 mtpt -152.97 168.43 25.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.345 -0.847 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.15 154.63 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.373 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.187 0.518 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.604 HG12 ' CE2' ' A' ' 157' ' ' PHE . 1.1 pt -125.87 176.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 3.9 t80 -127.11 160.63 30.59 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.532 -0.73 . . . . 0.0 109.2 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -144.73 140.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.44 ' HA2' HD22 ' A' ' 116' ' ' LEU . . . -136.86 157.89 23.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 94.78 -23.06 34.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.44 HD22 ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -49.45 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.477 ' HB3' ' NZ ' ' A' ' 177' ' ' LYS . 11.7 p -54.52 163.3 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 110.697 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 120' ' ' THR . 18.9 m -62.81 -153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -0.865 . . . . 0.0 110.441 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.18 -41.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.649 0.738 . . . . 0.0 110.382 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 118' ' ' VAL . 30.8 m -70.92 156.52 39.5 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.087 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.62 148.1 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' CD1' ' A' ' 140' ' ' LEU . 2.2 t -40.12 -51.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.424 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -42.94 -25.89 0.12 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.432 -0.793 . . . . 0.0 109.087 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 121' ' ' THR . 32.9 m-20 -72.28 -56.71 5.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.432 0.634 . . . . 0.0 109.503 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.477 ' CG2' ' CD1' ' A' ' 174' ' ' ILE . 2.4 t -65.66 -53.45 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.564 0.697 . . . . 0.0 109.144 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -41.23 -63.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.725 -0.609 . . . . 0.0 109.901 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.516 ' ND1' ' C ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -60.07 -30.12 69.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.955 . . . . 0.0 109.07 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -60.9 -69.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.622 -0.674 . . . . 0.0 110.315 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.524 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 74.3 m-85 -70.4 -15.26 62.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -0.967 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 8.8 tt0 -57.17 -37.35 71.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.191 -1.568 . . . . 0.0 107.825 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.2 pt20 -72.51 -16.66 61.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 3.6 m-30 -83.42 -28.78 28.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.752 -0.593 . . . . 0.0 109.446 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.73 -139.42 2.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.448 ' HD2' ' HG3' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -94.14 -33.83 13.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -1.05 . . . . 0.0 109.658 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 39.08 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.109 0.957 . . . . 0.0 111.456 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -92.66 -25.3 18.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.36 140.04 49.62 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -157.17 100.16 1.84 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.523 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 1.6 ptp -116.66 165.99 12.64 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.876 0.846 . . . . 0.0 112.216 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 122' ' ' VAL . 89.3 mt -142.92 146.48 34.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.85 -0.531 . . . . 0.0 109.579 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -120.64 110.12 16.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.0 -1.063 . . . . 0.0 110.337 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.837 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 17.7 p90 -144.85 138.83 27.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -1.103 . . . . 0.0 109.726 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -127.99 168.93 19.78 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.395 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.481 ' O ' ' HG3' ' A' ' 139' ' ' MET . 76.0 m-85 -126.82 115.94 20.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -1.134 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -108.79 -177.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.082 -1.011 . . . . 0.0 109.044 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.482 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 16.3 m -163.75 104.73 0.93 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.676 ' CE1' ' CG2' ' A' ' 162' ' ' ILE . 1.9 p90 -129.92 116.65 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.97 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.2 mm-40 -44.34 -32.58 1.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.387 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.53 ' HB3' ' CG1' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -51.77 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 110.544 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -56.57 -40.0 74.45 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.176 -0.952 . . . . 0.0 109.042 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -44.78 -38.05 4.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.676 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 41.3 mm -69.61 -49.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 20.0 t -58.25 -36.82 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.8 mm-40 -56.89 -44.39 82.25 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.627 -0.67 . . . . 0.0 110.715 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 161' ' ' ASP . 3.1 mttt -90.14 -64.96 1.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 181' ' ' CYS . 6.3 m -42.9 -24.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.856 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 8.4 t -71.73 -38.15 70.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.725 -1.235 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 165' ' ' LYS . 8.0 mt-10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 110.49 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.472 ' CE1' ' HA ' ' A' ' 166' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.347 0.594 . . . . 0.0 109.865 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 177' ' ' LYS . 3.6 tt0 -80.89 141.73 34.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 110.589 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.562 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 4.7 tt -114.58 115.43 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.186 -0.947 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 2.5 t-20 68.07 -55.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.631 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.561 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -174.22 24.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.863 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.549 ' HD2' ' CG1' ' A' ' 179' ' ' VAL . 0.1 OUTLIER -139.49 129.14 24.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.785 -1.197 . . . . 0.0 110.179 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.5 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -68.3 119.63 13.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.817 -1.177 . . . . 0.0 110.596 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.549 ' CG1' ' HD2' ' A' ' 177' ' ' LYS . 4.4 m -120.08 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.419 ' N ' ' CG2' ' A' ' 179' ' ' VAL . 57.1 tt0 -138.83 143.6 38.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 86.8 m -129.2 138.14 51.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.306 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 167' ' ' CYS . 7.9 mttt -133.91 175.67 9.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.29 -0.882 . . . . 0.0 109.816 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.511 ' CD ' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -75.25 163.74 27.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.264 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.524 ' HB1' ' CA ' ' A' ' 111' ' ' ILE . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.293 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.25 0.548 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.622 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -105.2 165.84 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -124.51 136.69 54.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -131.34 142.65 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 110.075 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -146.87 168.46 28.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.44 ' C ' HG13 ' A' ' 179' ' ' VAL . . . 94.3 -29.4 8.93 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -53.67 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 116' ' ' LEU . 4.3 p -52.47 -173.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.3 t -75.12 -149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 109.467 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER 64.06 -14.84 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.642 . . . . 0.0 111.398 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER -89.87 -167.13 1.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.684 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 122' ' ' VAL . 14.4 t -173.21 139.44 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.54 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -35.07 -49.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.633 -0.667 . . . . 0.0 111.303 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 122' ' ' VAL . 10.2 mt-10 -43.35 -25.88 0.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.487 ' CG ' ' ND2' ' A' ' 175' ' ' ASN . 66.2 m-20 -73.42 -47.64 40.11 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.421 0.629 . . . . 0.0 110.209 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.507 ' CG2' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -73.86 -44.56 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.663 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.2 ttpp -50.02 -65.2 0.6 Allowed 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.454 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -64.42 -32.32 73.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.025 -1.047 . . . . 0.0 110.681 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 4.5 t80 -66.1 -54.06 30.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 111.212 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 46.2 m-85 -83.98 -16.53 43.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.164 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 40.2 tt0 -57.42 -36.89 71.93 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.053 -1.654 . . . . 0.0 107.73 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 13.2 pt20 -74.6 -15.93 60.82 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CG ' HD12 ' A' ' 162' ' ' ILE . 3.1 m-30 -83.36 -28.24 29.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -164.07 -143.45 3.71 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CG ' ' N ' ' A' ' 135' ' ' VAL . 2.0 ptmt -88.45 -42.19 12.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.325 -1.103 . . . . 0.0 109.7 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 46.24 90.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.455 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -92.42 -25.63 18.39 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.63 145.73 50.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.057 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.515 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -158.35 101.66 1.72 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.54 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -112.58 163.81 14.06 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.937 0.875 . . . . 0.0 112.216 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.525 HD22 ' CZ ' ' A' ' 142' ' ' PHE . 4.8 tp -138.03 154.79 49.27 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.644 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 66.0 mmm -131.19 135.8 47.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.767 -1.208 . . . . 0.0 110.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CE1' ' HA ' ' A' ' 118' ' ' VAL . 9.4 m-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.696 . . . . 0.0 109.973 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.443 ' O ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 14.9 p90 -150.13 139.37 21.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.109 -1.23 . . . . 0.0 110.158 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -129.58 167.2 21.54 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.965 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.505 ' O ' ' HG3' ' A' ' 139' ' ' MET . 63.0 m-85 -123.5 117.8 25.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 108.879 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -109.2 -178.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 109.036 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 72.3 m -162.87 105.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.874 -1.53 . . . . 0.0 112.433 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -126.6 102.34 7.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.441 -0.787 . . . . 0.0 108.993 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -39.18 -29.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.503 -0.748 . . . . 0.0 110.962 -178.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.1 OUTLIER -56.23 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 110.235 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.517 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -58.09 -38.32 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.078 -1.014 . . . . 0.0 109.701 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.7 m-20 -39.24 -64.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.771 -0.581 . . . . 0.0 110.259 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.583 HD12 ' CG ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -61.84 -38.0 79.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.091 -1.006 . . . . 0.0 109.122 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 16.7 t -58.41 -33.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -58.77 -47.15 85.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.426 0.631 . . . . 0.0 110.079 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 167' ' ' CYS . 10.4 tttt -87.4 -63.82 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 110.499 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 1.4 p -42.31 -24.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.876 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 9.3 t -73.36 -47.02 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.075 -1.016 . . . . 0.0 109.458 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.55 -0.719 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 1.1 t60 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -100.72 88.76 3.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 110.266 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.485 HG12 ' CG2' ' A' ' 179' ' ' VAL . 1.3 mp -81.34 91.96 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.387 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER 68.56 -56.99 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.419 -0.801 . . . . 0.0 110.1 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -161.55 19.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.807 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HB3' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.68 148.39 46.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.118 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.446 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -92.02 41.56 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.485 ' CG2' HG12 ' A' ' 174' ' ' ILE . 10.3 m -70.47 -165.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 2.3 tm-20 -125.54 152.46 45.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.792 . . . . 0.0 110.103 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.51 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 37.9 t -141.41 103.02 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.421 ' HG3' ' OE2' ' A' ' 180' ' ' GLU . 6.1 mtmm -99.21 -175.56 3.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 109.886 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -100.32 -175.99 3.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.784 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 110.598 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.7 pt -99.7 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 110.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -118.57 153.74 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 109.675 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -146.94 152.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -145.93 162.91 28.35 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.43 ' O ' ' HE2' ' A' ' 177' ' ' LYS . . . 100.29 9.52 47.53 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.521 ' N ' HD21 ' A' ' 116' ' ' LEU . 2.7 mm? -57.67 97.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -1.09 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.3 168.21 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.105 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 120' ' ' THR . 19.5 m -63.19 169.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.272 -0.892 . . . . 0.0 110.988 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 61.95 -39.13 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.976 -0.452 . . . . 0.0 111.018 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 118' ' ' VAL . 91.8 m -42.3 153.74 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.483 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.546 ' HA ' ' CZ ' ' A' ' 142' ' ' PHE . 15.2 t -149.66 146.77 27.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -32.39 -47.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.81 -0.556 . . . . 0.0 111.396 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -41.94 -27.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.095 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.515 ' OD2' ' N ' ' A' ' 175' ' ' ASN . 15.6 t0 -72.24 -58.44 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.555 0.693 . . . . 0.0 109.966 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 140' ' ' LEU . 2.1 t -67.07 -52.9 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.7 tttt -42.44 -59.82 1.73 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.649 -0.657 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.517 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -62.44 -27.74 69.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.441 -0.787 . . . . 0.0 110.196 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 18.7 t80 -76.29 -53.77 7.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 112.479 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 14.6 m-85 -82.32 -17.41 45.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.0 112.638 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -52.7 -41.76 64.19 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 119.969 -1.707 . . . . 0.0 109.263 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 17.6 pt20 -73.72 -15.78 61.21 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.502 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.519 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 15.8 m-85 -84.27 -33.97 23.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -159.35 162.29 32.71 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -44.6 -34.01 2.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 38.05 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.967 0.889 . . . . 0.0 111.342 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -25.06 18.0 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -130.9 142.01 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.538 ' O ' ' CG1' ' A' ' 122' ' ' VAL . . . -157.4 102.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.406 ' HA ' HG12 ' A' ' 122' ' ' VAL . 3.2 tpp -110.39 160.21 16.78 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.775 0.797 . . . . 0.0 111.308 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 9.4 mt -147.04 145.42 29.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.774 -0.579 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.589 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 1.6 mmm -123.25 126.77 47.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.024 -1.047 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 42.2 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.865 . . . . 0.0 110.711 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.589 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.1 p90 -150.03 146.19 26.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -1.202 . . . . 0.0 109.977 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.529 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -138.16 174.62 21.84 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.174 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.96 118.26 18.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.495 -1.003 . . . . 0.0 109.246 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 138' ' ' ALA . 1.5 t -109.21 -174.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 96.3 m -163.98 106.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.002 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.4 OUTLIER -132.12 109.96 10.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.199 -0.938 . . . . 0.0 109.722 177.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.19 -32.06 1.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.431 -0.793 . . . . 0.0 111.507 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.4 OUTLIER -56.04 82.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.535 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -56.7 -38.61 72.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 110.086 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.4 OUTLIER -39.06 -69.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.815 -0.553 . . . . 0.0 110.426 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.519 HG21 ' N ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -57.57 -42.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.927 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 14.7 t -51.76 -38.95 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 3.1 tt0 -48.4 -55.95 9.46 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.359 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.3 tttm -90.52 -59.6 2.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.257 -0.902 . . . . 0.0 111.316 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.505 HG22 ' NE2' ' A' ' 172' ' ' HIS . 4.0 p -41.24 -25.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.247 -0.908 . . . . 0.0 110.859 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 183' ' ' LYS . 71.2 m -90.21 -20.34 23.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.882 -1.137 . . . . 0.0 110.071 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 165' ' ' LYS . 19.6 mm-40 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 110.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.505 ' NE2' HG22 ' A' ' 166' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.371 0.605 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 57.21 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 110.894 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 0.9 OUTLIER -113.83 116.15 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.632 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 1.4 t-20 69.41 -56.49 0.55 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 174' ' ' ILE . 6.3 p30 -177.14 29.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.633 -0.667 . . . . 0.0 109.813 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.533 ' HD3' ' O ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -143.72 123.89 13.71 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.059 -1.025 . . . . 0.0 110.432 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.533 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.6 OUTLIER -54.02 116.31 2.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.504 ' CG2' ' HB ' ' A' ' 174' ' ' ILE . 16.0 m -119.09 -161.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 0.0 110.6 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 10.3 tt0 -130.1 146.45 51.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 167' ' ' CYS . 71.3 m -117.42 152.32 35.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.52 -0.737 . . . . 0.0 109.917 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.539 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -110.03 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' CB ' ' OG1' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.223 0.535 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.8 pt -101.46 169.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.519 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.9 t80 -118.11 156.49 28.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.409 -0.807 . . . . 0.0 109.184 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 1.2 m -148.32 163.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.064 -1.022 . . . . 0.0 110.85 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.39 171.05 32.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 97.93 -22.39 41.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -41.43 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -1.06 . . . . 0.0 109.981 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' GLY . 38.7 m -96.19 -162.58 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.816 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' THR . 12.7 m -52.25 162.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 111.188 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 61.93 -38.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.872 -0.517 . . . . 0.0 110.984 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 118' ' ' VAL . 55.6 m -61.76 123.92 19.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 0.0 110.507 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.0 t -136.53 166.14 24.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 0.0 109.688 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -41.36 -55.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -0.989 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.31 -24.67 0.1 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.406 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.57 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 62.4 t0 -75.24 -59.28 2.81 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.682 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.502 ' CG2' HD13 ' A' ' 174' ' ' ILE . 1.8 t -64.3 -49.0 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.287 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 53.4 tttm -47.72 -63.47 1.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.522 -0.736 . . . . 0.0 110.057 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -61.14 -31.95 71.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -0.985 . . . . 0.0 109.861 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 21.4 t80 -61.97 -60.6 3.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.469 -0.769 . . . . 0.0 110.883 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 82.9 m-85 -79.7 -18.8 50.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.042 -1.036 . . . . 0.0 111.518 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 1.1 tp10 -54.45 -36.03 63.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.366 -1.459 . . . . 0.0 108.699 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -74.77 -20.62 59.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.527 ' O ' ' CD1' ' A' ' 162' ' ' ILE . 7.5 m-85 -82.24 -28.9 31.61 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.823 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -163.06 -157.72 9.3 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.893 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -72.24 -50.12 29.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.586 -0.95 . . . . 0.0 110.129 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.5 t 51.19 87.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.121 0.962 . . . . 0.0 110.353 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -87.79 -28.64 21.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 79.8 m-20 -134.49 137.99 44.35 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.127 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.508 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -147.18 93.93 2.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.478 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 9.1 ttm -105.62 167.05 10.02 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.833 0.825 . . . . 0.0 111.875 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.513 ' HA ' ' CA ' ' A' ' 153' ' ' GLY . 31.0 mt -146.03 132.51 19.71 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.527 ' O ' ' CD1' ' A' ' 116' ' ' LEU . 9.7 mmt -107.79 133.73 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.88 -1.137 . . . . 0.0 110.792 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 17.4 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.534 -0.728 . . . . 0.0 109.642 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.56 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 24.0 p90 -144.9 135.01 23.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -1.17 . . . . 0.0 110.022 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -114.62 164.87 12.04 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.332 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -127.78 113.12 15.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -1.106 . . . . 0.0 109.648 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -109.0 -178.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.909 . . . . 0.0 108.938 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 79.8 m -164.07 106.32 0.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.169 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.4 OUTLIER -126.32 113.06 16.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 109.511 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 4.0 tt0 -39.74 -26.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.435 -0.79 . . . . 0.0 111.123 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 162' ' ' ILE . 80.9 p -63.5 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 110.587 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -52.13 -38.9 58.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.864 -1.148 . . . . 0.0 109.17 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 160' ' ' GLU . 38.1 t70 -43.07 -53.54 4.83 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.778 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -60.66 -49.22 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.441 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.612 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 47.0 t -44.72 -46.78 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -52.21 12.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 167' ' ' CYS . 11.3 ttpt -90.02 -62.37 1.48 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.131 -0.98 . . . . 0.0 111.065 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 163' ' ' VAL . 8.5 p -40.01 -25.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.71 . . . . 0.0 110.637 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 23.3 m -76.3 -40.44 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.024 -1.047 . . . . 0.0 109.676 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 165' ' ' LYS . 1.2 mt-10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.511 ' NE2' HG21 ' A' ' 166' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 68.59 101.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.092 -1.005 . . . . 0.0 110.914 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 3.4 tt -122.25 118.74 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 29.1 m-20 64.19 -53.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.66 -0.65 . . . . 0.0 110.644 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.496 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.2 OUTLIER -175.48 27.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.001 -1.062 . . . . 0.0 110.699 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.556 ' HD3' ' C ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -143.49 137.06 28.26 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.065 -1.022 . . . . 0.0 109.488 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.498 ' O ' ' CE ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -77.87 88.05 4.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.326 -1.483 . . . . 0.0 110.097 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.452 HG11 ' HD2' ' A' ' 177' ' ' LYS . 28.7 m -76.46 -178.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 110.379 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -128.78 140.65 51.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.752 . . . . 0.0 109.549 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 167' ' ' CYS . 1.5 t -122.68 142.65 50.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 110.811 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.42 ' C ' ' SG ' ' A' ' 167' ' ' CYS . 7.5 mttp -138.64 178.91 6.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -111.65 142.37 44.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.069 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.268 -179.668 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 1.7 ptmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.972 0.415 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.652 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pp -123.26 178.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.795 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 56.6 t80 -125.03 162.31 24.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.593 -0.692 . . . . 0.0 109.15 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -146.84 135.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -130.17 162.28 23.11 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 92.92 -26.04 16.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.493 HD23 ' CA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -44.1 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -1.092 . . . . 0.0 109.607 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -43.19 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.734 0.778 . . . . 0.0 111.018 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 119' ' ' ASN . 0.9 OUTLIER -74.44 -64.14 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.409 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.581 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -43.44 -21.98 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 118' ' ' VAL . 23.6 m -72.71 142.21 48.2 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.778 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.0 158.98 36.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 110.563 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 140' ' ' LEU . 2.7 t -37.56 -52.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -40.65 -27.06 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 179.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 122' ' ' VAL . 1.7 m-20 -72.79 -57.67 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.469 0.652 . . . . 0.0 109.567 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' A' ' 129' ' ' PHE . 2.1 t -65.87 -50.1 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.615 0.721 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 23.9 tttt -46.58 -61.77 1.67 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -59.52 -33.14 71.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -66.44 -64.89 0.76 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 110.832 -179.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 125' ' ' VAL . 78.3 m-85 -70.68 -18.54 62.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.9 -1.125 . . . . 0.0 111.541 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 38.4 tt0 -55.96 -36.7 68.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.912 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 6.5 pt20 -73.47 -18.15 61.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.498 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 16.9 m-85 -86.55 -32.85 20.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -160.74 165.61 35.18 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.432 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -41.71 -55.13 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 110.336 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.4 t 58.79 89.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.01 0.91 . . . . 0.0 110.747 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.432 ' OD2' ' HE2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -92.84 -26.23 17.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -129.43 138.67 51.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -155.91 99.97 2.02 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -111.18 158.97 18.31 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.097 0.951 . . . . 0.0 112.854 -177.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.528 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 1.8 mp -137.82 148.55 45.57 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.559 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 1.4 mmt -125.28 147.54 49.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.729 -1.232 . . . . 0.0 110.927 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 141' ' ' MET . 16.1 m-85 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.647 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 152' ' ' PHE . 5.9 p90 -147.88 136.67 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -1.134 . . . . 0.0 109.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 139' ' ' MET . . . -128.91 172.54 19.57 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.367 -1.396 . . . . 0.0 110.463 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.541 ' O ' ' HG2' ' A' ' 139' ' ' MET . 71.0 m-85 -128.74 108.18 10.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.546 -0.973 . . . . 0.0 108.594 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -93.94 -178.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.456 -1.403 . . . . 0.0 109.648 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 36.4 m -163.66 105.92 0.96 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.224 -1.39 . . . . 0.0 112.216 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -130.4 120.62 24.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -0.812 . . . . 0.0 109.505 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -49.29 -20.35 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.655 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.511 ' O ' HG23 ' A' ' 162' ' ' ILE . 1.6 m -66.03 60.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.122 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -47.27 -38.7 12.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 179.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 162' ' ' ILE . 1.6 p30 -44.01 -49.58 8.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.378 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 1.4 tp -62.88 -49.79 82.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.636 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 44.3 t -46.81 -46.43 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -44.9 -55.19 5.67 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.242 0.544 . . . . 0.0 111.181 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 167' ' ' CYS . 21.0 tttp -87.06 -61.88 1.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.213 -0.929 . . . . 0.0 110.921 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.484 HG22 ' CE1' ' A' ' 172' ' ' HIS . 5.8 p -42.51 -24.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 40.8 t -82.98 -27.68 30.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 110.446 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' LYS . 9.0 mm-40 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.145 -0.972 . . . . 0.0 111.018 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.484 ' CE1' HG22 ' A' ' 166' ' ' VAL . 34.4 m-70 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 174.25 119.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 110.201 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 10.6 tp -98.27 78.64 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 49.0 m-80 63.84 -53.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 0.0 111.576 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -138.6 -0.67 1.93 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.987 -1.071 . . . . 0.0 111.383 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.517 ' HB3' ' CG2' ' A' ' 174' ' ' ILE . 0.9 OUTLIER -125.04 -175.53 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.913 -1.117 . . . . 0.0 111.079 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.438 ' N ' ' SD ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -121.72 79.03 1.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.627 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' A' ' 174' ' ' ILE . 5.2 m -79.09 130.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -80.17 163.0 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 167' ' ' CYS . 43.1 t -133.07 110.51 10.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.435 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 8.0 mmtm -105.29 163.42 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.525 ' HG3' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -76.32 154.95 34.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.022 . . . . 0.0 110.229 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.373 -0.829 . . . . 0.0 110.418 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.037 0.446 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pt -133.6 175.13 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 110.721 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.514 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 15.9 t80 -138.21 145.39 41.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.492 -0.755 . . . . 0.0 109.267 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.435 ' C ' HD12 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -130.13 148.43 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.51 166.07 25.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.489 ' O ' ' CE ' ' A' ' 177' ' ' LYS . . . 86.31 -13.61 57.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -54.23 97.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -1.111 . . . . 0.0 110.648 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -54.85 175.9 0.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.092 -1.005 . . . . 0.0 108.656 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' ' CB ' ' A' ' 119' ' ' ASN . 1.4 t -79.51 -155.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.658 -1.276 . . . . 0.0 110.115 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.56 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 75.44 -32.85 0.22 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' A' ' 121' ' ' THR . 1.8 m -81.47 172.14 13.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.606 0.717 . . . . 0.0 111.313 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 120' ' ' THR . 10.8 t -149.25 154.93 39.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 109.38 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 139' ' ' MET . 2.4 t -39.3 -50.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.465 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.64 -24.77 0.13 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.402 -0.812 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.576 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 25.5 t0 -74.95 -59.76 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.736 . . . . 0.0 109.696 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 140' ' ' LEU . 1.1 t -63.66 -48.92 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.541 -0.724 . . . . 0.0 109.388 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 12.5 tttp -48.47 -60.94 2.29 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.255 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.576 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -63.9 -36.29 83.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.012 -1.055 . . . . 0.0 110.255 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.509 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 35.8 t80 -58.39 -57.7 11.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.38 -0.825 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 72.5 m-85 -83.0 -16.36 47.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.025 . . . . 0.0 111.485 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 83.3 tt0 -55.89 -37.59 69.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.45 -1.406 . . . . 0.0 108.244 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.4 pt20 -74.41 -16.6 60.88 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 162' ' ' ILE . 4.3 m-30 -87.72 -32.32 19.22 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 109.127 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.9 35.75 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HD3' ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -50.81 -41.38 57.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.607 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 47.62 91.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.195 0.998 . . . . 0.0 111.074 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -25.39 17.59 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.45 144.24 51.27 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.509 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -160.41 100.97 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.204 -0.935 . . . . 0.0 108.59 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -114.92 165.4 12.9 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.813 0.816 . . . . 0.0 112.239 -178.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.466 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 34.2 mt -140.12 139.87 35.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.554 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -114.17 132.7 56.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.026 -1.046 . . . . 0.0 110.912 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 141' ' ' MET . 30.2 m-85 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 13.5 p90 -150.14 140.25 22.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -1.088 . . . . 0.0 109.387 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.435 ' HA3' HD22 ' A' ' 140' ' ' LEU . . . -123.54 165.57 16.25 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.249 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' CG ' ' A' ' 139' ' ' MET . 22.8 m-85 -120.37 112.18 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 0.0 109.162 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.509 HG11 ' HA ' ' A' ' 138' ' ' ALA . 1.6 t -108.31 -179.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.68 -1.262 . . . . 0.0 109.008 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 110' ' ' LYS . 32.3 m -161.08 105.14 1.32 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.765 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 1.1 p90 -127.28 102.47 6.93 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.222 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.27 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 111.195 -178.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.495 ' O ' HG21 ' A' ' 162' ' ' ILE . 0.8 OUTLIER -54.74 86.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.9 OUTLIER -54.91 -38.24 67.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.657 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.6 OUTLIER -39.39 -68.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.486 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.587 HD13 ' CD2' ' A' ' 132' ' ' PHE . 0.5 OUTLIER -58.61 -45.63 90.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.956 -1.09 . . . . 0.0 108.875 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 160' ' ' GLU . 9.9 t -47.29 -34.31 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -61.01 -42.81 99.18 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.617 0.722 . . . . 0.0 109.742 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.2 tptt -86.25 -62.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.56 -0.713 . . . . 0.0 110.81 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' A' ' 181' ' ' CYS . 4.9 m -46.63 -24.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 108.908 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 1.7 t -65.89 -31.27 72.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.039 -1.038 . . . . 0.0 108.457 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.193 0.52 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.525 ' CD2' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.224 0.535 . . . . 0.0 110.456 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.2 tt0 66.42 105.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.372 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.535 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 0.5 OUTLIER -112.43 118.03 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.271 179.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.486 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.4 m-20 67.45 -55.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.9 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -170.37 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 111.278 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.581 ' C ' ' CD ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -140.96 125.9 18.2 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.564 -1.335 . . . . 0.0 110.649 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.486 ' HG2' ' O ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -60.72 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.121 -0.987 . . . . 0.0 110.631 179.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.534 ' CG1' ' HD2' ' A' ' 177' ' ' LYS . 21.1 m -72.23 170.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 0.0 110.63 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.23 140.5 45.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 81.3 m -114.79 151.94 32.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -159.84 147.11 16.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 110.255 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.543 ' HG3' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -58.31 166.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.385 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.491 ' HB1' ' CA ' ' A' ' 111' ' ' ILE . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.991 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.572 ' HB ' ' HA ' ' A' ' 183' ' ' LYS . 1.3 pp -92.79 163.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.679 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.0 t80 -116.8 152.58 34.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.08 -1.013 . . . . 0.0 109.429 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' ' 182' ' ' LYS . 2.3 m -143.38 155.63 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -140.03 -179.03 17.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 179' ' ' VAL . . . 74.37 22.0 78.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' A' ' 140' ' ' LEU . 0.8 OUTLIER -42.43 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLY . 14.3 t -46.88 161.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 120' ' ' THR . 3.0 t -73.17 151.69 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.87 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.508 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 64.71 -44.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.459 0.647 . . . . 0.0 109.761 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 118' ' ' VAL . 2.6 m -41.16 132.26 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.993 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.498 ' N ' ' OD2' ' A' ' 124' ' ' ASP . 2.0 m -118.84 165.43 14.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 110.536 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 138' ' ' ALA . 2.3 t -39.36 -52.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 111.038 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' VAL . 7.3 mt-10 -42.52 -25.37 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.382 -0.823 . . . . 0.0 109.477 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.527 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 82.6 m-20 -74.51 -54.04 8.3 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.452 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 174' ' ' ILE . 2.0 t -65.77 -48.51 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 109.2 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 14.4 ttpt -47.65 -61.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -64.14 -32.32 73.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 109.599 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.576 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 31.8 t80 -59.6 -57.99 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.406 -0.809 . . . . 0.0 110.384 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.576 ' CE1' ' CE2' ' A' ' 128' ' ' TYR . 61.1 m-85 -82.59 -14.59 54.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.0 111.038 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.505 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 78.7 tt0 -55.0 -38.92 68.48 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.195 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.6 pt20 -73.12 -17.44 61.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 4.2 m-85 -91.66 -30.15 16.48 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -158.96 155.22 26.29 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HE3' ' HG2' ' A' ' 158' ' ' GLU . 1.9 ptpt -41.34 -40.6 1.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -1.129 . . . . 0.0 110.535 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 45.15 94.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 111.17 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.84 -25.74 19.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.17 144.47 48.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.534 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -153.83 99.03 2.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.46 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 4.9 tpp -99.66 164.61 11.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.897 0.856 . . . . 0.0 111.481 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' A' ' 116' ' ' LEU . 11.5 mt -149.78 133.56 16.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 15.9 mmm -111.26 122.03 46.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.833 -1.167 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 120' ' ' THR . 15.5 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.419 -0.801 . . . . 0.0 109.86 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 14.7 p90 -150.44 140.0 21.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -1.106 . . . . 0.0 109.596 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.517 ' N ' HD22 ' A' ' 116' ' ' LEU . . . -124.81 177.81 16.72 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.408 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.679 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 61.0 m-85 -138.37 117.41 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.929 . . . . 0.0 109.102 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.554 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 1.7 t -109.07 -174.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 155' ' ' VAL . 88.5 m -162.93 103.81 1.01 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.909 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.592 ' CE2' HG23 ' A' ' 163' ' ' VAL . 2.3 p90 -135.6 107.45 7.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.9 -22.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.434 -0.791 . . . . 0.0 111.118 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.4 OUTLIER -56.36 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.421 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -61.63 -38.03 86.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.051 -1.031 . . . . 0.0 109.827 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 160' ' ' GLU . 10.1 t70 -39.27 -67.61 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.366 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 5.6 tp -58.49 -42.68 85.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 108.79 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.592 HG23 ' CE2' ' A' ' 157' ' ' PHE . 38.2 t -50.94 -44.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.03 -46.51 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.7 tttt -90.26 -64.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -0.922 . . . . 0.0 111.202 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.527 HG11 ' N ' ' A' ' 167' ' ' CYS . 6.0 p -45.31 -21.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.722 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 43.5 t -79.86 -22.87 42.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.931 -1.106 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.502 ' NE2' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 10.6 tp10 -158.91 86.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.904 -1.123 . . . . 0.0 111.012 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.575 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 1.5 tt -102.98 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.941 -1.099 . . . . 0.0 109.854 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 4.8 m120 67.36 -56.75 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -170.93 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 110.174 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.8 tptt -128.19 163.98 23.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 111.018 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.533 ' O ' ' CG2' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -94.28 -18.63 21.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -0.785 . . . . 0.0 109.32 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.549 ' CG1' HG23 ' A' ' 174' ' ' ILE . 34.5 m 37.25 -160.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.44 140.1 21.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 26.2 p -81.39 132.47 35.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.438 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -129.5 11.02 5.75 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.235 1.017 . . . . 0.0 109.175 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.572 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 1.4 mptt -41.01 158.09 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.586 -0.696 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 -179.894 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 9.8 pttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.03 0.443 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.523 HD12 ' CE1' ' A' ' 157' ' ' PHE . 5.4 pt -103.55 169.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.968 -1.083 . . . . 0.0 111.16 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -123.69 144.73 49.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.706 -0.621 . . . . 0.0 109.647 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -140.14 138.65 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 110.33 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -127.98 165.48 20.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.502 ' O ' ' CG1' ' A' ' 179' ' ' VAL . . . 89.68 17.04 55.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.534 ' CD1' ' HG ' ' A' ' 140' ' ' LEU . 38.5 mt -39.54 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 110.278 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.2 OUTLIER -43.87 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.884 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 120' ' ' THR . 10.6 m -67.71 157.6 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.766 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.22 -38.95 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.911 -0.493 . . . . 0.0 110.779 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 118' ' ' VAL . 54.9 m -47.68 150.23 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.947 -1.095 . . . . 0.0 109.994 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 7.5 t -147.63 -167.28 2.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -60.21 -56.15 19.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 109.852 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -44.1 -24.62 0.16 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 109.604 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 121' ' ' THR . 40.7 m-20 -78.2 -58.98 2.97 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.746 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 155' ' ' VAL . 1.5 t -62.15 -47.79 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 108.943 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 138' ' ' ALA . 6.0 ttmt -46.66 -61.98 1.59 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.485 -0.76 . . . . 0.0 109.992 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.518 ' ND1' ' C ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -64.76 -34.55 78.6 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.439 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 29.7 t80 -55.6 -58.21 8.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.575 -0.703 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.469 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 94.0 m-85 -81.29 -15.81 54.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.7 tt0 -55.41 -38.12 68.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 4.2 pt20 -74.59 -15.82 60.82 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.298 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 18.5 m-85 -86.85 -30.67 21.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.445 0.64 . . . . 0.0 109.341 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -162.03 -174.59 32.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -56.15 24.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.4 t 56.07 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.208 1.004 . . . . 0.0 111.135 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -24.91 16.36 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -130.71 140.01 50.33 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -153.8 101.69 2.47 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.486 ' O ' ' HA3' ' A' ' 153' ' ' GLY . 1.3 ptm -113.16 168.79 9.43 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.92 0.867 . . . . 0.0 113.117 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.581 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 2.6 mp -139.1 139.18 37.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.851 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.575 ' SD ' ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -109.56 132.6 53.98 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.755 -1.215 . . . . 0.0 109.75 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 95.7 m-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.78 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.575 ' CE1' ' SD ' ' A' ' 141' ' ' MET . 5.4 p90 -151.02 139.5 20.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.01 -1.288 . . . . 0.0 109.999 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.544 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -104.56 158.3 16.5 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.18 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 139' ' ' MET . 89.4 m-85 -114.3 103.4 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.526 HG23 ' CG1' ' A' ' 125' ' ' VAL . 0.7 OUTLIER -97.0 -179.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.485 -178.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 73.7 m -163.95 104.52 0.9 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.782 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.583 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.9 OUTLIER -125.99 106.55 9.7 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.45 177.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.553 -0.717 . . . . 0.0 111.529 -178.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.3 OUTLIER -56.95 83.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 110.487 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -61.12 -38.43 86.32 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.774 -1.204 . . . . 0.0 109.478 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.8 m-20 -41.53 -62.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 1.1 tp -57.52 -47.14 85.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.033 -1.042 . . . . 0.0 108.564 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.583 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 43.2 t -47.67 -49.07 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.454 ' O ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -41.53 -52.28 3.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.674 -0.641 . . . . 0.0 111.386 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 167' ' ' CYS . 58.1 tttt -90.5 -61.79 1.6 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -0.999 . . . . 0.0 110.855 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 163' ' ' VAL . 7.1 p -42.36 -24.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 163' ' ' VAL . 13.9 p -81.2 -30.59 34.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.874 -1.141 . . . . 0.0 110.268 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.517 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.274 0.559 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.7 tt0 -90.09 96.74 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.148 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 2.0 tt -97.71 97.26 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 110.034 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.472 ' OD1' ' CG1' ' A' ' 174' ' ' ILE . 3.8 m120 67.78 -56.89 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 110.009 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.543 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -166.0 23.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 110.192 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -127.22 166.03 18.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 111.031 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.3 40.24 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.492 -0.755 . . . . 0.0 109.44 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 115' ' ' GLY . 19.0 m -47.76 167.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.5 -0.75 . . . . 0.0 111.332 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 1.8 tt0 -107.78 150.12 27.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.614 -0.679 . . . . 0.0 109.823 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 167' ' ' CYS . 3.1 p -131.0 90.6 2.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -89.66 143.24 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -79.99 163.87 23.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.296 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.318 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.359 0.599 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.612 HD13 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.99 174.19 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.753 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 41.0 t80 -123.53 156.76 35.04 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.947 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 1.4 m -145.0 154.38 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 179' ' ' VAL . . . -144.12 174.0 24.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 179' ' ' VAL . . . 77.85 12.84 84.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 153' ' ' GLY . 39.5 mt -53.48 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -1.171 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.504 ' HB2' ' CD ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -42.25 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.504 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 120' ' ' THR . 14.8 m -65.99 161.84 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 110.792 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.539 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 62.57 -38.6 0.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 110.67 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 118' ' ' VAL . 21.8 m -42.58 139.48 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 109.921 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 8.7 t -127.0 168.93 13.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.08 -1.013 . . . . 0.0 111.079 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 1.5 t -39.3 -47.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.679 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -44.38 -25.66 0.27 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 108.968 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.564 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 15.7 t0 -69.51 -46.31 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.699 . . . . 0.0 109.665 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -76.66 -44.17 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.807 0.813 . . . . 0.0 109.17 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 9.6 ttmt -59.38 -48.82 80.19 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.691 -0.63 . . . . 0.0 111.078 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.564 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.9 -28.63 63.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 110.123 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 67.4 t80 -79.13 -50.0 11.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 112.167 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.545 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 68.6 m-85 -88.43 -16.91 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.814 -1.179 . . . . 0.0 112.118 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.518 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 1.5 pp20? -53.73 -42.49 68.19 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.247 -1.781 . . . . 0.0 108.432 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.474 ' N ' ' CD ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -70.57 -17.04 62.92 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.802 179.527 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 7.7 m-85 -79.99 -27.77 39.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.35 -132.6 1.36 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.529 ' HD2' ' CB ' ' A' ' 158' ' ' GLU . 1.5 ptpp? -101.13 -37.48 8.55 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.516 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.4 t 42.45 89.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.11 0.957 . . . . 0.0 110.934 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.12 -27.2 23.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.72 136.92 37.8 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.377 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.502 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -143.2 91.1 2.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.501 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 6.3 ttp -96.32 162.94 13.29 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.098 0.951 . . . . 0.0 112.166 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.517 ' CD2' HG23 ' A' ' 125' ' ' VAL . 22.5 mt -139.35 129.95 25.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 35.2 mmm -103.68 111.46 23.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.011 -1.056 . . . . 0.0 110.616 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 110.034 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.7 p90 -147.46 140.4 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -1.054 . . . . 0.0 109.287 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.534 ' N ' HD12 ' A' ' 116' ' ' LEU . . . -111.05 161.55 12.77 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.375 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -123.82 109.85 14.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -1.013 . . . . 0.0 109.128 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -105.24 -178.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 109.372 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.514 ' N ' HD12 ' A' ' 111' ' ' ILE . 78.7 m -159.7 104.25 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.58 -1.325 . . . . 0.0 112.149 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CZ ' HD13 ' A' ' 111' ' ' ILE . 1.6 p90 -127.73 97.23 4.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 0.0 108.748 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLU . 1.0 OUTLIER -39.05 -31.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.755 . . . . 0.0 111.483 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -52.49 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -55.76 -38.11 69.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.091 -1.006 . . . . 0.0 109.755 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.9 OUTLIER -39.85 -64.46 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.305 -179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER -61.36 -46.28 96.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.853 -1.154 . . . . 0.0 108.815 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 160' ' ' GLU . 4.4 t -49.77 -35.3 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -50.1 -63.07 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.66 -0.65 . . . . 0.0 111.217 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 10.7 ptpt -90.43 -45.02 9.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.144 -0.973 . . . . 0.0 111.484 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 4.0 p -51.9 -22.05 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.517 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.524 ' CB ' ' HG2' ' A' ' 183' ' ' LYS . 89.5 m -89.61 -23.31 21.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.003 -1.061 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.592 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.479 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.246 0.545 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.3 pt-20 -96.78 109.89 22.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.525 HD12 ' CG2' ' A' ' 179' ' ' VAL . 4.7 pt -118.91 119.62 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.133 . . . . 0.0 109.789 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.7 OUTLIER 68.22 -56.69 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.933 . . . . 0.0 109.702 -179.133 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -179.07 31.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 109.401 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.4 tptp -139.14 136.7 35.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 111.352 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -82.29 45.44 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.837 . . . . 0.0 109.588 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.525 ' CG2' HD12 ' A' ' 174' ' ' ILE . 6.8 m -46.77 176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.676 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 38.7 tt0 -129.19 150.89 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 109.821 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -117.91 160.25 21.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.461 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -159.06 150.31 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.769 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.524 ' HG2' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -66.52 158.94 28.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.0 110.276 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 110.261 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.03 0.443 . . . . 0.0 110.126 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.655 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 6.1 pt -106.7 170.89 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.099 -1.001 . . . . 0.0 110.822 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 54.2 t80 -125.57 150.66 47.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.507 -0.746 . . . . 0.0 109.893 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -142.54 159.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.917 . . . . 0.0 110.297 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -151.15 168.66 30.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.14 48.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.524 ' HG ' ' CG ' ' A' ' 140' ' ' LEU . 2.6 mm? -63.89 93.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -1.196 . . . . 0.0 109.543 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 177' ' ' LYS . 4.9 t -64.6 -146.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 111.118 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 120' ' ' THR . 8.9 t -90.41 166.97 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 111.223 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 61.59 -40.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.285 0.564 . . . . 0.0 110.476 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 118' ' ' VAL . 24.2 m -51.22 134.51 27.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.045 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.6 t -138.57 159.18 42.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.53 HG22 ' CB ' ' A' ' 140' ' ' LEU . 2.6 t -39.74 -52.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.818 . . . . 0.0 110.556 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 122' ' ' VAL . 5.5 tt0 -39.68 -28.22 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.548 -0.72 . . . . 0.0 109.294 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 122' ' ' VAL . 28.0 m-20 -75.17 -59.79 2.58 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.004 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 129' ' ' PHE . 1.6 t -63.84 -48.86 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.25 -0.906 . . . . 0.0 108.99 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 5.2 ttpt -45.19 -70.14 0.11 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.413 -0.804 . . . . 0.0 109.495 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.515 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -55.99 -37.58 69.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.186 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.493 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 26.2 t80 -58.69 -47.4 84.63 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.59 -0.694 . . . . 0.0 111.409 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.525 ' CD2' HG12 ' A' ' 125' ' ' VAL . 69.2 m-85 -87.19 -15.11 39.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.05 -1.031 . . . . 0.0 113.425 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 126' ' ' LYS . 3.2 mt-10 -56.53 -34.58 67.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.632 -1.917 . . . . 0.0 108.618 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.555 ' HG3' ' CD1' ' A' ' 132' ' ' PHE . 20.3 pt20 -74.87 -17.39 60.59 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.411 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.555 ' CD1' ' HG3' ' A' ' 131' ' ' GLN . 28.1 m-85 -83.79 -31.82 25.71 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -163.55 169.48 38.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HD2' ' HG2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -42.39 -57.01 2.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -1.128 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.2 t 61.11 90.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.202 1.001 . . . . 0.0 111.268 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.13 -26.98 14.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.73 140.9 50.98 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.771 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -154.17 99.31 2.22 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.519 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 2.5 ptm -110.31 167.61 10.07 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.064 0.935 . . . . 0.0 112.265 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.53 ' CB ' HG22 ' A' ' 122' ' ' VAL . 5.1 tp -146.47 155.04 42.25 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 140' ' ' LEU . 75.5 mmm -142.22 144.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.523 ' CE1' HD22 ' A' ' 140' ' ' LEU . 23.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.615 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.8 p90 -149.0 146.87 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 109.641 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -123.71 152.84 17.2 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.883 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 139' ' ' MET . 30.6 m-85 -119.26 109.28 15.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.059 -1.259 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -103.92 179.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.758 -1.214 . . . . 0.0 109.042 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 61.0 m -162.74 107.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.944 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.655 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -127.62 127.21 43.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.446 ' HG2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -52.83 -17.25 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 110.952 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 162' ' ' ILE . 1.7 m -72.53 81.1 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -59.28 -39.09 81.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.76 -1.213 . . . . 0.0 109.25 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 1.5 m-20 -40.2 -58.72 1.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.766 -0.584 . . . . 0.0 110.344 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.563 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER -61.65 -47.5 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.614 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.599 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 36.1 t -47.07 -39.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 10.0 tt0 -46.13 -64.18 0.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.79 -0.569 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 3.9 pttm -90.5 -46.86 8.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.22 -0.925 . . . . 0.0 111.64 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 4.9 p -48.68 -23.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.075 . . . . 0.0 110.27 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 91.3 m -89.93 -27.32 19.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.353 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.864 . . . . 0.0 110.705 -179.565 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.449 ' N ' ' O ' ' A' ' 179' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.343 0.592 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -84.17 104.4 14.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.529 ' CD1' HG22 ' A' ' 179' ' ' VAL . 3.8 mt -103.59 100.88 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 0.0 109.655 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.0 m-20 66.25 -55.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.301 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 174' ' ' ILE . 6.6 p30 -168.01 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.49 -0.756 . . . . 0.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.564 ' CE ' ' CB ' ' A' ' 117' ' ' SER . 1.3 tptt -131.85 152.17 51.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 44.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.858 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 174' ' ' ILE . 33.5 m -48.06 170.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.354 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -122.87 146.51 47.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 167' ' ' CYS . 0.5 OUTLIER -114.75 165.51 12.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.358 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -161.05 175.82 12.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.074 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.84 144.52 25.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.093 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.315 0.578 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.567 HG22 ' CZ ' ' A' ' 157' ' ' PHE . 2.0 pt -104.92 176.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -0.806 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.479 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.9 OUTLIER -124.55 159.81 29.79 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.223 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.472 HG22 ' CA ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -149.3 161.66 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 0.0 110.483 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -150.86 152.69 24.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.3 -17.13 19.4 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -49.81 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -1.148 . . . . 0.0 110.097 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 118' ' ' VAL . 30.4 t -101.64 -167.57 1.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.747 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 120' ' ' THR . 16.4 m -42.25 168.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 111.081 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 62.69 -41.75 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.155 0.502 . . . . 0.0 110.33 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 118' ' ' VAL . 1.3 m -61.4 133.16 55.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.932 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.529 ' O ' ' HB ' ' A' ' 122' ' ' VAL . 10.2 t -149.27 60.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.091 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 3.1 t 63.97 -56.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.173 0.511 . . . . 0.0 110.425 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.563 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.4 mm-40 -44.57 -23.71 0.14 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.442 -0.786 . . . . 0.0 108.946 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.549 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-20 -70.23 -58.04 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.718 . . . . 0.0 109.686 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.575 HG12 ' CD2' ' A' ' 129' ' ' PHE . 2.0 t -68.38 -50.48 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.703 . . . . 0.0 109.326 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 15.8 tttt -49.01 -59.76 3.34 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.386 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.574 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -58.21 -29.53 65.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.477 ' O ' ' NE2' ' A' ' 131' ' ' GLN . 49.2 t80 -74.96 -62.41 1.56 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 111.827 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.575 ' CD2' HG12 ' A' ' 125' ' ' VAL . 67.8 m-85 -74.09 -15.09 61.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.902 -1.123 . . . . 0.0 112.668 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -52.41 -41.29 63.07 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 117.702 -1.599 . . . . 0.0 109.113 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.477 ' NE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -72.17 -16.97 61.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.648 -0.821 . . . . 0.0 108.874 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.522 ' HB3' HG13 ' A' ' 162' ' ' ILE . 2.8 m-85 -88.66 -25.36 22.43 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.564 0.697 . . . . 0.0 109.164 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -166.23 153.42 23.26 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.461 ' NZ ' ' HB3' ' A' ' 158' ' ' GLU . 12.3 ptpt -38.49 -41.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.599 -0.942 . . . . 0.0 110.727 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.2 t 47.52 90.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.099 0.952 . . . . 0.0 110.604 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.1 -26.06 19.31 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -127.92 140.23 52.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -157.77 98.93 1.68 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.545 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.95 169.37 9.7 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.971 0.891 . . . . 0.0 112.505 -177.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.537 ' HA ' ' CA ' ' A' ' 153' ' ' GLY . 18.0 mt -144.59 132.41 21.29 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.522 ' HE2' ' CE ' ' A' ' 139' ' ' MET . 1.9 mmt -103.16 112.27 25.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.179 -0.951 . . . . 0.0 110.784 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 140' ' ' LEU . 77.2 m-85 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 141' ' ' MET . 29.4 p90 -141.58 134.5 28.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -1.205 . . . . 0.0 110.248 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -117.0 165.15 12.35 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.489 ' O ' ' HG3' ' A' ' 139' ' ' MET . 46.6 m-85 -125.96 109.6 12.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.594 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -101.63 -177.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.973 -1.079 . . . . 0.0 108.922 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 155' ' ' VAL . 88.6 m -164.07 105.48 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.277 -1.369 . . . . 0.0 112.242 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.568 ' CE2' HG23 ' A' ' 163' ' ' VAL . 1.3 p90 -132.41 108.36 9.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.02 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 160' ' ' GLU . 5.3 tt0 -39.56 -27.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 0.0 110.847 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.52 ' O ' HG21 ' A' ' 162' ' ' ILE . 0.7 OUTLIER -53.58 88.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 110.427 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.0 tm-20 -66.35 -38.58 87.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.1 OUTLIER -40.84 -60.73 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.995 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -59.88 -48.86 86.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.772 178.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.587 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 42.1 t -46.98 -41.95 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 4.9 tt0 -51.09 -42.92 60.93 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.512 0.673 . . . . 0.0 110.259 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -88.86 -63.59 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.372 -0.83 . . . . 0.0 110.947 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 162' ' ' ILE . 12.4 m -47.25 -23.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.489 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 13.9 t -73.63 -24.41 60.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 108.983 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 165' ' ' LYS . 42.2 tp10 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.842 -0.536 . . . . 0.0 110.418 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.509 ' NE2' HG11 ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.304 0.574 . . . . 0.0 110.272 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 13.1 tt0 70.48 79.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 0.0 110.824 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.545 ' CG2' ' CB ' ' A' ' 177' ' ' LYS . 2.8 tt -78.29 -175.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.97 -1.081 . . . . 0.0 109.726 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' ILE . 48.0 m-80 -30.28 -57.36 0.19 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.8 -0.562 . . . . 0.0 111.819 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.7 OUTLIER -138.86 28.9 2.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.213 -0.929 . . . . 0.0 110.27 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.545 ' CB ' ' CG2' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -142.88 -166.63 2.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.729 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -135.39 33.61 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 114' ' ' GLY . 33.3 m -36.9 159.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.518 0.675 . . . . 0.0 111.375 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -114.57 153.72 29.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.78 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 166' ' ' VAL . 20.2 m -121.97 122.02 38.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 110.588 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -124.22 137.65 54.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -56.08 164.91 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 0.0 110.8 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.109 0.481 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.652 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pp -119.25 -179.15 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.853 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.6 t80 -131.43 159.49 37.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 109.563 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.435 HG21 ' CA ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -145.78 155.4 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.291 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 179' ' ' VAL . . . -156.63 140.62 7.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 121.62 -10.1 9.82 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.445 HD11 HD22 ' A' ' 140' ' ' LEU . 0.4 OUTLIER -50.89 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -1.12 . . . . 0.0 109.929 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' GLY . 53.7 p -65.49 -167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.782 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' THR . 23.1 m -58.84 171.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 0.0 111.225 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.3 OUTLIER 62.2 -39.87 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.914 -0.491 . . . . 0.0 110.775 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' VAL . 36.8 m -55.56 148.74 15.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.006 -1.059 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.7 t -158.28 166.88 31.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.623 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 140' ' ' LEU . 2.3 t -41.6 -53.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 110.558 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.08 -25.8 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.543 ' OD2' ' CG1' ' A' ' 174' ' ' ILE . 50.5 t0 -72.24 -49.94 31.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -69.37 -44.85 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.09 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 8.2 tttm -52.16 -63.99 0.96 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.518 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -62.85 -30.79 71.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.144 -0.972 . . . . 0.0 110.95 -179.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 84.9 t80 -70.59 -50.92 32.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.19 -0.944 . . . . 0.0 111.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.508 ' CD2' HG13 ' A' ' 125' ' ' VAL . 56.0 m-85 -89.48 -12.29 40.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 111.941 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.689 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 26.0 tt0 -56.31 -38.29 71.08 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.357 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 24.6 pt20 -74.65 -14.46 60.76 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 14.0 m-85 -86.8 -32.16 20.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.712 -0.617 . . . . 0.0 110.424 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -170.3 54.69 0.19 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.346 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER 60.15 -67.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.722 -0.869 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.689 ' HB ' ' HA ' ' A' ' 130' ' ' GLU . 0.9 OUTLIER 62.44 94.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.083 . . . . 0.0 110.903 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.41 -25.0 25.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.51 136.55 39.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.5 0.667 . . . . 0.0 109.793 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.558 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -145.18 92.51 2.26 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.505 ' SD ' ' CE ' ' A' ' 141' ' ' MET . 6.8 tpp -90.17 163.06 14.97 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.834 0.826 . . . . 0.0 111.328 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.529 ' CB ' HG21 ' A' ' 122' ' ' VAL . 5.0 tp -151.11 154.71 37.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.774 -0.579 . . . . 0.0 109.711 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.523 ' HB2' ' CD1' ' A' ' 152' ' ' PHE . 8.8 mmt -138.88 157.62 45.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.177 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.915 . . . . 0.0 110.062 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 6.6 p90 -149.7 141.84 24.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.994 . . . . 0.0 109.252 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -123.58 160.07 18.15 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.574 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -123.89 113.33 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.976 . . . . 0.0 108.748 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -104.42 178.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.879 -1.138 . . . . 0.0 109.543 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 45.8 m -160.6 104.92 1.41 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.178 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -128.83 112.31 14.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 177.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.444 ' CA ' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -39.48 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.499 -0.751 . . . . 0.0 110.585 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 162' ' ' ILE . 1.4 m -59.92 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.271 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -43.24 -61.13 1.42 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.892 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.4 OUTLIER -58.1 -46.41 88.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.39 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.629 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 44.5 t -48.96 -51.3 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 2.9 mt-10 -42.7 -43.97 4.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.612 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -90.92 -66.21 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 111.107 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.521 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 6.0 p -45.44 -20.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 0.0 110.936 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.518 ' HB2' ' N ' ' A' ' 183' ' ' LYS . 3.5 p -88.19 -29.19 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 109.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 168' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.896 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.551 ' CD2' ' SG ' ' A' ' 181' ' ' CYS . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.357 0.599 . . . . 0.0 110.446 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 178' ' ' MET . 14.3 tt0 -153.65 127.74 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.623 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 0.5 OUTLIER -116.3 102.82 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.01 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.463 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.9 OUTLIER 66.88 -58.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.188 . . . . 0.0 109.842 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.8 p30 -149.5 -31.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 110.587 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -76.72 -170.05 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.41 -0.806 . . . . 0.0 110.099 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.483 ' O ' ' CB ' ' A' ' 179' ' ' VAL . 21.8 mmt -100.63 -70.6 0.73 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 114' ' ' GLY . 2.6 t 70.48 160.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.551 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -120.75 152.77 37.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 172' ' ' HIS . 35.4 m -126.39 158.84 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 181' ' ' CYS . 15.4 mtmt -157.53 155.47 30.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.832 . . . . 0.0 109.961 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.518 ' N ' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -67.12 160.88 25.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.034 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.442 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.485 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.644 ' CD1' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -122.39 176.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.99 . . . . 0.0 110.389 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 56.4 t80 -126.08 160.22 30.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.812 . . . . 0.0 109.926 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.1 OUTLIER -147.42 149.25 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.037 -1.039 . . . . 0.0 110.667 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.22 174.2 22.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 89.59 13.19 61.64 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 140' ' ' LEU . 1.7 mp -40.81 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -1.051 . . . . 0.0 110.167 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 115' ' ' GLY . 22.7 t -64.92 178.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.731 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -72.33 150.23 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 0.0 110.454 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.537 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.25 -38.85 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.99 -0.444 . . . . 0.0 110.598 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 118' ' ' VAL . 18.0 m -41.4 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.304 -0.873 . . . . 0.0 110.015 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 124' ' ' ASP . 10.3 t -164.52 172.51 13.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 3.1 t -39.01 -54.54 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.682 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.474 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -41.98 -25.91 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 109.155 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.528 ' OD2' ' CG1' ' A' ' 174' ' ' ILE . 58.1 t0 -72.81 -55.56 6.52 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.493 0.663 . . . . 0.0 109.909 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -68.4 -54.75 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.1 tttt -39.29 -63.47 0.55 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.154 0.502 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' A' ' 124' ' ' ASP . 2.1 p-80 -61.87 -29.5 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.073 -1.017 . . . . 0.0 110.897 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -73.36 -55.29 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 0.0 111.707 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PHE . . . . . 0.534 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 38.6 m-85 -84.13 -17.53 39.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.104 . . . . 0.0 111.895 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.656 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 70.0 tt0 -57.2 -36.0 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.114 -1.616 . . . . 0.0 108.262 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLN . . . . . 0.479 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.9 pt20 -76.71 -13.56 60.03 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 4.1 m-30 -86.95 -35.11 19.07 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.806 -0.559 . . . . 0.0 111.101 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -169.45 65.01 0.18 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.273 -1.918 . . . . 0.0 111.181 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.86 -70.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.933 . . . . 0.0 111.591 178.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.656 ' HB ' ' HA ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER 64.95 92.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.09 0.948 . . . . 0.0 110.732 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.474 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -87.19 -21.61 25.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.06 137.9 41.59 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -155.9 98.17 1.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -113.61 171.79 7.36 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.145 0.974 . . . . 0.0 112.555 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.538 ' CD1' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -145.62 148.43 33.1 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.498 179.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . 0.446 ' O ' ' HA3' ' A' ' 151' ' ' GLY . 3.1 mmt -130.45 116.99 19.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.023 -1.048 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 109.997 179.61 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PHE . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 4.7 p90 -145.35 153.32 41.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -1.158 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -118.85 158.34 14.88 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.432 -1.366 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 139' ' ' MET . 11.9 m-85 -116.93 110.95 18.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -1.061 . . . . 0.0 109.352 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -107.65 179.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.638 -1.289 . . . . 0.0 109.392 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . 0.522 ' N ' HD12 ' A' ' 111' ' ' ILE . 97.2 m -163.49 104.75 0.96 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.293 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 111' ' ' ILE . 1.4 p90 -127.83 99.2 5.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.866 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -38.89 -31.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.757 -0.59 . . . . 0.0 111.381 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 162' ' ' ILE . 35.7 m -53.37 86.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.556 ' HA ' HG22 ' A' ' 163' ' ' VAL . 5.3 tt0 -54.36 -38.42 66.06 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.831 -1.168 . . . . 0.0 109.75 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.2 OUTLIER -38.42 -67.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.539 HG21 ' N ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -60.46 -38.23 77.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.325 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.568 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 7.7 t -58.2 -32.94 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.7 tm-20 -58.02 -49.59 76.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.478 -0.764 . . . . 0.0 110.604 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 168' ' ' GLU . 18.9 tttp -89.71 -60.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.577 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.51 HG21 ' NE2' ' A' ' 172' ' ' HIS . 2.5 p -42.34 -25.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.452 -0.78 . . . . 0.0 109.805 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' CYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.7 t -76.28 -34.52 59.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.894 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 165' ' ' LYS . 23.3 tt0 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 110.703 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.51 ' NE2' HG21 ' A' ' 166' ' ' VAL . 6.7 m80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.406 0.622 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 57.7 tt0 59.04 114.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.543 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -111.61 114.55 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.926 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.491 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.8 OUTLIER 68.84 -56.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.0 109.467 -178.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -174.24 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.571 -0.706 . . . . 0.0 110.312 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.534 ' HD2' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -139.92 122.31 16.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 110.138 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -54.53 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.856 -1.153 . . . . 0.0 110.504 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' VAL . . . . . 0.534 ' CG1' ' HD2' ' A' ' 177' ' ' LYS . 23.3 m -97.01 -161.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -134.88 157.12 47.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.975 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.0 t -145.01 141.37 28.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.918 . . . . 0.0 110.48 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 13.6 mtpp -138.02 -171.15 2.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 109.886 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.565 ' CD ' ' N ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -106.28 164.31 12.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.214 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.565 ' N ' ' CD ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.987 -1.071 . . . . 0.0 110.962 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.61 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.5 pt -114.77 174.84 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.123 -0.986 . . . . 0.0 110.881 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.7 t80 -121.93 157.7 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.495 -0.753 . . . . 0.0 109.422 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -149.72 153.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.009 . . . . 0.0 110.479 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.483 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -141.1 176.37 21.68 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 87.1 15.38 62.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.449 HD13 ' N ' ' A' ' 152' ' ' PHE . 15.4 mt -47.63 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 115' ' ' GLY . 2.2 t -57.52 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 110.66 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 120' ' ' THR . 15.6 m -89.06 154.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.496 -0.753 . . . . 0.0 110.867 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.515 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 62.26 -35.28 0.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.739 -0.601 . . . . 0.0 111.082 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 118' ' ' VAL . 62.2 m -43.63 128.65 5.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 110.13 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 15.3 t -117.69 158.58 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 110.248 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.541 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.4 t -37.5 -51.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.57 -0.706 . . . . 0.0 110.848 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -41.11 -26.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.556 -0.715 . . . . 0.0 109.441 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.514 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 1.6 m-20 -74.14 -55.76 5.71 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.728 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.528 ' CG2' HD23 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.6 -48.06 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.328 -0.857 . . . . 0.0 109.241 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 8.6 ttpp -47.53 -60.77 2.3 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.448 -0.783 . . . . 0.0 109.673 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.514 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -63.94 -33.51 75.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 7.1 t80 -57.77 -60.7 3.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.56 -0.712 . . . . 0.0 110.439 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 97.3 m-85 -80.43 -16.4 54.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.8 tt0 -56.64 -36.45 69.52 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.382 -1.449 . . . . 0.0 107.957 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.2 pt20 -73.75 -17.21 61.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.484 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 3.6 m-30 -86.31 -28.29 23.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.426 0.632 . . . . 0.0 109.608 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -165.83 -165.73 23.66 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -52.41 59.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.298 -1.119 . . . . 0.0 110.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.552 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 55.34 90.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.087 0.946 . . . . 0.0 110.913 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -92.83 -26.57 17.61 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -130.73 140.61 50.34 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.007 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -154.91 98.78 2.07 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.542 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 4.2 ptp -116.57 163.47 16.05 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.948 0.88 . . . . 0.0 112.461 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.528 HD23 ' CG2' ' A' ' 125' ' ' VAL . 89.2 mt -137.26 133.01 34.56 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.496 ' HA ' ' CE ' ' A' ' 141' ' ' MET . 2.6 mmt -107.19 125.05 50.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.933 -1.105 . . . . 0.0 110.577 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 27.0 m-85 -111.91 -133.22 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.472 ' HB3' ' OG1' ' A' ' 146' ' ' THR . 38.6 t0 -134.99 130.66 36.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.893 -1.13 . . . . 0.0 110.004 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.476 ' O ' ' OG1' ' A' ' 146' ' ' THR . 0.0 OUTLIER -42.48 125.81 3.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.56 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 7.8 p 44.37 31.75 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.426 -0.796 . . . . 0.0 110.516 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -150.0 53.33 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.71 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.01 53.34 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.555 -0.716 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 9.9 mtt180 -126.39 -45.87 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 110.642 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -67.65 -174.62 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -86.18 160.56 19.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.206 -0.934 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.26 -160.19 8.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.3 p90 -147.02 137.29 23.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -1.134 . . . . 0.0 109.992 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.527 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -114.71 159.56 13.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 139' ' ' MET . 30.8 m-85 -115.04 109.85 18.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -1.1 . . . . 0.0 109.372 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -104.66 -178.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.892 -1.13 . . . . 0.0 109.008 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 30.8 m -164.81 104.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.038 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' A' ' 111' ' ' ILE . 2.0 p90 -128.37 107.81 10.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 0.0 109.23 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -39.31 -26.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.793 . . . . 0.0 111.138 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 162' ' ' ILE . 2.3 m -56.48 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.777 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.6 tt0 -58.32 -38.61 77.45 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.693 -1.255 . . . . 0.0 109.463 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 6.6 t0 -40.37 -63.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 110.389 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 159' ' ' SER . 1.3 tp -57.99 -45.06 88.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.98 -1.075 . . . . 0.0 108.82 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.583 HG23 ' CE2' ' A' ' 157' ' ' PHE . 35.5 t -47.42 -39.82 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -51.17 -56.58 12.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.716 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 167' ' ' CYS . 5.9 tttp -84.8 -60.83 1.94 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.285 -0.884 . . . . 0.0 110.863 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 172' ' ' HIS . 4.3 p -41.34 -25.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.097 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.9 t -75.62 -38.3 59.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.152 -0.968 . . . . 0.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.577 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 4.4 mt-10 -77.18 -22.64 52.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.512 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 172' ' ' HIS . 12.6 mm -54.08 132.55 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 168' ' ' GLU . 89.9 m-70 -112.86 26.75 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.058 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.613 ' CE2' ' HG3' ' A' ' 178' ' ' MET . 0.2 OUTLIER -177.98 59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.291 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.568 ' CE1' HG22 ' A' ' 166' ' ' VAL . 18.6 m-70 -58.18 -159.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.921 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.473 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -141.32 99.41 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 109.988 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.59 ' CG2' ' CB ' ' A' ' 177' ' ' LYS . 0.5 OUTLIER -92.06 81.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.958 -1.089 . . . . 0.0 110.159 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.512 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 69.4 m-80 64.47 -53.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 111.287 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.427 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.1 p30 -147.75 7.45 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 111.191 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.59 ' CB ' ' CG2' ' A' ' 174' ' ' ILE . 0.3 OUTLIER -124.64 172.17 9.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.797 -1.19 . . . . 0.0 111.415 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.613 ' HG3' ' CE2' ' A' ' 171' ' ' PHE . 23.7 mmt -113.05 57.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.65 -0.656 . . . . 0.0 109.894 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 114' ' ' GLY . 15.4 m -56.88 -166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.822 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -136.34 162.88 31.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.715 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.562 ' HB3' ' CD2' ' A' ' 172' ' ' HIS . 41.4 t -144.1 130.81 20.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.72 173.38 9.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.431 ' HD2' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -95.59 156.23 16.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.275 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 110.58 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 5.7 ptpt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.576 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 5.1 pt -102.33 163.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.473 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 154' ' ' PHE . 64.7 t80 -125.73 137.22 53.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.854 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -130.06 149.41 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -147.27 177.43 25.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.436 ' C ' HG13 ' A' ' 179' ' ' VAL . . . 75.83 11.1 84.86 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' CA ' HG13 ' A' ' 179' ' ' VAL . 1.1 pp -87.53 97.19 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.196 -1.179 . . . . 0.0 110.458 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.0 t -52.91 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.575 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.3 t -78.28 -153.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.403 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.575 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.65 -17.34 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.776 -0.577 . . . . 0.0 111.169 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.537 ' H ' ' C ' ' A' ' 118' ' ' VAL . 40.7 m -91.41 143.62 26.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.735 -1.228 . . . . 0.0 110.695 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 11.8 t -127.98 151.16 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.682 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.497 ' HA ' HD13 ' A' ' 140' ' ' LEU . 2.4 t -41.75 -51.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.158 -0.964 . . . . 0.0 110.178 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.526 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 mt-10 -42.79 -26.01 0.11 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.584 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 66.0 m-20 -76.37 -57.37 3.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 110.094 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.459 ' HB ' HD13 ' A' ' 140' ' ' LEU . 1.3 t -67.34 -47.53 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.511 ' HA ' ' CB ' ' A' ' 138' ' ' ALA . 6.0 ttpp -48.4 -58.23 4.92 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.818 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.584 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -66.83 -32.49 73.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 109.697 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -59.21 -55.96 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.496 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 66.9 m-85 -83.66 -15.94 46.96 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.06 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 46.0 tt0 -56.41 -37.76 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.423 -1.423 . . . . 0.0 108.163 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -74.59 -15.93 60.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.496 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 4.9 m-30 -88.16 -32.79 18.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.44 168.18 36.56 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.522 ' CE ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -46.87 -40.02 13.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -1.17 . . . . 0.0 111.118 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.1 t 44.59 92.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.863 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -25.06 21.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 141.25 39.86 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.425 0.631 . . . . 0.0 109.604 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -149.45 95.21 2.32 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.437 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 6.4 ttp -101.07 164.78 11.64 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.873 0.844 . . . . 0.0 111.823 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.597 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 72.8 mt -143.93 133.59 23.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.7 OUTLIER -108.27 99.09 8.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.855 -1.153 . . . . 0.0 110.8 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.597 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -150.09 -167.35 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.1 OUTLIER 59.31 -162.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.007 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 143' ' ' ASP . 15.4 tttt 56.5 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 143' ' ' ASP . 15.3 t -151.12 15.61 0.73 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.043 . . . . 0.0 110.473 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 9.6 p -128.47 2.3 5.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.196 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.534 ' HB2' ' CG2' ' A' ' 118' ' ' VAL . 6.0 p30 -50.17 -42.84 51.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.528 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 147' ' ' ASN . 5.0 mtt180 -111.26 -24.79 10.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.512 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -76.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 110.113 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.8 92.99 3.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -98.95 122.73 7.66 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.551 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 38.2 p90 -146.68 136.56 23.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.77 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.472 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -111.25 157.34 15.02 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.645 -1.265 . . . . 0.0 110.26 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 112' ' ' PHE . 24.4 m-85 -121.83 109.41 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -1.068 . . . . 0.0 109.363 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -104.59 179.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.047 . . . . 0.0 109.342 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 155' ' ' VAL . 98.8 m -161.94 107.28 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.984 -1.486 . . . . 0.0 112.535 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.609 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -131.32 106.24 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.8 . . . . 0.0 108.915 177.346 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.522 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 5.0 mm-40 -39.33 -27.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 0.0 110.822 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 162' ' ' ILE . 3.4 m -55.58 85.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.129 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -62.94 -38.33 90.59 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.738 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.57 -67.38 0.23 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 110.137 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.532 HG21 ' N ' ' A' ' 163' ' ' VAL . 0.7 OUTLIER -58.17 -40.23 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.119 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.609 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 18.2 t -57.23 -34.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 160' ' ' GLU . 1.4 tt0 -55.34 -53.08 60.62 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.255 0.55 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.6 tttt -88.59 -59.51 2.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.267 -0.896 . . . . 0.0 110.829 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.82 -26.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 7.9 t -73.64 -45.67 51.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.591 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 169' ' ' ILE . 29.1 tt0 -61.16 -67.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.4 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' GLU . 93.2 mt -42.83 111.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.283 -0.886 . . . . 0.0 110.272 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.515 ' O ' ' N ' ' A' ' 172' ' ' HIS . 95.8 m-70 -83.73 -55.01 4.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.621 ' CE1' ' HG2' ' A' ' 178' ' ' MET . 10.3 t80 -61.16 76.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.14 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.515 ' N ' ' O ' ' A' ' 170' ' ' HIS . 0.1 OUTLIER -91.56 121.02 32.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 110.03 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.536 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 1.1 pt-20 -72.36 89.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.58 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' A' ' 177' ' ' LYS . 16.4 tt -89.27 91.75 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 3.4 m-20 65.73 -55.32 0.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.791 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.3 p30 -158.19 18.74 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.648 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.553 ' HB3' ' CG2' ' A' ' 174' ' ' ILE . 2.2 tptt -131.66 169.24 16.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 110.664 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.621 ' HG2' ' CE1' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -112.4 33.57 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.267 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.545 HG13 ' CA ' ' A' ' 116' ' ' LEU . 18.0 m -37.96 159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.514 0.673 . . . . 0.0 111.315 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.468 ' HA ' ' O ' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -99.06 141.37 31.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.761 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 167' ' ' CYS . 38.5 m -113.33 127.8 56.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 110.759 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.449 ' HE2' ' OE2' ' A' ' 180' ' ' GLU . 1.4 mmmt -125.77 170.32 11.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -0.846 . . . . 0.0 109.678 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.463 ' HB3' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -108.52 169.79 8.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.076 -1.015 . . . . 0.0 110.329 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.403 -0.811 . . . . 0.0 109.838 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.507 ' CB ' ' OG1' ' A' ' 156' ' ' THR . 27.1 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.065 0.459 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.571 HG22 ' CE1' ' A' ' 157' ' ' PHE . 1.1 pp -94.61 171.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.459 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.589 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 27.9 t80 -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 112' ' ' PHE . 0.3 OUTLIER -147.14 160.79 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -144.17 168.76 26.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.457 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 90.01 17.15 54.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 141' ' ' MET . 7.0 mt -44.81 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.361 -1.082 . . . . 0.0 110.032 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.47 ' HB3' ' OG1' ' A' ' 120' ' ' THR . 11.3 t -45.66 171.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.578 ' C ' ' H ' ' A' ' 120' ' ' THR . 2.7 t -70.81 149.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.526 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 65.08 -42.24 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.438 0.637 . . . . 0.0 109.996 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.578 ' H ' ' C ' ' A' ' 118' ' ' VAL . 6.1 m -38.76 120.91 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.572 . . . . 0.0 110.436 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 14.8 t -119.86 170.4 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.396 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 124' ' ' ASP . 1.9 t -38.48 -46.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.423 -0.798 . . . . 0.0 110.226 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.504 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 2.9 tt0 -40.95 -27.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.465 -0.772 . . . . 0.0 109.072 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.581 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 8.1 t70 -77.75 -59.41 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.356 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.461 ' HB ' HD13 ' A' ' 140' ' ' LEU . 1.4 t -62.74 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.798 . . . . 0.0 109.904 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 18.4 tttt -56.83 -56.72 17.91 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.581 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -64.0 -26.23 68.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.125 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 173' ' ' GLU . 19.8 t80 -79.4 -57.76 3.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.515 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 53.5 m-85 -77.38 -14.88 59.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.719 -1.238 . . . . 0.0 111.798 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.538 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -53.01 -41.68 64.91 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.152 -1.592 . . . . 0.0 108.859 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -70.49 -18.14 62.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 25.3 m-85 -83.23 -31.04 27.23 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -165.13 156.52 28.54 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -39.22 -38.85 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.983 . . . . 0.0 110.5 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.551 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 45.24 91.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.87 -25.63 23.18 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.74 137.6 43.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.507 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -147.08 93.96 2.34 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.513 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 2.8 ttm -101.01 162.86 12.59 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.954 0.883 . . . . 0.0 111.949 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.567 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 13.1 mt -142.82 132.2 23.5 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 21.5 mmm -112.76 113.54 25.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.962 -1.086 . . . . 0.0 110.823 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.567 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 13.3 m-85 -100.4 162.99 12.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 0.0 110.093 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 174.42 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -92.06 -41.24 10.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.324 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.9 m -123.97 -4.43 8.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -128.87 42.3 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.877 . . . . 0.0 109.726 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -74.63 52.03 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.554 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.476 ' HA ' ' CG2' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -106.38 -68.84 0.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.85 21.64 10.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -124.25 159.56 29.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 110.059 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.71 162.87 11.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.589 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 7.8 p90 -146.41 142.96 28.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 109.864 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.525 ' HA3' ' CD2' ' A' ' 140' ' ' LEU . . . -109.69 154.77 16.4 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.236 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 112' ' ' PHE . 21.5 m-85 -119.64 108.72 14.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -1.04 . . . . 0.0 109.262 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.507 HG11 ' HA ' ' A' ' 138' ' ' ALA . 1.3 t -104.76 178.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.06 . . . . 0.0 109.225 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.507 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 86.0 m -161.26 109.82 1.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.09 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.627 ' N ' ' CD1' ' A' ' 157' ' ' PHE . 0.5 OUTLIER -136.19 110.2 8.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -39.7 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.405 -0.809 . . . . 0.0 110.763 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.524 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.8 OUTLIER -55.29 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -68.2 -38.53 82.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 109.094 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 8.0 t70 -43.02 -57.26 2.95 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.664 -0.647 . . . . 0.0 110.032 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.571 HG21 ' N ' ' A' ' 163' ' ' VAL . 3.9 tp -64.01 -39.86 86.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.963 -1.085 . . . . 0.0 108.945 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.593 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 37.5 t -55.21 -39.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 2.7 tt0 -46.96 -59.45 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.798 -0.564 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 0.4 OUTLIER -90.96 -47.54 7.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.121 -0.987 . . . . 0.0 111.834 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 3.6 p -50.37 -23.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.861 -1.15 . . . . 0.0 110.073 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 61.7 m -83.63 -0.64 51.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.758 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 169' ' ' ILE . 0.5 OUTLIER -130.47 125.29 34.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.489 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.454 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 0.2 OUTLIER 175.08 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 66.03 20.75 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.798 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER 175.89 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.921 -1.112 . . . . 0.0 110.767 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -61.72 -145.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.527 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -155.24 108.24 2.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.554 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.513 ' CG2' ' OD2' ' A' ' 124' ' ' ASP . 1.6 mt -109.32 96.11 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.753 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 1.9 m-20 66.56 -55.91 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.436 -0.79 . . . . 0.0 110.429 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -164.86 21.49 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.701 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.467 ' HG2' ' HB2' ' A' ' 117' ' ' SER . 1.4 tptt -122.11 159.14 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -96.58 43.2 1.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 109.877 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.503 HG22 ' CD1' ' A' ' 174' ' ' ILE . 33.6 m -53.98 -174.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -137.3 152.7 50.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 109.819 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 19.9 t -130.78 143.19 50.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 110.487 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.499 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 10.7 mtmt -134.93 178.01 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.813 . . . . 0.0 109.857 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.437 ' HD2' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -101.23 158.64 15.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 110.511 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.54 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 26.0 pttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.116 0.484 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.02 177.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.445 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.703 ' CD1' ' CE2' ' A' ' 154' ' ' PHE . 3.8 t80 -130.13 154.42 47.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 109.498 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.485 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -142.34 151.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.352 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.09 174.33 26.93 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.412 ' C ' HG13 ' A' ' 179' ' ' VAL . . . 85.72 0.63 87.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.482 ' O ' ' HA3' ' A' ' 151' ' ' GLY . 0.6 OUTLIER -80.33 95.91 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 110.33 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 116' ' ' LEU . 68.0 m -53.41 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.632 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.4 t -81.28 -154.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.785 -1.197 . . . . 0.0 110.196 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.566 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.45 -17.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.712 -0.617 . . . . 0.0 111.081 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.545 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.3 m -91.18 172.81 8.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.806 -1.183 . . . . 0.0 110.469 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.473 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.7 t -150.89 144.16 24.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.761 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.531 HG22 ' CB ' ' A' ' 140' ' ' LEU . 1.5 t -37.57 -47.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.603 -0.686 . . . . 0.0 110.638 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 122' ' ' VAL . 1.4 tt0 -43.33 -26.05 0.17 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.216 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 24.7 m-20 -74.75 -56.23 5.01 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.404 0.621 . . . . 0.0 109.685 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 128' ' ' TYR . 2.0 t -63.05 -49.42 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.525 ' HA ' ' CB ' ' A' ' 138' ' ' ALA . 12.7 tttt -47.16 -65.71 0.52 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 110.058 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.544 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -58.93 -31.73 68.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 13.5 t80 -61.37 -68.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.453 ' CD2' HG23 ' A' ' 155' ' ' VAL . 73.1 m-85 -69.93 -15.87 63.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 110.911 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.535 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 23.0 tt0 -55.38 -37.82 68.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.75 -1.219 . . . . 0.0 108.124 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.561 ' CG ' ' CD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -73.5 -18.1 61.14 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.561 ' CD1' ' CG ' ' A' ' 131' ' ' GLN . 5.9 m-30 -89.98 -30.15 17.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.563 0.696 . . . . 0.0 109.442 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -160.45 161.93 32.98 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 15.1 ptpt -45.13 -41.05 7.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.539 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.1 t 49.92 92.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.944 0.878 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -90.36 -30.08 17.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.487 ' O ' HG11 ' A' ' 155' ' ' VAL . 14.3 m-20 -132.66 136.67 46.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 126' ' ' LYS . . . -144.94 92.32 2.26 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 5.0 ttm -91.85 165.79 13.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.883 0.849 . . . . 0.0 112.113 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.531 ' CB ' HG22 ' A' ' 122' ' ' VAL . 5.2 tp -154.73 161.28 41.59 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.584 ' HB2' ' CE1' ' A' ' 152' ' ' PHE . 7.5 mmt -143.12 158.23 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.009 -1.057 . . . . 0.0 110.576 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.506 ' CE1' HD22 ' A' ' 140' ' ' LEU . 54.7 m-85 -125.87 -154.37 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -0.821 . . . . 0.0 109.834 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.464 ' HB2' ' OD1' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -45.32 159.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -47.17 75.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.441 HG23 ' OG1' ' A' ' 146' ' ' THR . 47.3 m -111.52 -86.14 0.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.35 -0.844 . . . . 0.0 110.249 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.441 ' OG1' HG23 ' A' ' 145' ' ' THR . 4.7 p -146.8 24.64 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.149 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.464 ' OD1' ' HB2' ' A' ' 143' ' ' ASP . 2.7 p30 -90.28 -106.16 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -150.42 -70.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.204 . . . . 0.0 110.037 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 42.52 -157.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.815 . . . . 0.0 110.227 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -102.13 144.07 31.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.308 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -99.32 152.46 19.55 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 141' ' ' MET . 5.0 p90 -150.57 141.39 22.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -1.067 . . . . 0.0 109.115 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.489 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -135.07 178.01 18.89 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.771 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.703 ' CE2' ' CD1' ' A' ' 112' ' ' PHE . 88.0 m-85 -140.98 122.8 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.56 ' CB ' HD12 ' A' ' 111' ' ' ILE . 1.2 t -110.65 -172.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.439 -1.304 . . . . 0.0 109.691 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 18.6 m -158.54 102.62 1.72 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.006 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -126.12 111.55 14.79 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.281 177.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' GLU . 78.8 tt0 -41.69 -24.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 111.28 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -61.02 71.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.123 -0.986 . . . . 0.0 110.527 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.3 tt0 -51.86 -37.84 53.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.901 -1.124 . . . . 0.0 109.227 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.441 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -41.68 -59.66 1.58 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.965 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.578 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER -58.56 -47.7 87.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.59 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.578 ' N ' ' CG2' ' A' ' 162' ' ' ILE . 42.7 t -45.91 -45.19 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -42.54 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 167' ' ' CYS . 25.2 tttt -90.28 -57.93 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 111.422 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.574 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 4.1 p -42.35 -23.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 111.082 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.512 ' SG ' ' CG1' ' A' ' 163' ' ' VAL . 84.6 m -87.27 -15.19 38.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 110.413 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.87 36.07 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.392 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 1.6 tt -113.79 157.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.01 . . . . 0.0 110.268 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -116.56 -9.64 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 110.112 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.3 OUTLIER -140.8 90.66 2.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 110.307 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.574 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER -90.37 -16.67 28.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.347 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.6 OUTLIER 61.89 77.5 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 15.3 tt -96.46 98.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.273 -0.892 . . . . 0.0 110.002 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.2 m-20 65.33 -54.75 0.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 111.042 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -160.7 18.45 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.855 -179.342 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.1 tptt -130.58 159.33 37.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.067 -1.02 . . . . 0.0 111.443 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -102.22 29.69 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 108.897 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.474 ' CG2' HG23 ' A' ' 174' ' ' ILE . 6.6 m -35.27 152.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.489 0.661 . . . . 0.0 111.34 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.502 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 5.1 tt0 -106.0 148.47 27.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -0.773 . . . . 0.0 109.682 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.502 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 87.9 m -110.65 140.45 44.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.989 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.481 ' CG ' ' OE2' ' A' ' 180' ' ' GLU . 21.2 mmmt -128.57 167.32 17.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 109.855 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.463 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -92.73 152.64 19.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.422 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.54 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 110.128 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 3.5 pttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -122.36 173.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 24.7 t80 -132.96 151.17 52.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.242 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.1 OUTLIER -141.1 146.95 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.374 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.4 158.57 26.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 107.38 -6.8 36.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.474 ' O ' ' O ' ' A' ' 117' ' ' SER . 1.2 mp -68.28 96.24 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 110.037 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.01 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.4 t -89.53 -165.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.97 -1.081 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER 63.63 -11.54 0.1 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.681 -0.637 . . . . 0.0 110.509 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.557 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.4 m -90.43 -175.9 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.97 -1.081 . . . . 0.0 110.84 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 6.2 t -176.99 153.49 1.0 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.443 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.495 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -40.55 -51.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.522 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.9 -26.18 0.13 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.24 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.565 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 53.8 m-20 -77.27 -58.5 3.24 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.409 HG12 HG23 ' A' ' 155' ' ' VAL . 1.7 t -64.9 -48.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.38 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.532 ' HA ' ' CB ' ' A' ' 138' ' ' ALA . 3.2 tttt -49.03 -64.36 0.83 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.739 . . . . 0.0 110.523 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.565 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 6.1 p-80 -59.87 -32.26 70.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.112 -0.993 . . . . 0.0 110.013 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 63.6 t80 -62.93 -65.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.379 -0.826 . . . . 0.0 110.487 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 79.2 m-85 -72.77 -13.7 61.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 111.149 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.711 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 1.1 tp10 -57.55 -37.34 72.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.449 -1.407 . . . . 0.0 108.282 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.5 pt20 -76.43 -12.44 60.05 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.447 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.522 ' CA ' HD11 ' A' ' 162' ' ' ILE . 4.3 m-30 -88.26 -30.64 19.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.731 -0.606 . . . . 0.0 110.764 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -173.88 62.92 0.12 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 118.36 -1.876 . . . . 0.0 111.292 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.501 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 2.6 tptt 58.97 -68.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.458 -1.025 . . . . 0.0 111.521 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 130' ' ' GLU . 1.1 t 63.99 91.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.88 -29.27 27.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -129.95 139.38 51.1 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 126' ' ' LYS . . . -152.61 95.8 2.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 108.7 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.495 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.9 ttt -101.8 162.69 12.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.727 0.775 . . . . 0.0 111.462 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.499 ' O ' ' HG2' ' A' ' 141' ' ' MET . 53.7 tp -144.35 160.54 40.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.771 -0.581 . . . . 0.0 109.995 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.499 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -144.72 159.01 43.55 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.477 -0.764 . . . . 0.0 110.902 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.47 ' O ' ' O ' ' A' ' 143' ' ' ASP . 89.9 m-85 -130.23 -160.12 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.542 -0.724 . . . . 0.0 109.238 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 26.5 t0 58.94 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.08 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 148' ' ' ARG . 7.9 tptt -131.7 -48.64 0.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.196 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.508 HG21 ' N ' ' A' ' 146' ' ' THR . 5.3 t -119.49 -40.55 2.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.508 ' N ' HG21 ' A' ' 145' ' ' THR . 24.3 p -140.73 -80.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' O ' ' CZ ' ' A' ' 148' ' ' ARG . 5.5 p30 -91.21 -49.17 6.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 110.704 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.51 ' CZ ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -150.18 -89.38 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.976 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 150' ' ' ARG . 0.1 OUTLIER 62.55 74.22 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 149' ' ' HIS . 6.2 mtt180 58.87 147.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.792 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.9 -170.27 12.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 12.4 p90 -146.24 142.94 28.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 109.498 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.55 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -125.53 150.51 17.4 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.55 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 34.0 m-85 -112.48 113.43 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.459 -1.024 . . . . 0.0 108.41 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.497 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -110.77 -178.58 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -178.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.515 ' N ' HD12 ' A' ' 111' ' ' ILE . 27.6 m -159.09 103.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.811 -1.18 . . . . 0.0 111.26 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.617 ' CE2' ' CD1' ' A' ' 111' ' ' ILE . 2.0 p90 -126.54 106.92 9.77 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.85 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.9 mt-10 -40.25 -37.7 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 0.0 111.187 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.508 ' O ' HG21 ' A' ' 162' ' ' ILE . 58.7 m -46.54 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.535 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -64.02 -37.98 89.42 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.08 -1.013 . . . . 0.0 109.492 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 4.9 t0 -40.57 -64.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.186 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.7 OUTLIER -60.34 -44.92 96.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.97 -1.081 . . . . 0.0 108.693 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.547 ' N ' ' CG2' ' A' ' 162' ' ' ILE . 15.5 t -51.17 -41.7 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -48.25 -58.53 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 111.184 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 167' ' ' CYS . 12.0 tttt -90.47 -58.21 2.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.0 111.272 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.576 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 2.0 p -39.83 -26.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.762 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.504 ' N ' HG11 ' A' ' 166' ' ' VAL . 68.5 m -82.73 -31.96 28.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.954 -1.091 . . . . 0.0 110.15 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 -54.38 154.87 4.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.137 -0.977 . . . . 0.0 110.551 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.442 HG12 ' OE2' ' A' ' 180' ' ' GLU . 6.6 mt -67.34 124.16 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.88 -168.62 1.32 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 0.0 110.634 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.658 ' CE1' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER -100.66 89.11 3.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.576 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER -78.45 -158.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.486 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 5.1 tt0 -153.95 107.0 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 110.061 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.516 ' CD1' ' CG2' ' A' ' 179' ' ' VAL . 1.3 mp -113.42 102.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER 67.56 -56.24 0.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.557 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -168.97 25.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.99 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -130.74 151.81 50.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 0.0 111.14 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.658 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -90.36 46.9 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.54 -0.725 . . . . 0.0 109.607 179.388 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.516 ' CG2' ' CD1' ' A' ' 174' ' ' ILE . 20.3 m -54.77 -160.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.74 . . . . 0.0 110.802 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.442 ' OE2' HG12 ' A' ' 169' ' ' ILE . 15.6 tt0 -150.51 142.41 23.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.402 -0.811 . . . . 0.0 109.919 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.444 ' O ' ' O ' ' A' ' 167' ' ' CYS . 16.8 t -112.66 156.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.176 -0.953 . . . . 0.0 110.582 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 167' ' ' CYS . 51.2 mttt -138.78 -178.77 5.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 0.0 110.177 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -102.9 161.13 14.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 110.216 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.015 0.436 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.57 HG22 ' CE1' ' A' ' 157' ' ' PHE . 1.5 pt -110.3 169.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 7.9 t80 -125.01 158.39 33.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -150.16 142.84 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.383 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -134.43 150.84 20.15 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 151' ' ' GLY . . . 103.34 2.0 47.59 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.49 ' CD1' ' N ' ' A' ' 153' ' ' GLY . 2.5 mt -63.62 98.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -1.175 . . . . 0.0 110.022 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 120' ' ' THR . 0.0 OUTLIER -39.61 156.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.63 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.573 HG11 ' N ' ' A' ' 119' ' ' ASN . 2.4 t -62.75 -62.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 110.383 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.573 ' N ' HG11 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -44.58 -19.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.736 0.779 . . . . 0.0 108.914 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 142' ' ' PHE . 2.9 m -68.18 157.8 34.61 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.826 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.483 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 7.8 t -148.44 150.47 33.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.097 -1.002 . . . . 0.0 110.405 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.529 ' CG2' ' HB2' ' A' ' 140' ' ' LEU . 3.2 t -35.77 -53.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.764 -0.585 . . . . 0.0 111.097 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.536 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.5 mt-10 -41.02 -26.38 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.385 -0.822 . . . . 0.0 109.45 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.546 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 43.8 t0 -73.43 -59.44 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.526 0.679 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.505 HG21 ' CG1' ' A' ' 174' ' ' ILE . 2.4 t -68.71 -52.91 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.773 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.8 ttmt -41.04 -60.98 1.07 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.711 -0.618 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.879 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.478 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -65.59 -64.31 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 111.011 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 28.2 m-85 -74.03 -16.75 61.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.657 -1.277 . . . . 0.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.499 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 4.5 tt0 -55.6 -37.98 68.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.036 -1.466 . . . . 0.0 108.173 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.3 pt20 -72.59 -18.06 61.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 162' ' ' ILE . 16.0 m-85 -84.84 -37.09 21.12 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -154.76 159.01 28.69 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -42.42 -43.25 3.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.16 . . . . 0.0 110.365 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 48.1 89.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 122.02 0.914 . . . . 0.0 110.94 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -89.18 -24.9 22.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -126.57 137.91 53.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.91 101.23 1.61 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.51 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -112.9 157.61 21.23 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.861 0.839 . . . . 0.0 112.758 -177.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.529 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 1.3 mp -138.12 142.45 40.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.885 -0.509 . . . . 0.0 110.258 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.522 ' HG3' ' CE2' ' A' ' 152' ' ' PHE . 2.2 mmt -118.5 145.78 45.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.578 ' CE2' ' O ' ' A' ' 120' ' ' THR . 28.5 m-85 -136.21 -163.38 1.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 0.0 110.178 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -94.92 -142.31 0.25 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 110.321 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -90.5 -60.33 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.437 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.414 ' O ' HG13 ' A' ' 118' ' ' VAL . 70.8 p -132.01 -71.2 0.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 t -149.02 48.48 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 110.001 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.22 -59.53 2.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.421 -0.799 . . . . 0.0 110.22 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 40.8 ptt180 -112.24 141.24 46.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.141 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.422 ' O ' ' HA ' ' A' ' 117' ' ' SER . 2.2 m170 -90.24 29.83 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.517 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -140.28 152.18 45.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.337 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . -152.2 -169.06 17.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.522 ' CE2' ' HG3' ' A' ' 141' ' ' MET . 50.1 p90 -149.91 135.13 18.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -1.219 . . . . 0.0 109.855 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.49 ' N ' ' CD1' ' A' ' 116' ' ' LEU . . . -128.0 166.92 20.45 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.148 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 139' ' ' MET . 64.6 m-85 -122.99 109.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -1.095 . . . . 0.0 109.03 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -99.81 177.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 120.948 -1.095 . . . . 0.0 109.172 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 91.5 m -165.03 109.86 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.127 -1.429 . . . . 0.0 112.461 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.57 ' CE1' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -118.88 135.03 54.78 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.2 177.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.07 54.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.89 96.64 2.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 110.115 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.461 ' HA ' HG22 ' A' ' 163' ' ' VAL . 10.5 tt0 -49.71 -38.33 32.74 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -41.95 -47.33 4.32 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.254 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.566 HG23 ' CE2' ' A' ' 157' ' ' PHE . 20.1 mm -68.5 -42.6 83.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.583 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 11.8 t -63.28 -40.61 89.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -56.29 -47.11 79.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 110.621 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 168' ' ' GLU . 19.2 ttmt -90.25 -65.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.356 -0.84 . . . . 0.0 111.167 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 1.0 OUTLIER -41.42 -25.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 110.175 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 41.2 t -76.51 -36.15 57.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.374 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 87.3 mt-10 -83.72 -160.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.64 -0.663 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 168' ' ' GLU . 44.0 mt 57.32 152.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.471 -0.768 . . . . 0.0 110.173 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 171' ' ' PHE . 77.1 m-70 -53.17 -98.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.115 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.657 ' CZ ' ' HB3' ' A' ' 178' ' ' MET . 2.2 p90 -127.39 170.32 12.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 110.228 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.507 ' NE2' ' HA ' ' A' ' 166' ' ' VAL . 34.3 m-70 -102.83 24.94 9.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.646 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.499 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 46.47 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.556 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 1.0 OUTLIER -93.44 100.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.602 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 124' ' ' ASP . 2.6 m-20 65.58 -55.85 0.34 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.358 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.3 OUTLIER -168.66 28.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.414 -0.804 . . . . 0.0 109.537 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.5 tptt -132.51 158.02 43.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.483 -0.761 . . . . 0.0 110.769 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.657 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 1.0 OUTLIER -100.78 55.17 0.86 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.859 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.522 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 33.4 m -59.32 130.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.4 OUTLIER -70.65 148.01 48.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.328 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 166' ' ' VAL . 3.0 t -125.08 140.8 52.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -149.04 -174.34 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -109.82 150.28 28.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.106 179.83 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.522 ' CB ' ' OG1' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.58 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 3.3 pt -110.81 167.93 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 111.138 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -119.29 155.01 32.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.278 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -148.39 146.97 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 110.556 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.41 -170.33 12.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.472 ' O ' HG11 ' A' ' 179' ' ' VAL . . . 65.45 23.31 70.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' SER . 1.1 mt -84.15 93.91 8.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -1.109 . . . . 0.0 110.343 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 116' ' ' LEU . 99.2 p -52.66 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.787 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.582 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.5 t -85.22 -165.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.582 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER 63.11 -10.28 0.1 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.626 -0.671 . . . . 0.0 110.358 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.562 ' H ' ' C ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -88.7 -177.27 5.51 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.117 -0.99 . . . . 0.0 110.781 -178.156 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 12.1 t -178.8 153.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.878 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -38.42 -50.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.738 . . . . 0.0 110.735 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.477 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.67 -26.17 0.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.197 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.585 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.7 m-20 -76.58 -57.72 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 0.0 110.062 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.446 HG11 ' N ' ' A' ' 126' ' ' LYS . 0.9 OUTLIER -64.12 -47.83 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.549 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -51.13 -62.62 1.51 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 110.653 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.585 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -57.62 -26.53 61.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -78.48 -64.19 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 0.0 111.891 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.523 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 52.1 m-85 -70.91 -13.42 62.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.927 -1.108 . . . . 0.0 112.283 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.658 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -53.99 -41.39 67.86 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 119.893 -1.755 . . . . 0.0 109.115 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.456 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.9 pt20 -73.66 -14.86 61.23 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.523 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 16.2 m-85 -82.36 -31.11 29.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.725 -0.609 . . . . 0.0 110.051 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 157' ' ' PHE . . . -174.44 60.24 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.055 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 4.3 tptt 59.71 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.31 -1.112 . . . . 0.0 110.831 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.658 ' HB ' ' HA ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER 63.58 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 111.315 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -89.64 -23.15 21.98 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -133.29 137.67 46.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.502 0.668 . . . . 0.0 109.449 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.508 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -153.76 96.02 1.95 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.546 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 4.3 ttm -101.49 165.98 10.96 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.0 111.972 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 2.6 tp -143.57 151.08 39.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.636 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 3.0 mmt -128.11 130.87 48.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.772 -1.205 . . . . 0.0 111.253 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 10.4 m-85 -126.72 -174.56 3.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.515 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.478 ' O ' ' OG1' ' A' ' 146' ' ' THR . 7.6 t0 66.54 -162.25 0.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.106 -0.996 . . . . 0.0 110.487 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' ASP . 0.1 OUTLIER 63.16 53.98 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.817 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.26 11.63 4.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -128.33 5.89 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.002 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.475 ' N ' ' OD1' ' A' ' 147' ' ' ASN . 13.0 p-10 -47.18 -23.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 109.917 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 -31.57 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.394 -0.816 . . . . 0.0 110.264 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -80.75 47.57 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.464 ' O ' ' O ' ' A' ' 149' ' ' HIS . 1.4 mpt_? 57.09 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.062 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.41 -149.69 6.87 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 25.0 p90 -145.62 136.0 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.924 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -120.82 158.12 15.76 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.68 107.38 12.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -1.017 . . . . 0.0 109.246 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -102.7 179.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.947 -1.096 . . . . 0.0 109.08 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.522 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 62.9 m -163.35 106.62 1.01 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.184 -1.406 . . . . 0.0 111.915 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.618 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.5 OUTLIER -125.09 105.64 9.32 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.494 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -39.76 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.576 -0.703 . . . . 0.0 110.623 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.551 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.4 OUTLIER -57.73 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.326 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -57.28 -39.08 74.97 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.651 -1.281 . . . . 0.0 109.559 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' A' ' 160' ' ' GLU . 3.7 m-20 -40.65 -64.88 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.551 HG23 ' O ' ' A' ' 159' ' ' SER . 4.1 tp -57.25 -41.87 78.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.908 -1.12 . . . . 0.0 109.038 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.618 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 26.3 t -53.77 -37.56 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.7 OUTLIER -52.26 -56.72 12.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.809 -0.557 . . . . 0.0 110.975 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.9 tttp -85.87 -59.53 2.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.215 -0.928 . . . . 0.0 110.663 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 3.9 p -40.94 -26.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.488 -0.758 . . . . 0.0 109.834 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 11.1 t -75.29 -38.34 60.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.872 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.53 ' O ' ' CE1' ' A' ' 170' ' ' HIS . 2.7 tt0 -60.2 -82.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.537 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 169' ' ' ILE . 7.0 pt -39.31 125.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 168' ' ' GLU . 70.0 m80 -106.66 35.69 2.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 0.0 110.667 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.663 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 2.8 t80 -140.38 61.53 1.52 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.035 . . . . 0.0 110.522 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 1.2 m80 -74.0 115.89 14.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.677 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 4.0 mt-10 -65.84 100.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.542 HG23 ' CB ' ' A' ' 177' ' ' LYS . 1.8 tp -78.1 -178.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.828 -1.17 . . . . 0.0 109.386 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.508 ' N ' HG21 ' A' ' 174' ' ' ILE . 16.3 m-80 -34.56 -30.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.551 -0.718 . . . . 0.0 111.649 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.2 p30 -164.93 30.02 0.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.542 ' CB ' HG23 ' A' ' 174' ' ' ILE . 1.3 tptp -145.99 -166.25 2.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 110.967 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.663 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -131.22 38.9 3.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.525 HG22 ' CD1' ' A' ' 174' ' ' ILE . 27.6 m -35.6 153.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.461 0.648 . . . . 0.0 111.257 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -98.03 156.06 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.454 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 6.8 p -134.56 153.78 51.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 4.2 mtpt -152.97 168.43 25.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.345 -0.847 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.15 154.63 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.462 ' HB2' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.373 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.187 0.518 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.604 HG12 ' CE2' ' A' ' 157' ' ' PHE . 1.1 pt -125.87 176.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 3.9 t80 -127.11 160.63 30.59 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.532 -0.73 . . . . 0.0 109.2 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -144.73 140.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.44 ' HA2' HD22 ' A' ' 116' ' ' LEU . . . -136.86 157.89 23.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 94.78 -23.06 34.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.44 HD22 ' HA2' ' A' ' 114' ' ' GLY . 0.4 OUTLIER -49.45 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.477 ' HB3' ' NZ ' ' A' ' 177' ' ' LYS . 11.7 p -54.52 163.3 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 110.697 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.572 ' C ' ' H ' ' A' ' 120' ' ' THR . 18.9 m -62.81 -153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -0.865 . . . . 0.0 110.441 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.18 -41.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.649 0.738 . . . . 0.0 110.382 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.572 ' H ' ' C ' ' A' ' 118' ' ' VAL . 30.8 m -70.92 156.52 39.5 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.087 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.62 148.1 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.533 ' HA ' ' CD1' ' A' ' 140' ' ' LEU . 2.2 t -40.12 -51.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.424 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -42.94 -25.89 0.12 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.432 -0.793 . . . . 0.0 109.087 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 121' ' ' THR . 32.9 m-20 -72.28 -56.71 5.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.432 0.634 . . . . 0.0 109.503 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.477 ' CG2' ' CD1' ' A' ' 174' ' ' ILE . 2.4 t -65.66 -53.45 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.564 0.697 . . . . 0.0 109.144 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -41.23 -63.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.725 -0.609 . . . . 0.0 109.901 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.516 ' ND1' ' C ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -60.07 -30.12 69.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.955 . . . . 0.0 109.07 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.477 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -60.9 -69.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.622 -0.674 . . . . 0.0 110.315 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.524 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 74.3 m-85 -70.4 -15.26 62.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -0.967 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.537 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 8.8 tt0 -57.17 -37.35 71.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.191 -1.568 . . . . 0.0 107.825 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.435 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.2 pt20 -72.51 -16.66 61.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 3.6 m-30 -83.42 -28.78 28.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.752 -0.593 . . . . 0.0 109.446 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.73 -139.42 2.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.448 ' HD2' ' HG3' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -94.14 -33.83 13.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -1.05 . . . . 0.0 109.658 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 39.08 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.109 0.957 . . . . 0.0 111.456 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.405 ' OD2' ' NZ ' ' A' ' 134' ' ' LYS . 0.2 OUTLIER -92.66 -25.3 18.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.36 140.04 49.62 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -157.17 100.16 1.84 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.523 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 1.6 ptp -116.66 165.99 12.64 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.876 0.846 . . . . 0.0 112.216 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 122' ' ' VAL . 89.3 mt -142.92 146.48 34.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.85 -0.531 . . . . 0.0 109.579 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.481 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -120.64 110.12 16.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.0 -1.063 . . . . 0.0 110.337 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.43 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 144' ' ' LYS . 11.7 p-10 -86.92 -27.71 23.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER 170.6 -45.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.28 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.16 44.66 1.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.351 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.428 ' CB ' ' OD2' ' A' ' 143' ' ' ASP . 0.3 OUTLIER -90.43 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 110.379 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 149' ' ' HIS . 3.2 ptp180 -120.63 -132.15 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.116 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.529 ' HA ' ' CG1' ' A' ' 118' ' ' VAL . 54.5 p-80 -152.4 -143.49 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.987 . . . . 0.0 109.848 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.472 ' N ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER 55.13 -156.47 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 110.112 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 122.77 175.84 14.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.584 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 17.7 p90 -144.85 138.83 27.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -1.103 . . . . 0.0 109.726 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -127.99 168.93 19.78 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.395 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.481 ' O ' ' HG3' ' A' ' 139' ' ' MET . 76.0 m-85 -126.82 115.94 20.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -1.134 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.516 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -108.79 -177.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.082 -1.011 . . . . 0.0 109.044 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.482 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 16.3 m -163.75 104.73 0.93 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.676 ' CE1' ' CG2' ' A' ' 162' ' ' ILE . 1.9 p90 -129.92 116.65 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.97 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.2 mm-40 -44.34 -32.58 1.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.387 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.53 ' HB3' ' CG1' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -51.77 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 110.544 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -56.57 -40.0 74.45 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.176 -0.952 . . . . 0.0 109.042 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -44.78 -38.05 4.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.676 ' CG2' ' CE1' ' A' ' 157' ' ' PHE . 41.3 mm -69.61 -49.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 20.0 t -58.25 -36.82 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.8 mm-40 -56.89 -44.39 82.25 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.627 -0.67 . . . . 0.0 110.715 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 161' ' ' ASP . 3.1 mttt -90.14 -64.96 1.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.544 ' O ' ' CB ' ' A' ' 181' ' ' CYS . 6.3 m -42.9 -24.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.856 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 8.4 t -71.73 -38.15 70.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.725 -1.235 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 165' ' ' LYS . 8.0 mt-10 -64.67 173.1 2.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 2.6 mp -97.09 78.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.166 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -106.65 -162.03 0.83 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.65 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 2.2 t80 -94.55 54.35 1.79 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.242 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.472 ' CE1' ' HA ' ' A' ' 166' ' ' VAL . 0.5 OUTLIER -67.86 100.71 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' A' ' 177' ' ' LYS . 3.6 tt0 -80.89 141.73 34.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 110.589 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.562 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 4.7 tt -114.58 115.43 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.186 -0.947 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 2.5 t-20 68.07 -55.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.631 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.561 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -174.22 24.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.863 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.549 ' HD2' ' CG1' ' A' ' 179' ' ' VAL . 0.1 OUTLIER -139.49 129.14 24.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.785 -1.197 . . . . 0.0 110.179 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.65 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -68.3 119.63 13.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.817 -1.177 . . . . 0.0 110.596 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.549 ' CG1' ' HD2' ' A' ' 177' ' ' LYS . 4.4 m -120.08 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.419 ' N ' ' CG2' ' A' ' 179' ' ' VAL . 57.1 tt0 -138.83 143.6 38.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 86.8 m -129.2 138.14 51.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.306 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 167' ' ' CYS . 7.9 mttt -133.91 175.67 9.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.29 -0.882 . . . . 0.0 109.816 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.511 ' CD ' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -75.25 163.74 27.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.264 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.524 ' HB1' ' CA ' ' A' ' 111' ' ' ILE . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.293 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.537 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.25 0.548 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.622 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -105.2 165.84 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -124.51 136.69 54.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -131.34 142.65 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 110.075 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -146.87 168.46 28.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.44 ' C ' HG13 ' A' ' 179' ' ' VAL . . . 94.3 -29.4 8.93 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.45 HD11 ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -53.67 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 116' ' ' LEU . 4.3 p -52.47 -173.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.593 ' CG2' ' CD ' ' A' ' 148' ' ' ARG . 1.3 t -75.12 -149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 109.467 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.571 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER 64.06 -14.84 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.642 . . . . 0.0 111.398 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER -89.87 -167.13 1.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.684 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 122' ' ' VAL . 14.4 t -173.21 139.44 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.54 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -35.07 -49.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.633 -0.667 . . . . 0.0 111.303 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 122' ' ' VAL . 10.2 mt-10 -43.35 -25.88 0.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.487 ' CG ' ' ND2' ' A' ' 175' ' ' ASN . 66.2 m-20 -73.42 -47.64 40.11 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.421 0.629 . . . . 0.0 110.209 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.507 ' CG2' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -73.86 -44.56 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.663 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.2 ttpp -50.02 -65.2 0.6 Allowed 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.454 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -64.42 -32.32 73.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.025 -1.047 . . . . 0.0 110.681 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.471 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 4.5 t80 -66.1 -54.06 30.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 111.212 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 46.2 m-85 -83.98 -16.53 43.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.164 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 40.2 tt0 -57.42 -36.89 71.93 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.053 -1.654 . . . . 0.0 107.73 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 13.2 pt20 -74.6 -15.93 60.82 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.583 ' CG ' HD12 ' A' ' 162' ' ' ILE . 3.1 m-30 -83.36 -28.24 29.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -164.07 -143.45 3.71 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CG ' ' N ' ' A' ' 135' ' ' VAL . 2.0 ptmt -88.45 -42.19 12.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.325 -1.103 . . . . 0.0 109.7 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.544 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 46.24 90.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.455 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -92.42 -25.63 18.39 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.63 145.73 50.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.057 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.515 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -158.35 101.66 1.72 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.54 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -112.58 163.81 14.06 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.937 0.875 . . . . 0.0 112.216 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.525 HD22 ' CZ ' ' A' ' 142' ' ' PHE . 4.8 tp -138.03 154.79 49.27 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.644 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 66.0 mmm -131.19 135.8 47.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.767 -1.208 . . . . 0.0 110.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.568 ' CE1' ' HA ' ' A' ' 118' ' ' VAL . 9.4 m-85 -136.7 -173.13 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.696 . . . . 0.0 109.973 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.413 ' HB2' ' C ' ' A' ' 147' ' ' ASN . 36.8 m-20 -142.12 -127.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.987 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.453 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 0.9 OUTLIER -110.78 -131.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.956 -1.09 . . . . 0.0 110.302 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.46 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -79.85 -60.52 2.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.582 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.8 m -94.36 -20.94 19.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.504 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.413 ' C ' ' HB2' ' A' ' 143' ' ' ASP . 86.8 m-20 -73.94 -1.75 21.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.542 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.593 ' CD ' ' CG2' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -90.45 -112.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.106 -0.996 . . . . 0.0 109.95 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 65.8 -76.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.862 -1.149 . . . . 0.0 110.58 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.476 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -51.82 -69.18 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.741 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.443 ' O ' ' HG ' ' A' ' 116' ' ' LEU . . . 62.94 120.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 14.9 p90 -150.13 139.37 21.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.109 -1.23 . . . . 0.0 110.158 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -129.58 167.2 21.54 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.965 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.505 ' O ' ' HG3' ' A' ' 139' ' ' MET . 63.0 m-85 -123.5 117.8 25.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 108.879 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -109.2 -178.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 109.036 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 72.3 m -162.87 105.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.874 -1.53 . . . . 0.0 112.433 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.633 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -126.6 102.34 7.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.441 -0.787 . . . . 0.0 108.993 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -39.18 -29.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.503 -0.748 . . . . 0.0 110.962 -178.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.1 OUTLIER -56.23 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 110.235 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.517 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -58.09 -38.32 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.078 -1.014 . . . . 0.0 109.701 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.7 m-20 -39.24 -64.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.771 -0.581 . . . . 0.0 110.259 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.583 HD12 ' CG ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -61.84 -38.0 79.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.091 -1.006 . . . . 0.0 109.122 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.633 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 16.7 t -58.41 -33.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -58.77 -47.15 85.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.426 0.631 . . . . 0.0 110.079 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 167' ' ' CYS . 10.4 tttt -87.4 -63.82 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 110.499 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.53 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 1.4 p -42.31 -24.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.876 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 9.3 t -73.36 -47.02 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.075 -1.016 . . . . 0.0 109.458 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.86 130.84 4.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.55 -0.719 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 170' ' ' HIS . 2.9 mp -73.84 133.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 110.099 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 3.3 t-160 -177.73 62.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.64 ' CE1' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER 43.98 61.12 2.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -0.958 . . . . 0.0 109.899 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 1.1 t60 -60.83 145.03 51.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.47 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -100.72 88.76 3.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 110.266 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.485 HG12 ' CG2' ' A' ' 179' ' ' VAL . 1.3 mp -81.34 91.96 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.387 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER 68.56 -56.99 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.419 -0.801 . . . . 0.0 110.1 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -161.55 19.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.807 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.474 ' HB3' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.68 148.39 46.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.118 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.64 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -92.02 41.56 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.485 ' CG2' HG12 ' A' ' 174' ' ' ILE . 10.3 m -70.47 -165.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.51 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 2.3 tm-20 -125.54 152.46 45.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.792 . . . . 0.0 110.103 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.51 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 37.9 t -141.41 103.02 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.421 ' HG3' ' OE2' ' A' ' 180' ' ' GLU . 6.1 mtmm -99.21 -175.56 3.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 109.886 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HG2' ' N ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -100.32 -175.99 3.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.784 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 110.598 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.588 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.7 pt -99.7 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 110.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -118.57 153.74 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 109.675 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -146.94 152.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -145.93 162.91 28.35 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.43 ' O ' ' HE2' ' A' ' 177' ' ' LYS . . . 100.29 9.52 47.53 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.521 ' N ' HD21 ' A' ' 116' ' ' LEU . 2.7 mm? -57.67 97.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -1.09 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.3 168.21 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.105 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.547 ' C ' ' H ' ' A' ' 120' ' ' THR . 19.5 m -63.19 169.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.272 -0.892 . . . . 0.0 110.988 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 61.95 -39.13 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.976 -0.452 . . . . 0.0 111.018 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.547 ' H ' ' C ' ' A' ' 118' ' ' VAL . 91.8 m -42.3 153.74 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.483 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.546 ' HA ' ' CZ ' ' A' ' 142' ' ' PHE . 15.2 t -149.66 146.77 27.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.538 ' CG1' ' O ' ' A' ' 138' ' ' ALA . 0.0 OUTLIER -32.39 -47.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.81 -0.556 . . . . 0.0 111.396 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -41.94 -27.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.095 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' OD2' ' N ' ' A' ' 175' ' ' ASN . 15.6 t0 -72.24 -58.44 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.555 0.693 . . . . 0.0 109.966 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 140' ' ' LEU . 2.1 t -67.07 -52.9 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.7 tttt -42.44 -59.82 1.73 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.649 -0.657 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.517 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -62.44 -27.74 69.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.441 -0.787 . . . . 0.0 110.196 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.487 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 18.7 t80 -76.29 -53.77 7.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 112.479 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.519 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 14.6 m-85 -82.32 -17.41 45.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.0 112.638 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -52.7 -41.76 64.19 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 119.969 -1.707 . . . . 0.0 109.263 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 17.6 pt20 -73.72 -15.78 61.21 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.502 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.519 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 15.8 m-85 -84.27 -33.97 23.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -159.35 162.29 32.71 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -44.6 -34.01 2.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.3 t 38.05 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.967 0.889 . . . . 0.0 111.342 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -25.06 18.0 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -130.9 142.01 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.538 ' O ' ' CG1' ' A' ' 122' ' ' VAL . . . -157.4 102.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.406 ' HA ' HG12 ' A' ' 122' ' ' VAL . 3.2 tpp -110.39 160.21 16.78 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.775 0.797 . . . . 0.0 111.308 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 142' ' ' PHE . 9.4 mt -147.04 145.42 29.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.774 -0.579 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.589 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 1.6 mmm -123.25 126.77 47.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.024 -1.047 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 42.2 m-85 -120.37 170.87 8.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.865 . . . . 0.0 110.711 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 19.2 t70 43.43 -92.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.496 -0.752 . . . . 0.0 111.317 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 1.1 mttm 57.47 23.36 9.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 11.1 p 50.31 19.37 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.428 -0.795 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 p -151.04 -65.15 0.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.923 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 54.7 3.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.47 -0.769 . . . . 0.0 110.286 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.56 -28.15 19.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.403 ' C ' ' HG2' ' A' ' 150' ' ' ARG . 1.2 t-80 -87.1 -14.99 39.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.048 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 116' ' ' LEU . 11.9 mmt180 -126.62 -65.25 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.63 151.32 11.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.589 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.1 p90 -150.03 146.19 26.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -1.202 . . . . 0.0 109.977 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.529 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -138.16 174.62 21.84 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.174 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.96 118.26 18.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.495 -1.003 . . . . 0.0 109.246 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 138' ' ' ALA . 1.5 t -109.21 -174.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 96.3 m -163.98 106.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.002 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.4 OUTLIER -132.12 109.96 10.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.199 -0.938 . . . . 0.0 109.722 177.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.19 -32.06 1.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.431 -0.793 . . . . 0.0 111.507 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.4 OUTLIER -56.04 82.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.535 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -56.7 -38.61 72.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 110.086 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.4 OUTLIER -39.06 -69.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.815 -0.553 . . . . 0.0 110.426 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.519 HG21 ' N ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -57.57 -42.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.927 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.644 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 14.7 t -51.76 -38.95 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 3.1 tt0 -48.4 -55.95 9.46 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.359 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.3 tttm -90.52 -59.6 2.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.257 -0.902 . . . . 0.0 111.316 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.505 HG22 ' NE2' ' A' ' 172' ' ' HIS . 4.0 p -41.24 -25.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.247 -0.908 . . . . 0.0 110.859 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 183' ' ' LYS . 71.2 m -90.21 -20.34 23.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.882 -1.137 . . . . 0.0 110.071 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 165' ' ' LYS . 19.6 mm-40 -103.98 -30.03 10.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 110.186 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.547 HG23 ' CE1' ' A' ' 172' ' ' HIS . 18.0 tt -54.92 155.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -115.31 164.3 14.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.117 -0.99 . . . . 0.0 110.448 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.588 ' CD2' ' HB2' ' A' ' 178' ' ' MET . 0.3 OUTLIER 58.0 55.99 4.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.454 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.547 ' CE1' HG23 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -81.36 -8.06 59.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 57.21 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 110.894 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 0.9 OUTLIER -113.83 116.15 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.632 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 1.4 t-20 69.41 -56.49 0.55 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 174' ' ' ILE . 6.3 p30 -177.14 29.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.633 -0.667 . . . . 0.0 109.813 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.533 ' HD3' ' O ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -143.72 123.89 13.71 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.059 -1.025 . . . . 0.0 110.432 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.588 ' HB2' ' CD2' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -54.02 116.31 2.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.504 ' CG2' ' HB ' ' A' ' 174' ' ' ILE . 16.0 m -119.09 -161.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 0.0 110.6 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.436 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 10.3 tt0 -130.1 146.45 51.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 167' ' ' CYS . 71.3 m -117.42 152.32 35.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.52 -0.737 . . . . 0.0 109.917 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.539 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -110.03 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.417 ' HB1' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' CB ' ' OG1' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.223 0.535 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.57 HG12 ' CE1' ' A' ' 157' ' ' PHE . 1.8 pt -101.46 169.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.519 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.9 t80 -118.11 156.49 28.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.409 -0.807 . . . . 0.0 109.184 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.54 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 1.2 m -148.32 163.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.064 -1.022 . . . . 0.0 110.85 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.39 171.05 32.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 97.93 -22.39 41.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -41.43 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -1.06 . . . . 0.0 109.981 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' GLY . 38.7 m -96.19 -162.58 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.816 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' THR . 12.7 m -52.25 162.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 111.188 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 61.93 -38.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.872 -0.517 . . . . 0.0 110.984 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 118' ' ' VAL . 55.6 m -61.76 123.92 19.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 0.0 110.507 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.0 t -136.53 166.14 24.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 0.0 109.688 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.478 HG11 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -41.36 -55.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -0.989 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.31 -24.67 0.1 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.406 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.57 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 62.4 t0 -75.24 -59.28 2.81 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.682 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.502 ' CG2' HD13 ' A' ' 174' ' ' ILE . 1.8 t -64.3 -49.0 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.287 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 53.4 tttm -47.72 -63.47 1.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.522 -0.736 . . . . 0.0 110.057 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -61.14 -31.95 71.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -0.985 . . . . 0.0 109.861 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.468 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 21.4 t80 -61.97 -60.6 3.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.469 -0.769 . . . . 0.0 110.883 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 82.9 m-85 -79.7 -18.8 50.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.042 -1.036 . . . . 0.0 111.518 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 1.1 tp10 -54.45 -36.03 63.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.366 -1.459 . . . . 0.0 108.699 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -74.77 -20.62 59.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.527 ' O ' ' CD1' ' A' ' 162' ' ' ILE . 7.5 m-85 -82.24 -28.9 31.61 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.823 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -163.06 -157.72 9.3 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.893 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -72.24 -50.12 29.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.586 -0.95 . . . . 0.0 110.129 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.5 t 51.19 87.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.121 0.962 . . . . 0.0 110.353 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -87.79 -28.64 21.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 79.8 m-20 -134.49 137.99 44.35 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.127 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.508 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -147.18 93.93 2.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.478 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 9.1 ttm -105.62 167.05 10.02 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.833 0.825 . . . . 0.0 111.875 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.513 ' HA ' ' CA ' ' A' ' 153' ' ' GLY . 31.0 mt -146.03 132.51 19.71 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.527 ' O ' ' CD1' ' A' ' 116' ' ' LEU . 9.7 mmt -107.79 133.73 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.88 -1.137 . . . . 0.0 110.792 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 17.4 m-85 -120.84 -135.51 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.534 -0.728 . . . . 0.0 109.642 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 146' ' ' THR . 6.4 m-20 -133.55 174.39 10.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -78.03 118.99 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 25.6 p 42.59 26.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 143' ' ' ASP . 30.7 p -150.35 52.98 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.005 . . . . 0.0 110.008 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 147' ' ' ASN . 14.9 p-10 -72.13 52.29 0.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.46 -15.14 3.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.106 -0.996 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.5 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -104.85 144.35 31.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER 31.68 -147.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.319 0.581 . . . . 0.0 111.39 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.459 ' HA3' HD13 ' A' ' 116' ' ' LEU . . . 127.71 134.01 3.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.56 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 24.0 p90 -144.9 135.01 23.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -1.17 . . . . 0.0 110.022 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.54 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -114.62 164.87 12.04 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.332 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -127.78 113.12 15.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -1.106 . . . . 0.0 109.648 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.508 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -109.0 -178.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.909 . . . . 0.0 108.938 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.514 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 79.8 m -164.07 106.32 0.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.169 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.4 OUTLIER -126.32 113.06 16.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 109.511 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 4.0 tt0 -39.74 -26.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.435 -0.79 . . . . 0.0 111.123 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.541 ' O ' HG23 ' A' ' 162' ' ' ILE . 80.9 p -63.5 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 110.587 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -52.13 -38.9 58.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.864 -1.148 . . . . 0.0 109.17 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 160' ' ' GLU . 38.1 t70 -43.07 -53.54 4.83 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.778 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.581 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -60.66 -49.22 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.441 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.612 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 47.0 t -44.72 -46.78 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -52.21 12.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 167' ' ' CYS . 11.3 ttpt -90.02 -62.37 1.48 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.131 -0.98 . . . . 0.0 111.065 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 163' ' ' VAL . 8.5 p -40.01 -25.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.71 . . . . 0.0 110.637 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 23.3 m -76.3 -40.44 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.024 -1.047 . . . . 0.0 109.676 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.48 ' C ' ' CG1' ' A' ' 169' ' ' ILE . 1.2 mt-10 -68.67 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.48 ' CG1' ' C ' ' A' ' 168' ' ' GLU . 20.9 pt 35.82 91.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.558 -0.714 . . . . 0.0 110.755 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.498 ' CD2' ' N ' ' A' ' 170' ' ' HIS . 11.2 m170 -60.5 -166.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 178' ' ' MET . 1.4 t80 54.62 69.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.511 ' NE2' HG21 ' A' ' 166' ' ' VAL . 0.4 OUTLIER -82.15 -26.27 33.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.195 -0.94 . . . . 0.0 110.128 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 68.59 101.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.092 -1.005 . . . . 0.0 110.914 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.546 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 3.4 tt -122.25 118.74 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.543 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 29.1 m-20 64.19 -53.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.66 -0.65 . . . . 0.0 110.644 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.496 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.2 OUTLIER -175.48 27.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.001 -1.062 . . . . 0.0 110.699 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.556 ' HD3' ' C ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -143.49 137.06 28.26 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.065 -1.022 . . . . 0.0 109.488 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.64 ' CG ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -77.87 88.05 4.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.326 -1.483 . . . . 0.0 110.097 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.452 HG11 ' HD2' ' A' ' 177' ' ' LYS . 28.7 m -76.46 -178.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 110.379 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -128.78 140.65 51.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.752 . . . . 0.0 109.549 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 167' ' ' CYS . 1.5 t -122.68 142.65 50.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 110.811 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.42 ' C ' ' SG ' ' A' ' 167' ' ' CYS . 7.5 mttp -138.64 178.91 6.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.471 ' HD3' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -111.65 142.37 44.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.069 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.268 -179.668 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 1.7 ptmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.972 0.415 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.652 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pp -123.26 178.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.795 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.486 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 56.6 t80 -125.03 162.31 24.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.593 -0.692 . . . . 0.0 109.15 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -146.84 135.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -130.17 162.28 23.11 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 92.92 -26.04 16.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.493 HD23 ' CA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -44.1 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -1.092 . . . . 0.0 109.607 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -43.19 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.734 0.778 . . . . 0.0 111.018 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.581 ' CG1' ' N ' ' A' ' 119' ' ' ASN . 0.9 OUTLIER -74.44 -64.14 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.409 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.581 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 0.1 OUTLIER -43.44 -21.98 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.53 ' N ' ' O ' ' A' ' 118' ' ' VAL . 23.6 m -72.71 142.21 48.2 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.778 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.0 158.98 36.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 110.563 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 140' ' ' LEU . 2.7 t -37.56 -52.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -40.65 -27.06 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 179.703 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 122' ' ' VAL . 1.7 m-20 -72.79 -57.67 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.469 0.652 . . . . 0.0 109.567 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.558 HG12 ' CD2' ' A' ' 129' ' ' PHE . 2.1 t -65.87 -50.1 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.615 0.721 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 23.9 tttt -46.58 -61.77 1.67 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -59.52 -33.14 71.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -66.44 -64.89 0.76 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 110.832 -179.262 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.558 ' CD2' HG12 ' A' ' 125' ' ' VAL . 78.3 m-85 -70.68 -18.54 62.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.9 -1.125 . . . . 0.0 111.541 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 38.4 tt0 -55.96 -36.7 68.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.912 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 6.5 pt20 -73.47 -18.15 61.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.498 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 16.9 m-85 -86.55 -32.85 20.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -160.74 165.61 35.18 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.432 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -41.71 -55.13 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 110.336 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.4 t 58.79 89.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.01 0.91 . . . . 0.0 110.747 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.432 ' OD2' ' HE2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -92.84 -26.23 17.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -129.43 138.67 51.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -155.91 99.97 2.02 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.541 ' HG2' ' O ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -111.18 158.97 18.31 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.097 0.951 . . . . 0.0 112.854 -177.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.528 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 1.8 mp -137.82 148.55 45.57 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.559 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 1.4 mmt -125.28 147.54 49.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.729 -1.232 . . . . 0.0 110.927 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 141' ' ' MET . 16.1 m-85 -133.6 -177.63 4.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.647 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 148' ' ' ARG . 12.0 p30 -70.49 -176.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.049 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.449 ' O ' ' OG1' ' A' ' 145' ' ' THR . 4.5 pttt -65.62 -24.17 66.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 110.083 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 88.6 m -164.12 -79.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 110.312 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.7 t -146.17 40.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 110.248 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -76.01 -18.5 59.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.459 ' HG2' ' HB3' ' A' ' 143' ' ' ASP . 3.2 ptp180 -149.11 -149.08 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 110.303 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.499 ' C ' ' CD2' ' A' ' 149' ' ' HIS . 3.6 p-80 -149.18 14.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 110.511 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -114.53 -162.9 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -0.936 . . . . 0.0 110.311 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 169.14 176.37 39.12 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 152' ' ' PHE . 5.9 p90 -147.88 136.67 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -1.134 . . . . 0.0 109.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 139' ' ' MET . . . -128.91 172.54 19.57 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.367 -1.396 . . . . 0.0 110.463 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.541 ' O ' ' HG2' ' A' ' 139' ' ' MET . 71.0 m-85 -128.74 108.18 10.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.546 -0.973 . . . . 0.0 108.594 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -93.94 -178.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.456 -1.403 . . . . 0.0 109.648 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 36.4 m -163.66 105.92 0.96 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.224 -1.39 . . . . 0.0 112.216 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -130.4 120.62 24.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -0.812 . . . . 0.0 109.505 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -49.29 -20.35 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.655 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.511 ' O ' HG23 ' A' ' 162' ' ' ILE . 1.6 m -66.03 60.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.122 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -47.27 -38.7 12.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 179.713 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 162' ' ' ILE . 1.6 p30 -44.01 -49.58 8.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.378 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.596 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 1.4 tp -62.88 -49.79 82.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.636 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 44.3 t -46.81 -46.43 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -44.9 -55.19 5.67 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.242 0.544 . . . . 0.0 111.181 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 167' ' ' CYS . 21.0 tttp -87.06 -61.88 1.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.213 -0.929 . . . . 0.0 110.921 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.484 HG22 ' CE1' ' A' ' 172' ' ' HIS . 5.8 p -42.51 -24.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 40.8 t -82.98 -27.68 30.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 110.446 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.491 ' O ' ' HB ' ' A' ' 169' ' ' ILE . 9.0 mm-40 -91.56 -175.57 4.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.145 -0.972 . . . . 0.0 111.018 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.491 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 22.1 mt 62.1 161.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.574 -0.704 . . . . 0.0 110.57 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -42.92 167.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.899 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 178' ' ' MET . 0.1 OUTLIER -59.03 -172.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.189 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.484 ' CE1' HG22 ' A' ' 166' ' ' VAL . 34.4 m-70 -105.01 -95.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 174.25 119.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 110.201 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.541 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 10.6 tp -98.27 78.64 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 49.0 m-80 63.84 -53.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 0.0 111.576 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -138.6 -0.67 1.93 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.987 -1.071 . . . . 0.0 111.383 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.517 ' HB3' ' CG2' ' A' ' 174' ' ' ILE . 0.9 OUTLIER -125.04 -175.53 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.913 -1.117 . . . . 0.0 111.079 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -121.72 79.03 1.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.627 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.54 ' CG1' ' HB ' ' A' ' 174' ' ' ILE . 5.2 m -79.09 130.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.451 ' HA ' ' HB3' ' A' ' 171' ' ' PHE . 59.3 tt0 -80.17 163.0 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 167' ' ' CYS . 43.1 t -133.07 110.51 10.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.435 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 8.0 mmtm -105.29 163.42 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.525 ' HG3' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -76.32 154.95 34.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.022 . . . . 0.0 110.229 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.468 ' HB1' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.373 -0.829 . . . . 0.0 110.418 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 155' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.037 0.446 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.638 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pt -133.6 175.13 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 110.721 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.514 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 15.9 t80 -138.21 145.39 41.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.492 -0.755 . . . . 0.0 109.267 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.435 ' C ' HD12 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -130.13 148.43 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.51 166.07 25.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.489 ' O ' ' CE ' ' A' ' 177' ' ' LYS . . . 86.31 -13.61 57.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -54.23 97.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -1.111 . . . . 0.0 110.648 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -54.85 175.9 0.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.092 -1.005 . . . . 0.0 108.656 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' ' CB ' ' A' ' 119' ' ' ASN . 1.4 t -79.51 -155.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.658 -1.276 . . . . 0.0 110.115 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.56 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 75.44 -32.85 0.22 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' A' ' 121' ' ' THR . 1.8 m -81.47 172.14 13.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.606 0.717 . . . . 0.0 111.313 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 120' ' ' THR . 10.8 t -149.25 154.93 39.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 109.38 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 139' ' ' MET . 2.4 t -39.3 -50.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.465 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.64 -24.77 0.13 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.402 -0.812 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.576 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 25.5 t0 -74.95 -59.76 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.736 . . . . 0.0 109.696 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.463 ' HB ' HD13 ' A' ' 140' ' ' LEU . 1.1 t -63.66 -48.92 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.541 -0.724 . . . . 0.0 109.388 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 12.5 tttp -48.47 -60.94 2.29 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.255 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.576 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -63.9 -36.29 83.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.012 -1.055 . . . . 0.0 110.255 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.509 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 35.8 t80 -58.39 -57.7 11.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.38 -0.825 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 72.5 m-85 -83.0 -16.36 47.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.025 . . . . 0.0 111.485 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.507 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 83.3 tt0 -55.89 -37.59 69.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.45 -1.406 . . . . 0.0 108.244 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.4 pt20 -74.41 -16.6 60.88 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.587 ' CD2' HD13 ' A' ' 162' ' ' ILE . 4.3 m-30 -87.72 -32.32 19.22 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 109.127 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.9 35.75 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.408 ' HD3' ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -50.81 -41.38 57.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.607 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 47.62 91.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.195 0.998 . . . . 0.0 111.074 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -25.39 17.59 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.45 144.24 51.27 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.509 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -160.41 100.97 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.204 -0.935 . . . . 0.0 108.59 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.547 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 0.3 OUTLIER -114.92 165.4 12.9 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.813 0.816 . . . . 0.0 112.239 -178.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.466 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 34.2 mt -140.12 139.87 35.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.554 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -114.17 132.7 56.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.026 -1.046 . . . . 0.0 110.912 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 141' ' ' MET . 30.2 m-85 -142.72 -173.74 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 58.4 m-20 53.34 -166.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 62.97 -142.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.407 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.414 ' O ' HG21 ' A' ' 146' ' ' THR . 0.2 OUTLIER -83.16 10.45 8.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.495 ' CG2' ' HB3' ' A' ' 150' ' ' ARG . 17.2 p -139.32 41.68 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.997 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 21.9 m-80 -47.05 -87.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 110.416 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 150' ' ' ARG . 3.7 mtt180 -97.26 161.99 13.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.438 -0.789 . . . . 0.0 110.192 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CB ' ' O ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER 64.69 -75.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.495 ' HB3' ' CG2' ' A' ' 146' ' ' THR . 8.0 mpt_? -53.75 -17.27 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 110.7 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -41.87 133.91 3.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 13.5 p90 -150.14 140.25 22.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -1.088 . . . . 0.0 109.387 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.435 ' HA3' HD22 ' A' ' 140' ' ' LEU . . . -123.54 165.57 16.25 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.249 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' CG ' ' A' ' 139' ' ' MET . 22.8 m-85 -120.37 112.18 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 0.0 109.162 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.509 HG11 ' HA ' ' A' ' 138' ' ' ALA . 1.6 t -108.31 -179.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.68 -1.262 . . . . 0.0 109.008 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.459 ' OG1' ' HB2' ' A' ' 110' ' ' LYS . 32.3 m -161.08 105.14 1.32 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.765 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.638 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 1.1 p90 -127.28 102.47 6.93 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.222 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.27 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 111.195 -178.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.495 ' O ' HG21 ' A' ' 162' ' ' ILE . 0.8 OUTLIER -54.74 86.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.9 OUTLIER -54.91 -38.24 67.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.657 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.6 OUTLIER -39.39 -68.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.486 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.587 HD13 ' CD2' ' A' ' 132' ' ' PHE . 0.5 OUTLIER -58.61 -45.63 90.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.956 -1.09 . . . . 0.0 108.875 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 160' ' ' GLU . 9.9 t -47.29 -34.31 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -61.01 -42.81 99.18 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.617 0.722 . . . . 0.0 109.742 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.533 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.2 tptt -86.25 -62.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.56 -0.713 . . . . 0.0 110.81 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.545 ' O ' ' CB ' ' A' ' 181' ' ' CYS . 4.9 m -46.63 -24.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 108.908 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 1.7 t -65.89 -31.27 72.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.039 -1.038 . . . . 0.0 108.457 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -71.88 158.68 35.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.193 0.52 . . . . 0.0 110.717 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.483 ' O ' ' CG1' ' A' ' 169' ' ' ILE . 1.2 pp -90.57 85.5 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.424 -0.798 . . . . 0.0 110.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 172' ' ' HIS . 0.7 OUTLIER -126.79 139.61 52.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.373 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.632 ' CE1' ' HG3' ' A' ' 178' ' ' MET . 0.1 OUTLIER -42.54 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.058 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.525 ' CD2' ' SG ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -87.05 -41.24 14.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 110.456 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.2 tt0 66.42 105.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.372 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.535 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 0.5 OUTLIER -112.43 118.03 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.271 179.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.486 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.4 m-20 67.45 -55.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.9 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -170.37 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 111.278 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.581 ' C ' ' CD ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -140.96 125.9 18.2 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.564 -1.335 . . . . 0.0 110.649 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.632 ' HG3' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -60.72 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.121 -0.987 . . . . 0.0 110.631 179.125 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.534 ' CG1' ' HD2' ' A' ' 177' ' ' LYS . 21.1 m -72.23 170.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 0.0 110.63 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.23 140.5 45.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 81.3 m -114.79 151.94 32.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -159.84 147.11 16.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 110.255 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.543 ' HG3' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -58.31 166.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.385 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.491 ' HB1' ' CA ' ' A' ' 111' ' ' ILE . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.991 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.572 ' HB ' ' HA ' ' A' ' 183' ' ' LYS . 1.3 pp -92.79 163.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.679 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.0 t80 -116.8 152.58 34.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.08 -1.013 . . . . 0.0 109.429 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.516 ' HA ' ' HB2' ' A' ' 182' ' ' LYS . 2.3 m -143.38 155.63 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -140.03 -179.03 17.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 179' ' ' VAL . . . 74.37 22.0 78.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' A' ' 140' ' ' LEU . 0.8 OUTLIER -42.43 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLY . 14.3 t -46.88 161.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 120' ' ' THR . 3.0 t -73.17 151.69 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.87 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.508 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 64.71 -44.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.459 0.647 . . . . 0.0 109.761 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.565 ' H ' ' C ' ' A' ' 118' ' ' VAL . 2.6 m -41.16 132.26 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.993 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.498 ' N ' ' OD2' ' A' ' 124' ' ' ASP . 2.0 m -118.84 165.43 14.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 110.536 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 138' ' ' ALA . 2.3 t -39.36 -52.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 111.038 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' VAL . 7.3 mt-10 -42.52 -25.37 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.382 -0.823 . . . . 0.0 109.477 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.527 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 82.6 m-20 -74.51 -54.04 8.3 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.452 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 174' ' ' ILE . 2.0 t -65.77 -48.51 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 109.2 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.489 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 14.4 ttpt -47.65 -61.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.527 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -64.14 -32.32 73.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 109.599 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.576 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 31.8 t80 -59.6 -57.99 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.406 -0.809 . . . . 0.0 110.384 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.576 ' CE1' ' CE2' ' A' ' 128' ' ' TYR . 61.1 m-85 -82.59 -14.59 54.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.0 111.038 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.505 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 78.7 tt0 -55.0 -38.92 68.48 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.195 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.6 pt20 -73.12 -17.44 61.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 4.2 m-85 -91.66 -30.15 16.48 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -158.96 155.22 26.29 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HE3' ' HG2' ' A' ' 158' ' ' GLU . 1.9 ptpt -41.34 -40.6 1.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -1.129 . . . . 0.0 110.535 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 45.15 94.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 111.17 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.84 -25.74 19.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.17 144.47 48.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.534 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.548 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -153.83 99.03 2.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.46 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 4.9 tpp -99.66 164.61 11.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.897 0.856 . . . . 0.0 111.481 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' A' ' 116' ' ' LEU . 11.5 mt -149.78 133.56 16.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.487 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 15.9 mmm -111.26 122.03 46.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.833 -1.167 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.449 ' CE1' ' O ' ' A' ' 120' ' ' THR . 15.5 m-85 -106.92 -168.03 1.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.419 -0.801 . . . . 0.0 109.86 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 144' ' ' LYS . 8.8 t0 -109.19 -162.72 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 110.068 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 143' ' ' ASP . 0.2 OUTLIER -42.93 -55.2 3.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.405 HG21 ' N ' ' A' ' 146' ' ' THR . 53.2 m -148.86 -87.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.792 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.405 ' N ' HG21 ' A' ' 145' ' ' THR . 0.0 OUTLIER -111.56 3.39 17.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.363 -0.835 . . . . 0.0 110.102 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.87 59.14 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 109.807 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.421 ' HA ' ' HB2' ' A' ' 143' ' ' ASP . 0.0 OUTLIER -89.6 -56.5 3.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 111.282 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.4 ' H ' ' HG3' ' A' ' 148' ' ' ARG . 0.1 OUTLIER 53.34 18.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.152 -179.757 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -178.19 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.656 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 150' ' ' ARG . . . 58.39 150.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 14.7 p90 -150.44 140.0 21.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -1.106 . . . . 0.0 109.596 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.517 ' N ' HD22 ' A' ' 116' ' ' LEU . . . -124.81 177.81 16.72 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.408 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.679 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 61.0 m-85 -138.37 117.41 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.929 . . . . 0.0 109.102 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.554 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 1.7 t -109.07 -174.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 155' ' ' VAL . 88.5 m -162.93 103.81 1.01 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.909 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.592 ' CE2' HG23 ' A' ' 163' ' ' VAL . 2.3 p90 -135.6 107.45 7.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.9 -22.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.434 -0.791 . . . . 0.0 111.118 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.4 OUTLIER -56.36 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.421 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -61.63 -38.03 86.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.051 -1.031 . . . . 0.0 109.827 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 160' ' ' GLU . 10.1 t70 -39.27 -67.61 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.366 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.528 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 5.6 tp -58.49 -42.68 85.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 108.79 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.592 HG23 ' CE2' ' A' ' 157' ' ' PHE . 38.2 t -50.94 -44.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.03 -46.51 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.7 tttt -90.26 -64.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -0.922 . . . . 0.0 111.202 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.527 HG11 ' N ' ' A' ' 167' ' ' CYS . 6.0 p -45.31 -21.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.722 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 43.5 t -79.86 -22.87 42.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.931 -1.106 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 -68.26 156.43 37.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.78 113.83 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -163.23 32.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 110.331 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.659 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 0.0 OUTLIER 55.88 165.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.502 ' NE2' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -143.85 -156.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 10.6 tp10 -158.91 86.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.904 -1.123 . . . . 0.0 111.012 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.575 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 1.5 tt -102.98 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.941 -1.099 . . . . 0.0 109.854 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 4.8 m120 67.36 -56.75 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -170.93 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 110.174 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.8 tptt -128.19 163.98 23.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 111.018 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.659 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -94.28 -18.63 21.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -0.785 . . . . 0.0 109.32 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.549 ' CG1' HG23 ' A' ' 174' ' ' ILE . 34.5 m 37.25 -160.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.44 140.1 21.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 26.2 p -81.39 132.47 35.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.438 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -129.5 11.02 5.75 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.235 1.017 . . . . 0.0 109.175 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.572 ' HA ' ' HB ' ' A' ' 111' ' ' ILE . 1.4 mptt -41.01 158.09 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.586 -0.696 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 -179.894 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 9.8 pttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.03 0.443 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.523 HD12 ' CE1' ' A' ' 157' ' ' PHE . 5.4 pt -103.55 169.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.968 -1.083 . . . . 0.0 111.16 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -123.69 144.73 49.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.706 -0.621 . . . . 0.0 109.647 179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -140.14 138.65 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 110.33 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -127.98 165.48 20.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.502 ' O ' ' CG1' ' A' ' 179' ' ' VAL . . . 89.68 17.04 55.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.534 ' CD1' ' HG ' ' A' ' 140' ' ' LEU . 38.5 mt -39.54 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 110.278 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLY . 0.2 OUTLIER -43.87 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.884 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 120' ' ' THR . 10.6 m -67.71 157.6 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.766 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.532 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.22 -38.95 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.911 -0.493 . . . . 0.0 110.779 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 118' ' ' VAL . 54.9 m -47.68 150.23 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.947 -1.095 . . . . 0.0 109.994 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.547 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 7.5 t -147.63 -167.28 2.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.481 HG11 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -60.21 -56.15 19.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 109.852 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -44.1 -24.62 0.16 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 109.604 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 121' ' ' THR . 40.7 m-20 -78.2 -58.98 2.97 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.746 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 155' ' ' VAL . 1.5 t -62.15 -47.79 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 108.943 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.487 ' HA ' ' CB ' ' A' ' 138' ' ' ALA . 6.0 ttmt -46.66 -61.98 1.59 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.485 -0.76 . . . . 0.0 109.992 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.518 ' ND1' ' C ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -64.76 -34.55 78.6 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.439 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 29.7 t80 -55.6 -58.21 8.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.575 -0.703 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.469 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 94.0 m-85 -81.29 -15.81 54.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.7 tt0 -55.41 -38.12 68.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 4.2 pt20 -74.59 -15.82 60.82 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.298 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.469 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 18.5 m-85 -86.85 -30.67 21.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.445 0.64 . . . . 0.0 109.341 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -162.03 -174.59 32.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -56.15 24.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.4 t 56.07 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.208 1.004 . . . . 0.0 111.135 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -24.91 16.36 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -130.71 140.01 50.33 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -153.8 101.69 2.47 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.486 ' O ' ' HA3' ' A' ' 153' ' ' GLY . 1.3 ptm -113.16 168.79 9.43 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.92 0.867 . . . . 0.0 113.117 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.581 ' HB3' ' CE2' ' A' ' 142' ' ' PHE . 2.6 mp -139.1 139.18 37.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.851 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.575 ' SD ' ' CE1' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -109.56 132.6 53.98 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.755 -1.215 . . . . 0.0 109.75 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 95.7 m-85 -122.66 -156.18 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.78 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.443 ' O ' ' HB ' ' A' ' 146' ' ' THR . 0.4 OUTLIER 61.26 -177.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.182 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.535 ' O ' ' CG2' ' A' ' 145' ' ' THR . 0.2 OUTLIER 61.34 100.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.93 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 144' ' ' LYS . 10.5 t 39.6 26.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.481 -0.762 . . . . 0.0 110.382 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.582 ' CG2' ' O ' ' A' ' 146' ' ' THR . 2.3 m -151.08 56.46 0.89 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.115 0.959 . . . . 0.0 108.575 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 2.2 m120 -59.32 -10.97 3.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.903 -1.123 . . . . 0.0 110.898 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -144.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.68 34.66 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.149 -0.97 . . . . 0.0 110.485 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.483 ' HA ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -95.41 -158.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . 108.03 -147.46 16.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.575 ' CE1' ' SD ' ' A' ' 141' ' ' MET . 5.4 p90 -151.02 139.5 20.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.01 -1.288 . . . . 0.0 109.999 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.544 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -104.56 158.3 16.5 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.18 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.483 ' O ' ' HG3' ' A' ' 139' ' ' MET . 89.4 m-85 -114.3 103.4 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.526 HG23 ' CG1' ' A' ' 125' ' ' VAL . 0.7 OUTLIER -97.0 -179.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.485 -178.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.475 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 73.7 m -163.95 104.52 0.9 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.782 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.583 ' CE2' ' CG2' ' A' ' 163' ' ' VAL . 0.9 OUTLIER -125.99 106.55 9.7 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.45 177.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.553 -0.717 . . . . 0.0 111.529 -178.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.3 OUTLIER -56.95 83.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 110.487 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -61.12 -38.43 86.32 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.774 -1.204 . . . . 0.0 109.478 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.8 m-20 -41.53 -62.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.575 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 1.1 tp -57.52 -47.14 85.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.033 -1.042 . . . . 0.0 108.564 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.583 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 43.2 t -47.67 -49.07 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.454 ' O ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -41.53 -52.28 3.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.674 -0.641 . . . . 0.0 111.386 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 167' ' ' CYS . 58.1 tttt -90.5 -61.79 1.6 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -0.999 . . . . 0.0 110.855 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 163' ' ' VAL . 7.1 p -42.36 -24.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 163' ' ' VAL . 13.9 p -81.2 -30.59 34.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.874 -1.141 . . . . 0.0 110.268 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.7 OUTLIER -67.82 -56.07 10.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.605 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.455 HD13 ' HG2' ' A' ' 165' ' ' LYS . 2.4 mt -43.74 136.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -110.73 17.52 20.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 0.0 110.013 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 1.3 t80 -140.23 64.26 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.426 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.517 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -71.11 138.88 50.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 110.166 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.7 tt0 -90.09 96.74 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.148 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.552 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 2.0 tt -97.71 97.26 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 110.034 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.472 ' OD1' ' CG1' ' A' ' 174' ' ' ILE . 3.8 m120 67.78 -56.89 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 110.009 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.543 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -166.0 23.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 110.192 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -127.22 166.03 18.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 111.031 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -109.3 40.24 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.492 -0.755 . . . . 0.0 109.44 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 115' ' ' GLY . 19.0 m -47.76 167.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.5 -0.75 . . . . 0.0 111.332 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 1.8 tt0 -107.78 150.12 27.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.614 -0.679 . . . . 0.0 109.823 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 167' ' ' CYS . 3.1 p -131.0 90.6 2.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -89.66 143.24 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.424 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -79.99 163.87 23.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.296 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.318 -179.903 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.502 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.359 0.599 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.612 HD13 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.99 174.19 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.753 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.576 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 41.0 t80 -123.53 156.76 35.04 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.947 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 1.4 m -145.0 154.38 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 179' ' ' VAL . . . -144.12 174.0 24.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.407 ' O ' HG11 ' A' ' 179' ' ' VAL . . . 77.85 12.84 84.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 153' ' ' GLY . 39.5 mt -53.48 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -1.171 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.504 ' HB2' ' CD ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -42.25 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.504 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 120' ' ' THR . 14.8 m -65.99 161.84 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 110.792 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.539 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 62.57 -38.6 0.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 110.67 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 118' ' ' VAL . 21.8 m -42.58 139.48 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 109.921 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.443 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 8.7 t -127.0 168.93 13.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.08 -1.013 . . . . 0.0 111.079 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 1.5 t -39.3 -47.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.679 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -44.38 -25.66 0.27 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 108.968 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.564 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 15.7 t0 -69.51 -46.31 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.699 . . . . 0.0 109.665 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.517 HG23 ' CD2' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -76.66 -44.17 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.807 0.813 . . . . 0.0 109.17 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 9.6 ttmt -59.38 -48.82 80.19 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.691 -0.63 . . . . 0.0 111.078 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.564 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.9 -28.63 63.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 110.123 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 67.4 t80 -79.13 -50.0 11.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 112.167 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.545 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 68.6 m-85 -88.43 -16.91 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.814 -1.179 . . . . 0.0 112.118 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.518 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 1.5 pp20? -53.73 -42.49 68.19 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.247 -1.781 . . . . 0.0 108.432 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.474 ' N ' ' CD ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -70.57 -17.04 62.92 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.802 179.527 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.545 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 7.7 m-85 -79.99 -27.77 39.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.35 -132.6 1.36 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.529 ' HD2' ' CB ' ' A' ' 158' ' ' GLU . 1.5 ptpp? -101.13 -37.48 8.55 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.516 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.4 t 42.45 89.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.11 0.957 . . . . 0.0 110.934 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.12 -27.2 23.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.72 136.92 37.8 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.377 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.502 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -143.2 91.1 2.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.501 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 6.3 ttp -96.32 162.94 13.29 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.098 0.951 . . . . 0.0 112.166 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.517 ' CD2' HG23 ' A' ' 125' ' ' VAL . 22.5 mt -139.35 129.95 25.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 35.2 mmm -103.68 111.46 23.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.011 -1.056 . . . . 0.0 110.616 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -92.29 -136.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 110.034 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.72 95.98 2.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.06 . . . . 0.0 110.471 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 145' ' ' THR . 10.7 tptt 51.5 -109.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 110.117 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.441 ' N ' ' HG3' ' A' ' 144' ' ' LYS . 32.9 m -87.7 -90.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.799 -1.188 . . . . 0.0 110.043 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 148' ' ' ARG . 6.9 t -132.94 8.77 4.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.33 52.83 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -109.4 155.31 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -121.62 -21.19 6.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 0.0 109.916 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -156.68 -55.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 109.627 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 63.4 179.03 5.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.7 p90 -147.46 140.4 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -1.054 . . . . 0.0 109.287 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.534 ' N ' HD12 ' A' ' 116' ' ' LEU . . . -111.05 161.55 12.77 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.375 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -123.82 109.85 14.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -1.013 . . . . 0.0 109.128 179.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -105.24 -178.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 109.372 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.514 ' N ' HD12 ' A' ' 111' ' ' ILE . 78.7 m -159.7 104.25 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.58 -1.325 . . . . 0.0 112.149 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.612 ' CZ ' HD13 ' A' ' 111' ' ' ILE . 1.6 p90 -127.73 97.23 4.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 0.0 108.748 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLU . 1.0 OUTLIER -39.05 -31.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.755 . . . . 0.0 111.483 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -52.49 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -55.76 -38.11 69.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.091 -1.006 . . . . 0.0 109.755 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.9 OUTLIER -39.85 -64.46 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.305 -179.646 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER -61.36 -46.28 96.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.853 -1.154 . . . . 0.0 108.815 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 160' ' ' GLU . 4.4 t -49.77 -35.3 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -50.1 -63.07 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.66 -0.65 . . . . 0.0 111.217 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 10.7 ptpt -90.43 -45.02 9.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.144 -0.973 . . . . 0.0 111.484 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.545 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 4.0 p -51.9 -22.05 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.517 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.524 ' CB ' ' HG2' ' A' ' 183' ' ' LYS . 89.5 m -89.61 -23.31 21.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.003 -1.061 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 169.83 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.41 121.29 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.52 -152.27 0.25 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 110.314 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.641 ' CE1' ' HG3' ' A' ' 178' ' ' MET . 1.1 t80 -122.02 81.52 1.84 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.901 . . . . 0.0 110.083 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.479 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER -74.75 115.53 14.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.231 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.3 pt-20 -96.78 109.89 22.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.525 HD12 ' CG2' ' A' ' 179' ' ' VAL . 4.7 pt -118.91 119.62 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.133 . . . . 0.0 109.789 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.7 OUTLIER 68.22 -56.69 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.933 . . . . 0.0 109.702 -179.133 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -179.07 31.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 109.401 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.4 tptp -139.14 136.7 35.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 111.352 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.641 ' HG3' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -82.29 45.44 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.837 . . . . 0.0 109.588 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.525 ' CG2' HD12 ' A' ' 174' ' ' ILE . 6.8 m -46.77 176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.676 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 38.7 tt0 -129.19 150.89 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 109.821 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -117.91 160.25 21.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.461 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -159.06 150.31 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.769 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.524 ' HG2' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -66.52 158.94 28.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.0 110.276 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 110.261 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.03 0.443 . . . . 0.0 110.126 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.655 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 6.1 pt -106.7 170.89 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.099 -1.001 . . . . 0.0 110.822 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 54.2 t80 -125.57 150.66 47.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.507 -0.746 . . . . 0.0 109.893 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -142.54 159.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.917 . . . . 0.0 110.297 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -151.15 168.66 30.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.14 48.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.524 ' HG ' ' CG ' ' A' ' 140' ' ' LEU . 2.6 mm? -63.89 93.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -1.196 . . . . 0.0 109.543 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 177' ' ' LYS . 4.9 t -64.6 -146.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 111.118 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.577 ' O ' ' N ' ' A' ' 120' ' ' THR . 8.9 t -90.41 166.97 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 111.223 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 61.59 -40.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.285 0.564 . . . . 0.0 110.476 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.577 ' N ' ' O ' ' A' ' 118' ' ' VAL . 24.2 m -51.22 134.51 27.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.045 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.472 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.6 t -138.57 159.18 42.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.53 HG22 ' CB ' ' A' ' 140' ' ' LEU . 2.6 t -39.74 -52.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.818 . . . . 0.0 110.556 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 122' ' ' VAL . 5.5 tt0 -39.68 -28.22 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.548 -0.72 . . . . 0.0 109.294 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 122' ' ' VAL . 28.0 m-20 -75.17 -59.79 2.58 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.004 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 129' ' ' PHE . 1.6 t -63.84 -48.86 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.25 -0.906 . . . . 0.0 108.99 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 5.2 ttpt -45.19 -70.14 0.11 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.413 -0.804 . . . . 0.0 109.495 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.515 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -55.99 -37.58 69.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.186 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.493 ' O ' ' CD1' ' A' ' 132' ' ' PHE . 26.2 t80 -58.69 -47.4 84.63 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.59 -0.694 . . . . 0.0 111.409 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.525 ' CD2' HG12 ' A' ' 125' ' ' VAL . 69.2 m-85 -87.19 -15.11 39.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.05 -1.031 . . . . 0.0 113.425 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.594 ' CG ' ' O ' ' A' ' 126' ' ' LYS . 3.2 mt-10 -56.53 -34.58 67.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.632 -1.917 . . . . 0.0 108.618 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.555 ' HG3' ' CD1' ' A' ' 132' ' ' PHE . 20.3 pt20 -74.87 -17.39 60.59 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.411 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.555 ' CD1' ' HG3' ' A' ' 131' ' ' GLN . 28.1 m-85 -83.79 -31.82 25.71 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -163.55 169.48 38.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HD2' ' HG2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -42.39 -57.01 2.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -1.128 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.2 t 61.11 90.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.202 1.001 . . . . 0.0 111.268 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.13 -26.98 14.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.73 140.9 50.98 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.771 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.473 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -154.17 99.31 2.22 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.519 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 2.5 ptm -110.31 167.61 10.07 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.064 0.935 . . . . 0.0 112.265 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.53 ' CB ' HG22 ' A' ' 122' ' ' VAL . 5.1 tp -146.47 155.04 42.25 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 140' ' ' LEU . 75.5 mmm -142.22 144.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' CE1' HD22 ' A' ' 140' ' ' LEU . 23.3 m-85 -114.94 -143.85 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -114.59 -10.83 12.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.503 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' HD3' ' O ' ' A' ' 143' ' ' ASP . 0.3 OUTLIER 179.36 -148.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 110.162 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 m -105.5 -23.66 12.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.371 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.77 -51.22 0.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.145 -0.972 . . . . 0.0 110.122 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 144' ' ' LYS . 19.4 p-10 -80.45 49.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.487 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -94.07 156.78 16.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.43 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.451 ' HB3' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -159.63 -74.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 0.0 110.148 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.451 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -98.41 113.23 25.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.61 -164.05 11.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.615 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.8 p90 -149.0 146.87 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 109.641 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -123.71 152.84 17.2 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.883 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.519 ' O ' ' CG ' ' A' ' 139' ' ' MET . 30.6 m-85 -119.26 109.28 15.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.059 -1.259 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.473 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -103.92 179.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.758 -1.214 . . . . 0.0 109.042 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 61.0 m -162.74 107.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.944 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.655 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -127.62 127.21 43.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.446 ' HG2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -52.83 -17.25 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 110.952 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.535 ' O ' HG23 ' A' ' 162' ' ' ILE . 1.7 m -72.53 81.1 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -59.28 -39.09 81.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.76 -1.213 . . . . 0.0 109.25 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.487 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 1.5 m-20 -40.2 -58.72 1.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.766 -0.584 . . . . 0.0 110.344 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.563 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.5 OUTLIER -61.65 -47.5 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.614 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.599 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 36.1 t -47.07 -39.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 10.0 tt0 -46.13 -64.18 0.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.79 -0.569 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 3.9 pttm -90.5 -46.86 8.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.22 -0.925 . . . . 0.0 111.64 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 162' ' ' ILE . 4.9 p -48.68 -23.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.075 . . . . 0.0 110.27 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.499 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 91.3 m -89.93 -27.32 19.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.353 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 169' ' ' ILE . 39.1 tt0 -74.89 -35.72 62.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.864 . . . . 0.0 110.705 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.58 HG23 ' CE1' ' A' ' 172' ' ' HIS . 1.2 tt -42.42 145.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 110.441 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.568 ' CD2' ' OE1' ' A' ' 180' ' ' GLU . 1.8 t60 -114.8 28.53 8.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.035 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.656 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.9 OUTLIER -171.21 56.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.317 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.58 ' CE1' HG23 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.93 128.54 36.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 110.348 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.496 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -84.17 104.4 14.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.529 ' CD1' HG22 ' A' ' 179' ' ' VAL . 3.8 mt -103.59 100.88 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 0.0 109.655 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.0 m-20 66.25 -55.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.301 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 174' ' ' ILE . 6.6 p30 -168.01 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.49 -0.756 . . . . 0.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.564 ' CE ' ' CB ' ' A' ' 117' ' ' SER . 1.3 tptt -131.85 152.17 51.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.656 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -92.99 44.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.858 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 174' ' ' ILE . 33.5 m -48.06 170.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.354 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.568 ' OE1' ' CD2' ' A' ' 170' ' ' HIS . 30.5 tt0 -122.87 146.51 47.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 167' ' ' CYS . 0.5 OUTLIER -114.75 165.51 12.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.358 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -161.05 175.82 12.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.074 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.84 144.52 25.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.093 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.315 0.578 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.567 HG22 ' CZ ' ' A' ' 157' ' ' PHE . 2.0 pt -104.92 176.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -0.806 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.479 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 0.9 OUTLIER -124.55 159.81 29.79 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.223 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.472 HG22 ' CA ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -149.3 161.66 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 0.0 110.483 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.477 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -150.86 152.69 24.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 114.3 -17.13 19.4 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -49.81 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -1.148 . . . . 0.0 110.097 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 118' ' ' VAL . 30.4 t -101.64 -167.57 1.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.747 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 120' ' ' THR . 16.4 m -42.25 168.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 111.081 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.551 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 62.69 -41.75 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.155 0.502 . . . . 0.0 110.33 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 118' ' ' VAL . 1.3 m -61.4 133.16 55.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.932 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.529 ' O ' ' HB ' ' A' ' 122' ' ' VAL . 10.2 t -149.27 60.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.091 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.545 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 3.1 t 63.97 -56.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.173 0.511 . . . . 0.0 110.425 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.563 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.4 mm-40 -44.57 -23.71 0.14 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.442 -0.786 . . . . 0.0 108.946 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.549 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-20 -70.23 -58.04 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.718 . . . . 0.0 109.686 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.575 HG12 ' CD2' ' A' ' 129' ' ' PHE . 2.0 t -68.38 -50.48 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.703 . . . . 0.0 109.326 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 15.8 tttt -49.01 -59.76 3.34 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.386 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.574 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -58.21 -29.53 65.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.477 ' O ' ' NE2' ' A' ' 131' ' ' GLN . 49.2 t80 -74.96 -62.41 1.56 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 111.827 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.575 ' CD2' HG12 ' A' ' 125' ' ' VAL . 67.8 m-85 -74.09 -15.09 61.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.902 -1.123 . . . . 0.0 112.668 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -52.41 -41.29 63.07 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 117.702 -1.599 . . . . 0.0 109.113 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.477 ' NE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -72.17 -16.97 61.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.648 -0.821 . . . . 0.0 108.874 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.522 ' HB3' HG13 ' A' ' 162' ' ' ILE . 2.8 m-85 -88.66 -25.36 22.43 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.564 0.697 . . . . 0.0 109.164 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -166.23 153.42 23.26 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.461 ' NZ ' ' HB3' ' A' ' 158' ' ' GLU . 12.3 ptpt -38.49 -41.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.599 -0.942 . . . . 0.0 110.727 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.56 ' CG1' ' O ' ' A' ' 135' ' ' VAL . 1.2 t 47.52 90.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.099 0.952 . . . . 0.0 110.604 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.1 -26.06 19.31 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -127.92 140.23 52.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -157.77 98.93 1.68 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.545 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.95 169.37 9.7 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.971 0.891 . . . . 0.0 112.505 -177.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.537 ' HA ' ' CA ' ' A' ' 153' ' ' GLY . 18.0 mt -144.59 132.41 21.29 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.522 ' HE2' ' CE ' ' A' ' 139' ' ' MET . 1.9 mmt -103.16 112.27 25.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.179 -0.951 . . . . 0.0 110.784 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 140' ' ' LEU . 77.2 m-85 -99.98 154.96 17.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 147' ' ' ASN . 0.4 OUTLIER -101.77 90.16 3.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 109.946 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 143' ' ' ASP . 14.4 mttt -41.1 -32.38 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 110.541 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 65.9 p -74.1 -42.76 59.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.127 -0.983 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -150.45 53.71 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 110.111 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 143' ' ' ASP . 47.5 p30 -73.91 52.53 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.307 -0.871 . . . . 0.0 110.563 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.19 -38.45 1.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -101.25 -31.74 10.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.723 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -110.66 171.18 7.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 148.07 129.15 1.84 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 141' ' ' MET . 29.4 p90 -141.58 134.5 28.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -1.205 . . . . 0.0 110.248 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.537 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -117.0 165.15 12.35 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.489 ' O ' ' HG3' ' A' ' 139' ' ' MET . 46.6 m-85 -125.96 109.6 12.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.594 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.532 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -101.63 -177.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.973 -1.079 . . . . 0.0 108.922 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.472 ' OG1' ' O ' ' A' ' 155' ' ' VAL . 88.6 m -164.07 105.48 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.277 -1.369 . . . . 0.0 112.242 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.568 ' CE2' HG23 ' A' ' 163' ' ' VAL . 1.3 p90 -132.41 108.36 9.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.02 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 160' ' ' GLU . 5.3 tt0 -39.56 -27.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 0.0 110.847 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.52 ' O ' HG21 ' A' ' 162' ' ' ILE . 0.7 OUTLIER -53.58 88.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 110.427 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.0 tm-20 -66.35 -38.58 87.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.1 OUTLIER -40.84 -60.73 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.995 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.557 ' CD1' HG23 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -59.88 -48.86 86.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.772 178.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.587 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 42.1 t -46.98 -41.95 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 4.9 tt0 -51.09 -42.92 60.93 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.512 0.673 . . . . 0.0 110.259 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -88.86 -63.59 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.372 -0.83 . . . . 0.0 110.947 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 162' ' ' ILE . 12.4 m -47.25 -23.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.489 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 13.9 t -73.63 -24.41 60.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 108.983 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 165' ' ' LYS . 42.2 tp10 -105.64 -49.76 3.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.842 -0.536 . . . . 0.0 110.418 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.418 HG23 ' CE1' ' A' ' 172' ' ' HIS . 43.4 mt -52.77 111.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.447 ' NE2' ' OE1' ' A' ' 180' ' ' GLU . 0.4 OUTLIER -88.22 176.74 7.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.612 ' CE1' ' HG2' ' A' ' 178' ' ' MET . 2.8 t80 43.66 65.91 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -0.958 . . . . 0.0 110.004 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.509 ' NE2' HG11 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -66.5 -22.47 66.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.148 -0.97 . . . . 0.0 110.272 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.506 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 13.1 tt0 70.48 79.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 0.0 110.824 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.545 ' CG2' ' CB ' ' A' ' 177' ' ' LYS . 2.8 tt -78.29 -175.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.97 -1.081 . . . . 0.0 109.726 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' ILE . 48.0 m-80 -30.28 -57.36 0.19 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.8 -0.562 . . . . 0.0 111.819 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.7 OUTLIER -138.86 28.9 2.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.213 -0.929 . . . . 0.0 110.27 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.545 ' CB ' ' CG2' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -142.88 -166.63 2.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.729 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.612 ' HG2' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -135.39 33.61 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.477 ' HB ' ' O ' ' A' ' 114' ' ' GLY . 33.3 m -36.9 159.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.518 0.675 . . . . 0.0 111.375 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.447 ' OE1' ' NE2' ' A' ' 170' ' ' HIS . 28.4 tt0 -114.57 153.72 29.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.78 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 166' ' ' VAL . 20.2 m -121.97 122.02 38.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 110.588 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -124.22 137.65 54.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -56.08 164.91 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 0.0 110.8 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.109 0.481 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.652 ' CG2' ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pp -119.25 -179.15 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.853 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.574 ' N ' ' CD1' ' A' ' 111' ' ' ILE . 1.6 t80 -131.43 159.49 37.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 109.563 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.435 HG21 ' CA ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -145.78 155.4 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.291 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 179' ' ' VAL . . . -156.63 140.62 7.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 121.62 -10.1 9.82 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.445 HD11 HD22 ' A' ' 140' ' ' LEU . 0.4 OUTLIER -50.89 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -1.12 . . . . 0.0 109.929 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' GLY . 53.7 p -65.49 -167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.782 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.549 ' O ' ' N ' ' A' ' 120' ' ' THR . 23.1 m -58.84 171.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 0.0 111.225 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.526 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.3 OUTLIER 62.2 -39.87 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.914 -0.491 . . . . 0.0 110.775 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.549 ' N ' ' O ' ' A' ' 118' ' ' VAL . 36.8 m -55.56 148.74 15.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.006 -1.059 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.468 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.7 t -158.28 166.88 31.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.623 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 140' ' ' LEU . 2.3 t -41.6 -53.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 110.558 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.08 -25.8 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.543 ' OD2' ' CG1' ' A' ' 174' ' ' ILE . 50.5 t0 -72.24 -49.94 31.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.508 HG13 ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -69.37 -44.85 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.09 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 8.2 tttm -52.16 -63.99 0.96 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.518 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -62.85 -30.79 71.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.144 -0.972 . . . . 0.0 110.95 -179.256 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.47 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 84.9 t80 -70.59 -50.92 32.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.19 -0.944 . . . . 0.0 111.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.508 ' CD2' HG13 ' A' ' 125' ' ' VAL . 56.0 m-85 -89.48 -12.29 40.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 111.941 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.689 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 26.0 tt0 -56.31 -38.29 71.08 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.357 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 24.6 pt20 -74.65 -14.46 60.76 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 14.0 m-85 -86.8 -32.16 20.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.712 -0.617 . . . . 0.0 110.424 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -170.3 54.69 0.19 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.346 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.495 ' HB3' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER 60.15 -67.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.722 -0.869 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.689 ' HB ' ' HA ' ' A' ' 130' ' ' GLU . 0.9 OUTLIER 62.44 94.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.083 . . . . 0.0 110.903 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.41 -25.0 25.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.51 136.55 39.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.5 0.667 . . . . 0.0 109.793 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.558 ' HA ' HG11 ' A' ' 155' ' ' VAL . . . -145.18 92.51 2.26 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.505 ' SD ' ' CE ' ' A' ' 141' ' ' MET . 6.8 tpp -90.17 163.06 14.97 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.834 0.826 . . . . 0.0 111.328 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.529 ' CB ' HG21 ' A' ' 122' ' ' VAL . 5.0 tp -151.11 154.71 37.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.774 -0.579 . . . . 0.0 109.711 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.523 ' HB2' ' CD1' ' A' ' 152' ' ' PHE . 8.8 mmt -138.88 157.62 45.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.177 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -124.69 -146.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.915 . . . . 0.0 110.062 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.8 132.94 55.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.116 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -83.13 48.05 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.344 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -94.36 -57.11 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.975 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -149.5 -74.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.574 -0.704 . . . . 0.0 109.925 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -90.27 -82.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.864 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.47 ' O ' ' HB3' ' A' ' 142' ' ' PHE . 4.4 ptt180 -150.33 -49.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.104 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 150' ' ' ARG . 12.8 m170 54.76 177.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 110.657 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 149' ' ' HIS . 5.9 mtm180 -52.0 -174.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.217 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 173.89 -149.26 10.71 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.165 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 6.6 p90 -149.7 141.84 24.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.994 . . . . 0.0 109.252 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.523 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -123.58 160.07 18.15 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.574 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -123.89 113.33 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.976 . . . . 0.0 108.748 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.558 HG11 ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -104.42 178.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.879 -1.138 . . . . 0.0 109.543 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 45.8 m -160.6 104.92 1.41 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.178 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.652 ' CZ ' ' CG2' ' A' ' 111' ' ' ILE . 0.2 OUTLIER -128.83 112.31 14.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 177.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.444 ' CA ' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -39.48 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.499 -0.751 . . . . 0.0 110.585 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 162' ' ' ILE . 1.4 m -59.92 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.486 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.271 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -43.24 -61.13 1.42 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.892 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 163' ' ' VAL . 0.4 OUTLIER -58.1 -46.41 88.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.39 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.629 ' CG2' ' CE2' ' A' ' 157' ' ' PHE . 44.5 t -48.96 -51.3 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 2.9 mt-10 -42.7 -43.97 4.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.612 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -90.92 -66.21 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 111.107 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.521 ' CG2' ' NE2' ' A' ' 172' ' ' HIS . 6.0 p -45.44 -20.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 0.0 110.936 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.518 ' HB2' ' N ' ' A' ' 183' ' ' LYS . 3.5 p -88.19 -29.19 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 109.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.468 ' HA ' ' OE1' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -44.44 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.896 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -80.71 109.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 0.0 110.163 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 171' ' ' PHE . 18.4 t-160 -168.24 120.42 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.607 ' CE2' ' HG3' ' A' ' 178' ' ' MET . 0.1 OUTLIER -42.71 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 110.144 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.551 ' CD2' ' SG ' ' A' ' 181' ' ' CYS . 0.3 OUTLIER -79.79 -153.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 178' ' ' MET . 14.3 tt0 -153.65 127.74 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.623 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 0.5 OUTLIER -116.3 102.82 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.01 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.463 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.9 OUTLIER 66.88 -58.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.188 . . . . 0.0 109.842 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.8 p30 -149.5 -31.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 110.587 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -76.72 -170.05 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.41 -0.806 . . . . 0.0 110.099 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.607 ' HG3' ' CE2' ' A' ' 171' ' ' PHE . 21.8 mmt -100.63 -70.6 0.73 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 114' ' ' GLY . 2.6 t 70.48 160.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.551 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -120.75 152.77 37.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 172' ' ' HIS . 35.4 m -126.39 158.84 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 181' ' ' CYS . 15.4 mtmt -157.53 155.47 30.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.832 . . . . 0.0 109.961 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.518 ' N ' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -67.12 160.88 25.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.034 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.442 ' HB2' ' HG2' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.485 ' HB2' ' OG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.644 ' CD1' ' CE2' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -122.39 176.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.99 . . . . 0.0 110.389 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 56.4 t80 -126.08 160.22 30.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.812 . . . . 0.0 109.926 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.1 OUTLIER -147.42 149.25 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.037 -1.039 . . . . 0.0 110.667 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.22 174.2 22.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 89.59 13.19 61.64 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.511 ' HG ' ' CD2' ' A' ' 140' ' ' LEU . 1.7 mp -40.81 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -1.051 . . . . 0.0 110.167 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 115' ' ' GLY . 22.7 t -64.92 178.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.731 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -72.33 150.23 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 0.0 110.454 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.537 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.25 -38.85 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.99 -0.444 . . . . 0.0 110.598 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 118' ' ' VAL . 18.0 m -41.4 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.304 -0.873 . . . . 0.0 110.015 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 124' ' ' ASP . 10.3 t -164.52 172.51 13.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 3.1 t -39.01 -54.54 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.682 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -41.98 -25.91 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 109.155 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.528 ' OD2' ' CG1' ' A' ' 174' ' ' ILE . 58.1 t0 -72.81 -55.56 6.52 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.493 0.663 . . . . 0.0 109.909 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.538 HG23 ' CD1' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -68.4 -54.75 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.1 tttt -39.29 -63.47 0.55 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.154 0.502 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.48 ' CE1' ' O ' ' A' ' 124' ' ' ASP . 2.1 p-80 -61.87 -29.5 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.073 -1.017 . . . . 0.0 110.897 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -73.36 -55.29 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 0.0 111.707 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PHE . . . . . 0.534 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 38.6 m-85 -84.13 -17.53 39.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.104 . . . . 0.0 111.895 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.656 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 70.0 tt0 -57.2 -36.0 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.114 -1.616 . . . . 0.0 108.262 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . 0.479 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.9 pt20 -76.71 -13.56 60.03 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.534 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 4.1 m-30 -86.95 -35.11 19.07 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.806 -0.559 . . . . 0.0 111.101 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -169.45 65.01 0.18 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.273 -1.918 . . . . 0.0 111.181 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.485 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.86 -70.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.933 . . . . 0.0 111.591 178.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.656 ' HB ' ' HA ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER 64.95 92.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.09 0.948 . . . . 0.0 110.732 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.474 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -87.19 -21.61 25.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.06 137.9 41.59 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.526 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -155.9 98.17 1.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' MET . . . . . 0.533 ' CG ' ' O ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -113.61 171.79 7.36 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.145 0.974 . . . . 0.0 112.555 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.538 ' CD1' HG23 ' A' ' 125' ' ' VAL . 1.0 OUTLIER -145.62 148.43 33.1 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.498 179.683 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . 0.446 ' O ' ' HA3' ' A' ' 151' ' ' GLY . 3.1 mmt -130.45 116.99 19.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.023 -1.048 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -92.64 -173.35 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 109.997 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.02 177.93 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -20.66 65.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.146 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 85.0 m -130.48 -105.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.7 p -150.49 49.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.953 -1.092 . . . . 0.0 109.827 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -53.48 -90.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.593 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.428 ' O ' ' HB3' ' A' ' 149' ' ' HIS . 1.1 tpp180 -150.23 -58.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 110.626 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.549 ' N ' ' ND1' ' A' ' 149' ' ' HIS . 0.0 OUTLIER 178.01 110.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -176.64 36.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . -111.5 -160.14 16.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PHE . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 4.7 p90 -145.35 153.32 41.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -1.158 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.526 ' CA ' ' HA ' ' A' ' 140' ' ' LEU . . . -118.85 158.34 14.88 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.432 -1.366 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 139' ' ' MET . 11.9 m-85 -116.93 110.95 18.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -1.061 . . . . 0.0 109.352 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.529 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -107.65 179.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.638 -1.289 . . . . 0.0 109.392 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . 0.522 ' N ' HD12 ' A' ' 111' ' ' ILE . 97.2 m -163.49 104.75 0.96 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.293 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.644 ' CE2' ' CD1' ' A' ' 111' ' ' ILE . 1.4 p90 -127.83 99.2 5.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.866 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -38.89 -31.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.757 -0.59 . . . . 0.0 111.381 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.513 ' O ' HG23 ' A' ' 162' ' ' ILE . 35.7 m -53.37 86.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.556 ' HA ' HG22 ' A' ' 163' ' ' VAL . 5.3 tt0 -54.36 -38.42 66.06 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.831 -1.168 . . . . 0.0 109.75 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.2 OUTLIER -38.42 -67.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.539 HG21 ' N ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -60.46 -38.23 77.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.325 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.568 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 7.7 t -58.2 -32.94 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.7 tm-20 -58.02 -49.59 76.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.478 -0.764 . . . . 0.0 110.604 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 168' ' ' GLU . 18.9 tttp -89.71 -60.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.577 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.51 HG21 ' NE2' ' A' ' 172' ' ' HIS . 2.5 p -42.34 -25.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.452 -0.78 . . . . 0.0 109.805 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' CYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.7 t -76.28 -34.52 59.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.894 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.577 ' O ' ' CE1' ' A' ' 170' ' ' HIS . 23.3 tt0 -87.04 -86.86 0.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 110.703 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER -41.44 138.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.424 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 168' ' ' GLU . 21.9 m-70 -112.2 -154.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.117 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.664 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.4 OUTLIER 57.09 51.68 10.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.51 ' NE2' HG21 ' A' ' 166' ' ' VAL . 6.7 m80 -83.0 -5.94 59.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 109.775 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 57.7 tt0 59.04 114.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.543 ' CG2' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -111.61 114.55 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.926 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.491 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.8 OUTLIER 68.84 -56.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.0 109.467 -178.448 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . 0.454 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -174.24 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.571 -0.706 . . . . 0.0 110.312 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.534 ' HD2' ' CG1' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -139.92 122.31 16.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 110.138 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' MET . . . . . 0.664 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -54.53 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.856 -1.153 . . . . 0.0 110.504 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' VAL . . . . . 0.534 ' CG1' ' HD2' ' A' ' 177' ' ' LYS . 23.3 m -97.01 -161.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . 0.513 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 19.7 tt0 -134.88 157.12 47.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.975 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.0 t -145.01 141.37 28.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.918 . . . . 0.0 110.48 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 13.6 mtpp -138.02 -171.15 2.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 109.886 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.565 ' CD ' ' N ' ' A' ' 184' ' ' ALA . 0.1 OUTLIER -106.28 164.31 12.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.214 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.565 ' N ' ' CD ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.987 -1.071 . . . . 0.0 110.962 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.821 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.964 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.5 pt -114.77 174.84 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.123 -0.986 . . . . 0.0 110.881 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.7 t80 -121.93 157.7 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.495 -0.753 . . . . 0.0 109.422 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -149.72 153.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.009 . . . . 0.0 110.479 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -141.1 176.37 21.68 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.499 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 87.1 15.38 62.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.65 HD22 HD22 ' A' ' 140' ' ' LEU . 15.4 mt -47.63 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 115' ' ' GLY . 2.2 t -57.52 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 110.66 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 120' ' ' THR . 15.6 m -89.06 154.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.496 -0.753 . . . . 0.0 110.867 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 1.4 t-20 62.26 -35.28 0.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.739 -0.601 . . . . 0.0 111.082 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' VAL . 62.2 m -43.63 128.65 5.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 110.13 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 15.3 t -117.69 158.58 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 110.248 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.4 t -37.5 -51.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.57 -0.706 . . . . 0.0 110.848 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -41.11 -26.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.556 -0.715 . . . . 0.0 109.441 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 1.6 m-20 -74.14 -55.76 5.71 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.728 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 1.007 HG21 HD21 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.6 -48.06 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.328 -0.857 . . . . 0.0 109.241 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 8.6 ttpp -47.53 -60.77 2.3 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.448 -0.783 . . . . 0.0 109.673 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -63.94 -33.51 75.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 7.1 t80 -57.77 -60.7 3.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.56 -0.712 . . . . 0.0 110.439 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 97.3 m-85 -80.43 -16.4 54.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.8 tt0 -56.64 -36.45 69.52 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.382 -1.449 . . . . 0.0 107.957 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.2 pt20 -73.75 -17.21 61.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.511 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 3.6 m-30 -86.31 -28.29 23.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.426 0.632 . . . . 0.0 109.608 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -165.83 -165.73 23.66 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -52.41 59.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.298 -1.119 . . . . 0.0 110.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 55.34 90.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.087 0.946 . . . . 0.0 110.913 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -92.83 -26.57 17.61 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -130.73 140.61 50.34 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.007 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.725 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -154.91 98.78 2.07 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.701 ' HA ' HG22 ' A' ' 122' ' ' VAL . 4.2 ptp -116.57 163.47 16.05 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.948 0.88 . . . . 0.0 112.461 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 125' ' ' VAL . 89.2 mt -137.26 133.01 34.56 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.614 ' O ' HD12 ' A' ' 116' ' ' LEU . 2.6 mmt -107.19 125.05 50.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.933 -1.105 . . . . 0.0 110.577 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 27.0 m-85 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.478 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.3 p90 -147.02 137.29 23.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -1.134 . . . . 0.0 109.992 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.687 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -114.71 159.56 13.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 139' ' ' MET . 30.8 m-85 -115.04 109.85 18.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -1.1 . . . . 0.0 109.372 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.49 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -104.66 -178.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.892 -1.13 . . . . 0.0 109.008 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 30.8 m -164.81 104.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.038 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.964 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 2.0 p90 -128.37 107.81 10.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 0.0 109.23 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -39.31 -26.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.793 . . . . 0.0 111.138 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 163' ' ' VAL . 2.3 m -56.48 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.777 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.6 tt0 -58.32 -38.61 77.45 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.693 -1.255 . . . . 0.0 109.463 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 6.6 t0 -40.37 -63.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 110.389 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.715 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.3 tp -57.99 -45.06 88.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.98 -1.075 . . . . 0.0 108.82 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 157' ' ' PHE . 35.5 t -47.42 -39.82 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -51.17 -56.58 12.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.716 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 167' ' ' CYS . 5.9 tttp -84.8 -60.83 1.94 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.285 -0.884 . . . . 0.0 110.863 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.3 p -41.34 -25.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.097 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.9 t -75.62 -38.3 59.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.152 -0.968 . . . . 0.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 165' ' ' LYS . 4.4 mt-10 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.512 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.587 ' CD2' ' HB3' ' A' ' 181' ' ' CYS . 18.6 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.082 0.468 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -141.32 99.41 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 109.988 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 174' ' ' ILE . 0.5 OUTLIER -92.06 81.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.958 -1.089 . . . . 0.0 110.159 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 33.3 m120 64.47 -53.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 111.287 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.1 p30 -147.75 7.45 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 111.191 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.3 OUTLIER -124.64 172.17 9.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.797 -1.19 . . . . 0.0 111.415 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 23.7 mmt -113.05 57.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.65 -0.656 . . . . 0.0 109.894 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.499 HG12 ' C ' ' A' ' 115' ' ' GLY . 15.4 m -56.88 -166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.822 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -136.34 162.88 31.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.715 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.587 ' HB3' ' CD2' ' A' ' 172' ' ' HIS . 41.4 t -144.1 130.81 20.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.72 173.38 9.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.445 ' H ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -95.59 156.23 16.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.275 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 110.58 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.926 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 5.7 ptpt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.036 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 5.1 pt -102.33 163.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.473 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 154' ' ' PHE . 64.7 t80 -125.73 137.22 53.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.854 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -130.06 149.41 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.27 177.43 25.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.518 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 75.83 11.1 84.86 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 116' ' ' LEU . 1.1 pp -87.53 97.19 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.196 -1.179 . . . . 0.0 110.458 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.0 t -52.91 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.3 t -78.28 -153.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.403 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.607 ' H ' HG12 ' A' ' 118' ' ' VAL . 1.4 t-20 64.65 -17.34 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.776 -0.577 . . . . 0.0 111.169 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' ' 118' ' ' VAL . 40.7 m -91.41 143.62 26.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.735 -1.228 . . . . 0.0 110.695 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.592 HG22 ' CG ' ' A' ' 124' ' ' ASP . 11.8 t -127.98 151.16 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.682 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.61 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.4 t -41.75 -51.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.158 -0.964 . . . . 0.0 110.178 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.526 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 mt-10 -42.79 -26.01 0.11 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 66.0 m-20 -76.37 -57.37 3.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 110.094 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.733 HG21 HD21 ' A' ' 140' ' ' LEU . 1.3 t -67.34 -47.53 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 6.0 ttpp -48.4 -58.23 4.92 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.818 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -66.83 -32.49 73.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 109.697 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -59.21 -55.96 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.549 ' HZ ' ' HG ' ' A' ' 181' ' ' CYS . 66.9 m-85 -83.66 -15.94 46.96 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.06 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 46.0 tt0 -56.41 -37.76 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.423 -1.423 . . . . 0.0 108.163 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -74.59 -15.93 60.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 4.9 m-30 -88.16 -32.79 18.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.44 168.18 36.56 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.527 ' CE ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -46.87 -40.02 13.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -1.17 . . . . 0.0 111.118 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 44.59 92.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.863 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -25.06 21.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 141.25 39.86 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.425 0.631 . . . . 0.0 109.604 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -149.45 95.21 2.32 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.437 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 6.4 ttp -101.07 164.78 11.64 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.873 0.844 . . . . 0.0 111.823 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.91 HD23 ' HA3' ' A' ' 153' ' ' GLY . 72.8 mt -143.93 133.59 23.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.7 OUTLIER -108.27 99.09 8.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.855 -1.153 . . . . 0.0 110.8 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.562 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 38.2 p90 -146.68 136.56 23.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.77 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.91 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -111.25 157.34 15.02 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.645 -1.265 . . . . 0.0 110.26 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 112' ' ' PHE . 24.4 m-85 -121.83 109.41 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -1.068 . . . . 0.0 109.363 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.518 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 1.2 t -104.59 179.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.047 . . . . 0.0 109.342 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.525 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 98.8 m -161.94 107.28 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.984 -1.486 . . . . 0.0 112.535 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.05 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -131.32 106.24 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.8 . . . . 0.0 108.915 177.346 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.527 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 5.0 mm-40 -39.33 -27.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 0.0 110.822 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 163' ' ' VAL . 3.4 m -55.58 85.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.129 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -62.94 -38.33 90.59 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.738 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.57 -67.38 0.23 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 110.137 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.781 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.7 OUTLIER -58.17 -40.23 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.119 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.05 HG22 ' CE2' ' A' ' 157' ' ' PHE . 18.2 t -57.23 -34.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 160' ' ' GLU . 1.4 tt0 -55.34 -53.08 60.62 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.255 0.55 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.6 tttt -88.59 -59.51 2.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.267 -0.896 . . . . 0.0 110.829 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.82 -26.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 7.9 t -73.64 -45.67 51.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.591 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' LYS . 29.1 tt0 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.4 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.509 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.323 0.582 . . . . 0.0 110.03 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 1.1 pt-20 -72.36 89.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.58 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 174' ' ' ILE . 16.4 tt -89.27 91.75 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 3.4 m-20 65.73 -55.32 0.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.791 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.1 p-10 -158.19 18.74 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.648 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 tptt -131.66 169.24 16.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 110.664 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 178' ' ' MET . 0.8 OUTLIER -112.4 33.57 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.267 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.518 HG12 ' C ' ' A' ' 115' ' ' GLY . 18.0 m -37.96 159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.514 0.673 . . . . 0.0 111.315 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.467 ' OE1' ' HG3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -99.06 141.37 31.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.761 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.549 ' HG ' ' HZ ' ' A' ' 129' ' ' PHE . 38.5 m -113.33 127.8 56.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 110.759 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.467 ' HG3' ' OE1' ' A' ' 180' ' ' GLU . 1.4 mmmt -125.77 170.32 11.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -0.846 . . . . 0.0 109.678 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -108.52 169.79 8.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.076 -1.015 . . . . 0.0 110.329 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.403 -0.811 . . . . 0.0 109.838 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.823 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 27.1 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.065 0.459 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.899 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.1 pp -94.61 171.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.459 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.821 ' N ' HD12 ' A' ' 111' ' ' ILE . 27.9 t80 -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 181' ' ' CYS . 0.3 OUTLIER -147.14 160.79 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -144.17 168.76 26.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.603 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 90.01 17.15 54.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 140' ' ' LEU . 7.0 mt -44.81 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.361 -1.082 . . . . 0.0 110.032 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.471 ' HB3' ' OG1' ' A' ' 120' ' ' THR . 11.3 t -45.66 171.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -70.81 149.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 65.08 -42.24 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.438 0.637 . . . . 0.0 109.996 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' VAL . 6.1 m -38.76 120.91 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.572 . . . . 0.0 110.436 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 14.8 t -119.86 170.4 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.396 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 138' ' ' ALA . 1.9 t -38.48 -46.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.423 -0.798 . . . . 0.0 110.226 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.504 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 2.9 tt0 -40.95 -27.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.465 -0.772 . . . . 0.0 109.072 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 1.027 ' OD2' HG23 ' A' ' 174' ' ' ILE . 8.1 t70 -77.75 -59.41 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.356 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.784 HG21 HD21 ' A' ' 140' ' ' LEU . 1.4 t -62.74 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.798 . . . . 0.0 109.904 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 18.4 tttt -56.83 -56.72 17.91 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.62 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -64.0 -26.23 68.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.125 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 173' ' ' GLU . 19.8 t80 -79.4 -57.76 3.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 53.5 m-85 -77.38 -14.88 59.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.719 -1.238 . . . . 0.0 111.798 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -53.01 -41.68 64.91 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.152 -1.592 . . . . 0.0 108.859 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -70.49 -18.14 62.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.541 ' O ' HG21 ' A' ' 162' ' ' ILE . 25.3 m-85 -83.23 -31.04 27.23 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -165.13 156.52 28.54 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -39.22 -38.85 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.983 . . . . 0.0 110.5 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 45.24 91.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.87 -25.63 23.18 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.74 137.6 43.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB1' HG12 ' A' ' 125' ' ' VAL . . . -147.08 93.96 2.34 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.557 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.8 ttm -101.01 162.86 12.59 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.954 0.883 . . . . 0.0 111.949 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.997 HD23 ' HA3' ' A' ' 153' ' ' GLY . 13.1 mt -142.82 132.2 23.5 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 21.5 mmm -112.76 113.54 25.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.962 -1.086 . . . . 0.0 110.823 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 13.3 m-85 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 0.0 110.093 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 7.8 p90 -146.41 142.96 28.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 109.864 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.997 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -109.69 154.77 16.4 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.236 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 112' ' ' PHE . 21.5 m-85 -119.64 108.72 14.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -1.04 . . . . 0.0 109.262 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 1.3 t -104.76 178.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.06 . . . . 0.0 109.225 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.507 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 86.0 m -161.26 109.82 1.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.09 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.974 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -136.19 110.2 8.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -39.7 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.405 -0.809 . . . . 0.0 110.763 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.854 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -55.29 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -68.2 -38.53 82.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 109.094 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 8.0 t70 -43.02 -57.26 2.95 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.664 -0.647 . . . . 0.0 110.032 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.9 tp -64.01 -39.86 86.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.963 -1.085 . . . . 0.0 108.945 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.974 HG22 ' CE2' ' A' ' 157' ' ' PHE . 37.5 t -55.21 -39.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 2.7 tt0 -46.96 -59.45 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.798 -0.564 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 0.4 OUTLIER -90.96 -47.54 7.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.121 -0.987 . . . . 0.0 111.834 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 162' ' ' ILE . 3.6 p -50.37 -23.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.861 -1.15 . . . . 0.0 110.073 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.531 ' SG ' HG13 ' A' ' 163' ' ' VAL . 61.7 m -83.63 -0.64 51.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.758 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.489 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.428 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -155.24 108.24 2.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.554 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.027 HG23 ' OD2' ' A' ' 124' ' ' ASP . 1.6 mt -109.32 96.11 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.753 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 1.9 m-20 66.56 -55.91 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.436 -0.79 . . . . 0.0 110.429 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.0 p30 -164.86 21.49 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.701 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.597 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.4 tptt -122.11 159.14 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.58 43.2 1.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 109.877 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.791 HG21 ' CG1' ' A' ' 174' ' ' ILE . 33.6 m -53.98 -174.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -137.3 152.7 50.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 109.819 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.748 ' SG ' HD13 ' A' ' 111' ' ' ILE . 19.9 t -130.78 143.19 50.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 110.487 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 10.7 mtmt -134.93 178.01 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.813 . . . . 0.0 109.857 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -101.23 158.64 15.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 110.511 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.823 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 1.01 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 26.0 pttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.116 0.484 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.871 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.02 177.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.445 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.703 ' CD1' ' CE2' ' A' ' 154' ' ' PHE . 3.8 t80 -130.13 154.42 47.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 109.498 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.485 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -142.34 151.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.352 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.09 174.33 26.93 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.447 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 85.72 0.63 87.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.638 HD23 HG11 ' A' ' 179' ' ' VAL . 0.6 OUTLIER -80.33 95.91 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 110.33 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 116' ' ' LEU . 68.0 m -53.41 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.632 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -81.28 -154.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.785 -1.197 . . . . 0.0 110.196 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.633 ' H ' HG12 ' A' ' 118' ' ' VAL . 1.1 t-20 64.45 -17.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.712 -0.617 . . . . 0.0 111.081 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.3 m -91.18 172.81 8.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.806 -1.183 . . . . 0.0 110.469 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.7 t -150.89 144.16 24.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.761 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 138' ' ' ALA . 1.5 t -37.57 -47.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.603 -0.686 . . . . 0.0 110.638 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 122' ' ' VAL . 1.4 tt0 -43.33 -26.05 0.17 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.216 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 24.7 m-20 -74.75 -56.23 5.01 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.404 0.621 . . . . 0.0 109.685 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 129' ' ' PHE . 2.0 t -63.05 -49.42 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 12.7 tttt -47.16 -65.71 0.52 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 110.058 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -58.93 -31.73 68.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 13.5 t80 -61.37 -68.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' A' ' 125' ' ' VAL . 73.1 m-85 -69.93 -15.87 63.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 110.911 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 23.0 tt0 -55.38 -37.82 68.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.75 -1.219 . . . . 0.0 108.124 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.561 ' CG ' ' CD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -73.5 -18.1 61.14 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.561 ' CD1' ' CG ' ' A' ' 131' ' ' GLN . 5.9 m-30 -89.98 -30.15 17.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.563 0.696 . . . . 0.0 109.442 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -160.45 161.93 32.98 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 15.1 ptpt -45.13 -41.05 7.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 49.92 92.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.944 0.878 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -90.36 -30.08 17.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 14.3 m-20 -132.66 136.67 46.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.772 ' HA ' HG13 ' A' ' 155' ' ' VAL . . . -144.94 92.32 2.26 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 5.0 ttm -91.85 165.79 13.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.883 0.849 . . . . 0.0 112.113 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.556 ' CB ' HG23 ' A' ' 122' ' ' VAL . 5.2 tp -154.73 161.28 41.59 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.609 ' HB2' ' CE1' ' A' ' 152' ' ' PHE . 7.5 mmt -143.12 158.23 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.009 -1.057 . . . . 0.0 110.576 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.532 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 54.7 m-85 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.387 -0.821 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 141' ' ' MET . 5.0 p90 -150.57 141.39 22.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -1.067 . . . . 0.0 109.115 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -135.07 178.01 18.89 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.771 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.703 ' CE2' ' CD1' ' A' ' 112' ' ' PHE . 88.0 m-85 -140.98 122.8 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.772 HG13 ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -110.65 -172.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.439 -1.304 . . . . 0.0 109.691 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.548 ' H ' HG12 ' A' ' 155' ' ' VAL . 18.6 m -158.54 102.62 1.72 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.006 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.871 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -126.12 111.55 14.79 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.281 177.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' GLU . 78.8 tt0 -41.69 -24.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 111.28 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.552 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -61.02 71.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.123 -0.986 . . . . 0.0 110.527 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.3 tt0 -51.86 -37.84 53.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.901 -1.124 . . . . 0.0 109.227 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -41.68 -59.66 1.58 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.965 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.789 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -58.56 -47.7 87.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.59 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 157' ' ' PHE . 42.7 t -45.91 -45.19 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -42.54 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 167' ' ' CYS . 25.2 tttt -90.28 -57.93 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 111.422 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.1 p -42.35 -23.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 111.082 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.661 ' SG ' HG13 ' A' ' 163' ' ' VAL . 84.6 m -87.27 -15.19 38.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 110.413 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.392 -179.916 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.673 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.347 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.6 OUTLIER 61.89 77.5 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 174' ' ' ILE . 15.3 tt -96.46 98.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.273 -0.892 . . . . 0.0 110.002 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.2 m-20 65.33 -54.75 0.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 111.042 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 174' ' ' ILE . 10.1 p-10 -160.7 18.45 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.855 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.1 tptt -130.58 159.33 37.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.067 -1.02 . . . . 0.0 111.443 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.449 ' O ' ' C ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -102.22 29.69 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 108.897 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.638 HG11 HD23 ' A' ' 116' ' ' LEU . 6.6 m -35.27 152.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.489 0.661 . . . . 0.0 111.34 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.505 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 5.1 tt0 -106.0 148.47 27.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -0.773 . . . . 0.0 109.682 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.505 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 87.9 m -110.65 140.45 44.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.989 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.481 ' CG ' ' OE2' ' A' ' 180' ' ' GLU . 21.2 mmmt -128.57 167.32 17.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 109.855 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -92.73 152.64 19.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.422 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 1.01 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 110.128 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.923 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 3.5 pttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER -122.36 173.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 24.7 t80 -132.96 151.17 52.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.242 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -141.1 146.95 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.374 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.4 158.57 26.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 107.38 -6.8 36.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 174' ' ' ILE . 1.2 mp -68.28 96.24 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 110.037 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.01 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -89.53 -165.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.97 -1.081 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.697 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.9 OUTLIER 63.63 -11.54 0.1 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.681 -0.637 . . . . 0.0 110.509 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 121' ' ' THR . 3.4 m -90.43 -175.9 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.97 -1.081 . . . . 0.0 110.84 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.685 ' H ' HG22 ' A' ' 120' ' ' THR . 6.2 t -176.99 153.49 1.0 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.443 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -40.55 -51.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.522 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.9 -26.18 0.13 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.24 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.619 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 53.8 m-20 -77.27 -58.5 3.24 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.9 -48.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.38 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 3.2 tttt -49.03 -64.36 0.83 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.739 . . . . 0.0 110.523 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.619 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 6.1 p-80 -59.87 -32.26 70.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.112 -0.993 . . . . 0.0 110.013 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 63.6 t80 -62.93 -65.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.379 -0.826 . . . . 0.0 110.487 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 79.2 m-85 -72.77 -13.7 61.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 111.149 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.721 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 1.1 tp10 -57.55 -37.34 72.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.449 -1.407 . . . . 0.0 108.282 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.5 pt20 -76.43 -12.44 60.05 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.447 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.545 ' CA ' HD13 ' A' ' 162' ' ' ILE . 4.3 m-30 -88.26 -30.64 19.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.731 -0.606 . . . . 0.0 110.764 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -173.88 62.92 0.12 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 118.36 -1.876 . . . . 0.0 111.292 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 2.6 tptt 58.97 -68.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.458 -1.025 . . . . 0.0 111.521 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 63.99 91.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.88 -29.27 27.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -129.95 139.38 51.1 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.718 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -152.61 95.8 2.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 108.7 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.565 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.9 ttt -101.8 162.69 12.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.727 0.775 . . . . 0.0 111.462 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.527 ' CD1' HD22 ' A' ' 116' ' ' LEU . 53.7 tp -144.35 160.54 40.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.771 -0.581 . . . . 0.0 109.995 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -144.72 159.01 43.55 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.477 -0.764 . . . . 0.0 110.902 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.542 -0.724 . . . . 0.0 109.238 178.885 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 12.4 p90 -146.24 142.94 28.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 109.498 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.55 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -125.53 150.51 17.4 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.55 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 34.0 m-85 -112.48 113.43 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.459 -1.024 . . . . 0.0 108.41 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -110.77 -178.58 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -178.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.656 ' HA ' HD13 ' A' ' 111' ' ' ILE . 27.6 m -159.09 103.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.811 -1.18 . . . . 0.0 111.26 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.001 ' CE1' HG22 ' A' ' 163' ' ' VAL . 2.0 p90 -126.54 106.92 9.77 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.85 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.9 mt-10 -40.25 -37.7 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 0.0 111.187 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.959 ' O ' HG23 ' A' ' 163' ' ' VAL . 58.7 m -46.54 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -64.02 -37.98 89.42 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.08 -1.013 . . . . 0.0 109.492 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 4.9 t0 -40.57 -64.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.186 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.776 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.7 OUTLIER -60.34 -44.92 96.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.97 -1.081 . . . . 0.0 108.693 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.001 HG22 ' CE1' ' A' ' 157' ' ' PHE . 15.5 t -51.17 -41.7 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -48.25 -58.53 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 111.184 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 167' ' ' CYS . 12.0 tttt -90.47 -58.21 2.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.0 111.272 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 162' ' ' ILE . 2.0 p -39.83 -26.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.762 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 68.5 m -82.73 -31.96 28.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.954 -1.091 . . . . 0.0 110.15 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.137 -0.977 . . . . 0.0 110.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.576 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.252 0.549 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 174' ' ' ILE . 5.1 tt0 -153.95 107.0 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 110.061 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.877 HD13 ' CG2' ' A' ' 179' ' ' VAL . 1.3 mp -113.42 102.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.9 OUTLIER 67.56 -56.24 0.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.3 p30 -168.97 25.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.99 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.657 ' HB3' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -130.74 151.81 50.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 0.0 111.14 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -90.36 46.9 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.54 -0.725 . . . . 0.0 109.607 179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.877 ' CG2' HD13 ' A' ' 174' ' ' ILE . 20.3 m -54.77 -160.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.74 . . . . 0.0 110.802 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -150.51 142.41 23.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.402 -0.811 . . . . 0.0 109.919 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.576 ' HA ' HG12 ' A' ' 113' ' ' VAL . 16.8 t -112.66 156.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.176 -0.953 . . . . 0.0 110.582 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' CYS . 51.2 mttt -138.78 -178.77 5.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 0.0 110.177 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -102.9 161.13 14.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 110.216 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.015 0.436 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.65 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.5 pt -110.3 169.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 7.9 t80 -125.01 158.39 33.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -150.16 142.84 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.383 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -134.43 150.84 20.15 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.716 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 103.34 2.0 47.59 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.707 HD12 ' CA ' ' A' ' 152' ' ' PHE . 2.5 mt -63.62 98.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -1.175 . . . . 0.0 110.022 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.509 ' HB2' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -39.61 156.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.63 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 119' ' ' ASN . 2.4 t -62.75 -62.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 110.383 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.563 ' N ' HG12 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -44.58 -19.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.736 0.779 . . . . 0.0 108.914 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 142' ' ' PHE . 2.9 m -68.18 157.8 34.61 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.826 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 123' ' ' GLU . 7.8 t -148.44 150.47 33.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.097 -1.002 . . . . 0.0 110.405 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 140' ' ' LEU . 3.2 t -35.77 -53.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.764 -0.585 . . . . 0.0 111.097 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.536 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.5 mt-10 -41.02 -26.38 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.385 -0.822 . . . . 0.0 109.45 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.546 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 43.8 t0 -73.43 -59.44 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.526 0.679 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 140' ' ' LEU . 2.4 t -68.71 -52.91 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.773 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.8 ttmt -41.04 -60.98 1.07 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.711 -0.618 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.879 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.478 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -65.59 -64.31 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 111.011 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 28.2 m-85 -74.03 -16.75 61.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.657 -1.277 . . . . 0.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 4.5 tt0 -55.6 -37.98 68.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.036 -1.466 . . . . 0.0 108.173 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.3 pt20 -72.59 -18.06 61.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 162' ' ' ILE . 16.0 m-85 -84.84 -37.09 21.12 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -154.76 159.01 28.69 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -42.42 -43.25 3.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.16 . . . . 0.0 110.365 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 48.1 89.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 122.02 0.914 . . . . 0.0 110.94 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -89.18 -24.9 22.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -126.57 137.91 53.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.91 101.23 1.61 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.707 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -112.9 157.61 21.23 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.861 0.839 . . . . 0.0 112.758 -177.405 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 139' ' ' MET . 1.3 mp -138.12 142.45 40.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.885 -0.509 . . . . 0.0 110.258 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.508 ' HG3' ' CE2' ' A' ' 152' ' ' PHE . 2.2 mmt -118.5 145.78 45.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.647 ' HZ ' HD23 ' A' ' 140' ' ' LEU . 28.5 m-85 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 0.0 110.178 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.707 ' CA ' HD12 ' A' ' 116' ' ' LEU . 50.1 p90 -149.91 135.13 18.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -1.219 . . . . 0.0 109.855 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.6 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -128.0 166.92 20.45 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.148 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 139' ' ' MET . 64.6 m-85 -122.99 109.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -1.095 . . . . 0.0 109.03 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -99.81 177.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 120.948 -1.095 . . . . 0.0 109.172 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.561 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 91.5 m -165.03 109.86 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.127 -1.429 . . . . 0.0 112.461 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.75 ' HE1' HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -118.88 135.03 54.78 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.2 177.116 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -72.07 54.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.89 96.64 2.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 110.115 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 161' ' ' ASP . 10.5 tt0 -49.71 -38.33 32.74 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -41.95 -47.33 4.32 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.254 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.758 ' O ' HG12 ' A' ' 166' ' ' VAL . 20.1 mm -68.5 -42.6 83.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.75 HG22 ' HE1' ' A' ' 157' ' ' PHE . 11.8 t -63.28 -40.61 89.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLU . 52.5 mt-10 -56.29 -47.11 79.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 168' ' ' GLU . 19.2 ttmt -90.25 -65.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.356 -0.84 . . . . 0.0 111.167 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 162' ' ' ILE . 1.0 OUTLIER -41.42 -25.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 110.175 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 41.2 t -76.51 -36.15 57.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.374 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 87.3 mt-10 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.64 -0.663 . . . . 0.0 110.105 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 166' ' ' VAL . 34.3 m-70 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.229 0.538 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 46.47 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.699 ' O ' HG22 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -93.44 100.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.602 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 124' ' ' ASP . 2.6 m-20 65.58 -55.85 0.34 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.358 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.8 p30 -168.66 28.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.414 -0.804 . . . . 0.0 109.537 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.5 tptt -132.51 158.02 43.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.483 -0.761 . . . . 0.0 110.769 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.78 55.17 0.86 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.859 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.716 HG12 ' C ' ' A' ' 115' ' ' GLY . 33.4 m -59.32 130.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.4 OUTLIER -70.65 148.01 48.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.328 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 166' ' ' VAL . 3.0 t -125.08 140.8 52.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.405 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 0.9 OUTLIER -149.04 -174.34 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -109.82 150.28 28.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.106 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.877 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.012 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 3.3 pt -110.81 167.93 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 111.138 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -119.29 155.01 32.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.278 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -148.39 146.97 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 110.556 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.41 -170.33 12.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.622 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 65.45 23.31 70.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' SER . 1.1 mt -84.15 93.91 8.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -1.109 . . . . 0.0 110.343 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.481 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 99.2 p -52.66 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.787 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.5 t -85.22 -165.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.718 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.9 OUTLIER 63.11 -10.28 0.1 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.626 -0.671 . . . . 0.0 110.358 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -88.7 -177.27 5.51 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.117 -0.99 . . . . 0.0 110.781 -178.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.546 HG22 ' OD1' ' A' ' 124' ' ' ASP . 12.1 t -178.8 153.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.878 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.628 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -38.42 -50.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.738 . . . . 0.0 110.735 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.477 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.67 -26.17 0.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.197 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.64 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.7 m-20 -76.58 -57.72 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 0.0 110.062 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.603 HG12 ' HB1' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -64.12 -47.83 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.549 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -51.13 -62.62 1.51 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 110.653 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.64 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -57.62 -26.53 61.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -78.48 -64.19 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 0.0 111.891 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 52.1 m-85 -70.91 -13.42 62.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.927 -1.108 . . . . 0.0 112.283 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.667 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -53.99 -41.39 67.86 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 119.893 -1.755 . . . . 0.0 109.115 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.9 pt20 -73.66 -14.86 61.23 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 16.2 m-85 -82.36 -31.11 29.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.725 -0.609 . . . . 0.0 110.051 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 157' ' ' PHE . . . -174.44 60.24 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.055 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 4.3 tptt 59.71 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.31 -1.112 . . . . 0.0 110.831 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 63.58 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 111.315 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -89.64 -23.15 21.98 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -133.29 137.67 46.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.502 0.668 . . . . 0.0 109.449 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.603 ' HB1' HG12 ' A' ' 125' ' ' VAL . . . -153.76 96.02 1.95 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.628 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 4.3 ttm -101.49 165.98 10.96 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.0 111.972 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.794 HD23 ' CZ ' ' A' ' 142' ' ' PHE . 2.6 tp -143.57 151.08 39.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.636 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 3.0 mmt -128.11 130.87 48.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.772 -1.205 . . . . 0.0 111.253 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.794 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 10.4 m-85 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.515 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 25.0 p90 -145.62 136.0 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.924 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.737 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -120.82 158.12 15.76 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.68 107.38 12.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -1.017 . . . . 0.0 109.246 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -102.7 179.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.947 -1.096 . . . . 0.0 109.08 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.55 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 62.9 m -163.35 106.62 1.01 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.184 -1.406 . . . . 0.0 111.915 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.026 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -125.09 105.64 9.32 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.494 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -39.76 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.576 -0.703 . . . . 0.0 110.623 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -57.73 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.326 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -57.28 -39.08 74.97 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.651 -1.281 . . . . 0.0 109.559 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 3.7 m-20 -40.65 -64.88 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.791 ' O ' HG12 ' A' ' 166' ' ' VAL . 4.1 tp -57.25 -41.87 78.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.908 -1.12 . . . . 0.0 109.038 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.026 HG22 ' CE2' ' A' ' 157' ' ' PHE . 26.3 t -53.77 -37.56 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.7 OUTLIER -52.26 -56.72 12.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.809 -0.557 . . . . 0.0 110.975 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.9 tttp -85.87 -59.53 2.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.215 -0.928 . . . . 0.0 110.663 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 162' ' ' ILE . 3.9 p -40.94 -26.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.488 -0.758 . . . . 0.0 109.834 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 11.1 t -75.29 -38.34 60.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.872 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.7 tt0 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.537 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.623 ' NE2' HG23 ' A' ' 166' ' ' VAL . 1.2 m80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.298 0.571 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 4.0 mt-10 -65.84 100.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.031 HD13 HG21 ' A' ' 179' ' ' VAL . 1.8 tp -78.1 -178.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.828 -1.17 . . . . 0.0 109.386 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.466 ' N ' HG23 ' A' ' 174' ' ' ILE . 5.2 m120 -34.56 -30.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.551 -0.718 . . . . 0.0 111.649 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 174' ' ' ILE . 12.2 p-10 -164.93 30.02 0.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 tptp -145.99 -166.25 2.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 110.967 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.451 ' O ' ' C ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -131.22 38.9 3.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 1.031 HG21 HD13 ' A' ' 174' ' ' ILE . 27.6 m -35.6 153.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.461 0.648 . . . . 0.0 111.257 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -98.03 156.06 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 6.8 p -134.56 153.78 51.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 4.2 mtpt -152.97 168.43 25.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.345 -0.847 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.15 154.63 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.373 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.187 0.518 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.907 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.1 pt -125.87 176.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 3.9 t80 -127.11 160.63 30.59 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.532 -0.73 . . . . 0.0 109.2 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -144.73 140.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.86 157.89 23.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 94.78 -23.06 34.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.822 HD21 ' HA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -49.45 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 115' ' ' GLY . 11.7 p -54.52 163.3 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 110.697 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 120' ' ' THR . 18.9 m -62.81 -153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -0.865 . . . . 0.0 110.441 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 3.8 t-20 62.18 -41.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.649 0.738 . . . . 0.0 110.382 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' VAL . 30.8 m -70.92 156.52 39.5 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.087 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.62 148.1 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.2 t -40.12 -51.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.424 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -42.94 -25.89 0.12 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.432 -0.793 . . . . 0.0 109.087 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 121' ' ' THR . 32.9 m-20 -72.28 -56.71 5.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.432 0.634 . . . . 0.0 109.503 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.796 ' CG2' HD11 ' A' ' 174' ' ' ILE . 2.4 t -65.66 -53.45 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.564 0.697 . . . . 0.0 109.144 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -41.23 -63.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.725 -0.609 . . . . 0.0 109.901 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.712 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -60.07 -30.12 69.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.955 . . . . 0.0 109.07 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.517 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -60.9 -69.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.622 -0.674 . . . . 0.0 110.315 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 74.3 m-85 -70.4 -15.26 62.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -0.967 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 8.8 tt0 -57.17 -37.35 71.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.191 -1.568 . . . . 0.0 107.825 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.2 pt20 -72.51 -16.66 61.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.685 ' HB3' HD12 ' A' ' 162' ' ' ILE . 3.6 m-30 -83.42 -28.78 28.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.752 -0.593 . . . . 0.0 109.446 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 159' ' ' SER . . . -161.73 -139.42 2.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HD2' ' HG3' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -94.14 -33.83 13.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -1.05 . . . . 0.0 109.658 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 39.08 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.109 0.957 . . . . 0.0 111.456 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -25.3 18.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.36 140.04 49.62 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.676 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -157.17 100.16 1.84 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.575 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 1.6 ptp -116.66 165.99 12.64 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.876 0.846 . . . . 0.0 112.216 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.715 HD23 ' HA3' ' A' ' 153' ' ' GLY . 89.3 mt -142.92 146.48 34.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.85 -0.531 . . . . 0.0 109.579 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -120.64 110.12 16.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.0 -1.063 . . . . 0.0 110.337 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.837 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.822 ' HA ' HD21 ' A' ' 116' ' ' LEU . 17.7 p90 -144.85 138.83 27.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -1.103 . . . . 0.0 109.726 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.715 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -127.99 168.93 19.78 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.395 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 139' ' ' MET . 76.0 m-85 -126.82 115.94 20.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -1.134 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -108.79 -177.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.082 -1.011 . . . . 0.0 109.044 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 16.3 m -163.75 104.73 0.93 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.907 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.9 p90 -129.92 116.65 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.97 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.2 mm-40 -44.34 -32.58 1.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.387 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.543 ' HB3' ' CG1' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -51.77 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 110.544 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -56.57 -40.0 74.45 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.176 -0.952 . . . . 0.0 109.042 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -44.78 -38.05 4.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.943 ' O ' HG22 ' A' ' 166' ' ' VAL . 41.3 mm -69.61 -49.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 20.0 t -58.25 -36.82 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.8 mm-40 -56.89 -44.39 82.25 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.627 -0.67 . . . . 0.0 110.715 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 161' ' ' ASP . 3.1 mttt -90.14 -64.96 1.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 162' ' ' ILE . 6.3 m -42.9 -24.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.856 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 8.4 t -71.73 -38.15 70.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.725 -1.235 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 165' ' ' LYS . 8.0 mt-10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 110.49 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.873 ' O ' HG22 ' A' ' 179' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.347 0.594 . . . . 0.0 109.865 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.535 ' HG3' ' N ' ' A' ' 177' ' ' LYS . 3.6 tt0 -80.89 141.73 34.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 110.589 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.796 HD11 ' CG2' ' A' ' 125' ' ' VAL . 4.7 tt -114.58 115.43 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.186 -0.947 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 6.7 t30 68.07 -55.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.631 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.9 p30 -174.22 24.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.863 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.627 ' HD2' HG12 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -139.49 129.14 24.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.785 -1.197 . . . . 0.0 110.179 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.512 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -68.3 119.63 13.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.817 -1.177 . . . . 0.0 110.596 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 172' ' ' HIS . 4.4 m -120.08 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.646 ' N ' HG23 ' A' ' 179' ' ' VAL . 57.1 tt0 -138.83 143.6 38.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 86.8 m -129.2 138.14 51.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.306 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.9 mttt -133.91 175.67 9.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.29 -0.882 . . . . 0.0 109.816 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.511 ' CD ' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -75.25 163.74 27.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.264 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.293 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.978 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.25 0.548 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.146 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -105.2 165.84 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -124.51 136.69 54.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -131.34 142.65 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 110.075 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -146.87 168.46 28.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.3 -29.4 8.93 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -53.67 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 116' ' ' LEU . 4.3 p -52.47 -173.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.3 t -75.12 -149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 109.467 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER 64.06 -14.84 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.642 . . . . 0.0 111.398 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -89.87 -167.13 1.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.684 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 120' ' ' THR . 14.4 t -173.21 139.44 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -35.07 -49.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.633 -0.667 . . . . 0.0 111.303 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 122' ' ' VAL . 10.2 mt-10 -43.35 -25.88 0.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 128' ' ' TYR . 66.2 m-20 -73.42 -47.64 40.11 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.421 0.629 . . . . 0.0 110.209 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -73.86 -44.56 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.663 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.2 ttpp -50.02 -65.2 0.6 Allowed 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.454 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -64.42 -32.32 73.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.025 -1.047 . . . . 0.0 110.681 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 4.5 t80 -66.1 -54.06 30.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 111.212 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.762 ' CD2' HG12 ' A' ' 125' ' ' VAL . 46.2 m-85 -83.98 -16.53 43.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.164 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 40.2 tt0 -57.42 -36.89 71.93 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.053 -1.654 . . . . 0.0 107.73 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 13.2 pt20 -74.6 -15.93 60.82 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.704 ' O ' HD13 ' A' ' 162' ' ' ILE . 3.1 m-30 -83.36 -28.24 29.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -164.07 -143.45 3.71 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CG ' ' N ' ' A' ' 135' ' ' VAL . 2.0 ptmt -88.45 -42.19 12.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.325 -1.103 . . . . 0.0 109.7 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 46.24 90.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.484 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -92.42 -25.63 18.39 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.63 145.73 50.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.057 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.35 101.66 1.72 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.59 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -112.58 163.81 14.06 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.937 0.875 . . . . 0.0 112.216 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 125' ' ' VAL . 4.8 tp -138.03 154.79 49.27 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.644 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 66.0 mmm -131.19 135.8 47.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.767 -1.208 . . . . 0.0 110.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 118' ' ' VAL . 9.4 m-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.696 . . . . 0.0 109.973 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 14.9 p90 -150.13 139.37 21.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.109 -1.23 . . . . 0.0 110.158 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -129.58 167.2 21.54 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.965 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.536 ' O ' ' HG3' ' A' ' 139' ' ' MET . 63.0 m-85 -123.5 117.8 25.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 108.879 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.543 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -109.2 -178.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 109.036 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 72.3 m -162.87 105.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.874 -1.53 . . . . 0.0 112.433 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.146 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -126.6 102.34 7.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.441 -0.787 . . . . 0.0 108.993 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -39.18 -29.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.503 -0.748 . . . . 0.0 110.962 -178.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.804 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -56.23 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 110.235 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -58.09 -38.32 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.078 -1.014 . . . . 0.0 109.701 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.7 m-20 -39.24 -64.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.771 -0.581 . . . . 0.0 110.259 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.704 HD13 ' O ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -61.84 -38.0 79.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.091 -1.006 . . . . 0.0 109.122 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.096 HG22 ' CE2' ' A' ' 157' ' ' PHE . 16.7 t -58.41 -33.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -58.77 -47.15 85.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.426 0.631 . . . . 0.0 110.079 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 167' ' ' CYS . 10.4 tttt -87.4 -63.82 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 110.499 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 163' ' ' VAL . 1.4 p -42.31 -24.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.876 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 9.3 t -73.36 -47.02 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.075 -1.016 . . . . 0.0 109.458 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.55 -0.719 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 1.1 t60 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -100.72 88.76 3.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 110.266 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 174' ' ' ILE . 1.3 mp -81.34 91.96 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.387 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER 68.56 -56.99 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.419 -0.801 . . . . 0.0 110.1 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 174' ' ' ILE . 8.3 p-10 -161.55 19.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.807 . . . . 0.0 110.416 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.824 ' HB3' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.68 148.39 46.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.118 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -92.02 41.56 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 177' ' ' LYS . 10.3 m -70.47 -165.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.5 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 2.3 tm-20 -125.54 152.46 45.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.792 . . . . 0.0 110.103 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.5 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 37.9 t -141.41 103.02 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.417 ' HG3' ' OE2' ' A' ' 180' ' ' GLU . 6.1 mtmm -99.21 -175.56 3.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 109.886 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -100.32 -175.99 3.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.784 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.978 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 110.598 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.949 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.72 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -99.7 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 110.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -118.57 153.74 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 109.675 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -146.94 152.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -145.93 162.91 28.35 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 100.29 9.52 47.53 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.695 ' HG ' HD22 ' A' ' 140' ' ' LEU . 2.7 mm? -57.67 97.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -1.09 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.3 168.21 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.105 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 120' ' ' THR . 19.5 m -63.19 169.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.272 -0.892 . . . . 0.0 110.988 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 3.5 t-20 61.95 -39.13 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.976 -0.452 . . . . 0.0 111.018 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 118' ' ' VAL . 91.8 m -42.3 153.74 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.483 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 142' ' ' PHE . 15.2 t -149.66 146.77 27.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.718 ' HA ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -32.39 -47.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.81 -0.556 . . . . 0.0 111.396 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -41.94 -27.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.095 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.515 ' OD2' ' N ' ' A' ' 175' ' ' ASN . 15.6 t0 -72.24 -58.44 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.555 0.693 . . . . 0.0 109.966 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.658 ' CG2' HD11 ' A' ' 174' ' ' ILE . 2.1 t -67.07 -52.9 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.7 tttt -42.44 -59.82 1.73 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.649 -0.657 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.702 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -62.44 -27.74 69.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.441 -0.787 . . . . 0.0 110.196 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 18.7 t80 -76.29 -53.77 7.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 112.479 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.546 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 14.6 m-85 -82.32 -17.41 45.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.0 112.638 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -52.7 -41.76 64.19 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 119.969 -1.707 . . . . 0.0 109.263 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 17.6 pt20 -73.72 -15.78 61.21 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.502 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 15.8 m-85 -84.27 -33.97 23.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -159.35 162.29 32.71 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -44.6 -34.01 2.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 38.05 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.967 0.889 . . . . 0.0 111.342 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -25.06 18.0 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -130.9 142.01 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' HG11 ' A' ' 122' ' ' VAL . . . -157.4 102.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.418 ' HA ' HG11 ' A' ' 122' ' ' VAL . 3.2 tpp -110.39 160.21 16.78 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.775 0.797 . . . . 0.0 111.308 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.93 HD23 ' HA3' ' A' ' 153' ' ' GLY . 9.4 mt -147.04 145.42 29.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.774 -0.579 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.585 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 1.6 mmm -123.25 126.77 47.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.024 -1.047 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 42.2 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.865 . . . . 0.0 110.711 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.585 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.1 p90 -150.03 146.19 26.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -1.202 . . . . 0.0 109.977 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.93 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -138.16 174.62 21.84 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.174 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.96 118.26 18.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.495 -1.003 . . . . 0.0 109.246 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 156' ' ' THR . 1.5 t -109.21 -174.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.514 ' H ' HG12 ' A' ' 155' ' ' VAL . 96.3 m -163.98 106.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.002 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.181 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -132.12 109.96 10.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.199 -0.938 . . . . 0.0 109.722 177.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.19 -32.06 1.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.431 -0.793 . . . . 0.0 111.507 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.892 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -56.04 82.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -56.7 -38.61 72.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 110.086 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.4 OUTLIER -39.06 -69.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.815 -0.553 . . . . 0.0 110.426 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.778 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.8 OUTLIER -57.57 -42.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.927 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.181 HG22 ' CE2' ' A' ' 157' ' ' PHE . 14.7 t -51.76 -38.95 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 3.1 tt0 -48.4 -55.95 9.46 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.359 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.3 tttm -90.52 -59.6 2.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.257 -0.902 . . . . 0.0 111.316 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.24 -25.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.247 -0.908 . . . . 0.0 110.859 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 163' ' ' VAL . 71.2 m -90.21 -20.34 23.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.882 -1.137 . . . . 0.0 110.071 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 165' ' ' LYS . 19.6 mm-40 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 110.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.666 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.371 0.605 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 57.21 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 110.894 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.782 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.9 OUTLIER -113.83 116.15 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.632 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.535 ' HB2' HG23 ' A' ' 120' ' ' THR . 8.2 t30 69.41 -56.49 0.55 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 174' ' ' ILE . 5.2 p-10 -177.14 29.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.633 -0.667 . . . . 0.0 109.813 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.623 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -143.72 123.89 13.71 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.059 -1.025 . . . . 0.0 110.432 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.557 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.6 OUTLIER -54.02 116.31 2.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.782 HG21 ' HB ' ' A' ' 174' ' ' ILE . 16.0 m -119.09 -161.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 0.0 110.6 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 10.3 tt0 -130.1 146.45 51.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 71.3 m -117.42 152.32 35.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.52 -0.737 . . . . 0.0 109.917 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -110.03 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.949 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.699 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.223 0.535 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.962 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.8 pt -101.46 169.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.519 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.9 t80 -118.11 156.49 28.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.409 -0.807 . . . . 0.0 109.184 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.541 HG23 ' CA ' ' A' ' 153' ' ' GLY . 1.2 m -148.32 163.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.064 -1.022 . . . . 0.0 110.85 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.39 171.05 32.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 97.93 -22.39 41.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.661 HD11 ' O ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -41.43 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -1.06 . . . . 0.0 109.981 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' GLY . 38.7 m -96.19 -162.58 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.816 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' THR . 12.7 m -52.25 162.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 111.188 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 2.9 t-20 61.93 -38.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.872 -0.517 . . . . 0.0 110.984 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.585 HG23 ' OD2' ' A' ' 124' ' ' ASP . 55.6 m -61.76 123.92 19.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 0.0 110.507 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.0 t -136.53 166.14 24.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 0.0 109.688 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -41.36 -55.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -0.989 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.31 -24.67 0.1 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.406 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.609 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 62.4 t0 -75.24 -59.28 2.81 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.682 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.666 HG21 HD21 ' A' ' 140' ' ' LEU . 1.8 t -64.3 -49.0 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.287 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 53.4 tttm -47.72 -63.47 1.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.522 -0.736 . . . . 0.0 110.057 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.609 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -61.14 -31.95 71.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -0.985 . . . . 0.0 109.861 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 21.4 t80 -61.97 -60.6 3.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.469 -0.769 . . . . 0.0 110.883 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 82.9 m-85 -79.7 -18.8 50.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.042 -1.036 . . . . 0.0 111.518 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 1.1 tp10 -54.45 -36.03 63.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.366 -1.459 . . . . 0.0 108.699 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -74.77 -20.62 59.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 1.066 ' O ' HD13 ' A' ' 162' ' ' ILE . 7.5 m-85 -82.24 -28.9 31.61 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.823 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -163.06 -157.72 9.3 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.893 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -72.24 -50.12 29.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.586 -0.95 . . . . 0.0 110.129 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.5 t 51.19 87.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.121 0.962 . . . . 0.0 110.353 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -87.79 -28.64 21.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 79.8 m-20 -134.49 137.99 44.35 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.127 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.824 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -147.18 93.93 2.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.661 ' HA ' HG22 ' A' ' 122' ' ' VAL . 9.1 ttm -105.62 167.05 10.02 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.833 0.825 . . . . 0.0 111.875 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.948 HD23 ' HA3' ' A' ' 153' ' ' GLY . 31.0 mt -146.03 132.51 19.71 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.661 ' O ' HD11 ' A' ' 116' ' ' LEU . 9.7 mmt -107.79 133.73 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.88 -1.137 . . . . 0.0 110.792 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 17.4 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.534 -0.728 . . . . 0.0 109.642 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.581 ' CA ' HD21 ' A' ' 116' ' ' LEU . 24.0 p90 -144.9 135.01 23.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -1.17 . . . . 0.0 110.022 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.948 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -114.62 164.87 12.04 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.332 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -127.78 113.12 15.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -1.106 . . . . 0.0 109.648 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -109.0 -178.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.909 . . . . 0.0 108.938 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.699 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 79.8 m -164.07 106.32 0.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.169 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.962 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -126.32 113.06 16.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 109.511 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 4.0 tt0 -39.74 -26.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.435 -0.79 . . . . 0.0 111.123 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.534 ' O ' HG22 ' A' ' 162' ' ' ILE . 80.9 p -63.5 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 110.587 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -52.13 -38.9 58.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.864 -1.148 . . . . 0.0 109.17 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 160' ' ' GLU . 38.1 t70 -43.07 -53.54 4.83 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.778 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 1.066 HD13 ' O ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -60.66 -49.22 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.441 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' CE2' ' A' ' 157' ' ' PHE . 47.0 t -44.72 -46.78 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -52.21 12.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 167' ' ' CYS . 11.3 ttpt -90.02 -62.37 1.48 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.131 -0.98 . . . . 0.0 111.065 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 162' ' ' ILE . 8.5 p -40.01 -25.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.71 . . . . 0.0 110.637 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 23.3 m -76.3 -40.44 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.024 -1.047 . . . . 0.0 109.676 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 165' ' ' LYS . 1.2 mt-10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 173' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 68.59 101.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.092 -1.005 . . . . 0.0 110.914 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 125' ' ' VAL . 3.4 tt -122.25 118.74 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 29.1 m-20 64.19 -53.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.66 -0.65 . . . . 0.0 110.644 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.1 p30 -175.48 27.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.001 -1.062 . . . . 0.0 110.699 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.536 ' HD3' ' C ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -143.49 137.06 28.26 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.065 -1.022 . . . . 0.0 109.488 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.5 ' O ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -77.87 88.05 4.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.326 -1.483 . . . . 0.0 110.097 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 174' ' ' ILE . 28.7 m -76.46 -178.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 110.379 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CD ' ' HE3' ' A' ' 182' ' ' LYS . 26.0 tt0 -128.78 140.65 51.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.752 . . . . 0.0 109.549 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 167' ' ' CYS . 1.5 t -122.68 142.65 50.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 110.811 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.42 ' C ' ' SG ' ' A' ' 167' ' ' CYS . 7.5 mttp -138.64 178.91 6.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.497 ' HD3' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -111.65 142.37 44.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.069 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.268 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 1.7 ptmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.972 0.415 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.93 HD12 ' N ' ' A' ' 112' ' ' PHE . 1.2 pp -123.26 178.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.795 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.93 ' N ' HD12 ' A' ' 111' ' ' ILE . 56.6 t80 -125.03 162.31 24.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.593 -0.692 . . . . 0.0 109.15 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.596 HG13 HD11 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -146.84 135.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -130.17 162.28 23.11 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.446 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 92.92 -26.04 16.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.003 HD21 ' HA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -44.1 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -1.092 . . . . 0.0 109.607 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -43.19 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.734 0.778 . . . . 0.0 111.018 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.825 HG12 ' N ' ' A' ' 119' ' ' ASN . 0.9 OUTLIER -74.44 -64.14 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.409 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.825 ' N ' HG12 ' A' ' 118' ' ' VAL . 0.8 OUTLIER -43.44 -21.98 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.75 HG21 HG12 ' A' ' 174' ' ' ILE . 23.6 m -72.71 142.21 48.2 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.778 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.0 158.98 36.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 110.563 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.722 HG23 ' HB2' ' A' ' 140' ' ' LEU . 2.7 t -37.56 -52.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -40.65 -27.06 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 122' ' ' VAL . 1.7 m-20 -72.79 -57.67 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.469 0.652 . . . . 0.0 109.567 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.72 HG21 HD11 ' A' ' 140' ' ' LEU . 2.1 t -65.87 -50.1 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.615 0.721 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 23.9 tttt -46.58 -61.77 1.67 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.714 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -59.52 -33.14 71.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.588 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -66.44 -64.89 0.76 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 110.832 -179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.645 ' CD2' HG13 ' A' ' 125' ' ' VAL . 78.3 m-85 -70.68 -18.54 62.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.9 -1.125 . . . . 0.0 111.541 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 38.4 tt0 -55.96 -36.7 68.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.912 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 6.5 pt20 -73.47 -18.15 61.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 16.9 m-85 -86.55 -32.85 20.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -160.74 165.61 35.18 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -41.71 -55.13 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 110.336 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 58.79 89.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.01 0.91 . . . . 0.0 110.747 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' OD2' ' HE2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -92.84 -26.23 17.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.515 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -129.43 138.67 51.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -155.91 99.97 2.02 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.788 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -111.18 158.97 18.31 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.097 0.951 . . . . 0.0 112.854 -177.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 139' ' ' MET . 1.8 mp -137.82 148.55 45.57 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.559 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 1.4 mmt -125.28 147.54 49.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.729 -1.232 . . . . 0.0 110.927 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 141' ' ' MET . 16.1 m-85 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.647 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.598 ' C ' HD11 ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 1.003 ' HA ' HD21 ' A' ' 116' ' ' LEU . 5.9 p90 -147.88 136.67 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -1.134 . . . . 0.0 109.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -128.91 172.54 19.57 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.367 -1.396 . . . . 0.0 110.463 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' A' ' 139' ' ' MET . 71.0 m-85 -128.74 108.18 10.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.546 -0.973 . . . . 0.0 108.594 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -93.94 -178.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.456 -1.403 . . . . 0.0 109.648 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.547 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 36.4 m -163.66 105.92 0.96 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.224 -1.39 . . . . 0.0 112.216 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -130.4 120.62 24.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -0.812 . . . . 0.0 109.505 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -49.29 -20.35 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.655 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 162' ' ' ILE . 1.6 m -66.03 60.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.122 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -47.27 -38.7 12.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 179.713 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 162' ' ' ILE . 1.6 p30 -44.01 -49.58 8.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.378 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.784 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.4 tp -62.88 -49.79 82.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.872 HG22 ' CE2' ' A' ' 157' ' ' PHE . 44.3 t -46.81 -46.43 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -44.9 -55.19 5.67 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.242 0.544 . . . . 0.0 111.181 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 167' ' ' CYS . 21.0 tttp -87.06 -61.88 1.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.213 -0.929 . . . . 0.0 110.921 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 162' ' ' ILE . 5.8 p -42.51 -24.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 40.8 t -82.98 -27.68 30.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 110.446 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' LYS . 9.0 mm-40 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.145 -0.972 . . . . 0.0 111.018 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.721 ' CE1' HG23 ' A' ' 166' ' ' VAL . 34.4 m-70 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 174.25 119.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 110.201 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.781 HG23 ' O ' ' A' ' 174' ' ' ILE . 10.6 tp -98.27 78.64 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 22.9 m120 63.84 -53.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 0.0 111.576 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -138.6 -0.67 1.93 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.987 -1.071 . . . . 0.0 111.383 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.9 OUTLIER -125.04 -175.53 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.913 -1.117 . . . . 0.0 111.079 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.438 ' N ' ' SD ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -121.72 79.03 1.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.627 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 174' ' ' ILE . 5.2 m -79.09 130.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -80.17 163.0 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.818 ' SG ' HD13 ' A' ' 111' ' ' ILE . 43.1 t -133.07 110.51 10.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.49 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 8.0 mmtm -105.29 163.42 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.55 ' HG3' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -76.32 154.95 34.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.022 . . . . 0.0 110.229 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.373 -0.829 . . . . 0.0 110.418 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.037 0.446 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 1.045 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pt -133.6 175.13 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 110.721 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 15.9 t80 -138.21 145.39 41.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.492 -0.755 . . . . 0.0 109.267 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.449 ' C ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -130.13 148.43 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.51 166.07 25.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.514 ' O ' ' HE2' ' A' ' 177' ' ' LYS . . . 86.31 -13.61 57.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -54.23 97.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -1.111 . . . . 0.0 110.648 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -54.85 175.9 0.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.092 -1.005 . . . . 0.0 108.656 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -79.51 -155.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.658 -1.276 . . . . 0.0 110.115 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.625 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER 75.44 -32.85 0.22 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' A' ' 121' ' ' THR . 1.8 m -81.47 172.14 13.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.606 0.717 . . . . 0.0 111.313 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 120' ' ' THR . 10.8 t -149.25 154.93 39.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 109.38 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.586 ' HA ' HD12 ' A' ' 140' ' ' LEU . 2.4 t -39.3 -50.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.465 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.64 -24.77 0.13 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.402 -0.812 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.617 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 25.5 t0 -74.95 -59.76 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.736 . . . . 0.0 109.696 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.706 HG21 HD21 ' A' ' 140' ' ' LEU . 1.1 t -63.66 -48.92 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.541 -0.724 . . . . 0.0 109.388 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 12.5 tttp -48.47 -60.94 2.29 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.255 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.617 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -63.9 -36.29 83.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.012 -1.055 . . . . 0.0 110.255 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 35.8 t80 -58.39 -57.7 11.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.38 -0.825 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.521 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 72.5 m-85 -83.0 -16.36 47.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.025 . . . . 0.0 111.485 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 83.3 tt0 -55.89 -37.59 69.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.45 -1.406 . . . . 0.0 108.244 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.4 pt20 -74.41 -16.6 60.88 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 162' ' ' ILE . 4.3 m-30 -87.72 -32.32 19.22 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 109.127 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.9 35.75 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HD3' ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -50.81 -41.38 57.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.607 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 47.62 91.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.195 0.998 . . . . 0.0 111.074 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -25.39 17.59 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.45 144.24 51.27 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -160.41 100.97 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.204 -0.935 . . . . 0.0 108.59 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.56 ' HA ' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -114.92 165.4 12.9 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.813 0.816 . . . . 0.0 112.239 -178.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 125' ' ' VAL . 34.2 mt -140.12 139.87 35.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.554 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -114.17 132.7 56.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.026 -1.046 . . . . 0.0 110.912 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 141' ' ' MET . 30.2 m-85 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 13.5 p90 -150.14 140.25 22.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -1.088 . . . . 0.0 109.387 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.46 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -123.54 165.57 16.25 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.249 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' CG ' ' A' ' 139' ' ' MET . 22.8 m-85 -120.37 112.18 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 0.0 109.162 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.6 t -108.31 -179.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.68 -1.262 . . . . 0.0 109.008 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 110' ' ' LYS . 32.3 m -161.08 105.14 1.32 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.765 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.045 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.1 p90 -127.28 102.47 6.93 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.222 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.27 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 111.195 -178.757 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.872 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -54.74 86.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -54.91 -38.24 67.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.657 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.6 OUTLIER -39.39 -68.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.486 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 1.038 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -58.61 -45.63 90.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.956 -1.09 . . . . 0.0 108.875 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.978 HG22 ' CE1' ' A' ' 157' ' ' PHE . 9.9 t -47.29 -34.31 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -61.01 -42.81 99.18 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.617 0.722 . . . . 0.0 109.742 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.2 tptt -86.25 -62.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.56 -0.713 . . . . 0.0 110.81 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 1.038 HG22 ' O ' ' A' ' 162' ' ' ILE . 4.9 m -46.63 -24.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 108.908 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 1.7 t -65.89 -31.27 72.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.039 -1.038 . . . . 0.0 108.457 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.193 0.52 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 1.034 ' CE1' HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.224 0.535 . . . . 0.0 110.456 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.2 tt0 66.42 105.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.372 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.744 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -112.43 118.03 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.271 179.319 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.483 ' HA ' HD21 ' A' ' 175' ' ' ASN . 0.0 OUTLIER 67.45 -55.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.9 -178.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.2 p-10 -170.37 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 111.278 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.713 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -140.96 125.9 18.2 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.564 -1.335 . . . . 0.0 110.649 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -60.72 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.121 -0.987 . . . . 0.0 110.631 179.125 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.744 HG21 ' HB ' ' A' ' 174' ' ' ILE . 21.1 m -72.23 170.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 0.0 110.63 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.23 140.5 45.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 81.3 m -114.79 151.94 32.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 0.1 OUTLIER -159.84 147.11 16.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 110.255 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.631 ' HG3' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -58.31 166.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.385 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.991 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.842 HD11 ' CG2' ' A' ' 155' ' ' VAL . 1.3 pp -92.79 163.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.679 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.0 t80 -116.8 152.58 34.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.08 -1.013 . . . . 0.0 109.429 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 182' ' ' LYS . 2.3 m -143.38 155.63 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -140.03 -179.03 17.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.562 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 74.37 22.0 78.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.03 ' CD1' HD22 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -42.43 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLY . 14.3 t -46.88 161.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.562 ' O ' ' ND2' ' A' ' 119' ' ' ASN . 3.0 t -73.17 151.69 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.87 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.71 -44.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.459 0.647 . . . . 0.0 109.761 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 118' ' ' VAL . 2.6 m -41.16 132.26 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.993 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.511 ' N ' ' OD2' ' A' ' 124' ' ' ASP . 2.0 m -118.84 165.43 14.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 110.536 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -39.36 -52.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 111.038 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' VAL . 7.3 mt-10 -42.52 -25.37 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.382 -0.823 . . . . 0.0 109.477 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.563 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 82.6 m-20 -74.51 -54.04 8.3 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.452 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 140' ' ' LEU . 2.0 t -65.77 -48.51 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 109.2 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 14.4 ttpt -47.65 -61.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.563 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -64.14 -32.32 73.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 109.599 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.576 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 31.8 t80 -59.6 -57.99 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.406 -0.809 . . . . 0.0 110.384 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.576 ' CE1' ' CE2' ' A' ' 128' ' ' TYR . 61.1 m-85 -82.59 -14.59 54.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.0 111.038 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 78.7 tt0 -55.0 -38.92 68.48 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.195 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.6 pt20 -73.12 -17.44 61.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 4.2 m-85 -91.66 -30.15 16.48 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -158.96 155.22 26.29 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HE3' ' HG2' ' A' ' 158' ' ' GLU . 1.9 ptpt -41.34 -40.6 1.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -1.129 . . . . 0.0 110.535 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 45.15 94.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 111.17 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.84 -25.74 19.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.17 144.47 48.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.534 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.801 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -153.83 99.03 2.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 4.9 tpp -99.66 164.61 11.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.897 0.856 . . . . 0.0 111.481 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.03 HD22 ' CD1' ' A' ' 116' ' ' LEU . 11.5 mt -149.78 133.56 16.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 15.9 mmm -111.26 122.03 46.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.833 -1.167 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.462 ' CE1' HD12 ' A' ' 116' ' ' LEU . 15.5 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.419 -0.801 . . . . 0.0 109.86 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 14.7 p90 -150.44 140.0 21.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -1.106 . . . . 0.0 109.596 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.78 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -124.81 177.81 16.72 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.408 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.679 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 61.0 m-85 -138.37 117.41 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.929 . . . . 0.0 109.102 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.842 ' CG2' HD11 ' A' ' 111' ' ' ILE . 1.7 t -109.07 -174.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 155' ' ' VAL . 88.5 m -162.93 103.81 1.01 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.909 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.958 ' CE2' HG22 ' A' ' 163' ' ' VAL . 2.3 p90 -135.6 107.45 7.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.9 -22.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.434 -0.791 . . . . 0.0 111.118 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.853 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -56.36 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.421 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -61.63 -38.03 86.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.051 -1.031 . . . . 0.0 109.827 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 160' ' ' GLU . 10.1 t70 -39.27 -67.61 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.366 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.686 ' O ' HG12 ' A' ' 166' ' ' VAL . 5.6 tp -58.49 -42.68 85.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 108.79 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.958 HG22 ' CE2' ' A' ' 157' ' ' PHE . 38.2 t -50.94 -44.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.03 -46.51 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.7 tttt -90.26 -64.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -0.922 . . . . 0.0 111.202 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.866 HG13 ' HD3' ' A' ' 183' ' ' LYS . 6.0 p -45.31 -21.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.722 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 43.5 t -79.86 -22.87 42.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.931 -1.106 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 10.6 tp10 -158.91 86.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.904 -1.123 . . . . 0.0 111.012 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.754 HD11 HG23 ' A' ' 125' ' ' VAL . 1.5 tt -102.98 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.941 -1.099 . . . . 0.0 109.854 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 4.8 m120 67.36 -56.75 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.9 p30 -170.93 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 110.174 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.8 tptt -128.19 163.98 23.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 111.018 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.594 ' C ' HG22 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -94.28 -18.63 21.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -0.785 . . . . 0.0 109.32 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.594 HG22 ' C ' ' A' ' 178' ' ' MET . 34.5 m 37.25 -160.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.44 140.1 21.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 26.2 p -81.39 132.47 35.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.438 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -129.5 11.02 5.75 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.235 1.017 . . . . 0.0 109.175 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.866 ' HD3' HG13 ' A' ' 166' ' ' VAL . 1.4 mptt -41.01 158.09 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.586 -0.696 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 -179.894 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 9.8 pttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.03 0.443 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.955 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 5.4 pt -103.55 169.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.968 -1.083 . . . . 0.0 111.16 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 21.4 t80 -123.69 144.73 49.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.706 -0.621 . . . . 0.0 109.647 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -140.14 138.65 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 110.33 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -127.98 165.48 20.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.664 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 89.68 17.04 55.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.599 HD13 ' HG ' ' A' ' 140' ' ' LEU . 38.5 mt -39.54 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 110.278 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 177' ' ' LYS . 0.2 OUTLIER -43.87 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.884 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 120' ' ' THR . 10.6 m -67.71 157.6 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.766 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 3.9 t-20 62.22 -38.95 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.911 -0.493 . . . . 0.0 110.779 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 118' ' ' VAL . 54.9 m -47.68 150.23 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.947 -1.095 . . . . 0.0 109.994 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.801 ' C ' HD22 ' A' ' 140' ' ' LEU . 7.5 t -147.63 -167.28 2.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -60.21 -56.15 19.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 109.852 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -44.1 -24.62 0.16 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 109.604 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.719 ' OD2' HG22 ' A' ' 121' ' ' THR . 40.7 m-20 -78.2 -58.98 2.97 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.746 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.837 HG23 HD11 ' A' ' 174' ' ' ILE . 1.5 t -62.15 -47.79 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 108.943 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 6.0 ttmt -46.66 -61.98 1.59 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.485 -0.76 . . . . 0.0 109.992 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.713 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -64.76 -34.55 78.6 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.439 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.615 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 29.7 t80 -55.6 -58.21 8.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.575 -0.703 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 94.0 m-85 -81.29 -15.81 54.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.7 tt0 -55.41 -38.12 68.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 4.2 pt20 -74.59 -15.82 60.82 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.298 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 18.5 m-85 -86.85 -30.67 21.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.445 0.64 . . . . 0.0 109.341 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -162.03 -174.59 32.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -56.15 24.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 56.07 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.208 1.004 . . . . 0.0 111.135 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -24.91 16.36 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -130.71 140.01 50.33 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.753 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -153.8 101.69 2.47 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.873 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.3 ptm -113.16 168.79 9.43 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.92 0.867 . . . . 0.0 113.117 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.873 HD12 ' O ' ' A' ' 139' ' ' MET . 2.6 mp -139.1 139.18 37.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.851 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.583 ' HB3' ' O ' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -109.56 132.6 53.98 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.755 -1.215 . . . . 0.0 109.75 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 95.7 m-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.78 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.583 ' O ' ' HB3' ' A' ' 141' ' ' MET . 5.4 p90 -151.02 139.5 20.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.01 -1.288 . . . . 0.0 109.999 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -104.56 158.3 16.5 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.18 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 139' ' ' MET . 89.4 m-85 -114.3 103.4 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -97.0 -179.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.485 -178.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.627 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 73.7 m -163.95 104.52 0.9 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.782 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.955 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -125.99 106.55 9.7 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.45 177.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.553 -0.717 . . . . 0.0 111.529 -178.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -56.95 83.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 110.487 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -61.12 -38.43 86.32 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.774 -1.204 . . . . 0.0 109.478 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.8 m-20 -41.53 -62.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.788 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.1 tp -57.52 -47.14 85.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.033 -1.042 . . . . 0.0 108.564 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.949 HG22 ' CE2' ' A' ' 157' ' ' PHE . 43.2 t -47.67 -49.07 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.433 ' O ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -41.53 -52.28 3.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.674 -0.641 . . . . 0.0 111.386 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 167' ' ' CYS . 58.1 tttt -90.5 -61.79 1.6 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -0.999 . . . . 0.0 110.855 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 162' ' ' ILE . 7.1 p -42.36 -24.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 181' ' ' CYS . 13.9 p -81.2 -30.59 34.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.874 -1.141 . . . . 0.0 110.268 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.517 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.274 0.559 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.7 tt0 -90.09 96.74 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.148 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.837 HD11 HG23 ' A' ' 125' ' ' VAL . 2.0 tt -97.71 97.26 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 110.034 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.472 ' OD1' ' CG1' ' A' ' 174' ' ' ILE . 3.8 m120 67.78 -56.89 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 110.009 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.8 p30 -166.0 23.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 110.192 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.557 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.4 OUTLIER -127.22 166.03 18.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 111.031 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -109.3 40.24 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.492 -0.755 . . . . 0.0 109.44 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.664 HG12 ' C ' ' A' ' 115' ' ' GLY . 19.0 m -47.76 167.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.5 -0.75 . . . . 0.0 111.332 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 1.8 tt0 -107.78 150.12 27.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.614 -0.679 . . . . 0.0 109.823 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 167' ' ' CYS . 3.1 p -131.0 90.6 2.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -89.66 143.24 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -79.99 163.87 23.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.296 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.318 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.861 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.359 0.599 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.687 HG21 ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.99 174.19 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.753 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 41.0 t80 -123.53 156.76 35.04 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.947 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 1.4 m -145.0 154.38 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 179' ' ' VAL . . . -144.12 174.0 24.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.813 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 77.85 12.84 84.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.763 HD11 ' N ' ' A' ' 153' ' ' GLY . 39.5 mt -53.48 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -1.171 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.519 ' HB2' ' CD ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -42.25 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.504 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 120' ' ' THR . 14.8 m -65.99 161.84 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 110.792 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 1.3 t-20 62.57 -38.6 0.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 110.67 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 118' ' ' VAL . 21.8 m -42.58 139.48 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 109.921 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.757 ' C ' HD12 ' A' ' 140' ' ' LEU . 8.7 t -127.0 168.93 13.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.08 -1.013 . . . . 0.0 111.079 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.792 ' N ' HD12 ' A' ' 140' ' ' LEU . 1.5 t -39.3 -47.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.679 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -44.38 -25.66 0.27 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 108.968 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.53 ' OD2' ' CG2' ' A' ' 120' ' ' THR . 15.7 t0 -69.51 -46.31 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.699 . . . . 0.0 109.665 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.818 HG22 HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -76.66 -44.17 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.807 0.813 . . . . 0.0 109.17 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 9.6 ttmt -59.38 -48.82 80.19 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.691 -0.63 . . . . 0.0 111.078 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.713 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -71.9 -28.63 63.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 110.123 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.503 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 67.4 t80 -79.13 -50.0 11.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 112.167 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 125' ' ' VAL . 68.6 m-85 -88.43 -16.91 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.814 -1.179 . . . . 0.0 112.118 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 1.5 pp20? -53.73 -42.49 68.19 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.247 -1.781 . . . . 0.0 108.432 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -70.57 -17.04 62.92 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.802 179.527 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.745 ' O ' HD13 ' A' ' 162' ' ' ILE . 7.7 m-85 -79.99 -27.77 39.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.35 -132.6 1.36 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 158' ' ' GLU . 1.5 ptpp? -101.13 -37.48 8.55 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.516 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 42.45 89.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.11 0.957 . . . . 0.0 110.934 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.12 -27.2 23.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.72 136.92 37.8 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.377 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -143.2 91.1 2.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.558 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 6.3 ttp -96.32 162.94 13.29 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.098 0.951 . . . . 0.0 112.166 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.818 HD11 HG22 ' A' ' 125' ' ' VAL . 22.5 mt -139.35 129.95 25.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 35.2 mmm -103.68 111.46 23.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.011 -1.056 . . . . 0.0 110.616 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 110.034 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.7 p90 -147.46 140.4 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -1.054 . . . . 0.0 109.287 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.79 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -111.05 161.55 12.77 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.375 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' HB2' ' HE3' ' A' ' 139' ' ' MET . 28.3 m-85 -123.82 109.85 14.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -1.013 . . . . 0.0 109.128 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -105.24 -178.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 109.372 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.623 ' HA ' HD13 ' A' ' 111' ' ' ILE . 78.7 m -159.7 104.25 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.58 -1.325 . . . . 0.0 112.149 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.065 ' CE1' HG22 ' A' ' 163' ' ' VAL . 1.6 p90 -127.73 97.23 4.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 0.0 108.748 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLU . 1.0 OUTLIER -39.05 -31.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.755 . . . . 0.0 111.483 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -52.49 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.791 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -55.76 -38.11 69.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.091 -1.006 . . . . 0.0 109.755 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.9 OUTLIER -39.85 -64.46 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.305 -179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.847 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -61.36 -46.28 96.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.853 -1.154 . . . . 0.0 108.815 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.065 HG22 ' CE1' ' A' ' 157' ' ' PHE . 4.4 t -49.77 -35.3 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -50.1 -63.07 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.66 -0.65 . . . . 0.0 111.217 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 10.7 ptpt -90.43 -45.02 9.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.144 -0.973 . . . . 0.0 111.484 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -51.9 -22.05 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.517 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.536 ' CB ' ' HG2' ' A' ' 183' ' ' LYS . 89.5 m -89.61 -23.31 21.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.003 -1.061 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.592 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 178' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.246 0.545 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.3 pt-20 -96.78 109.89 22.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.003 HD13 HG21 ' A' ' 179' ' ' VAL . 4.7 pt -118.91 119.62 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.133 . . . . 0.0 109.789 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.7 OUTLIER 68.22 -56.69 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.933 . . . . 0.0 109.702 -179.133 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 174' ' ' ILE . 4.8 p30 -179.07 31.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 109.401 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.59 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.4 tptp -139.14 136.7 35.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 111.352 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -82.29 45.44 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.837 . . . . 0.0 109.588 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 1.003 HG21 HD13 ' A' ' 174' ' ' ILE . 6.8 m -46.77 176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.676 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 38.7 tt0 -129.19 150.89 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 109.821 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -117.91 160.25 21.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.461 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -159.06 150.31 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.769 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.536 ' HG2' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -66.52 158.94 28.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.0 110.276 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 110.261 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.902 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.03 0.443 . . . . 0.0 110.126 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.987 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 6.1 pt -106.7 170.89 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.099 -1.001 . . . . 0.0 110.822 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 54.2 t80 -125.57 150.66 47.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.507 -0.746 . . . . 0.0 109.893 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -142.54 159.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.917 . . . . 0.0 110.297 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -151.15 168.66 30.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.14 48.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 140' ' ' LEU . 2.6 mm? -63.89 93.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -1.196 . . . . 0.0 109.543 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 177' ' ' LYS . 4.9 t -64.6 -146.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 111.118 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' THR . 8.9 t -90.41 166.97 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 111.223 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 2.5 t-20 61.59 -40.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.285 0.564 . . . . 0.0 110.476 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' VAL . 24.2 m -51.22 134.51 27.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.045 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.6 t -138.57 159.18 42.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.574 HG23 ' CB ' ' A' ' 140' ' ' LEU . 2.6 t -39.74 -52.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.818 . . . . 0.0 110.556 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 122' ' ' VAL . 5.5 tt0 -39.68 -28.22 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.548 -0.72 . . . . 0.0 109.294 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 122' ' ' VAL . 28.0 m-20 -75.17 -59.79 2.58 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.004 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 129' ' ' PHE . 1.6 t -63.84 -48.86 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.25 -0.906 . . . . 0.0 108.99 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 5.2 ttpt -45.19 -70.14 0.11 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.413 -0.804 . . . . 0.0 109.495 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.545 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -55.99 -37.58 69.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.186 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 26.2 t80 -58.69 -47.4 84.63 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.59 -0.694 . . . . 0.0 111.409 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.614 ' CD2' HG13 ' A' ' 125' ' ' VAL . 69.2 m-85 -87.19 -15.11 39.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.05 -1.031 . . . . 0.0 113.425 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.792 ' HG2' HG11 ' A' ' 135' ' ' VAL . 3.2 mt-10 -56.53 -34.58 67.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.632 -1.917 . . . . 0.0 108.618 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.58 ' HG3' ' CD1' ' A' ' 132' ' ' PHE . 20.3 pt20 -74.87 -17.39 60.59 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.411 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.58 ' CD1' ' HG3' ' A' ' 131' ' ' GLN . 28.1 m-85 -83.79 -31.82 25.71 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -163.55 169.48 38.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.469 ' HD2' ' HG2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -42.39 -57.01 2.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -1.128 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.792 HG11 ' HG2' ' A' ' 130' ' ' GLU . 1.2 t 61.11 90.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.202 1.001 . . . . 0.0 111.268 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.13 -26.98 14.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.73 140.9 50.98 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.771 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -154.17 99.31 2.22 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 154' ' ' PHE . 2.5 ptm -110.31 167.61 10.07 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.064 0.935 . . . . 0.0 112.265 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 116' ' ' LEU . 5.1 tp -146.47 155.04 42.25 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 140' ' ' LEU . 75.5 mmm -142.22 144.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 23.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.615 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.8 p90 -149.0 146.87 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 109.641 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -123.71 152.84 17.2 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.883 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' HG3' ' A' ' 139' ' ' MET . 30.6 m-85 -119.26 109.28 15.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.059 -1.259 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -103.92 179.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.758 -1.214 . . . . 0.0 109.042 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.579 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 61.0 m -162.74 107.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.944 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.987 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -127.62 127.21 43.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -52.83 -17.25 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 110.952 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.7 m -72.53 81.1 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -59.28 -39.09 81.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.76 -1.213 . . . . 0.0 109.25 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 1.5 m-20 -40.2 -58.72 1.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.766 -0.584 . . . . 0.0 110.344 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.855 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -61.65 -47.5 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.614 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.911 HG22 ' CE2' ' A' ' 157' ' ' PHE . 36.1 t -47.07 -39.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 10.0 tt0 -46.13 -64.18 0.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.79 -0.569 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 3.9 pttm -90.5 -46.86 8.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.22 -0.925 . . . . 0.0 111.64 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.9 p -48.68 -23.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.075 . . . . 0.0 110.27 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 163' ' ' VAL . 91.3 m -89.93 -27.32 19.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.353 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.864 . . . . 0.0 110.705 -179.565 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.603 ' O ' HG22 ' A' ' 179' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.343 0.592 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -84.17 104.4 14.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 1.001 ' CD1' HG21 ' A' ' 179' ' ' VAL . 3.8 mt -103.59 100.88 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 0.0 109.655 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 0.2 OUTLIER 66.25 -55.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.301 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 174' ' ' ILE . 3.2 p-10 -168.01 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.49 -0.756 . . . . 0.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.592 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.3 tptt -131.85 152.17 51.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 44.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.858 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 1.001 HG21 ' CD1' ' A' ' 174' ' ' ILE . 33.5 m -48.06 170.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.354 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 30.5 tt0 -122.87 146.51 47.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.706 ' SG ' HD12 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -114.75 165.51 12.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.358 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -161.05 175.82 12.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.074 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -93.84 144.52 25.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.093 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.961 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.315 0.578 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.841 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 2.0 pt -104.92 176.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -0.806 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -124.55 159.81 29.79 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.223 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -149.3 161.66 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 0.0 110.483 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -150.86 152.69 24.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.773 ' HA3' HG12 ' A' ' 179' ' ' VAL . . . 114.3 -17.13 19.4 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.917 HD22 HD22 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -49.81 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -1.148 . . . . 0.0 110.097 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 118' ' ' VAL . 30.4 t -101.64 -167.57 1.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.747 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 120' ' ' THR . 16.4 m -42.25 168.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 111.081 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.556 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 2.6 t-20 62.69 -41.75 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.155 0.502 . . . . 0.0 110.33 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 118' ' ' VAL . 1.3 m -61.4 133.16 55.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.932 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLU . 10.2 t -149.27 60.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.091 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.89 ' H ' HD12 ' A' ' 140' ' ' LEU . 3.1 t 63.97 -56.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.173 0.511 . . . . 0.0 110.425 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.786 ' O ' ' HD2' ' A' ' 127' ' ' HIS . 1.4 mm-40 -44.57 -23.71 0.14 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.442 -0.786 . . . . 0.0 108.946 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.716 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 2.4 m-20 -70.23 -58.04 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.718 . . . . 0.0 109.686 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.76 HG22 ' HE2' ' A' ' 129' ' ' PHE . 2.0 t -68.38 -50.48 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.703 . . . . 0.0 109.326 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 15.8 tttt -49.01 -59.76 3.34 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.386 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.786 ' HD2' ' O ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -58.21 -29.53 65.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -74.96 -62.41 1.56 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 111.827 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.76 ' HE2' HG22 ' A' ' 125' ' ' VAL . 67.8 m-85 -74.09 -15.09 61.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.902 -1.123 . . . . 0.0 112.668 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -52.41 -41.29 63.07 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 117.702 -1.599 . . . . 0.0 109.113 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.17 -16.97 61.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.648 -0.821 . . . . 0.0 108.874 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.531 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 2.8 m-85 -88.66 -25.36 22.43 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.564 0.697 . . . . 0.0 109.164 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -166.23 153.42 23.26 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 158' ' ' GLU . 12.3 ptpt -38.49 -41.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.599 -0.942 . . . . 0.0 110.727 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.2 t 47.52 90.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.099 0.952 . . . . 0.0 110.604 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.1 -26.06 19.31 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -127.92 140.23 52.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.739 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -157.77 98.93 1.68 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.682 ' HA ' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.95 169.37 9.7 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.971 0.891 . . . . 0.0 112.505 -177.428 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 1.029 HD23 ' HA3' ' A' ' 153' ' ' GLY . 18.0 mt -144.59 132.41 21.29 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.488 ' O ' HD11 ' A' ' 116' ' ' LEU . 1.9 mmt -103.16 112.27 25.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.179 -0.951 . . . . 0.0 110.784 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 140' ' ' LEU . 77.2 m-85 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.529 ' CA ' HD21 ' A' ' 116' ' ' LEU . 29.4 p90 -141.58 134.5 28.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -1.205 . . . . 0.0 110.248 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 1.029 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -117.0 165.15 12.35 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.52 ' O ' ' HG3' ' A' ' 139' ' ' MET . 46.6 m-85 -125.96 109.6 12.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.594 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -101.63 -177.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.973 -1.079 . . . . 0.0 108.922 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 88.6 m -164.07 105.48 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.277 -1.369 . . . . 0.0 112.242 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.841 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.3 p90 -132.41 108.36 9.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.02 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 160' ' ' GLU . 5.3 tt0 -39.56 -27.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 0.0 110.847 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.703 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -53.58 88.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 110.427 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.0 tm-20 -66.35 -38.58 87.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.1 OUTLIER -40.84 -60.73 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.995 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.942 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -59.88 -48.86 86.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.772 178.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.815 HG22 ' CE2' ' A' ' 157' ' ' PHE . 42.1 t -46.98 -41.95 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 4.9 tt0 -51.09 -42.92 60.93 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.512 0.673 . . . . 0.0 110.259 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -88.86 -63.59 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.372 -0.83 . . . . 0.0 110.947 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.942 HG22 ' O ' ' A' ' 162' ' ' ILE . 12.4 m -47.25 -23.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.489 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 13.9 t -73.63 -24.41 60.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 108.983 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 165' ' ' LYS . 42.2 tp10 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.842 -0.536 . . . . 0.0 110.418 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.808 ' NE2' HG12 ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.304 0.574 . . . . 0.0 110.272 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 13.1 tt0 70.48 79.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 0.0 110.824 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.669 HG22 ' CB ' ' A' ' 177' ' ' LYS . 2.8 tt -78.29 -175.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.97 -1.081 . . . . 0.0 109.726 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' ILE . 28.4 m120 -30.28 -57.36 0.19 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.8 -0.562 . . . . 0.0 111.819 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.7 OUTLIER -138.86 28.9 2.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.213 -0.929 . . . . 0.0 110.27 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.669 ' CB ' HG22 ' A' ' 174' ' ' ILE . 0.2 OUTLIER -142.88 -166.63 2.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.729 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -135.39 33.61 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.773 HG12 ' HA3' ' A' ' 115' ' ' GLY . 33.3 m -36.9 159.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.518 0.675 . . . . 0.0 111.375 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -114.57 153.72 29.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.78 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 166' ' ' VAL . 20.2 m -121.97 122.02 38.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 110.588 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -124.22 137.65 54.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.565 ' HD3' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -56.08 164.91 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 0.0 110.8 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.961 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.715 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.109 0.481 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.975 HD12 ' N ' ' A' ' 112' ' ' PHE . 1.2 pp -119.25 -179.15 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.853 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.975 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.6 t80 -131.43 159.49 37.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 109.563 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.443 HG23 ' CA ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -145.78 155.4 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.291 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 179' ' ' VAL . . . -156.63 140.62 7.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 121.62 -10.1 9.82 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.792 HD11 ' O ' ' A' ' 141' ' ' MET . 0.4 OUTLIER -50.89 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -1.12 . . . . 0.0 109.929 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' GLY . 53.7 p -65.49 -167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.782 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 120' ' ' THR . 23.1 m -58.84 171.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 0.0 111.225 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 1.8 t-20 62.2 -39.87 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.914 -0.491 . . . . 0.0 110.775 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.672 HG23 ' OD2' ' A' ' 124' ' ' ASP . 36.8 m -55.56 148.74 15.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.006 -1.059 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.7 t -158.28 166.88 31.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.623 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -41.6 -53.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 110.558 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.08 -25.8 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.672 ' OD2' HG23 ' A' ' 120' ' ' THR . 50.5 t0 -72.24 -49.94 31.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.769 ' CG2' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -69.37 -44.85 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.09 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 8.2 tttm -52.16 -63.99 0.96 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.518 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -62.85 -30.79 71.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.144 -0.972 . . . . 0.0 110.95 -179.256 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 84.9 t80 -70.59 -50.92 32.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.19 -0.944 . . . . 0.0 111.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.721 ' CE2' HG12 ' A' ' 125' ' ' VAL . 56.0 m-85 -89.48 -12.29 40.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 111.941 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.695 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 26.0 tt0 -56.31 -38.29 71.08 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.357 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 24.6 pt20 -74.65 -14.46 60.76 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.565 ' O ' HD13 ' A' ' 162' ' ' ILE . 14.0 m-85 -86.8 -32.16 20.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.712 -0.617 . . . . 0.0 110.424 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -170.3 54.69 0.19 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.346 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER 60.15 -67.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.722 -0.869 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 135' ' ' VAL . 0.9 OUTLIER 62.44 94.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.083 . . . . 0.0 110.903 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.41 -25.0 25.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.51 136.55 39.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.5 0.667 . . . . 0.0 109.793 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.843 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -145.18 92.51 2.26 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.505 ' SD ' ' CE ' ' A' ' 141' ' ' MET . 6.8 tpp -90.17 163.06 14.97 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.834 0.826 . . . . 0.0 111.328 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.776 HD12 ' HA3' ' A' ' 153' ' ' GLY . 5.0 tp -151.11 154.71 37.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.774 -0.579 . . . . 0.0 109.711 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.792 ' O ' HD11 ' A' ' 116' ' ' LEU . 8.8 mmt -138.88 157.62 45.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.177 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.915 . . . . 0.0 110.062 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 6.6 p90 -149.7 141.84 24.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.994 . . . . 0.0 109.252 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.776 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -123.58 160.07 18.15 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.574 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -123.89 113.33 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.976 . . . . 0.0 108.748 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -104.42 178.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.879 -1.138 . . . . 0.0 109.543 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 45.8 m -160.6 104.92 1.41 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.178 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.018 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -128.83 112.31 14.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 177.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.444 ' CA ' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -39.48 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.499 -0.751 . . . . 0.0 110.585 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.865 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.4 m -59.92 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.499 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.271 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.463 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -43.24 -61.13 1.42 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.892 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.4 OUTLIER -58.1 -46.41 88.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.39 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.018 HG22 ' CE2' ' A' ' 157' ' ' PHE . 44.5 t -48.96 -51.3 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 161' ' ' ASP . 2.9 mt-10 -42.7 -43.97 4.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.612 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -90.92 -66.21 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 111.107 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.841 HG23 ' CE1' ' A' ' 172' ' ' HIS . 6.0 p -45.44 -20.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 0.0 110.936 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 183' ' ' LYS . 3.5 p -88.19 -29.19 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 109.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.896 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.841 ' CE1' HG23 ' A' ' 166' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.357 0.599 . . . . 0.0 110.446 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 178' ' ' MET . 14.3 tt0 -153.65 127.74 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.812 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -116.3 102.82 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.01 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.468 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.0 OUTLIER 66.88 -58.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.188 . . . . 0.0 109.842 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 174' ' ' ILE . 3.6 p-10 -149.5 -31.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 110.587 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -76.72 -170.05 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.41 -0.806 . . . . 0.0 110.099 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.639 ' C ' HG23 ' A' ' 179' ' ' VAL . 21.8 mmt -100.63 -70.6 0.73 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.812 HG21 ' HB ' ' A' ' 174' ' ' ILE . 2.6 t 70.48 160.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.551 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -120.75 152.77 37.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' CYS . . . . . 0.476 ' O ' ' CG ' ' A' ' 182' ' ' LYS . 35.4 m -126.39 158.84 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 181' ' ' CYS . 15.4 mtmt -157.53 155.47 30.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.832 . . . . 0.0 109.961 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -67.12 160.88 25.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.034 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.822 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.648 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -122.39 176.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.99 . . . . 0.0 110.389 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 56.4 t80 -126.08 160.22 30.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.812 . . . . 0.0 109.926 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.1 OUTLIER -147.42 149.25 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.037 -1.039 . . . . 0.0 110.667 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.22 174.2 22.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 89.59 13.19 61.64 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.889 HD21 ' HG ' ' A' ' 140' ' ' LEU . 1.7 mp -40.81 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -1.051 . . . . 0.0 110.167 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 115' ' ' GLY . 22.7 t -64.92 178.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.731 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -72.33 150.23 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 0.0 110.454 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 3.7 t-20 62.25 -38.85 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.99 -0.444 . . . . 0.0 110.598 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.642 HG23 ' OD2' ' A' ' 124' ' ' ASP . 18.0 m -41.4 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.304 -0.873 . . . . 0.0 110.015 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 124' ' ' ASP . 10.3 t -164.52 172.51 13.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 140' ' ' LEU . 3.1 t -39.01 -54.54 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.682 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.474 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -41.98 -25.91 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 109.155 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.642 ' OD2' HG23 ' A' ' 120' ' ' THR . 58.1 t0 -72.81 -55.56 6.52 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.493 0.663 . . . . 0.0 109.909 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' VAL . . . . . 0.848 HG12 ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -68.4 -54.75 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.1 tttt -39.29 -63.47 0.55 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.154 0.502 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.527 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 2.1 p-80 -61.87 -29.5 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.073 -1.017 . . . . 0.0 110.897 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -73.36 -55.29 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 0.0 111.707 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PHE . . . . . 0.848 ' CD2' HG12 ' A' ' 125' ' ' VAL . 38.6 m-85 -84.13 -17.53 39.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.104 . . . . 0.0 111.895 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.659 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 70.0 tt0 -57.2 -36.0 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.114 -1.616 . . . . 0.0 108.262 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLN . . . . . 0.479 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.9 pt20 -76.71 -13.56 60.03 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.651 ' CD2' HD11 ' A' ' 162' ' ' ILE . 4.1 m-30 -86.95 -35.11 19.07 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.806 -0.559 . . . . 0.0 111.101 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -169.45 65.01 0.18 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.273 -1.918 . . . . 0.0 111.181 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.86 -70.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.933 . . . . 0.0 111.591 178.504 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 64.95 92.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.09 0.948 . . . . 0.0 110.732 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -87.19 -21.61 25.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.06 137.9 41.59 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -155.9 98.17 1.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' MET . . . . . 0.577 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -113.61 171.79 7.36 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.145 0.974 . . . . 0.0 112.555 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.889 ' HG ' HD21 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -145.62 148.43 33.1 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.498 179.683 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . 0.448 ' O ' ' HA3' ' A' ' 151' ' ' GLY . 3.1 mmt -130.45 116.99 19.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.023 -1.048 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 116' ' ' LEU . 45.1 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 109.997 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PHE . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 4.7 p90 -145.35 153.32 41.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -1.158 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -118.85 158.34 14.88 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.432 -1.366 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 139' ' ' MET . 11.9 m-85 -116.93 110.95 18.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -1.061 . . . . 0.0 109.352 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -107.65 179.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.638 -1.289 . . . . 0.0 109.392 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . 0.822 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 97.2 m -163.49 104.75 0.96 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.293 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 1.055 ' CE1' HG22 ' A' ' 163' ' ' VAL . 1.4 p90 -127.83 99.2 5.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.866 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -38.89 -31.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.757 -0.59 . . . . 0.0 111.381 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 163' ' ' VAL . 35.7 m -53.37 86.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.3 tt0 -54.36 -38.42 66.06 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.831 -1.168 . . . . 0.0 109.75 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.2 OUTLIER -38.42 -67.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -60.46 -38.23 77.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.325 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.055 HG22 ' CE1' ' A' ' 157' ' ' PHE . 7.7 t -58.2 -32.94 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.7 tm-20 -58.02 -49.59 76.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.478 -0.764 . . . . 0.0 110.604 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 168' ' ' GLU . 18.9 tttp -89.71 -60.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.577 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 162' ' ' ILE . 2.5 p -42.34 -25.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.452 -0.78 . . . . 0.0 109.805 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' CYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.7 t -76.28 -34.52 59.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.894 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 165' ' ' LYS . 23.3 tt0 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 110.703 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 173' ' ' GLU . 6.7 m80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.406 0.622 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 57.7 tt0 59.04 114.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . 0.633 ' CG2' HG11 ' A' ' 179' ' ' VAL . 0.4 OUTLIER -111.61 114.55 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.926 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.49 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.8 OUTLIER 68.84 -56.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.0 109.467 -178.448 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.7 OUTLIER -174.24 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.571 -0.706 . . . . 0.0 110.312 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.628 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -139.92 122.31 16.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 110.138 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -54.53 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.856 -1.153 . . . . 0.0 110.504 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' VAL . . . . . 0.633 HG11 ' CG2' ' A' ' 174' ' ' ILE . 23.3 m -97.01 -161.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -134.88 157.12 47.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.975 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.0 t -145.01 141.37 28.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.918 . . . . 0.0 110.48 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 13.6 mtpp -138.02 -171.15 2.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 109.886 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.639 ' HA ' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -106.28 164.31 12.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.214 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.565 ' N ' ' CD ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.987 -1.071 . . . . 0.0 110.962 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.821 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.964 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.5 pt -114.77 174.84 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.123 -0.986 . . . . 0.0 110.881 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.7 t80 -121.93 157.7 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.495 -0.753 . . . . 0.0 109.422 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -149.72 153.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.009 . . . . 0.0 110.479 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -141.1 176.37 21.68 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.499 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 87.1 15.38 62.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.65 HD22 HD22 ' A' ' 140' ' ' LEU . 15.4 mt -47.63 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 115' ' ' GLY . 2.2 t -57.52 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 110.66 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 148' ' ' ARG . 15.6 m -89.06 154.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.496 -0.753 . . . . 0.0 110.867 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 1.4 t-20 62.26 -35.28 0.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.739 -0.601 . . . . 0.0 111.082 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' VAL . 62.2 m -43.63 128.65 5.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 110.13 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 15.3 t -117.69 158.58 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 110.248 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.4 t -37.5 -51.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.57 -0.706 . . . . 0.0 110.848 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -41.11 -26.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.556 -0.715 . . . . 0.0 109.441 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 1.6 m-20 -74.14 -55.76 5.71 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.728 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 1.007 HG21 HD21 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.6 -48.06 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.328 -0.857 . . . . 0.0 109.241 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 8.6 ttpp -47.53 -60.77 2.3 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.448 -0.783 . . . . 0.0 109.673 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -63.94 -33.51 75.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 7.1 t80 -57.77 -60.7 3.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.56 -0.712 . . . . 0.0 110.439 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 97.3 m-85 -80.43 -16.4 54.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.8 tt0 -56.64 -36.45 69.52 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.382 -1.449 . . . . 0.0 107.957 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.2 pt20 -73.75 -17.21 61.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.511 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 3.6 m-30 -86.31 -28.29 23.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.426 0.632 . . . . 0.0 109.608 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -165.83 -165.73 23.66 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -52.41 59.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.298 -1.119 . . . . 0.0 110.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 55.34 90.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.087 0.946 . . . . 0.0 110.913 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -92.83 -26.57 17.61 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -130.73 140.61 50.34 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.007 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.725 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -154.91 98.78 2.07 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.701 ' HA ' HG22 ' A' ' 122' ' ' VAL . 4.2 ptp -116.57 163.47 16.05 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.948 0.88 . . . . 0.0 112.461 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 125' ' ' VAL . 89.2 mt -137.26 133.01 34.56 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.614 ' O ' HD12 ' A' ' 116' ' ' LEU . 2.6 mmt -107.19 125.05 50.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.933 -1.105 . . . . 0.0 110.577 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 27.0 m-85 -111.91 -133.22 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 146' ' ' THR . 38.6 t0 -134.99 130.66 36.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.893 -1.13 . . . . 0.0 110.004 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -42.48 125.81 3.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.56 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 7.8 p 44.37 31.75 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.426 -0.796 . . . . 0.0 110.516 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -150.0 53.33 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.71 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.01 53.34 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.555 -0.716 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.602 ' HA ' HG12 ' A' ' 118' ' ' VAL . 9.9 mtt180 -126.39 -45.87 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 110.642 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -67.65 -174.62 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -86.18 160.56 19.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.206 -0.934 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.26 -160.19 8.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.3 p90 -147.02 137.29 23.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -1.134 . . . . 0.0 109.992 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.687 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -114.71 159.56 13.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 139' ' ' MET . 30.8 m-85 -115.04 109.85 18.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -1.1 . . . . 0.0 109.372 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.49 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -104.66 -178.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.892 -1.13 . . . . 0.0 109.008 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 30.8 m -164.81 104.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.038 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.964 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 2.0 p90 -128.37 107.81 10.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 0.0 109.23 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -39.31 -26.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.793 . . . . 0.0 111.138 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 163' ' ' VAL . 2.3 m -56.48 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.777 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.6 tt0 -58.32 -38.61 77.45 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.693 -1.255 . . . . 0.0 109.463 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 6.6 t0 -40.37 -63.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 110.389 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.715 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.3 tp -57.99 -45.06 88.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.98 -1.075 . . . . 0.0 108.82 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 157' ' ' PHE . 35.5 t -47.42 -39.82 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -51.17 -56.58 12.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.716 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 167' ' ' CYS . 5.9 tttp -84.8 -60.83 1.94 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.285 -0.884 . . . . 0.0 110.863 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.3 p -41.34 -25.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.097 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.9 t -75.62 -38.3 59.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.152 -0.968 . . . . 0.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 165' ' ' LYS . 4.4 mt-10 -77.18 -22.64 52.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.512 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.677 HG21 ' ND1' ' A' ' 172' ' ' HIS . 12.6 mm -54.08 132.55 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 63.0 m80 -112.86 26.75 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.058 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.62 ' CG ' ' HB3' ' A' ' 178' ' ' MET . 0.2 OUTLIER -177.98 59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.291 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.677 ' ND1' HG21 ' A' ' 169' ' ' ILE . 18.6 m-70 -58.18 -159.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.921 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -141.32 99.41 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 109.988 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 174' ' ' ILE . 0.5 OUTLIER -92.06 81.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.958 -1.089 . . . . 0.0 110.159 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 33.3 m120 64.47 -53.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 111.287 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.1 p30 -147.75 7.45 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 111.191 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.3 OUTLIER -124.64 172.17 9.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.797 -1.19 . . . . 0.0 111.415 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.62 ' HB3' ' CG ' ' A' ' 171' ' ' PHE . 23.7 mmt -113.05 57.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.65 -0.656 . . . . 0.0 109.894 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.499 HG12 ' C ' ' A' ' 115' ' ' GLY . 15.4 m -56.88 -166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.822 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -136.34 162.88 31.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.715 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.587 ' HB3' ' CD2' ' A' ' 172' ' ' HIS . 41.4 t -144.1 130.81 20.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.72 173.38 9.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.445 ' H ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -95.59 156.23 16.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.275 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 110.58 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.926 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 5.7 ptpt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.036 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 5.1 pt -102.33 163.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.473 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 154' ' ' PHE . 64.7 t80 -125.73 137.22 53.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.854 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -130.06 149.41 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.27 177.43 25.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.518 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 75.83 11.1 84.86 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 116' ' ' LEU . 1.1 pp -87.53 97.19 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.196 -1.179 . . . . 0.0 110.458 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.0 t -52.91 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 147' ' ' ASN . 1.3 t -78.28 -153.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.403 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.607 ' H ' HG12 ' A' ' 118' ' ' VAL . 1.4 t-20 64.65 -17.34 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.776 -0.577 . . . . 0.0 111.169 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' ' 118' ' ' VAL . 40.7 m -91.41 143.62 26.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.735 -1.228 . . . . 0.0 110.695 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.592 HG22 ' CG ' ' A' ' 124' ' ' ASP . 11.8 t -127.98 151.16 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.682 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.61 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.4 t -41.75 -51.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.158 -0.964 . . . . 0.0 110.178 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.526 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 mt-10 -42.79 -26.01 0.11 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 66.0 m-20 -76.37 -57.37 3.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 110.094 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.733 HG21 HD21 ' A' ' 140' ' ' LEU . 1.3 t -67.34 -47.53 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 6.0 ttpp -48.4 -58.23 4.92 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.818 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -66.83 -32.49 73.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 109.697 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -59.21 -55.96 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.549 ' HZ ' ' HG ' ' A' ' 181' ' ' CYS . 66.9 m-85 -83.66 -15.94 46.96 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.06 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 46.0 tt0 -56.41 -37.76 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.423 -1.423 . . . . 0.0 108.163 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -74.59 -15.93 60.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 4.9 m-30 -88.16 -32.79 18.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.44 168.18 36.56 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.527 ' CE ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -46.87 -40.02 13.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -1.17 . . . . 0.0 111.118 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 44.59 92.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.863 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -25.06 21.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 141.25 39.86 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.425 0.631 . . . . 0.0 109.604 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -149.45 95.21 2.32 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.437 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 6.4 ttp -101.07 164.78 11.64 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.873 0.844 . . . . 0.0 111.823 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.91 HD23 ' HA3' ' A' ' 153' ' ' GLY . 72.8 mt -143.93 133.59 23.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.7 OUTLIER -108.27 99.09 8.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.855 -1.153 . . . . 0.0 110.8 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -150.09 -167.35 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.1 OUTLIER 59.31 -162.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.007 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 143' ' ' ASP . 15.4 tttt 56.5 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 143' ' ' ASP . 15.3 t -151.12 15.61 0.73 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.043 . . . . 0.0 110.473 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 150' ' ' ARG . 9.6 p -128.47 2.3 5.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.196 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.693 ' HB2' HG22 ' A' ' 118' ' ' VAL . 6.0 p30 -50.17 -42.84 51.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.528 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 147' ' ' ASN . 5.0 mtt180 -111.26 -24.79 10.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.512 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -76.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 110.113 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -133.8 92.99 3.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -98.95 122.73 7.66 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.562 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 38.2 p90 -146.68 136.56 23.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.77 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.91 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -111.25 157.34 15.02 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.645 -1.265 . . . . 0.0 110.26 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 112' ' ' PHE . 24.4 m-85 -121.83 109.41 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -1.068 . . . . 0.0 109.363 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.518 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 1.2 t -104.59 179.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.047 . . . . 0.0 109.342 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.525 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 98.8 m -161.94 107.28 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.984 -1.486 . . . . 0.0 112.535 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.05 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -131.32 106.24 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.8 . . . . 0.0 108.915 177.346 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.527 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 5.0 mm-40 -39.33 -27.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 0.0 110.822 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 163' ' ' VAL . 3.4 m -55.58 85.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.129 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -62.94 -38.33 90.59 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.738 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.57 -67.38 0.23 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 110.137 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.781 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.7 OUTLIER -58.17 -40.23 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.119 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.05 HG22 ' CE2' ' A' ' 157' ' ' PHE . 18.2 t -57.23 -34.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 160' ' ' GLU . 1.4 tt0 -55.34 -53.08 60.62 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.255 0.55 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.6 tttt -88.59 -59.51 2.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.267 -0.896 . . . . 0.0 110.829 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.82 -26.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 7.9 t -73.64 -45.67 51.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.591 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 169' ' ' ILE . 29.1 tt0 -61.16 -67.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.4 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' GLU . 93.2 mt -42.83 111.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.283 -0.886 . . . . 0.0 110.272 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.524 ' O ' ' N ' ' A' ' 172' ' ' HIS . 95.8 m-70 -83.73 -55.01 4.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.625 ' CZ ' ' HB3' ' A' ' 178' ' ' MET . 10.3 t80 -61.16 76.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.14 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 170' ' ' HIS . 0.1 OUTLIER -91.56 121.02 32.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 110.03 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 1.1 pt-20 -72.36 89.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.58 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 174' ' ' ILE . 16.4 tt -89.27 91.75 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 3.4 m-20 65.73 -55.32 0.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.791 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.1 p-10 -158.19 18.74 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.648 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 tptt -131.66 169.24 16.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 110.664 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -112.4 33.57 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.267 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.518 HG12 ' C ' ' A' ' 115' ' ' GLY . 18.0 m -37.96 159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.514 0.673 . . . . 0.0 111.315 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -99.06 141.37 31.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.761 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.549 ' HG ' ' HZ ' ' A' ' 129' ' ' PHE . 38.5 m -113.33 127.8 56.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 110.759 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.467 ' HG3' ' OE1' ' A' ' 180' ' ' GLU . 1.4 mmmt -125.77 170.32 11.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -0.846 . . . . 0.0 109.678 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -108.52 169.79 8.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.076 -1.015 . . . . 0.0 110.329 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.403 -0.811 . . . . 0.0 109.838 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.823 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 27.1 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.065 0.459 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.899 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.1 pp -94.61 171.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.459 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.821 ' N ' HD12 ' A' ' 111' ' ' ILE . 27.9 t80 -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 181' ' ' CYS . 0.3 OUTLIER -147.14 160.79 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -144.17 168.76 26.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.603 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 90.01 17.15 54.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 140' ' ' LEU . 7.0 mt -44.81 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.361 -1.082 . . . . 0.0 110.032 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.471 ' HB3' ' OG1' ' A' ' 120' ' ' THR . 11.3 t -45.66 171.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -70.81 149.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.571 ' ND2' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 65.08 -42.24 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.438 0.637 . . . . 0.0 109.996 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' VAL . 6.1 m -38.76 120.91 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.572 . . . . 0.0 110.436 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 14.8 t -119.86 170.4 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.396 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 138' ' ' ALA . 1.9 t -38.48 -46.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.423 -0.798 . . . . 0.0 110.226 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.504 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 2.9 tt0 -40.95 -27.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.465 -0.772 . . . . 0.0 109.072 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 1.027 ' OD2' HG23 ' A' ' 174' ' ' ILE . 8.1 t70 -77.75 -59.41 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.356 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.784 HG21 HD21 ' A' ' 140' ' ' LEU . 1.4 t -62.74 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.798 . . . . 0.0 109.904 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 18.4 tttt -56.83 -56.72 17.91 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.62 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -64.0 -26.23 68.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.125 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 173' ' ' GLU . 19.8 t80 -79.4 -57.76 3.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 53.5 m-85 -77.38 -14.88 59.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.719 -1.238 . . . . 0.0 111.798 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -53.01 -41.68 64.91 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.152 -1.592 . . . . 0.0 108.859 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -70.49 -18.14 62.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.541 ' O ' HG21 ' A' ' 162' ' ' ILE . 25.3 m-85 -83.23 -31.04 27.23 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -165.13 156.52 28.54 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -39.22 -38.85 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.983 . . . . 0.0 110.5 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 45.24 91.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.87 -25.63 23.18 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.74 137.6 43.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB1' HG12 ' A' ' 125' ' ' VAL . . . -147.08 93.96 2.34 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.557 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.8 ttm -101.01 162.86 12.59 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.954 0.883 . . . . 0.0 111.949 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.997 HD23 ' HA3' ' A' ' 153' ' ' GLY . 13.1 mt -142.82 132.2 23.5 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 21.5 mmm -112.76 113.54 25.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.962 -1.086 . . . . 0.0 110.823 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 13.3 m-85 -100.4 162.99 12.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 0.0 110.093 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 174.42 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -92.06 -41.24 10.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.324 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.9 m -123.97 -4.43 8.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -128.87 42.3 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.877 . . . . 0.0 109.726 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -74.63 52.03 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.554 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HA ' ' CG2' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -106.38 -68.84 0.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.85 21.64 10.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -124.25 159.56 29.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 110.059 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.71 162.87 11.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 7.8 p90 -146.41 142.96 28.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 109.864 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.997 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -109.69 154.77 16.4 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.236 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 112' ' ' PHE . 21.5 m-85 -119.64 108.72 14.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -1.04 . . . . 0.0 109.262 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 1.3 t -104.76 178.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.06 . . . . 0.0 109.225 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.507 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 86.0 m -161.26 109.82 1.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.09 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.974 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -136.19 110.2 8.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -39.7 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.405 -0.809 . . . . 0.0 110.763 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.854 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -55.29 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -68.2 -38.53 82.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 109.094 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 8.0 t70 -43.02 -57.26 2.95 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.664 -0.647 . . . . 0.0 110.032 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.9 tp -64.01 -39.86 86.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.963 -1.085 . . . . 0.0 108.945 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.974 HG22 ' CE2' ' A' ' 157' ' ' PHE . 37.5 t -55.21 -39.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 2.7 tt0 -46.96 -59.45 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.798 -0.564 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 0.4 OUTLIER -90.96 -47.54 7.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.121 -0.987 . . . . 0.0 111.834 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 162' ' ' ILE . 3.6 p -50.37 -23.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.861 -1.15 . . . . 0.0 110.073 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.531 ' SG ' HG13 ' A' ' 163' ' ' VAL . 61.7 m -83.63 -0.64 51.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.758 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 169' ' ' ILE . 0.5 OUTLIER -130.47 125.29 34.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.489 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 0.2 OUTLIER 175.08 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 66.03 20.75 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.798 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER 175.89 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.921 -1.112 . . . . 0.0 110.767 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -61.72 -145.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.527 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -155.24 108.24 2.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.554 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.027 HG23 ' OD2' ' A' ' 124' ' ' ASP . 1.6 mt -109.32 96.11 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.753 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 1.9 m-20 66.56 -55.91 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.436 -0.79 . . . . 0.0 110.429 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.0 p30 -164.86 21.49 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.701 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.597 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.4 tptt -122.11 159.14 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -96.58 43.2 1.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 109.877 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.791 HG21 ' CG1' ' A' ' 174' ' ' ILE . 33.6 m -53.98 -174.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -137.3 152.7 50.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 109.819 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.748 ' SG ' HD13 ' A' ' 111' ' ' ILE . 19.9 t -130.78 143.19 50.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 110.487 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 10.7 mtmt -134.93 178.01 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.813 . . . . 0.0 109.857 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -101.23 158.64 15.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 110.511 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.823 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 1.01 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 26.0 pttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.116 0.484 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.871 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.02 177.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.445 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.703 ' CD1' ' CE2' ' A' ' 154' ' ' PHE . 3.8 t80 -130.13 154.42 47.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 109.498 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.485 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -142.34 151.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.352 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.09 174.33 26.93 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.447 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 85.72 0.63 87.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.638 HD23 HG11 ' A' ' 179' ' ' VAL . 0.6 OUTLIER -80.33 95.91 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 110.33 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 116' ' ' LEU . 68.0 m -53.41 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.632 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -81.28 -154.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.785 -1.197 . . . . 0.0 110.196 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.633 ' H ' HG12 ' A' ' 118' ' ' VAL . 1.1 t-20 64.45 -17.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.712 -0.617 . . . . 0.0 111.081 -178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.3 m -91.18 172.81 8.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.806 -1.183 . . . . 0.0 110.469 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.7 t -150.89 144.16 24.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.761 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 138' ' ' ALA . 1.5 t -37.57 -47.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.603 -0.686 . . . . 0.0 110.638 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 122' ' ' VAL . 1.4 tt0 -43.33 -26.05 0.17 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.216 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 24.7 m-20 -74.75 -56.23 5.01 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.404 0.621 . . . . 0.0 109.685 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 129' ' ' PHE . 2.0 t -63.05 -49.42 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 12.7 tttt -47.16 -65.71 0.52 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 110.058 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -58.93 -31.73 68.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 13.5 t80 -61.37 -68.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' A' ' 125' ' ' VAL . 73.1 m-85 -69.93 -15.87 63.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 110.911 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 23.0 tt0 -55.38 -37.82 68.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.75 -1.219 . . . . 0.0 108.124 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.561 ' CG ' ' CD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -73.5 -18.1 61.14 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.561 ' CD1' ' CG ' ' A' ' 131' ' ' GLN . 5.9 m-30 -89.98 -30.15 17.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.563 0.696 . . . . 0.0 109.442 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -160.45 161.93 32.98 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 15.1 ptpt -45.13 -41.05 7.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 49.92 92.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.944 0.878 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -90.36 -30.08 17.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 14.3 m-20 -132.66 136.67 46.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.772 ' HA ' HG13 ' A' ' 155' ' ' VAL . . . -144.94 92.32 2.26 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 5.0 ttm -91.85 165.79 13.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.883 0.849 . . . . 0.0 112.113 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' CB ' HG23 ' A' ' 122' ' ' VAL . 5.2 tp -154.73 161.28 41.59 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.609 ' HB2' ' CE1' ' A' ' 152' ' ' PHE . 7.5 mmt -143.12 158.23 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.009 -1.057 . . . . 0.0 110.576 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.532 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 54.7 m-85 -125.87 -154.37 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -0.821 . . . . 0.0 109.834 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.49 ' HB2' ' OD1' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -45.32 159.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -47.17 75.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 146' ' ' THR . 47.3 m -111.52 -86.14 0.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.35 -0.844 . . . . 0.0 110.249 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 145' ' ' THR . 4.7 p -146.8 24.64 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.149 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 143' ' ' ASP . 2.7 p30 -90.28 -106.16 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -150.42 -70.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.204 . . . . 0.0 110.037 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 42.52 -157.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.815 . . . . 0.0 110.227 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -102.13 144.07 31.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.308 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -99.32 152.46 19.55 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 141' ' ' MET . 5.0 p90 -150.57 141.39 22.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -1.067 . . . . 0.0 109.115 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -135.07 178.01 18.89 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.771 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.703 ' CE2' ' CD1' ' A' ' 112' ' ' PHE . 88.0 m-85 -140.98 122.8 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.772 HG13 ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -110.65 -172.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.439 -1.304 . . . . 0.0 109.691 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.548 ' H ' HG12 ' A' ' 155' ' ' VAL . 18.6 m -158.54 102.62 1.72 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.006 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.871 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -126.12 111.55 14.79 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.281 177.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' GLU . 78.8 tt0 -41.69 -24.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 111.28 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.552 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -61.02 71.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.123 -0.986 . . . . 0.0 110.527 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.3 tt0 -51.86 -37.84 53.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.901 -1.124 . . . . 0.0 109.227 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -41.68 -59.66 1.58 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.965 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.789 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -58.56 -47.7 87.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.59 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 157' ' ' PHE . 42.7 t -45.91 -45.19 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -42.54 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 167' ' ' CYS . 25.2 tttt -90.28 -57.93 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 111.422 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.1 p -42.35 -23.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 111.082 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.661 ' SG ' HG13 ' A' ' 163' ' ' VAL . 84.6 m -87.27 -15.19 38.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 110.413 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.87 36.07 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.392 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.494 HG21 ' ND1' ' A' ' 172' ' ' HIS . 1.6 tt -113.79 157.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.01 . . . . 0.0 110.268 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -116.56 -9.64 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 110.112 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.3 OUTLIER -140.8 90.66 2.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 110.307 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.673 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -90.37 -16.67 28.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.347 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.6 OUTLIER 61.89 77.5 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 174' ' ' ILE . 15.3 tt -96.46 98.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.273 -0.892 . . . . 0.0 110.002 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.2 m-20 65.33 -54.75 0.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 111.042 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 174' ' ' ILE . 10.1 p-10 -160.7 18.45 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.855 -179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.1 tptt -130.58 159.33 37.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.067 -1.02 . . . . 0.0 111.443 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -102.22 29.69 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 108.897 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.638 HG11 HD23 ' A' ' 116' ' ' LEU . 6.6 m -35.27 152.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.489 0.661 . . . . 0.0 111.34 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.505 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 5.1 tt0 -106.0 148.47 27.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -0.773 . . . . 0.0 109.682 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.505 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 87.9 m -110.65 140.45 44.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.989 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.481 ' CG ' ' OE2' ' A' ' 180' ' ' GLU . 21.2 mmmt -128.57 167.32 17.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 109.855 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -92.73 152.64 19.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.422 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 1.01 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 110.128 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.923 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 3.5 pttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER -122.36 173.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 24.7 t80 -132.96 151.17 52.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.242 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -141.1 146.95 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.374 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.4 158.57 26.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 107.38 -6.8 36.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 174' ' ' ILE . 1.2 mp -68.28 96.24 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 110.037 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.01 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -89.53 -165.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.97 -1.081 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.697 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.9 OUTLIER 63.63 -11.54 0.1 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.681 -0.637 . . . . 0.0 110.509 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 121' ' ' THR . 3.4 m -90.43 -175.9 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.97 -1.081 . . . . 0.0 110.84 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.685 ' H ' HG22 ' A' ' 120' ' ' THR . 6.2 t -176.99 153.49 1.0 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.443 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -40.55 -51.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.522 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.9 -26.18 0.13 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.24 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.619 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 53.8 m-20 -77.27 -58.5 3.24 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.9 -48.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.38 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 3.2 tttt -49.03 -64.36 0.83 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.739 . . . . 0.0 110.523 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.619 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 6.1 p-80 -59.87 -32.26 70.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.112 -0.993 . . . . 0.0 110.013 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 63.6 t80 -62.93 -65.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.379 -0.826 . . . . 0.0 110.487 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 79.2 m-85 -72.77 -13.7 61.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 111.149 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.721 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 1.1 tp10 -57.55 -37.34 72.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.449 -1.407 . . . . 0.0 108.282 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.5 pt20 -76.43 -12.44 60.05 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.447 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.545 ' CA ' HD13 ' A' ' 162' ' ' ILE . 4.3 m-30 -88.26 -30.64 19.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.731 -0.606 . . . . 0.0 110.764 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -173.88 62.92 0.12 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 118.36 -1.876 . . . . 0.0 111.292 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 2.6 tptt 58.97 -68.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.458 -1.025 . . . . 0.0 111.521 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 63.99 91.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.88 -29.27 27.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -129.95 139.38 51.1 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.718 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -152.61 95.8 2.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 108.7 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.565 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.9 ttt -101.8 162.69 12.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.727 0.775 . . . . 0.0 111.462 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' CD1' HD22 ' A' ' 116' ' ' LEU . 53.7 tp -144.35 160.54 40.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.771 -0.581 . . . . 0.0 109.995 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -144.72 159.01 43.55 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.477 -0.764 . . . . 0.0 110.902 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 143' ' ' ASP . 89.9 m-85 -130.23 -160.12 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.542 -0.724 . . . . 0.0 109.238 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 26.5 t0 58.94 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.08 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 7.9 tptt -131.7 -48.64 0.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.196 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 146' ' ' THR . 5.3 t -119.49 -40.55 2.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 145' ' ' THR . 24.3 p -140.73 -80.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' O ' ' CZ ' ' A' ' 148' ' ' ARG . 5.5 p30 -91.21 -49.17 6.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 110.704 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.51 ' CZ ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -150.18 -89.38 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.976 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 150' ' ' ARG . 0.1 OUTLIER 62.55 74.22 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 149' ' ' HIS . 6.2 mtt180 58.87 147.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.792 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.9 -170.27 12.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 12.4 p90 -146.24 142.94 28.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 109.498 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.55 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -125.53 150.51 17.4 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.55 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 34.0 m-85 -112.48 113.43 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.459 -1.024 . . . . 0.0 108.41 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -110.77 -178.58 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -178.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.656 ' HA ' HD13 ' A' ' 111' ' ' ILE . 27.6 m -159.09 103.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.811 -1.18 . . . . 0.0 111.26 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.001 ' CE1' HG22 ' A' ' 163' ' ' VAL . 2.0 p90 -126.54 106.92 9.77 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.85 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.9 mt-10 -40.25 -37.7 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 0.0 111.187 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.959 ' O ' HG23 ' A' ' 163' ' ' VAL . 58.7 m -46.54 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -64.02 -37.98 89.42 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.08 -1.013 . . . . 0.0 109.492 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 4.9 t0 -40.57 -64.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.186 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.776 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.7 OUTLIER -60.34 -44.92 96.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.97 -1.081 . . . . 0.0 108.693 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.001 HG22 ' CE1' ' A' ' 157' ' ' PHE . 15.5 t -51.17 -41.7 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -48.25 -58.53 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 111.184 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 167' ' ' CYS . 12.0 tttt -90.47 -58.21 2.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.0 111.272 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 162' ' ' ILE . 2.0 p -39.83 -26.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.762 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 68.5 m -82.73 -31.96 28.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.954 -1.091 . . . . 0.0 110.15 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 -54.38 154.87 4.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.137 -0.977 . . . . 0.0 110.551 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.458 HG12 ' OE2' ' A' ' 180' ' ' GLU . 6.6 mt -67.34 124.16 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -165.88 -168.62 1.32 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 0.0 110.634 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.658 ' CE1' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER -100.66 89.11 3.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.576 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER -78.45 -158.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 174' ' ' ILE . 5.1 tt0 -153.95 107.0 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 110.061 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.877 HD13 ' CG2' ' A' ' 179' ' ' VAL . 1.3 mp -113.42 102.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.9 OUTLIER 67.56 -56.24 0.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.3 p30 -168.97 25.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.99 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.657 ' HB3' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -130.74 151.81 50.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 0.0 111.14 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.658 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -90.36 46.9 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.54 -0.725 . . . . 0.0 109.607 179.388 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.877 ' CG2' HD13 ' A' ' 174' ' ' ILE . 20.3 m -54.77 -160.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.74 . . . . 0.0 110.802 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.458 ' OE2' HG12 ' A' ' 169' ' ' ILE . 15.6 tt0 -150.51 142.41 23.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.402 -0.811 . . . . 0.0 109.919 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.576 ' HA ' HG12 ' A' ' 113' ' ' VAL . 16.8 t -112.66 156.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.176 -0.953 . . . . 0.0 110.582 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' CYS . 51.2 mttt -138.78 -178.77 5.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 0.0 110.177 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -102.9 161.13 14.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 110.216 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.015 0.436 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.65 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.5 pt -110.3 169.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 7.9 t80 -125.01 158.39 33.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -150.16 142.84 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.383 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -134.43 150.84 20.15 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.716 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 103.34 2.0 47.59 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.707 HD12 ' CA ' ' A' ' 152' ' ' PHE . 2.5 mt -63.62 98.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -1.175 . . . . 0.0 110.022 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.509 ' HB2' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -39.61 156.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.63 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 119' ' ' ASN . 2.4 t -62.75 -62.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 110.383 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.563 ' N ' HG12 ' A' ' 118' ' ' VAL . 0.6 OUTLIER -44.58 -19.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.736 0.779 . . . . 0.0 108.914 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 142' ' ' PHE . 2.9 m -68.18 157.8 34.61 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.826 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 123' ' ' GLU . 7.8 t -148.44 150.47 33.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.097 -1.002 . . . . 0.0 110.405 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 140' ' ' LEU . 3.2 t -35.77 -53.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.764 -0.585 . . . . 0.0 111.097 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.536 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.5 mt-10 -41.02 -26.38 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.385 -0.822 . . . . 0.0 109.45 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.546 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 43.8 t0 -73.43 -59.44 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.526 0.679 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 140' ' ' LEU . 2.4 t -68.71 -52.91 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.773 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.8 ttmt -41.04 -60.98 1.07 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.711 -0.618 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.879 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.478 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -65.59 -64.31 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 111.011 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 28.2 m-85 -74.03 -16.75 61.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.657 -1.277 . . . . 0.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 4.5 tt0 -55.6 -37.98 68.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.036 -1.466 . . . . 0.0 108.173 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.3 pt20 -72.59 -18.06 61.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 162' ' ' ILE . 16.0 m-85 -84.84 -37.09 21.12 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -154.76 159.01 28.69 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -42.42 -43.25 3.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.16 . . . . 0.0 110.365 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 48.1 89.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 122.02 0.914 . . . . 0.0 110.94 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -89.18 -24.9 22.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -126.57 137.91 53.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.91 101.23 1.61 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.707 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -112.9 157.61 21.23 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.861 0.839 . . . . 0.0 112.758 -177.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 139' ' ' MET . 1.3 mp -138.12 142.45 40.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.885 -0.509 . . . . 0.0 110.258 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.508 ' HG3' ' CE2' ' A' ' 152' ' ' PHE . 2.2 mmt -118.5 145.78 45.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.647 ' HZ ' HD23 ' A' ' 140' ' ' LEU . 28.5 m-85 -136.21 -163.38 1.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 0.0 110.178 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 148' ' ' ARG . 5.5 t0 -94.92 -142.31 0.25 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 110.321 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -90.5 -60.33 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.437 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.442 ' O ' HG11 ' A' ' 118' ' ' VAL . 70.8 p -132.01 -71.2 0.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 t -149.02 48.48 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 110.001 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.22 -59.53 2.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.421 -0.799 . . . . 0.0 110.22 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 143' ' ' ASP . 40.8 ptt180 -112.24 141.24 46.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.141 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 117' ' ' SER . 2.2 m170 -90.24 29.83 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.517 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -140.28 152.18 45.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.337 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . -152.2 -169.06 17.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.707 ' CA ' HD12 ' A' ' 116' ' ' LEU . 50.1 p90 -149.91 135.13 18.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -1.219 . . . . 0.0 109.855 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.6 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -128.0 166.92 20.45 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.148 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 139' ' ' MET . 64.6 m-85 -122.99 109.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -1.095 . . . . 0.0 109.03 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -99.81 177.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 120.948 -1.095 . . . . 0.0 109.172 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.561 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 91.5 m -165.03 109.86 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.127 -1.429 . . . . 0.0 112.461 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.75 ' HE1' HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -118.88 135.03 54.78 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.2 177.116 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -72.07 54.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.475 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.89 96.64 2.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 110.115 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 161' ' ' ASP . 10.5 tt0 -49.71 -38.33 32.74 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -41.95 -47.33 4.32 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.254 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.758 ' O ' HG12 ' A' ' 166' ' ' VAL . 20.1 mm -68.5 -42.6 83.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.75 HG22 ' HE1' ' A' ' 157' ' ' PHE . 11.8 t -63.28 -40.61 89.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLU . 52.5 mt-10 -56.29 -47.11 79.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 168' ' ' GLU . 19.2 ttmt -90.25 -65.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.356 -0.84 . . . . 0.0 111.167 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 162' ' ' ILE . 1.0 OUTLIER -41.42 -25.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 110.175 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 41.2 t -76.51 -36.15 57.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.374 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 87.3 mt-10 -83.72 -160.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.64 -0.663 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 168' ' ' GLU . 44.0 mt 57.32 152.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.471 -0.768 . . . . 0.0 110.173 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.506 ' HB3' ' CD1' ' A' ' 171' ' ' PHE . 77.1 m-70 -53.17 -98.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.115 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.66 ' CZ ' ' HB3' ' A' ' 178' ' ' MET . 2.2 p90 -127.39 170.32 12.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 110.228 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 166' ' ' VAL . 34.3 m-70 -102.83 24.94 9.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.646 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 46.47 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.699 ' O ' HG22 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -93.44 100.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.602 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 124' ' ' ASP . 2.6 m-20 65.58 -55.85 0.34 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.358 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.8 p30 -168.66 28.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.414 -0.804 . . . . 0.0 109.537 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.5 tptt -132.51 158.02 43.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.483 -0.761 . . . . 0.0 110.769 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.66 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 1.0 OUTLIER -100.78 55.17 0.86 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.859 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.716 HG12 ' C ' ' A' ' 115' ' ' GLY . 33.4 m -59.32 130.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.4 OUTLIER -70.65 148.01 48.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.328 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 166' ' ' VAL . 3.0 t -125.08 140.8 52.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.405 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 0.9 OUTLIER -149.04 -174.34 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -109.82 150.28 28.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.106 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.877 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.012 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 3.3 pt -110.81 167.93 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 111.138 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -119.29 155.01 32.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.278 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -148.39 146.97 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 110.556 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.41 -170.33 12.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.622 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 65.45 23.31 70.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' SER . 1.1 mt -84.15 93.91 8.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -1.109 . . . . 0.0 110.343 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.481 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 99.2 p -52.66 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.787 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.5 t -85.22 -165.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.718 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.9 OUTLIER 63.11 -10.28 0.1 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.626 -0.671 . . . . 0.0 110.358 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -88.7 -177.27 5.51 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.117 -0.99 . . . . 0.0 110.781 -178.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.546 HG22 ' OD1' ' A' ' 124' ' ' ASP . 12.1 t -178.8 153.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.878 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.628 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -38.42 -50.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.738 . . . . 0.0 110.735 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.477 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.67 -26.17 0.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.197 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.64 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.7 m-20 -76.58 -57.72 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 0.0 110.062 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.603 HG12 ' HB1' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -64.12 -47.83 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.549 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -51.13 -62.62 1.51 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 110.653 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.64 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -57.62 -26.53 61.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -78.48 -64.19 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 0.0 111.891 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 52.1 m-85 -70.91 -13.42 62.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.927 -1.108 . . . . 0.0 112.283 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.667 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -53.99 -41.39 67.86 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 119.893 -1.755 . . . . 0.0 109.115 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.9 pt20 -73.66 -14.86 61.23 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 16.2 m-85 -82.36 -31.11 29.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.725 -0.609 . . . . 0.0 110.051 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 157' ' ' PHE . . . -174.44 60.24 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.055 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 4.3 tptt 59.71 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.31 -1.112 . . . . 0.0 110.831 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 63.58 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 111.315 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -89.64 -23.15 21.98 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -133.29 137.67 46.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.502 0.668 . . . . 0.0 109.449 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.603 ' HB1' HG12 ' A' ' 125' ' ' VAL . . . -153.76 96.02 1.95 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.628 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 4.3 ttm -101.49 165.98 10.96 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.0 111.972 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.794 HD23 ' CZ ' ' A' ' 142' ' ' PHE . 2.6 tp -143.57 151.08 39.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.636 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 3.0 mmt -128.11 130.87 48.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.772 -1.205 . . . . 0.0 111.253 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.794 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 10.4 m-85 -126.72 -174.56 3.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.515 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 142' ' ' PHE . 7.6 t0 66.54 -162.25 0.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.106 -0.996 . . . . 0.0 110.487 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' ASP . 0.1 OUTLIER 63.16 53.98 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.817 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.26 11.63 4.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -128.33 5.89 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.002 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.693 ' O ' HG22 ' A' ' 118' ' ' VAL . 13.0 p-10 -47.18 -23.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 109.917 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 -31.57 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.394 -0.816 . . . . 0.0 110.264 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -80.75 47.57 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 146' ' ' THR . 1.4 mpt_? 57.09 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.062 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.41 -149.69 6.87 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 25.0 p90 -145.62 136.0 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.924 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.737 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -120.82 158.12 15.76 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.68 107.38 12.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -1.017 . . . . 0.0 109.246 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -102.7 179.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.947 -1.096 . . . . 0.0 109.08 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.55 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 62.9 m -163.35 106.62 1.01 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.184 -1.406 . . . . 0.0 111.915 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.026 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -125.09 105.64 9.32 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.494 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -39.76 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.576 -0.703 . . . . 0.0 110.623 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -57.73 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.326 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -57.28 -39.08 74.97 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.651 -1.281 . . . . 0.0 109.559 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 3.7 m-20 -40.65 -64.88 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.791 ' O ' HG12 ' A' ' 166' ' ' VAL . 4.1 tp -57.25 -41.87 78.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.908 -1.12 . . . . 0.0 109.038 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.026 HG22 ' CE2' ' A' ' 157' ' ' PHE . 26.3 t -53.77 -37.56 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.7 OUTLIER -52.26 -56.72 12.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.809 -0.557 . . . . 0.0 110.975 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.9 tttp -85.87 -59.53 2.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.215 -0.928 . . . . 0.0 110.663 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 162' ' ' ILE . 3.9 p -40.94 -26.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.488 -0.758 . . . . 0.0 109.834 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 11.1 t -75.29 -38.34 60.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.872 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.53 ' O ' ' CE1' ' A' ' 170' ' ' HIS . 2.7 tt0 -60.2 -82.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.537 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 168' ' ' GLU . 7.0 pt -39.31 125.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 168' ' ' GLU . 70.0 m80 -106.66 35.69 2.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 0.0 110.667 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.663 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 2.8 t80 -140.38 61.53 1.52 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.035 . . . . 0.0 110.522 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.623 ' NE2' HG23 ' A' ' 166' ' ' VAL . 1.2 m80 -74.0 115.89 14.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.677 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 4.0 mt-10 -65.84 100.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.031 HD13 HG21 ' A' ' 179' ' ' VAL . 1.8 tp -78.1 -178.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.828 -1.17 . . . . 0.0 109.386 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.466 ' N ' HG23 ' A' ' 174' ' ' ILE . 5.2 m120 -34.56 -30.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.551 -0.718 . . . . 0.0 111.649 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 174' ' ' ILE . 12.2 p-10 -164.93 30.02 0.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 tptp -145.99 -166.25 2.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 110.967 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.663 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -131.22 38.9 3.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 1.031 HG21 HD13 ' A' ' 174' ' ' ILE . 27.6 m -35.6 153.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.461 0.648 . . . . 0.0 111.257 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -98.03 156.06 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 6.8 p -134.56 153.78 51.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 4.2 mtpt -152.97 168.43 25.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.345 -0.847 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.15 154.63 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.373 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.187 0.518 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.907 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.1 pt -125.87 176.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 3.9 t80 -127.11 160.63 30.59 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.532 -0.73 . . . . 0.0 109.2 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -144.73 140.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.86 157.89 23.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 94.78 -23.06 34.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.822 HD21 ' HA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -49.45 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.477 ' HA ' ' N ' ' A' ' 150' ' ' ARG . 11.7 p -54.52 163.3 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 110.697 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.977 HG13 ' HA ' ' A' ' 149' ' ' HIS . 18.9 m -62.81 -153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -0.865 . . . . 0.0 110.441 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 3.8 t-20 62.18 -41.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.649 0.738 . . . . 0.0 110.382 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' VAL . 30.8 m -70.92 156.52 39.5 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.087 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.62 148.1 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.2 t -40.12 -51.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.424 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -42.94 -25.89 0.12 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.432 -0.793 . . . . 0.0 109.087 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 121' ' ' THR . 32.9 m-20 -72.28 -56.71 5.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.432 0.634 . . . . 0.0 109.503 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.796 ' CG2' HD11 ' A' ' 174' ' ' ILE . 2.4 t -65.66 -53.45 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.564 0.697 . . . . 0.0 109.144 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -41.23 -63.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.725 -0.609 . . . . 0.0 109.901 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.712 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -60.07 -30.12 69.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.955 . . . . 0.0 109.07 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.517 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -60.9 -69.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.622 -0.674 . . . . 0.0 110.315 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 74.3 m-85 -70.4 -15.26 62.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -0.967 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 8.8 tt0 -57.17 -37.35 71.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.191 -1.568 . . . . 0.0 107.825 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.2 pt20 -72.51 -16.66 61.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.685 ' HB3' HD12 ' A' ' 162' ' ' ILE . 3.6 m-30 -83.42 -28.78 28.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.752 -0.593 . . . . 0.0 109.446 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 159' ' ' SER . . . -161.73 -139.42 2.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HD2' ' HG3' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -94.14 -33.83 13.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -1.05 . . . . 0.0 109.658 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 39.08 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.109 0.957 . . . . 0.0 111.456 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -25.3 18.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.36 140.04 49.62 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.676 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -157.17 100.16 1.84 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.575 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 1.6 ptp -116.66 165.99 12.64 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.876 0.846 . . . . 0.0 112.216 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.715 HD23 ' HA3' ' A' ' 153' ' ' GLY . 89.3 mt -142.92 146.48 34.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.85 -0.531 . . . . 0.0 109.579 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -120.64 110.12 16.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.0 -1.063 . . . . 0.0 110.337 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.43 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 144' ' ' LYS . 11.7 p-10 -86.92 -27.71 23.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER 170.6 -45.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.28 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.16 44.66 1.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.351 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.439 ' HB2' ' OD2' ' A' ' 143' ' ' ASP . 0.3 OUTLIER -90.43 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 110.379 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' A' ' 149' ' ' HIS . 3.2 ptp180 -120.63 -132.15 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.116 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.977 ' HA ' HG13 ' A' ' 118' ' ' VAL . 54.5 p-80 -152.4 -143.49 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.987 . . . . 0.0 109.848 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' N ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER 55.13 -156.47 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 110.112 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 122.77 175.84 14.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.822 ' HA ' HD21 ' A' ' 116' ' ' LEU . 17.7 p90 -144.85 138.83 27.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -1.103 . . . . 0.0 109.726 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.715 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -127.99 168.93 19.78 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.395 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 139' ' ' MET . 76.0 m-85 -126.82 115.94 20.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -1.134 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -108.79 -177.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.082 -1.011 . . . . 0.0 109.044 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 16.3 m -163.75 104.73 0.93 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.907 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.9 p90 -129.92 116.65 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.97 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.2 mm-40 -44.34 -32.58 1.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.387 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.543 ' HB3' ' CG1' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -51.77 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 110.544 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -56.57 -40.0 74.45 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.176 -0.952 . . . . 0.0 109.042 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -44.78 -38.05 4.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.943 ' O ' HG22 ' A' ' 166' ' ' VAL . 41.3 mm -69.61 -49.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 20.0 t -58.25 -36.82 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.8 mm-40 -56.89 -44.39 82.25 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.627 -0.67 . . . . 0.0 110.715 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 161' ' ' ASP . 3.1 mttt -90.14 -64.96 1.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 162' ' ' ILE . 6.3 m -42.9 -24.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.856 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 8.4 t -71.73 -38.15 70.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.725 -1.235 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 165' ' ' LYS . 8.0 mt-10 -64.67 173.1 2.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 169' ' ' ILE . 2.6 mp -97.09 78.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.166 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -106.65 -162.03 0.83 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.65 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 2.2 t80 -94.55 54.35 1.79 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.242 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.873 ' O ' HG22 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -67.86 100.71 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.535 ' HG3' ' N ' ' A' ' 177' ' ' LYS . 3.6 tt0 -80.89 141.73 34.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 110.589 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.796 HD11 ' CG2' ' A' ' 125' ' ' VAL . 4.7 tt -114.58 115.43 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.186 -0.947 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 6.7 t30 68.07 -55.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.631 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.512 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.9 p30 -174.22 24.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.863 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.627 ' HD2' HG12 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -139.49 129.14 24.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.785 -1.197 . . . . 0.0 110.179 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.65 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -68.3 119.63 13.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.817 -1.177 . . . . 0.0 110.596 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 172' ' ' HIS . 4.4 m -120.08 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.646 ' N ' HG23 ' A' ' 179' ' ' VAL . 57.1 tt0 -138.83 143.6 38.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 86.8 m -129.2 138.14 51.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.306 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.9 mttt -133.91 175.67 9.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.29 -0.882 . . . . 0.0 109.816 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.511 ' CD ' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -75.25 163.74 27.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.264 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.293 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.978 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.25 0.548 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.146 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -105.2 165.84 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -124.51 136.69 54.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -131.34 142.65 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 110.075 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -146.87 168.46 28.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.3 -29.4 8.93 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -53.67 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 116' ' ' LEU . 4.3 p -52.47 -173.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.741 HG21 ' HD3' ' A' ' 148' ' ' ARG . 1.3 t -75.12 -149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 109.467 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.9 OUTLIER 64.06 -14.84 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.642 . . . . 0.0 111.398 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -89.87 -167.13 1.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.684 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 120' ' ' THR . 14.4 t -173.21 139.44 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -35.07 -49.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.633 -0.667 . . . . 0.0 111.303 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 122' ' ' VAL . 10.2 mt-10 -43.35 -25.88 0.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 128' ' ' TYR . 66.2 m-20 -73.42 -47.64 40.11 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.421 0.629 . . . . 0.0 110.209 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -73.86 -44.56 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.663 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.2 ttpp -50.02 -65.2 0.6 Allowed 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.454 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -64.42 -32.32 73.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.025 -1.047 . . . . 0.0 110.681 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 4.5 t80 -66.1 -54.06 30.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 111.212 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.762 ' CD2' HG12 ' A' ' 125' ' ' VAL . 46.2 m-85 -83.98 -16.53 43.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.164 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 40.2 tt0 -57.42 -36.89 71.93 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.053 -1.654 . . . . 0.0 107.73 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 13.2 pt20 -74.6 -15.93 60.82 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.704 ' O ' HD13 ' A' ' 162' ' ' ILE . 3.1 m-30 -83.36 -28.24 29.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -164.07 -143.45 3.71 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CG ' ' N ' ' A' ' 135' ' ' VAL . 2.0 ptmt -88.45 -42.19 12.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.325 -1.103 . . . . 0.0 109.7 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 46.24 90.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.484 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -92.42 -25.63 18.39 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.63 145.73 50.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.057 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.35 101.66 1.72 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.59 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -112.58 163.81 14.06 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.937 0.875 . . . . 0.0 112.216 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 125' ' ' VAL . 4.8 tp -138.03 154.79 49.27 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.644 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 66.0 mmm -131.19 135.8 47.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.767 -1.208 . . . . 0.0 110.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 118' ' ' VAL . 9.4 m-85 -136.7 -173.13 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.696 . . . . 0.0 109.973 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 147' ' ' ASN . 36.8 m-20 -142.12 -127.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.987 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 0.9 OUTLIER -110.78 -131.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.956 -1.09 . . . . 0.0 110.302 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.46 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -79.85 -60.52 2.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.582 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.8 m -94.36 -20.94 19.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.504 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 143' ' ' ASP . 86.8 m-20 -73.94 -1.75 21.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.542 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.741 ' HD3' HG21 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -90.45 -112.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.106 -0.996 . . . . 0.0 109.95 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 65.8 -76.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.862 -1.149 . . . . 0.0 110.58 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.475 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -51.82 -69.18 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.741 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' A' ' 116' ' ' LEU . . . 62.94 120.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 14.9 p90 -150.13 139.37 21.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.109 -1.23 . . . . 0.0 110.158 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -129.58 167.2 21.54 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.965 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.536 ' O ' ' HG3' ' A' ' 139' ' ' MET . 63.0 m-85 -123.5 117.8 25.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 108.879 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.543 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -109.2 -178.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 109.036 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 72.3 m -162.87 105.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.874 -1.53 . . . . 0.0 112.433 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.146 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -126.6 102.34 7.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.441 -0.787 . . . . 0.0 108.993 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -39.18 -29.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.503 -0.748 . . . . 0.0 110.962 -178.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.804 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -56.23 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 110.235 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -58.09 -38.32 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.078 -1.014 . . . . 0.0 109.701 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.7 m-20 -39.24 -64.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.771 -0.581 . . . . 0.0 110.259 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.704 HD13 ' O ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -61.84 -38.0 79.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.091 -1.006 . . . . 0.0 109.122 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.096 HG22 ' CE2' ' A' ' 157' ' ' PHE . 16.7 t -58.41 -33.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -58.77 -47.15 85.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.426 0.631 . . . . 0.0 110.079 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 167' ' ' CYS . 10.4 tttt -87.4 -63.82 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 110.499 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 163' ' ' VAL . 1.4 p -42.31 -24.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.876 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 9.3 t -73.36 -47.02 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.075 -1.016 . . . . 0.0 109.458 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.86 130.84 4.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.55 -0.719 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 170' ' ' HIS . 2.9 mp -73.84 133.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 110.099 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 3.3 t-160 -177.73 62.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.64 ' CE1' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER 43.98 61.12 2.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -0.958 . . . . 0.0 109.899 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 1.1 t60 -60.83 145.03 51.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -100.72 88.76 3.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 110.266 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 174' ' ' ILE . 1.3 mp -81.34 91.96 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.387 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER 68.56 -56.99 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.419 -0.801 . . . . 0.0 110.1 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 174' ' ' ILE . 8.3 p-10 -161.55 19.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.807 . . . . 0.0 110.416 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.824 ' HB3' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.68 148.39 46.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.118 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.64 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -92.02 41.56 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 177' ' ' LYS . 10.3 m -70.47 -165.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.5 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 2.3 tm-20 -125.54 152.46 45.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.792 . . . . 0.0 110.103 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.5 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 37.9 t -141.41 103.02 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.417 ' HG3' ' OE2' ' A' ' 180' ' ' GLU . 6.1 mtmm -99.21 -175.56 3.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 109.886 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -100.32 -175.99 3.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.784 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.978 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 110.598 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.949 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.72 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -99.7 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 110.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -118.57 153.74 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 109.675 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -146.94 152.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -145.93 162.91 28.35 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 100.29 9.52 47.53 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.695 ' HG ' HD22 ' A' ' 140' ' ' LEU . 2.7 mm? -57.67 97.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -1.09 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.3 168.21 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.105 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 120' ' ' THR . 19.5 m -63.19 169.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.272 -0.892 . . . . 0.0 110.988 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 3.5 t-20 61.95 -39.13 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.976 -0.452 . . . . 0.0 111.018 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 118' ' ' VAL . 91.8 m -42.3 153.74 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.483 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 142' ' ' PHE . 15.2 t -149.66 146.77 27.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.718 ' HA ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -32.39 -47.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.81 -0.556 . . . . 0.0 111.396 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -41.94 -27.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.095 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' OD2' ' N ' ' A' ' 175' ' ' ASN . 15.6 t0 -72.24 -58.44 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.555 0.693 . . . . 0.0 109.966 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.658 ' CG2' HD11 ' A' ' 174' ' ' ILE . 2.1 t -67.07 -52.9 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.7 tttt -42.44 -59.82 1.73 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.649 -0.657 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.702 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -62.44 -27.74 69.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.441 -0.787 . . . . 0.0 110.196 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 18.7 t80 -76.29 -53.77 7.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 112.479 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.546 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 14.6 m-85 -82.32 -17.41 45.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.0 112.638 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -52.7 -41.76 64.19 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 119.969 -1.707 . . . . 0.0 109.263 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 17.6 pt20 -73.72 -15.78 61.21 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.502 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 15.8 m-85 -84.27 -33.97 23.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -159.35 162.29 32.71 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -44.6 -34.01 2.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 38.05 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.967 0.889 . . . . 0.0 111.342 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -25.06 18.0 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -130.9 142.01 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' HG11 ' A' ' 122' ' ' VAL . . . -157.4 102.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.418 ' HA ' HG11 ' A' ' 122' ' ' VAL . 3.2 tpp -110.39 160.21 16.78 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.775 0.797 . . . . 0.0 111.308 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.93 HD23 ' HA3' ' A' ' 153' ' ' GLY . 9.4 mt -147.04 145.42 29.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.774 -0.579 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.585 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 1.6 mmm -123.25 126.77 47.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.024 -1.047 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 42.2 m-85 -120.37 170.87 8.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.865 . . . . 0.0 110.711 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 19.2 t70 43.43 -92.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.496 -0.752 . . . . 0.0 111.317 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 1.1 mttm 57.47 23.36 9.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 11.1 p 50.31 19.37 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.428 -0.795 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 145' ' ' THR . 7.7 p -151.04 -65.15 0.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.923 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 54.7 3.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.47 -0.769 . . . . 0.0 110.286 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.414 ' HB2' ' HA ' ' A' ' 143' ' ' ASP . 0.9 OUTLIER -89.56 -28.15 19.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.402 ' C ' ' HG2' ' A' ' 150' ' ' ARG . 1.2 t-80 -87.1 -14.99 39.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.048 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 116' ' ' LEU . 11.9 mmt180 -126.62 -65.25 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.63 151.32 11.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.585 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.1 p90 -150.03 146.19 26.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -1.202 . . . . 0.0 109.977 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.93 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -138.16 174.62 21.84 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.174 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.96 118.26 18.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.495 -1.003 . . . . 0.0 109.246 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 156' ' ' THR . 1.5 t -109.21 -174.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.514 ' H ' HG12 ' A' ' 155' ' ' VAL . 96.3 m -163.98 106.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.002 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.181 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -132.12 109.96 10.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.199 -0.938 . . . . 0.0 109.722 177.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.19 -32.06 1.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.431 -0.793 . . . . 0.0 111.507 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.892 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -56.04 82.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -56.7 -38.61 72.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 110.086 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.4 OUTLIER -39.06 -69.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.815 -0.553 . . . . 0.0 110.426 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.778 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.8 OUTLIER -57.57 -42.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.927 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.181 HG22 ' CE2' ' A' ' 157' ' ' PHE . 14.7 t -51.76 -38.95 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 3.1 tt0 -48.4 -55.95 9.46 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.359 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.3 tttm -90.52 -59.6 2.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.257 -0.902 . . . . 0.0 111.316 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.24 -25.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.247 -0.908 . . . . 0.0 110.859 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 163' ' ' VAL . 71.2 m -90.21 -20.34 23.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.882 -1.137 . . . . 0.0 110.071 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 165' ' ' LYS . 19.6 mm-40 -103.98 -30.03 10.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 110.186 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.684 HG21 ' CE1' ' A' ' 172' ' ' HIS . 18.0 tt -54.92 155.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -115.31 164.3 14.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.117 -0.99 . . . . 0.0 110.448 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 178' ' ' MET . 0.3 OUTLIER 58.0 55.99 4.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.454 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.684 ' CE1' HG21 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -81.36 -8.06 59.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 57.21 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 110.894 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.782 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.9 OUTLIER -113.83 116.15 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.632 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.535 ' HB2' HG23 ' A' ' 120' ' ' THR . 8.2 t30 69.41 -56.49 0.55 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 174' ' ' ILE . 5.2 p-10 -177.14 29.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.633 -0.667 . . . . 0.0 109.813 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.623 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -143.72 123.89 13.71 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.059 -1.025 . . . . 0.0 110.432 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.612 ' HB2' ' CD2' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -54.02 116.31 2.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.782 HG21 ' HB ' ' A' ' 174' ' ' ILE . 16.0 m -119.09 -161.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 0.0 110.6 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 10.3 tt0 -130.1 146.45 51.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 71.3 m -117.42 152.32 35.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.52 -0.737 . . . . 0.0 109.917 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -110.03 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.949 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.699 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.223 0.535 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.962 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.8 pt -101.46 169.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.519 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.9 t80 -118.11 156.49 28.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.409 -0.807 . . . . 0.0 109.184 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.541 HG23 ' CA ' ' A' ' 153' ' ' GLY . 1.2 m -148.32 163.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.064 -1.022 . . . . 0.0 110.85 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.39 171.05 32.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 97.93 -22.39 41.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.661 HD11 ' O ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -41.43 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -1.06 . . . . 0.0 109.981 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' GLY . 38.7 m -96.19 -162.58 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.816 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' THR . 12.7 m -52.25 162.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 111.188 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 2.9 t-20 61.93 -38.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.872 -0.517 . . . . 0.0 110.984 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.585 HG23 ' OD2' ' A' ' 124' ' ' ASP . 55.6 m -61.76 123.92 19.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 0.0 110.507 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.0 t -136.53 166.14 24.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 0.0 109.688 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -41.36 -55.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -0.989 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.31 -24.67 0.1 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.406 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.609 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 62.4 t0 -75.24 -59.28 2.81 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.682 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.666 HG21 HD21 ' A' ' 140' ' ' LEU . 1.8 t -64.3 -49.0 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.287 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 53.4 tttm -47.72 -63.47 1.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.522 -0.736 . . . . 0.0 110.057 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.609 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -61.14 -31.95 71.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -0.985 . . . . 0.0 109.861 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 21.4 t80 -61.97 -60.6 3.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.469 -0.769 . . . . 0.0 110.883 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 82.9 m-85 -79.7 -18.8 50.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.042 -1.036 . . . . 0.0 111.518 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 1.1 tp10 -54.45 -36.03 63.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.366 -1.459 . . . . 0.0 108.699 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -74.77 -20.62 59.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 1.066 ' O ' HD13 ' A' ' 162' ' ' ILE . 7.5 m-85 -82.24 -28.9 31.61 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.823 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -163.06 -157.72 9.3 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.893 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -72.24 -50.12 29.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.586 -0.95 . . . . 0.0 110.129 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.5 t 51.19 87.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.121 0.962 . . . . 0.0 110.353 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -87.79 -28.64 21.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 79.8 m-20 -134.49 137.99 44.35 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.127 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.824 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -147.18 93.93 2.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.661 ' HA ' HG22 ' A' ' 122' ' ' VAL . 9.1 ttm -105.62 167.05 10.02 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.833 0.825 . . . . 0.0 111.875 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.948 HD23 ' HA3' ' A' ' 153' ' ' GLY . 31.0 mt -146.03 132.51 19.71 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.661 ' O ' HD11 ' A' ' 116' ' ' LEU . 9.7 mmt -107.79 133.73 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.88 -1.137 . . . . 0.0 110.792 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 17.4 m-85 -120.84 -135.51 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.534 -0.728 . . . . 0.0 109.642 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 146' ' ' THR . 6.4 m-20 -133.55 174.39 10.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -78.03 118.99 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 25.6 p 42.59 26.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 143' ' ' ASP . 30.7 p -150.35 52.98 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.005 . . . . 0.0 110.008 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 147' ' ' ASN . 14.9 p-10 -72.13 52.29 0.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.46 -15.14 3.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.106 -0.996 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.497 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -104.85 144.35 31.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER 31.68 -147.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.319 0.581 . . . . 0.0 111.39 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 150' ' ' ARG . . . 127.71 134.01 3.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.581 ' CA ' HD21 ' A' ' 116' ' ' LEU . 24.0 p90 -144.9 135.01 23.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -1.17 . . . . 0.0 110.022 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.948 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -114.62 164.87 12.04 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.332 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -127.78 113.12 15.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -1.106 . . . . 0.0 109.648 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -109.0 -178.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.909 . . . . 0.0 108.938 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.699 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 79.8 m -164.07 106.32 0.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.169 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.962 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -126.32 113.06 16.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 109.511 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 4.0 tt0 -39.74 -26.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.435 -0.79 . . . . 0.0 111.123 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.534 ' O ' HG22 ' A' ' 162' ' ' ILE . 80.9 p -63.5 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 110.587 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -52.13 -38.9 58.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.864 -1.148 . . . . 0.0 109.17 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 160' ' ' GLU . 38.1 t70 -43.07 -53.54 4.83 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.778 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 1.066 HD13 ' O ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -60.66 -49.22 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.441 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' CE2' ' A' ' 157' ' ' PHE . 47.0 t -44.72 -46.78 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -52.21 12.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 167' ' ' CYS . 11.3 ttpt -90.02 -62.37 1.48 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.131 -0.98 . . . . 0.0 111.065 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 162' ' ' ILE . 8.5 p -40.01 -25.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.71 . . . . 0.0 110.637 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 23.3 m -76.3 -40.44 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.024 -1.047 . . . . 0.0 109.676 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 169' ' ' ILE . 1.2 mt-10 -68.67 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 168' ' ' GLU . 20.9 pt 35.82 91.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.558 -0.714 . . . . 0.0 110.755 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -166.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 178' ' ' MET . 1.4 t80 54.62 69.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -82.15 -26.27 33.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.195 -0.94 . . . . 0.0 110.128 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 68.59 101.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.092 -1.005 . . . . 0.0 110.914 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 125' ' ' VAL . 3.4 tt -122.25 118.74 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 29.1 m-20 64.19 -53.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.66 -0.65 . . . . 0.0 110.644 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.1 p30 -175.48 27.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.001 -1.062 . . . . 0.0 110.699 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.536 ' HD3' ' C ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -143.49 137.06 28.26 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.065 -1.022 . . . . 0.0 109.488 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.64 ' CG ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -77.87 88.05 4.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.326 -1.483 . . . . 0.0 110.097 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 174' ' ' ILE . 28.7 m -76.46 -178.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 110.379 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CD ' ' HE3' ' A' ' 182' ' ' LYS . 26.0 tt0 -128.78 140.65 51.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.752 . . . . 0.0 109.549 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 167' ' ' CYS . 1.5 t -122.68 142.65 50.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 110.811 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.42 ' C ' ' SG ' ' A' ' 167' ' ' CYS . 7.5 mttp -138.64 178.91 6.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.497 ' HD3' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -111.65 142.37 44.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.069 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.268 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 1.7 ptmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.972 0.415 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.93 HD12 ' N ' ' A' ' 112' ' ' PHE . 1.2 pp -123.26 178.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.795 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.93 ' N ' HD12 ' A' ' 111' ' ' ILE . 56.6 t80 -125.03 162.31 24.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.593 -0.692 . . . . 0.0 109.15 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.596 HG13 HD11 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -146.84 135.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -130.17 162.28 23.11 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.446 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 92.92 -26.04 16.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.003 HD21 ' HA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -44.1 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -1.092 . . . . 0.0 109.607 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -43.19 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.734 0.778 . . . . 0.0 111.018 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.825 HG12 ' N ' ' A' ' 119' ' ' ASN . 0.9 OUTLIER -74.44 -64.14 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.409 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.825 ' N ' HG12 ' A' ' 118' ' ' VAL . 0.8 OUTLIER -43.44 -21.98 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.75 HG21 HG12 ' A' ' 174' ' ' ILE . 23.6 m -72.71 142.21 48.2 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.778 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.0 158.98 36.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 110.563 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.722 HG23 ' HB2' ' A' ' 140' ' ' LEU . 2.7 t -37.56 -52.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -40.65 -27.06 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 179.703 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 122' ' ' VAL . 1.7 m-20 -72.79 -57.67 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.469 0.652 . . . . 0.0 109.567 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.72 HG21 HD11 ' A' ' 140' ' ' LEU . 2.1 t -65.87 -50.1 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.615 0.721 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 23.9 tttt -46.58 -61.77 1.67 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.714 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.5 OUTLIER -59.52 -33.14 71.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.588 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -66.44 -64.89 0.76 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 110.832 -179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.645 ' CD2' HG13 ' A' ' 125' ' ' VAL . 78.3 m-85 -70.68 -18.54 62.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.9 -1.125 . . . . 0.0 111.541 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 38.4 tt0 -55.96 -36.7 68.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.912 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 6.5 pt20 -73.47 -18.15 61.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 16.9 m-85 -86.55 -32.85 20.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -160.74 165.61 35.18 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -41.71 -55.13 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 110.336 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 58.79 89.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.01 0.91 . . . . 0.0 110.747 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' OD2' ' HE2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -92.84 -26.23 17.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -129.43 138.67 51.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -155.91 99.97 2.02 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.788 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -111.18 158.97 18.31 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.097 0.951 . . . . 0.0 112.854 -177.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 139' ' ' MET . 1.8 mp -137.82 148.55 45.57 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.559 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 1.4 mmt -125.28 147.54 49.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.729 -1.232 . . . . 0.0 110.927 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 141' ' ' MET . 16.1 m-85 -133.6 -177.63 4.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.647 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.481 ' HB3' ' HG2' ' A' ' 148' ' ' ARG . 12.0 p30 -70.49 -176.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.049 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 145' ' ' THR . 4.5 pttt -65.62 -24.17 66.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 110.083 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 88.6 m -164.12 -79.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 110.312 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 146' ' ' THR . 7.7 t -146.17 40.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 110.248 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -76.01 -18.5 59.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.481 ' HG2' ' HB3' ' A' ' 143' ' ' ASP . 3.2 ptp180 -149.11 -149.08 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 110.303 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -149.18 14.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 110.511 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -114.53 -162.9 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -0.936 . . . . 0.0 110.311 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.598 ' C ' HD11 ' A' ' 116' ' ' LEU . . . 169.14 176.37 39.12 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 1.003 ' HA ' HD21 ' A' ' 116' ' ' LEU . 5.9 p90 -147.88 136.67 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -1.134 . . . . 0.0 109.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -128.91 172.54 19.57 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.367 -1.396 . . . . 0.0 110.463 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' A' ' 139' ' ' MET . 71.0 m-85 -128.74 108.18 10.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.546 -0.973 . . . . 0.0 108.594 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -93.94 -178.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.456 -1.403 . . . . 0.0 109.648 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.547 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 36.4 m -163.66 105.92 0.96 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.224 -1.39 . . . . 0.0 112.216 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -130.4 120.62 24.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -0.812 . . . . 0.0 109.505 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -49.29 -20.35 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.655 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 162' ' ' ILE . 1.6 m -66.03 60.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.122 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -47.27 -38.7 12.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 179.713 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 162' ' ' ILE . 1.6 p30 -44.01 -49.58 8.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.378 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.784 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.4 tp -62.88 -49.79 82.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.872 HG22 ' CE2' ' A' ' 157' ' ' PHE . 44.3 t -46.81 -46.43 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -44.9 -55.19 5.67 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.242 0.544 . . . . 0.0 111.181 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 167' ' ' CYS . 21.0 tttp -87.06 -61.88 1.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.213 -0.929 . . . . 0.0 110.921 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 162' ' ' ILE . 5.8 p -42.51 -24.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 40.8 t -82.98 -27.68 30.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 110.446 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 169' ' ' ILE . 9.0 mm-40 -91.56 -175.57 4.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.145 -0.972 . . . . 0.0 111.018 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 22.1 mt 62.1 161.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.574 -0.704 . . . . 0.0 110.57 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -42.92 167.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.899 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.642 ' CZ ' ' HB2' ' A' ' 178' ' ' MET . 0.1 OUTLIER -59.03 -172.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.189 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.721 ' CE1' HG23 ' A' ' 166' ' ' VAL . 34.4 m-70 -105.01 -95.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 174.25 119.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 110.201 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.781 HG23 ' O ' ' A' ' 174' ' ' ILE . 10.6 tp -98.27 78.64 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 22.9 m120 63.84 -53.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 0.0 111.576 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -138.6 -0.67 1.93 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.987 -1.071 . . . . 0.0 111.383 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.9 OUTLIER -125.04 -175.53 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.913 -1.117 . . . . 0.0 111.079 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.642 ' HB2' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -121.72 79.03 1.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.627 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 174' ' ' ILE . 5.2 m -79.09 130.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 171' ' ' PHE . 59.3 tt0 -80.17 163.0 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.818 ' SG ' HD13 ' A' ' 111' ' ' ILE . 43.1 t -133.07 110.51 10.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.49 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 8.0 mmtm -105.29 163.42 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.55 ' HG3' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -76.32 154.95 34.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.022 . . . . 0.0 110.229 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.373 -0.829 . . . . 0.0 110.418 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.037 0.446 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 1.045 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pt -133.6 175.13 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 110.721 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 15.9 t80 -138.21 145.39 41.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.492 -0.755 . . . . 0.0 109.267 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.449 ' C ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -130.13 148.43 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.51 166.07 25.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.514 ' O ' ' HE2' ' A' ' 177' ' ' LYS . . . 86.31 -13.61 57.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -54.23 97.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -1.111 . . . . 0.0 110.648 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -54.85 175.9 0.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.092 -1.005 . . . . 0.0 108.656 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -79.51 -155.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.658 -1.276 . . . . 0.0 110.115 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.625 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER 75.44 -32.85 0.22 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' A' ' 121' ' ' THR . 1.8 m -81.47 172.14 13.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.606 0.717 . . . . 0.0 111.313 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 120' ' ' THR . 10.8 t -149.25 154.93 39.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 109.38 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.586 ' HA ' HD12 ' A' ' 140' ' ' LEU . 2.4 t -39.3 -50.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.465 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.64 -24.77 0.13 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.402 -0.812 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.617 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 25.5 t0 -74.95 -59.76 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.736 . . . . 0.0 109.696 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.706 HG21 HD21 ' A' ' 140' ' ' LEU . 1.1 t -63.66 -48.92 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.541 -0.724 . . . . 0.0 109.388 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 12.5 tttp -48.47 -60.94 2.29 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.255 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.617 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -63.9 -36.29 83.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.012 -1.055 . . . . 0.0 110.255 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 35.8 t80 -58.39 -57.7 11.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.38 -0.825 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.521 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 72.5 m-85 -83.0 -16.36 47.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.025 . . . . 0.0 111.485 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 83.3 tt0 -55.89 -37.59 69.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.45 -1.406 . . . . 0.0 108.244 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.4 pt20 -74.41 -16.6 60.88 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 162' ' ' ILE . 4.3 m-30 -87.72 -32.32 19.22 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 109.127 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.9 35.75 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HD3' ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -50.81 -41.38 57.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.607 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 47.62 91.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.195 0.998 . . . . 0.0 111.074 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -25.39 17.59 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.45 144.24 51.27 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -160.41 100.97 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.204 -0.935 . . . . 0.0 108.59 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.56 ' HA ' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -114.92 165.4 12.9 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.813 0.816 . . . . 0.0 112.239 -178.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 125' ' ' VAL . 34.2 mt -140.12 139.87 35.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.554 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -114.17 132.7 56.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.026 -1.046 . . . . 0.0 110.912 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 141' ' ' MET . 30.2 m-85 -142.72 -173.74 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.627 ' HA ' ' ND2' ' A' ' 147' ' ' ASN . 58.4 m-20 53.34 -166.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 0.1 OUTLIER 62.97 -142.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.407 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.16 10.45 8.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.653 HG22 ' HB3' ' A' ' 150' ' ' ARG . 17.2 p -139.32 41.68 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.997 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.627 ' ND2' ' HA ' ' A' ' 143' ' ' ASP . 9.1 m120 -47.05 -87.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 110.416 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 150' ' ' ARG . 3.7 mtt180 -97.26 161.99 13.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.438 -0.789 . . . . 0.0 110.192 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CB ' ' O ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER 64.69 -75.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.653 ' HB3' HG22 ' A' ' 146' ' ' THR . 8.0 mpt_? -53.75 -17.27 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 110.7 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -41.87 133.91 3.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 13.5 p90 -150.14 140.25 22.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -1.088 . . . . 0.0 109.387 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.46 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -123.54 165.57 16.25 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.249 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' CG ' ' A' ' 139' ' ' MET . 22.8 m-85 -120.37 112.18 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 0.0 109.162 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.6 t -108.31 -179.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.68 -1.262 . . . . 0.0 109.008 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 110' ' ' LYS . 32.3 m -161.08 105.14 1.32 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.765 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.045 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.1 p90 -127.28 102.47 6.93 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.222 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.27 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 111.195 -178.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.872 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -54.74 86.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -54.91 -38.24 67.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.657 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.6 OUTLIER -39.39 -68.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.486 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 1.038 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -58.61 -45.63 90.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.956 -1.09 . . . . 0.0 108.875 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.978 HG22 ' CE1' ' A' ' 157' ' ' PHE . 9.9 t -47.29 -34.31 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -61.01 -42.81 99.18 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.617 0.722 . . . . 0.0 109.742 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.2 tptt -86.25 -62.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.56 -0.713 . . . . 0.0 110.81 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 1.038 HG22 ' O ' ' A' ' 162' ' ' ILE . 4.9 m -46.63 -24.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 108.908 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 1.7 t -65.89 -31.27 72.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.039 -1.038 . . . . 0.0 108.457 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -71.88 158.68 35.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.193 0.52 . . . . 0.0 110.717 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 169' ' ' ILE . 1.2 pp -90.57 85.5 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.424 -0.798 . . . . 0.0 110.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 172' ' ' HIS . 0.2 OUTLIER -126.79 139.61 52.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.373 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.615 ' CE1' ' HG3' ' A' ' 178' ' ' MET . 0.1 OUTLIER -42.54 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.058 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 1.034 ' CE1' HG12 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -87.05 -41.24 14.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 110.456 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.2 tt0 66.42 105.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.372 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.744 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -112.43 118.03 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.271 179.319 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.483 ' HA ' HD21 ' A' ' 175' ' ' ASN . 0.0 OUTLIER 67.45 -55.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.9 -178.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.2 p-10 -170.37 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 111.278 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.713 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -140.96 125.9 18.2 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.564 -1.335 . . . . 0.0 110.649 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.615 ' HG3' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -60.72 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.121 -0.987 . . . . 0.0 110.631 179.125 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.744 HG21 ' HB ' ' A' ' 174' ' ' ILE . 21.1 m -72.23 170.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 0.0 110.63 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.23 140.5 45.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 81.3 m -114.79 151.94 32.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 0.1 OUTLIER -159.84 147.11 16.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 110.255 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.631 ' HG3' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -58.31 166.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.385 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.991 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.842 HD11 ' CG2' ' A' ' 155' ' ' VAL . 1.3 pp -92.79 163.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.679 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.0 t80 -116.8 152.58 34.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.08 -1.013 . . . . 0.0 109.429 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 182' ' ' LYS . 2.3 m -143.38 155.63 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -140.03 -179.03 17.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.562 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 74.37 22.0 78.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.03 ' CD1' HD22 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -42.43 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLY . 14.3 t -46.88 161.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.893 HG23 ' HE ' ' A' ' 148' ' ' ARG . 3.0 t -73.17 151.69 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.87 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.562 ' ND2' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.71 -44.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.459 0.647 . . . . 0.0 109.761 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 118' ' ' VAL . 2.6 m -41.16 132.26 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.993 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.511 ' N ' ' OD2' ' A' ' 124' ' ' ASP . 2.0 m -118.84 165.43 14.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 110.536 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -39.36 -52.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 111.038 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' VAL . 7.3 mt-10 -42.52 -25.37 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.382 -0.823 . . . . 0.0 109.477 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.563 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 82.6 m-20 -74.51 -54.04 8.3 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.452 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 140' ' ' LEU . 2.0 t -65.77 -48.51 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 109.2 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 14.4 ttpt -47.65 -61.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.563 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -64.14 -32.32 73.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 109.599 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.576 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 31.8 t80 -59.6 -57.99 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.406 -0.809 . . . . 0.0 110.384 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.576 ' CE1' ' CE2' ' A' ' 128' ' ' TYR . 61.1 m-85 -82.59 -14.59 54.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.0 111.038 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 78.7 tt0 -55.0 -38.92 68.48 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.195 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.6 pt20 -73.12 -17.44 61.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 4.2 m-85 -91.66 -30.15 16.48 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -158.96 155.22 26.29 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HE3' ' HG2' ' A' ' 158' ' ' GLU . 1.9 ptpt -41.34 -40.6 1.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -1.129 . . . . 0.0 110.535 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 45.15 94.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 111.17 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.84 -25.74 19.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.17 144.47 48.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.534 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.801 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -153.83 99.03 2.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 4.9 tpp -99.66 164.61 11.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.897 0.856 . . . . 0.0 111.481 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.03 HD22 ' CD1' ' A' ' 116' ' ' LEU . 11.5 mt -149.78 133.56 16.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 15.9 mmm -111.26 122.03 46.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.833 -1.167 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.462 ' CE1' HD12 ' A' ' 116' ' ' LEU . 15.5 m-85 -106.92 -168.03 1.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.419 -0.801 . . . . 0.0 109.86 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 144' ' ' LYS . 8.8 t0 -109.19 -162.72 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 110.068 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 143' ' ' ASP . 0.2 OUTLIER -42.93 -55.2 3.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 146' ' ' THR . 53.2 m -148.86 -87.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.792 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.487 HG22 HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -111.56 3.39 17.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.363 -0.835 . . . . 0.0 110.102 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.87 59.14 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 109.807 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.893 ' HE ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -89.6 -56.5 3.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 111.282 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.34 18.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.152 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -178.19 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.656 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 150' ' ' ARG . . . 58.39 150.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 14.7 p90 -150.44 140.0 21.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -1.106 . . . . 0.0 109.596 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.78 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -124.81 177.81 16.72 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.408 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.679 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 61.0 m-85 -138.37 117.41 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.929 . . . . 0.0 109.102 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.842 ' CG2' HD11 ' A' ' 111' ' ' ILE . 1.7 t -109.07 -174.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 155' ' ' VAL . 88.5 m -162.93 103.81 1.01 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.909 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.958 ' CE2' HG22 ' A' ' 163' ' ' VAL . 2.3 p90 -135.6 107.45 7.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.9 -22.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.434 -0.791 . . . . 0.0 111.118 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.853 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -56.36 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.421 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -61.63 -38.03 86.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.051 -1.031 . . . . 0.0 109.827 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 160' ' ' GLU . 10.1 t70 -39.27 -67.61 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.366 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.686 ' O ' HG12 ' A' ' 166' ' ' VAL . 5.6 tp -58.49 -42.68 85.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 108.79 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.958 HG22 ' CE2' ' A' ' 157' ' ' PHE . 38.2 t -50.94 -44.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.03 -46.51 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.7 tttt -90.26 -64.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -0.922 . . . . 0.0 111.202 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.866 HG13 ' HD3' ' A' ' 183' ' ' LYS . 6.0 p -45.31 -21.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.722 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 43.5 t -79.86 -22.87 42.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.931 -1.106 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 -68.26 156.43 37.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.78 113.83 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -163.23 32.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 110.331 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.659 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 0.0 OUTLIER 55.88 165.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -143.85 -156.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 10.6 tp10 -158.91 86.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.904 -1.123 . . . . 0.0 111.012 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.754 HD11 HG23 ' A' ' 125' ' ' VAL . 1.5 tt -102.98 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.941 -1.099 . . . . 0.0 109.854 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 4.8 m120 67.36 -56.75 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.497 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.9 p30 -170.93 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 110.174 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.8 tptt -128.19 163.98 23.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 111.018 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.659 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -94.28 -18.63 21.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -0.785 . . . . 0.0 109.32 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.594 HG22 ' C ' ' A' ' 178' ' ' MET . 34.5 m 37.25 -160.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.44 140.1 21.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 26.2 p -81.39 132.47 35.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.438 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -129.5 11.02 5.75 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.235 1.017 . . . . 0.0 109.175 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.866 ' HD3' HG13 ' A' ' 166' ' ' VAL . 1.4 mptt -41.01 158.09 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.586 -0.696 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 -179.894 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 9.8 pttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.03 0.443 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.955 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 5.4 pt -103.55 169.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.968 -1.083 . . . . 0.0 111.16 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 21.4 t80 -123.69 144.73 49.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.706 -0.621 . . . . 0.0 109.647 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -140.14 138.65 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 110.33 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -127.98 165.48 20.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.664 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 89.68 17.04 55.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.599 HD13 ' HG ' ' A' ' 140' ' ' LEU . 38.5 mt -39.54 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 110.278 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 177' ' ' LYS . 0.2 OUTLIER -43.87 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.884 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 120' ' ' THR . 10.6 m -67.71 157.6 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.766 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 3.9 t-20 62.22 -38.95 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.911 -0.493 . . . . 0.0 110.779 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 118' ' ' VAL . 54.9 m -47.68 150.23 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.947 -1.095 . . . . 0.0 109.994 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.801 ' C ' HD22 ' A' ' 140' ' ' LEU . 7.5 t -147.63 -167.28 2.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -60.21 -56.15 19.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 109.852 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -44.1 -24.62 0.16 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 109.604 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.719 ' OD2' HG22 ' A' ' 121' ' ' THR . 40.7 m-20 -78.2 -58.98 2.97 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.746 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.837 HG23 HD11 ' A' ' 174' ' ' ILE . 1.5 t -62.15 -47.79 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 108.943 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 6.0 ttmt -46.66 -61.98 1.59 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.485 -0.76 . . . . 0.0 109.992 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.713 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.4 OUTLIER -64.76 -34.55 78.6 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.439 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.615 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 29.7 t80 -55.6 -58.21 8.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.575 -0.703 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 94.0 m-85 -81.29 -15.81 54.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.7 tt0 -55.41 -38.12 68.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 4.2 pt20 -74.59 -15.82 60.82 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.298 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 18.5 m-85 -86.85 -30.67 21.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.445 0.64 . . . . 0.0 109.341 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -162.03 -174.59 32.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -56.15 24.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 56.07 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.208 1.004 . . . . 0.0 111.135 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -24.91 16.36 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -130.71 140.01 50.33 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.753 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -153.8 101.69 2.47 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.873 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.3 ptm -113.16 168.79 9.43 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.92 0.867 . . . . 0.0 113.117 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.873 HD12 ' O ' ' A' ' 139' ' ' MET . 2.6 mp -139.1 139.18 37.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.851 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.583 ' HB3' ' O ' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -109.56 132.6 53.98 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.755 -1.215 . . . . 0.0 109.75 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 95.7 m-85 -122.66 -156.18 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.78 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 146' ' ' THR . 0.4 OUTLIER 61.26 -177.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.182 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.695 ' O ' HG22 ' A' ' 145' ' ' THR . 0.2 OUTLIER 61.34 100.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.93 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 144' ' ' LYS . 10.5 t 39.6 26.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.481 -0.762 . . . . 0.0 110.382 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.83 ' O ' HG22 ' A' ' 146' ' ' THR . 2.3 m -151.08 56.46 0.89 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.115 0.959 . . . . 0.0 108.575 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 2.2 m120 -59.32 -10.97 3.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.903 -1.123 . . . . 0.0 110.898 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -144.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.68 34.66 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.149 -0.97 . . . . 0.0 110.485 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -95.41 -158.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . 108.03 -147.46 16.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.583 ' O ' ' HB3' ' A' ' 141' ' ' MET . 5.4 p90 -151.02 139.5 20.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.01 -1.288 . . . . 0.0 109.999 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -104.56 158.3 16.5 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.18 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 139' ' ' MET . 89.4 m-85 -114.3 103.4 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -97.0 -179.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.485 -178.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.627 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 73.7 m -163.95 104.52 0.9 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.782 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.955 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -125.99 106.55 9.7 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.45 177.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.553 -0.717 . . . . 0.0 111.529 -178.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -56.95 83.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 110.487 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -61.12 -38.43 86.32 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.774 -1.204 . . . . 0.0 109.478 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.8 m-20 -41.53 -62.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.788 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.1 tp -57.52 -47.14 85.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.033 -1.042 . . . . 0.0 108.564 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.949 HG22 ' CE2' ' A' ' 157' ' ' PHE . 43.2 t -47.67 -49.07 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.433 ' O ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -41.53 -52.28 3.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.674 -0.641 . . . . 0.0 111.386 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 167' ' ' CYS . 58.1 tttt -90.5 -61.79 1.6 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -0.999 . . . . 0.0 110.855 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 162' ' ' ILE . 7.1 p -42.36 -24.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 181' ' ' CYS . 13.9 p -81.2 -30.59 34.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.874 -1.141 . . . . 0.0 110.268 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.7 OUTLIER -67.82 -56.07 10.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.605 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 171' ' ' PHE . 2.4 mt -43.74 136.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -110.73 17.52 20.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 0.0 110.013 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 1.3 t80 -140.23 64.26 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.426 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.517 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -71.11 138.88 50.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 110.166 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.7 tt0 -90.09 96.74 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.148 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.837 HD11 HG23 ' A' ' 125' ' ' VAL . 2.0 tt -97.71 97.26 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 110.034 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.472 ' OD1' ' CG1' ' A' ' 174' ' ' ILE . 3.8 m120 67.78 -56.89 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 110.009 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.8 p30 -166.0 23.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 110.192 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.557 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.4 OUTLIER -127.22 166.03 18.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 111.031 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -109.3 40.24 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.492 -0.755 . . . . 0.0 109.44 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.664 HG12 ' C ' ' A' ' 115' ' ' GLY . 19.0 m -47.76 167.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.5 -0.75 . . . . 0.0 111.332 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 1.8 tt0 -107.78 150.12 27.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.614 -0.679 . . . . 0.0 109.823 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 167' ' ' CYS . 3.1 p -131.0 90.6 2.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -89.66 143.24 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -79.99 163.87 23.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.296 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.318 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.861 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.359 0.599 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.687 HG21 ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.99 174.19 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.753 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 41.0 t80 -123.53 156.76 35.04 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.947 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 1.4 m -145.0 154.38 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 179' ' ' VAL . . . -144.12 174.0 24.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.813 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 77.85 12.84 84.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.763 HD11 ' N ' ' A' ' 153' ' ' GLY . 39.5 mt -53.48 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -1.171 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.519 ' HB2' ' CD ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -42.25 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.504 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 120' ' ' THR . 14.8 m -65.99 161.84 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 110.792 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 1.3 t-20 62.57 -38.6 0.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 110.67 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 118' ' ' VAL . 21.8 m -42.58 139.48 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 109.921 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.757 ' C ' HD12 ' A' ' 140' ' ' LEU . 8.7 t -127.0 168.93 13.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.08 -1.013 . . . . 0.0 111.079 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.792 ' N ' HD12 ' A' ' 140' ' ' LEU . 1.5 t -39.3 -47.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.679 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.438 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.6 OUTLIER -44.38 -25.66 0.27 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 108.968 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.53 ' OD2' ' CG2' ' A' ' 120' ' ' THR . 15.7 t0 -69.51 -46.31 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.699 . . . . 0.0 109.665 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.818 HG22 HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -76.66 -44.17 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.807 0.813 . . . . 0.0 109.17 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 9.6 ttmt -59.38 -48.82 80.19 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.691 -0.63 . . . . 0.0 111.078 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.713 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -71.9 -28.63 63.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 110.123 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.503 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 67.4 t80 -79.13 -50.0 11.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 112.167 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 125' ' ' VAL . 68.6 m-85 -88.43 -16.91 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.814 -1.179 . . . . 0.0 112.118 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 1.5 pp20? -53.73 -42.49 68.19 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.247 -1.781 . . . . 0.0 108.432 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -70.57 -17.04 62.92 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.802 179.527 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.745 ' O ' HD13 ' A' ' 162' ' ' ILE . 7.7 m-85 -79.99 -27.77 39.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.35 -132.6 1.36 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 158' ' ' GLU . 1.5 ptpp? -101.13 -37.48 8.55 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.516 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 42.45 89.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.11 0.957 . . . . 0.0 110.934 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.12 -27.2 23.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.72 136.92 37.8 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.377 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -143.2 91.1 2.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.558 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 6.3 ttp -96.32 162.94 13.29 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.098 0.951 . . . . 0.0 112.166 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.818 HD11 HG22 ' A' ' 125' ' ' VAL . 22.5 mt -139.35 129.95 25.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 35.2 mmm -103.68 111.46 23.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.011 -1.056 . . . . 0.0 110.616 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -92.29 -136.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 110.034 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.72 95.98 2.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.06 . . . . 0.0 110.471 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 145' ' ' THR . 10.7 tptt 51.5 -109.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 110.117 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.543 HG22 HG22 ' A' ' 146' ' ' THR . 32.9 m -87.7 -90.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.799 -1.188 . . . . 0.0 110.043 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 HG22 ' A' ' 145' ' ' THR . 6.9 t -132.94 8.77 4.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.33 52.83 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -109.4 155.31 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -121.62 -21.19 6.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 0.0 109.916 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -156.68 -55.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 109.627 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 63.4 179.03 5.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.7 p90 -147.46 140.4 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -1.054 . . . . 0.0 109.287 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.79 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -111.05 161.55 12.77 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.375 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' HB2' ' HE3' ' A' ' 139' ' ' MET . 28.3 m-85 -123.82 109.85 14.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -1.013 . . . . 0.0 109.128 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -105.24 -178.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 109.372 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.623 ' HA ' HD13 ' A' ' 111' ' ' ILE . 78.7 m -159.7 104.25 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.58 -1.325 . . . . 0.0 112.149 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.065 ' CE1' HG22 ' A' ' 163' ' ' VAL . 1.6 p90 -127.73 97.23 4.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 0.0 108.748 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLU . 1.0 OUTLIER -39.05 -31.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.755 . . . . 0.0 111.483 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -52.49 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.791 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -55.76 -38.11 69.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.091 -1.006 . . . . 0.0 109.755 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.9 OUTLIER -39.85 -64.46 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.305 -179.646 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.847 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -61.36 -46.28 96.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.853 -1.154 . . . . 0.0 108.815 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.065 HG22 ' CE1' ' A' ' 157' ' ' PHE . 4.4 t -49.77 -35.3 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -50.1 -63.07 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.66 -0.65 . . . . 0.0 111.217 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 10.7 ptpt -90.43 -45.02 9.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.144 -0.973 . . . . 0.0 111.484 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -51.9 -22.05 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.517 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.536 ' CB ' ' HG2' ' A' ' 183' ' ' LYS . 89.5 m -89.61 -23.31 21.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.003 -1.061 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 169.83 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.41 121.29 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.52 -152.27 0.25 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 110.314 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 1.1 t80 -122.02 81.52 1.84 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.901 . . . . 0.0 110.083 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 178' ' ' MET . 0.1 OUTLIER -74.75 115.53 14.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.231 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.3 pt-20 -96.78 109.89 22.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.003 HD13 HG21 ' A' ' 179' ' ' VAL . 4.7 pt -118.91 119.62 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.133 . . . . 0.0 109.789 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.7 OUTLIER 68.22 -56.69 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.933 . . . . 0.0 109.702 -179.133 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 174' ' ' ILE . 4.8 p30 -179.07 31.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 109.401 179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.59 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.4 tptp -139.14 136.7 35.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 111.352 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -82.29 45.44 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.837 . . . . 0.0 109.588 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 1.003 HG21 HD13 ' A' ' 174' ' ' ILE . 6.8 m -46.77 176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.676 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 38.7 tt0 -129.19 150.89 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 109.821 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -117.91 160.25 21.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.461 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -159.06 150.31 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.769 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.536 ' HG2' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -66.52 158.94 28.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.0 110.276 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 110.261 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.902 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.03 0.443 . . . . 0.0 110.126 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.987 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 6.1 pt -106.7 170.89 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.099 -1.001 . . . . 0.0 110.822 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 54.2 t80 -125.57 150.66 47.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.507 -0.746 . . . . 0.0 109.893 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -142.54 159.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.917 . . . . 0.0 110.297 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -151.15 168.66 30.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.14 48.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 140' ' ' LEU . 2.6 mm? -63.89 93.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -1.196 . . . . 0.0 109.543 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 177' ' ' LYS . 4.9 t -64.6 -146.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 111.118 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' THR . 8.9 t -90.41 166.97 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 111.223 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 2.5 t-20 61.59 -40.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.285 0.564 . . . . 0.0 110.476 178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' VAL . 24.2 m -51.22 134.51 27.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.045 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.6 t -138.57 159.18 42.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.574 HG23 ' CB ' ' A' ' 140' ' ' LEU . 2.6 t -39.74 -52.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.818 . . . . 0.0 110.556 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 122' ' ' VAL . 5.5 tt0 -39.68 -28.22 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.548 -0.72 . . . . 0.0 109.294 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 122' ' ' VAL . 28.0 m-20 -75.17 -59.79 2.58 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.004 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 129' ' ' PHE . 1.6 t -63.84 -48.86 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.25 -0.906 . . . . 0.0 108.99 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 5.2 ttpt -45.19 -70.14 0.11 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.413 -0.804 . . . . 0.0 109.495 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.545 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -55.99 -37.58 69.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.186 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 26.2 t80 -58.69 -47.4 84.63 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.59 -0.694 . . . . 0.0 111.409 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.614 ' CD2' HG13 ' A' ' 125' ' ' VAL . 69.2 m-85 -87.19 -15.11 39.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.05 -1.031 . . . . 0.0 113.425 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.792 ' HG2' HG11 ' A' ' 135' ' ' VAL . 3.2 mt-10 -56.53 -34.58 67.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.632 -1.917 . . . . 0.0 108.618 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.58 ' HG3' ' CD1' ' A' ' 132' ' ' PHE . 20.3 pt20 -74.87 -17.39 60.59 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.411 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.58 ' CD1' ' HG3' ' A' ' 131' ' ' GLN . 28.1 m-85 -83.79 -31.82 25.71 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -163.55 169.48 38.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.469 ' HD2' ' HG2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -42.39 -57.01 2.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -1.128 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.792 HG11 ' HG2' ' A' ' 130' ' ' GLU . 1.2 t 61.11 90.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.202 1.001 . . . . 0.0 111.268 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.13 -26.98 14.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.73 140.9 50.98 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.771 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -154.17 99.31 2.22 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 154' ' ' PHE . 2.5 ptm -110.31 167.61 10.07 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.064 0.935 . . . . 0.0 112.265 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 116' ' ' LEU . 5.1 tp -146.47 155.04 42.25 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 140' ' ' LEU . 75.5 mmm -142.22 144.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 23.3 m-85 -114.94 -143.85 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.447 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -114.59 -10.83 12.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.503 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 147' ' ' ASN . 0.3 OUTLIER 179.36 -148.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 110.162 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 m -105.5 -23.66 12.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.371 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.77 -51.22 0.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.145 -0.972 . . . . 0.0 110.122 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 144' ' ' LYS . 19.4 p-10 -80.45 49.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -94.07 156.78 16.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.43 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -159.63 -74.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 0.0 110.148 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -98.41 113.23 25.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.61 -164.05 11.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.615 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.8 p90 -149.0 146.87 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 109.641 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -123.71 152.84 17.2 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.883 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' HG3' ' A' ' 139' ' ' MET . 30.6 m-85 -119.26 109.28 15.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.059 -1.259 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -103.92 179.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.758 -1.214 . . . . 0.0 109.042 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.579 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 61.0 m -162.74 107.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.944 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.987 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -127.62 127.21 43.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -52.83 -17.25 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 110.952 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.7 m -72.53 81.1 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -59.28 -39.09 81.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.76 -1.213 . . . . 0.0 109.25 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 1.5 m-20 -40.2 -58.72 1.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.766 -0.584 . . . . 0.0 110.344 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.855 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -61.65 -47.5 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.614 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.911 HG22 ' CE2' ' A' ' 157' ' ' PHE . 36.1 t -47.07 -39.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 10.0 tt0 -46.13 -64.18 0.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.79 -0.569 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 3.9 pttm -90.5 -46.86 8.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.22 -0.925 . . . . 0.0 111.64 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.9 p -48.68 -23.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.075 . . . . 0.0 110.27 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 163' ' ' VAL . 91.3 m -89.93 -27.32 19.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.353 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 169' ' ' ILE . 39.1 tt0 -74.89 -35.72 62.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.864 . . . . 0.0 110.705 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.672 HG21 ' ND1' ' A' ' 172' ' ' HIS . 1.2 tt -42.42 145.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 110.441 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.568 ' CD2' ' OE1' ' A' ' 180' ' ' GLU . 1.8 t60 -114.8 28.53 8.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.035 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.656 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.9 OUTLIER -171.21 56.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.317 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.672 ' ND1' HG21 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.93 128.54 36.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 110.348 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -84.17 104.4 14.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 1.001 ' CD1' HG21 ' A' ' 179' ' ' VAL . 3.8 mt -103.59 100.88 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 0.0 109.655 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 0.2 OUTLIER 66.25 -55.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.301 -179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 174' ' ' ILE . 3.2 p-10 -168.01 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.49 -0.756 . . . . 0.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.592 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.3 tptt -131.85 152.17 51.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.656 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -92.99 44.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.858 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 1.001 HG21 ' CD1' ' A' ' 174' ' ' ILE . 33.5 m -48.06 170.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.354 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.568 ' OE1' ' CD2' ' A' ' 170' ' ' HIS . 30.5 tt0 -122.87 146.51 47.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.706 ' SG ' HD12 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -114.75 165.51 12.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.358 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -161.05 175.82 12.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.074 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -93.84 144.52 25.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.093 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.961 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.315 0.578 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.841 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 2.0 pt -104.92 176.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -0.806 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -124.55 159.81 29.79 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.223 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -149.3 161.66 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 0.0 110.483 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -150.86 152.69 24.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.773 ' HA3' HG12 ' A' ' 179' ' ' VAL . . . 114.3 -17.13 19.4 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.917 HD22 HD22 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -49.81 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -1.148 . . . . 0.0 110.097 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 118' ' ' VAL . 30.4 t -101.64 -167.57 1.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.747 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 120' ' ' THR . 16.4 m -42.25 168.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 111.081 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.556 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 2.6 t-20 62.69 -41.75 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.155 0.502 . . . . 0.0 110.33 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 118' ' ' VAL . 1.3 m -61.4 133.16 55.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.932 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLU . 10.2 t -149.27 60.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.091 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.89 ' H ' HD12 ' A' ' 140' ' ' LEU . 3.1 t 63.97 -56.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.173 0.511 . . . . 0.0 110.425 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.786 ' O ' ' HD2' ' A' ' 127' ' ' HIS . 1.4 mm-40 -44.57 -23.71 0.14 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.442 -0.786 . . . . 0.0 108.946 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.716 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 2.4 m-20 -70.23 -58.04 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.718 . . . . 0.0 109.686 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.76 HG22 ' HE2' ' A' ' 129' ' ' PHE . 2.0 t -68.38 -50.48 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.703 . . . . 0.0 109.326 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 15.8 tttt -49.01 -59.76 3.34 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.386 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.786 ' HD2' ' O ' ' A' ' 123' ' ' GLU . 0.1 OUTLIER -58.21 -29.53 65.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -74.96 -62.41 1.56 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 111.827 -178.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.76 ' HE2' HG22 ' A' ' 125' ' ' VAL . 67.8 m-85 -74.09 -15.09 61.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.902 -1.123 . . . . 0.0 112.668 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -52.41 -41.29 63.07 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 117.702 -1.599 . . . . 0.0 109.113 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -72.17 -16.97 61.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.648 -0.821 . . . . 0.0 108.874 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.531 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 2.8 m-85 -88.66 -25.36 22.43 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.564 0.697 . . . . 0.0 109.164 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -166.23 153.42 23.26 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 158' ' ' GLU . 12.3 ptpt -38.49 -41.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.599 -0.942 . . . . 0.0 110.727 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.2 t 47.52 90.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.099 0.952 . . . . 0.0 110.604 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.1 -26.06 19.31 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -127.92 140.23 52.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.739 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -157.77 98.93 1.68 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.682 ' HA ' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.95 169.37 9.7 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.971 0.891 . . . . 0.0 112.505 -177.428 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 1.029 HD23 ' HA3' ' A' ' 153' ' ' GLY . 18.0 mt -144.59 132.41 21.29 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.488 ' O ' HD11 ' A' ' 116' ' ' LEU . 1.9 mmt -103.16 112.27 25.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.179 -0.951 . . . . 0.0 110.784 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 140' ' ' LEU . 77.2 m-85 -99.98 154.96 17.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 147' ' ' ASN . 0.4 OUTLIER -101.77 90.16 3.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 109.946 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 143' ' ' ASP . 14.4 mttt -41.1 -32.38 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 110.541 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 65.9 p -74.1 -42.76 59.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.127 -0.983 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -150.45 53.71 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 110.111 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 143' ' ' ASP . 47.5 p30 -73.91 52.53 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.307 -0.871 . . . . 0.0 110.563 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.19 -38.45 1.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -101.25 -31.74 10.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.723 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -110.66 171.18 7.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 148.07 129.15 1.84 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.529 ' CA ' HD21 ' A' ' 116' ' ' LEU . 29.4 p90 -141.58 134.5 28.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -1.205 . . . . 0.0 110.248 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 1.029 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -117.0 165.15 12.35 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.52 ' O ' ' HG3' ' A' ' 139' ' ' MET . 46.6 m-85 -125.96 109.6 12.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.594 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -101.63 -177.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.973 -1.079 . . . . 0.0 108.922 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 88.6 m -164.07 105.48 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.277 -1.369 . . . . 0.0 112.242 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.841 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.3 p90 -132.41 108.36 9.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.02 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 160' ' ' GLU . 5.3 tt0 -39.56 -27.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 0.0 110.847 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.703 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -53.58 88.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 110.427 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.0 tm-20 -66.35 -38.58 87.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.1 OUTLIER -40.84 -60.73 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.995 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.942 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -59.88 -48.86 86.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.772 178.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.815 HG22 ' CE2' ' A' ' 157' ' ' PHE . 42.1 t -46.98 -41.95 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 4.9 tt0 -51.09 -42.92 60.93 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.512 0.673 . . . . 0.0 110.259 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -88.86 -63.59 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.372 -0.83 . . . . 0.0 110.947 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.942 HG22 ' O ' ' A' ' 162' ' ' ILE . 12.4 m -47.25 -23.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.489 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 13.9 t -73.63 -24.41 60.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 108.983 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 165' ' ' LYS . 42.2 tp10 -105.64 -49.76 3.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.842 -0.536 . . . . 0.0 110.418 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.4 mt -52.77 111.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.447 ' NE2' ' OE1' ' A' ' 180' ' ' GLU . 0.4 OUTLIER -88.22 176.74 7.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 178' ' ' MET . 2.8 t80 43.66 65.91 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -0.958 . . . . 0.0 110.004 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.808 ' NE2' HG12 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -66.5 -22.47 66.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.148 -0.97 . . . . 0.0 110.272 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 13.1 tt0 70.48 79.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 0.0 110.824 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.669 HG22 ' CB ' ' A' ' 177' ' ' LYS . 2.8 tt -78.29 -175.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.97 -1.081 . . . . 0.0 109.726 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' ILE . 28.4 m120 -30.28 -57.36 0.19 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.8 -0.562 . . . . 0.0 111.819 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.7 OUTLIER -138.86 28.9 2.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.213 -0.929 . . . . 0.0 110.27 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.669 ' CB ' HG22 ' A' ' 174' ' ' ILE . 0.2 OUTLIER -142.88 -166.63 2.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.729 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.617 ' HB2' ' CD1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -135.39 33.61 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.773 HG12 ' HA3' ' A' ' 115' ' ' GLY . 33.3 m -36.9 159.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.518 0.675 . . . . 0.0 111.375 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.447 ' OE1' ' NE2' ' A' ' 170' ' ' HIS . 28.4 tt0 -114.57 153.72 29.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.78 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 166' ' ' VAL . 20.2 m -121.97 122.02 38.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 110.588 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -124.22 137.65 54.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.565 ' HD3' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -56.08 164.91 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 0.0 110.8 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.961 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.715 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.109 0.481 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.975 HD12 ' N ' ' A' ' 112' ' ' PHE . 1.2 pp -119.25 -179.15 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.853 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.975 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.6 t80 -131.43 159.49 37.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 109.563 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.443 HG23 ' CA ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -145.78 155.4 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.291 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 179' ' ' VAL . . . -156.63 140.62 7.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 121.62 -10.1 9.82 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.792 HD11 ' O ' ' A' ' 141' ' ' MET . 0.4 OUTLIER -50.89 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -1.12 . . . . 0.0 109.929 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' GLY . 53.7 p -65.49 -167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.782 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 120' ' ' THR . 23.1 m -58.84 171.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 0.0 111.225 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 1.8 t-20 62.2 -39.87 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.914 -0.491 . . . . 0.0 110.775 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.672 HG23 ' OD2' ' A' ' 124' ' ' ASP . 36.8 m -55.56 148.74 15.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.006 -1.059 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.7 t -158.28 166.88 31.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.623 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -41.6 -53.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 110.558 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.08 -25.8 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.672 ' OD2' HG23 ' A' ' 120' ' ' THR . 50.5 t0 -72.24 -49.94 31.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.769 ' CG2' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -69.37 -44.85 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.09 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 8.2 tttm -52.16 -63.99 0.96 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.518 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -62.85 -30.79 71.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.144 -0.972 . . . . 0.0 110.95 -179.256 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 84.9 t80 -70.59 -50.92 32.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.19 -0.944 . . . . 0.0 111.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.721 ' CE2' HG12 ' A' ' 125' ' ' VAL . 56.0 m-85 -89.48 -12.29 40.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 111.941 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.695 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 26.0 tt0 -56.31 -38.29 71.08 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.357 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 24.6 pt20 -74.65 -14.46 60.76 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.565 ' O ' HD13 ' A' ' 162' ' ' ILE . 14.0 m-85 -86.8 -32.16 20.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.712 -0.617 . . . . 0.0 110.424 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -170.3 54.69 0.19 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.346 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER 60.15 -67.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.722 -0.869 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 135' ' ' VAL . 0.9 OUTLIER 62.44 94.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.083 . . . . 0.0 110.903 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.41 -25.0 25.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.51 136.55 39.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.5 0.667 . . . . 0.0 109.793 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.843 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -145.18 92.51 2.26 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.505 ' SD ' ' CE ' ' A' ' 141' ' ' MET . 6.8 tpp -90.17 163.06 14.97 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.834 0.826 . . . . 0.0 111.328 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.776 HD12 ' HA3' ' A' ' 153' ' ' GLY . 5.0 tp -151.11 154.71 37.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.774 -0.579 . . . . 0.0 109.711 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.792 ' O ' HD11 ' A' ' 116' ' ' LEU . 8.8 mmt -138.88 157.62 45.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.177 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -124.69 -146.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.915 . . . . 0.0 110.062 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.8 132.94 55.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.116 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -83.13 48.05 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.344 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -94.36 -57.11 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.975 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.646 HG23 ' H ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -149.5 -74.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.574 -0.704 . . . . 0.0 109.925 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.646 ' H ' HG23 ' A' ' 146' ' ' THR . 9.0 m-20 -90.27 -82.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.864 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 142' ' ' PHE . 4.4 ptt180 -150.33 -49.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.104 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 150' ' ' ARG . 12.8 m170 54.76 177.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 110.657 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 149' ' ' HIS . 5.9 mtm180 -52.0 -174.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.217 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 173.89 -149.26 10.71 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.165 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 6.6 p90 -149.7 141.84 24.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.994 . . . . 0.0 109.252 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.776 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -123.58 160.07 18.15 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.574 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -123.89 113.33 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.976 . . . . 0.0 108.748 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -104.42 178.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.879 -1.138 . . . . 0.0 109.543 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 45.8 m -160.6 104.92 1.41 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.178 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.018 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -128.83 112.31 14.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 177.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.444 ' CA ' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -39.48 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.499 -0.751 . . . . 0.0 110.585 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.865 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.4 m -59.92 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.499 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.271 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.463 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -43.24 -61.13 1.42 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.892 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.4 OUTLIER -58.1 -46.41 88.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.39 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.018 HG22 ' CE2' ' A' ' 157' ' ' PHE . 44.5 t -48.96 -51.3 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 161' ' ' ASP . 2.9 mt-10 -42.7 -43.97 4.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.612 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -90.92 -66.21 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 111.107 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.841 HG23 ' CE1' ' A' ' 172' ' ' HIS . 6.0 p -45.44 -20.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 0.0 110.936 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 183' ' ' LYS . 3.5 p -88.19 -29.19 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 109.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -44.44 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.896 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -80.71 109.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 0.0 110.163 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 171' ' ' PHE . 18.4 t-160 -168.24 120.42 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.61 ' CD1' ' HB3' ' A' ' 178' ' ' MET . 0.1 OUTLIER -42.71 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 110.144 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.841 ' CE1' HG23 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -79.79 -153.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 178' ' ' MET . 14.3 tt0 -153.65 127.74 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.812 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -116.3 102.82 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.01 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.468 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.0 OUTLIER 66.88 -58.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.188 . . . . 0.0 109.842 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 174' ' ' ILE . 3.6 p-10 -149.5 -31.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 110.587 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -76.72 -170.05 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.41 -0.806 . . . . 0.0 110.099 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.639 ' C ' HG23 ' A' ' 179' ' ' VAL . 21.8 mmt -100.63 -70.6 0.73 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.812 HG21 ' HB ' ' A' ' 174' ' ' ILE . 2.6 t 70.48 160.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.551 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -120.75 152.77 37.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' CYS . . . . . 0.476 ' O ' ' CG ' ' A' ' 182' ' ' LYS . 35.4 m -126.39 158.84 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 181' ' ' CYS . 15.4 mtmt -157.53 155.47 30.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.832 . . . . 0.0 109.961 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -67.12 160.88 25.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.034 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.822 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.648 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -122.39 176.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.99 . . . . 0.0 110.389 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 56.4 t80 -126.08 160.22 30.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.812 . . . . 0.0 109.926 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.1 OUTLIER -147.42 149.25 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.037 -1.039 . . . . 0.0 110.667 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.22 174.2 22.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 89.59 13.19 61.64 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.889 HD21 ' HG ' ' A' ' 140' ' ' LEU . 1.7 mp -40.81 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -1.051 . . . . 0.0 110.167 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 115' ' ' GLY . 22.7 t -64.92 178.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.731 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -72.33 150.23 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 0.0 110.454 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 3.7 t-20 62.25 -38.85 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.99 -0.444 . . . . 0.0 110.598 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.642 HG23 ' OD2' ' A' ' 124' ' ' ASP . 18.0 m -41.4 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.304 -0.873 . . . . 0.0 110.015 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 124' ' ' ASP . 10.3 t -164.52 172.51 13.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 140' ' ' LEU . 3.1 t -39.01 -54.54 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.682 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -41.98 -25.91 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 109.155 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.642 ' OD2' HG23 ' A' ' 120' ' ' THR . 58.1 t0 -72.81 -55.56 6.52 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.493 0.663 . . . . 0.0 109.909 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.848 HG12 ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -68.4 -54.75 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.1 tttt -39.29 -63.47 0.55 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.154 0.502 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.527 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 2.1 p-80 -61.87 -29.5 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.073 -1.017 . . . . 0.0 110.897 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -73.36 -55.29 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 0.0 111.707 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PHE . . . . . 0.848 ' CD2' HG12 ' A' ' 125' ' ' VAL . 38.6 m-85 -84.13 -17.53 39.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.104 . . . . 0.0 111.895 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.659 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 70.0 tt0 -57.2 -36.0 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.114 -1.616 . . . . 0.0 108.262 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLN . . . . . 0.479 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.9 pt20 -76.71 -13.56 60.03 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.651 ' CD2' HD11 ' A' ' 162' ' ' ILE . 4.1 m-30 -86.95 -35.11 19.07 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.806 -0.559 . . . . 0.0 111.101 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -169.45 65.01 0.18 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.273 -1.918 . . . . 0.0 111.181 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.86 -70.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.933 . . . . 0.0 111.591 178.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 64.95 92.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.09 0.948 . . . . 0.0 110.732 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -87.19 -21.61 25.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.06 137.9 41.59 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -155.9 98.17 1.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' MET . . . . . 0.577 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -113.61 171.79 7.36 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.145 0.974 . . . . 0.0 112.555 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.889 ' HG ' HD21 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -145.62 148.43 33.1 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.498 179.683 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . 0.448 ' O ' ' HA3' ' A' ' 151' ' ' GLY . 3.1 mmt -130.45 116.99 19.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.023 -1.048 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 116' ' ' LEU . 45.1 m-85 -92.64 -173.35 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 109.997 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.02 177.93 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -20.66 65.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.146 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.517 HG22 ' N ' ' A' ' 146' ' ' THR . 85.0 m -130.48 -105.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.517 ' N ' HG22 ' A' ' 145' ' ' THR . 10.7 p -150.49 49.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.953 -1.092 . . . . 0.0 109.827 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -53.48 -90.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.593 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 149' ' ' HIS . 1.1 tpp180 -150.23 -58.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 110.626 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.549 ' N ' ' ND1' ' A' ' 149' ' ' HIS . 0.0 OUTLIER 178.01 110.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -176.64 36.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . -111.5 -160.14 16.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PHE . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 4.7 p90 -145.35 153.32 41.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -1.158 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -118.85 158.34 14.88 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.432 -1.366 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 139' ' ' MET . 11.9 m-85 -116.93 110.95 18.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -1.061 . . . . 0.0 109.352 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -107.65 179.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.638 -1.289 . . . . 0.0 109.392 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . 0.822 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 97.2 m -163.49 104.75 0.96 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.293 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 1.055 ' CE1' HG22 ' A' ' 163' ' ' VAL . 1.4 p90 -127.83 99.2 5.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.866 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -38.89 -31.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.757 -0.59 . . . . 0.0 111.381 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 163' ' ' VAL . 35.7 m -53.37 86.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.3 tt0 -54.36 -38.42 66.06 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.831 -1.168 . . . . 0.0 109.75 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.2 OUTLIER -38.42 -67.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -60.46 -38.23 77.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.325 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.055 HG22 ' CE1' ' A' ' 157' ' ' PHE . 7.7 t -58.2 -32.94 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.7 tm-20 -58.02 -49.59 76.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.478 -0.764 . . . . 0.0 110.604 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 168' ' ' GLU . 18.9 tttp -89.71 -60.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.577 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 162' ' ' ILE . 2.5 p -42.34 -25.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.452 -0.78 . . . . 0.0 109.805 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' CYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.7 t -76.28 -34.52 59.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.894 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.577 ' O ' ' CE1' ' A' ' 170' ' ' HIS . 23.3 tt0 -87.04 -86.86 0.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 110.703 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER -41.44 138.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.424 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 168' ' ' GLU . 21.9 m-70 -112.2 -154.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.117 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.664 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.4 OUTLIER 57.09 51.68 10.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 173' ' ' GLU . 6.7 m80 -83.0 -5.94 59.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 109.775 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 57.7 tt0 59.04 114.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . 0.633 ' CG2' HG11 ' A' ' 179' ' ' VAL . 0.4 OUTLIER -111.61 114.55 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.926 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.49 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.8 OUTLIER 68.84 -56.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.0 109.467 -178.448 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.7 OUTLIER -174.24 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.571 -0.706 . . . . 0.0 110.312 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.628 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -139.92 122.31 16.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 110.138 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' MET . . . . . 0.664 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -54.53 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.856 -1.153 . . . . 0.0 110.504 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' VAL . . . . . 0.633 HG11 ' CG2' ' A' ' 174' ' ' ILE . 23.3 m -97.01 -161.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLU . . . . . 0.513 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 19.7 tt0 -134.88 157.12 47.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.975 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.0 t -145.01 141.37 28.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.918 . . . . 0.0 110.48 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 13.6 mtpp -138.02 -171.15 2.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 109.886 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.639 ' HA ' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -106.28 164.31 12.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.214 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.565 ' N ' ' CD ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.987 -1.071 . . . . 0.0 110.962 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.821 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.964 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.5 pt -114.77 174.84 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.123 -0.986 . . . . 0.0 110.881 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.7 t80 -121.93 157.7 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.495 -0.753 . . . . 0.0 109.422 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -149.72 153.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.009 . . . . 0.0 110.479 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -141.1 176.37 21.68 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.499 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 87.1 15.38 62.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.65 HD22 HD22 ' A' ' 140' ' ' LEU . 15.4 mt -47.63 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 115' ' ' GLY . 2.2 t -57.52 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 110.66 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.548 ' O ' ' N ' ' A' ' 120' ' ' THR . 15.6 m -89.06 154.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.496 -0.753 . . . . 0.0 110.867 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 62.26 -35.28 0.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.739 -0.601 . . . . 0.0 111.082 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' VAL . 62.2 m -43.63 128.65 5.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 110.13 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 15.3 t -117.69 158.58 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 110.248 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.4 t -37.5 -51.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.57 -0.706 . . . . 0.0 110.848 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -41.11 -26.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.556 -0.715 . . . . 0.0 109.441 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 1.6 m-20 -74.14 -55.76 5.71 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.728 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 1.007 HG21 HD21 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.6 -48.06 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.328 -0.857 . . . . 0.0 109.241 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 8.6 ttpp -47.53 -60.77 2.3 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.448 -0.783 . . . . 0.0 109.673 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -63.94 -33.51 75.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 7.1 t80 -57.77 -60.7 3.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.56 -0.712 . . . . 0.0 110.439 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.511 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 97.3 m-85 -80.43 -16.4 54.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.8 tt0 -56.64 -36.45 69.52 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.382 -1.449 . . . . 0.0 107.957 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.2 pt20 -73.75 -17.21 61.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.511 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 3.6 m-30 -86.31 -28.29 23.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.426 0.632 . . . . 0.0 109.608 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -165.83 -165.73 23.66 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -52.41 59.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.298 -1.119 . . . . 0.0 110.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 55.34 90.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.087 0.946 . . . . 0.0 110.913 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -92.83 -26.57 17.61 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -130.73 140.61 50.34 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.007 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.725 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -154.91 98.78 2.07 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.701 ' HA ' HG22 ' A' ' 122' ' ' VAL . 4.2 ptp -116.57 163.47 16.05 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.948 0.88 . . . . 0.0 112.461 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 125' ' ' VAL . 89.2 mt -137.26 133.01 34.56 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.614 ' O ' HD12 ' A' ' 116' ' ' LEU . 2.6 mmt -107.19 125.05 50.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.933 -1.105 . . . . 0.0 110.577 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 27.0 m-85 . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.478 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.3 p90 -147.02 137.29 23.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -1.134 . . . . 0.0 109.992 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.687 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -114.71 159.56 13.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 139' ' ' MET . 30.8 m-85 -115.04 109.85 18.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -1.1 . . . . 0.0 109.372 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.49 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -104.66 -178.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.892 -1.13 . . . . 0.0 109.008 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 30.8 m -164.81 104.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.038 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.964 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 2.0 p90 -128.37 107.81 10.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 0.0 109.23 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -39.31 -26.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.793 . . . . 0.0 111.138 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 163' ' ' VAL . 2.3 m -56.48 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.777 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.6 tt0 -58.32 -38.61 77.45 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.693 -1.255 . . . . 0.0 109.463 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 6.6 t0 -40.37 -63.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 110.389 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.715 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.3 tp -57.99 -45.06 88.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.98 -1.075 . . . . 0.0 108.82 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 157' ' ' PHE . 35.5 t -47.42 -39.82 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -51.17 -56.58 12.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.716 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 167' ' ' CYS . 5.9 tttp -84.8 -60.83 1.94 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.285 -0.884 . . . . 0.0 110.863 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.3 p -41.34 -25.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.097 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.9 t -75.62 -38.3 59.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.152 -0.968 . . . . 0.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.439 ' N ' ' O ' ' A' ' 165' ' ' LYS . 4.4 mt-10 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.512 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.587 ' CD2' ' HB3' ' A' ' 181' ' ' CYS . 18.6 m-70 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.082 0.468 . . . . 0.0 109.921 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -141.32 99.41 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 109.988 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 174' ' ' ILE . 0.5 OUTLIER -92.06 81.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.958 -1.089 . . . . 0.0 110.159 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 69.4 m-80 64.47 -53.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 111.287 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.1 p30 -147.75 7.45 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 111.191 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.3 OUTLIER -124.64 172.17 9.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.797 -1.19 . . . . 0.0 111.415 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 23.7 mmt -113.05 57.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.65 -0.656 . . . . 0.0 109.894 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.499 HG12 ' C ' ' A' ' 115' ' ' GLY . 15.4 m -56.88 -166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.822 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -136.34 162.88 31.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.715 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.587 ' HB3' ' CD2' ' A' ' 172' ' ' HIS . 41.4 t -144.1 130.81 20.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.72 173.38 9.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.445 ' H ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -95.59 156.23 16.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.275 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 110.58 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.926 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 5.7 ptpt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.036 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 5.1 pt -102.33 163.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.473 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 154' ' ' PHE . 64.7 t80 -125.73 137.22 53.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.854 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -130.06 149.41 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.27 177.43 25.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.518 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 75.83 11.1 84.86 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 116' ' ' LEU . 1.1 pp -87.53 97.19 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.196 -1.179 . . . . 0.0 110.458 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.0 t -52.91 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.607 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.3 t -78.28 -153.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.403 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.607 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.65 -17.34 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.776 -0.577 . . . . 0.0 111.169 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' ' 118' ' ' VAL . 40.7 m -91.41 143.62 26.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.735 -1.228 . . . . 0.0 110.695 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.592 HG22 ' CG ' ' A' ' 124' ' ' ASP . 11.8 t -127.98 151.16 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.682 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.61 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.4 t -41.75 -51.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.158 -0.964 . . . . 0.0 110.178 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.526 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 mt-10 -42.79 -26.01 0.11 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 66.0 m-20 -76.37 -57.37 3.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 110.094 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.733 HG21 HD21 ' A' ' 140' ' ' LEU . 1.3 t -67.34 -47.53 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 6.0 ttpp -48.4 -58.23 4.92 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.818 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -66.83 -32.49 73.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 109.697 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -59.21 -55.96 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.549 ' HZ ' ' HG ' ' A' ' 181' ' ' CYS . 66.9 m-85 -83.66 -15.94 46.96 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.06 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 46.0 tt0 -56.41 -37.76 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.423 -1.423 . . . . 0.0 108.163 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -74.59 -15.93 60.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 4.9 m-30 -88.16 -32.79 18.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.44 168.18 36.56 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.527 ' CE ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -46.87 -40.02 13.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -1.17 . . . . 0.0 111.118 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 44.59 92.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.863 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -25.06 21.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 141.25 39.86 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.425 0.631 . . . . 0.0 109.604 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -149.45 95.21 2.32 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.437 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 6.4 ttp -101.07 164.78 11.64 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.873 0.844 . . . . 0.0 111.823 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.91 HD23 ' HA3' ' A' ' 153' ' ' GLY . 72.8 mt -143.93 133.59 23.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.7 OUTLIER -108.27 99.09 8.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.855 -1.153 . . . . 0.0 110.8 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 178.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.562 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 38.2 p90 -146.68 136.56 23.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.77 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.91 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -111.25 157.34 15.02 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.645 -1.265 . . . . 0.0 110.26 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 112' ' ' PHE . 24.4 m-85 -121.83 109.41 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -1.068 . . . . 0.0 109.363 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.518 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 1.2 t -104.59 179.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.047 . . . . 0.0 109.342 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.525 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 98.8 m -161.94 107.28 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.984 -1.486 . . . . 0.0 112.535 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.05 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -131.32 106.24 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.8 . . . . 0.0 108.915 177.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.527 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 5.0 mm-40 -39.33 -27.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 0.0 110.822 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 163' ' ' VAL . 3.4 m -55.58 85.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.129 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -62.94 -38.33 90.59 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.738 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.57 -67.38 0.23 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 110.137 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.781 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.7 OUTLIER -58.17 -40.23 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.119 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.05 HG22 ' CE2' ' A' ' 157' ' ' PHE . 18.2 t -57.23 -34.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 160' ' ' GLU . 1.4 tt0 -55.34 -53.08 60.62 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.255 0.55 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.6 tttt -88.59 -59.51 2.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.267 -0.896 . . . . 0.0 110.829 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.82 -26.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 7.9 t -73.64 -45.67 51.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.591 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 165' ' ' LYS . 29.1 tt0 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.4 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.509 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.323 0.582 . . . . 0.0 110.03 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 1.1 pt-20 -72.36 89.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.58 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 174' ' ' ILE . 16.4 tt -89.27 91.75 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 3.4 m-20 65.73 -55.32 0.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.791 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.3 p30 -158.19 18.74 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.648 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 tptt -131.66 169.24 16.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 110.664 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.435 ' C ' ' SD ' ' A' ' 178' ' ' MET . 0.8 OUTLIER -112.4 33.57 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.267 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.518 HG12 ' C ' ' A' ' 115' ' ' GLY . 18.0 m -37.96 159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.514 0.673 . . . . 0.0 111.315 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.467 ' OE1' ' HG3' ' A' ' 182' ' ' LYS . 0.0 OUTLIER -99.06 141.37 31.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.761 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.549 ' HG ' ' HZ ' ' A' ' 129' ' ' PHE . 38.5 m -113.33 127.8 56.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 110.759 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.467 ' HG3' ' OE1' ' A' ' 180' ' ' GLU . 1.4 mmmt -125.77 170.32 11.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -0.846 . . . . 0.0 109.678 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -108.52 169.79 8.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.076 -1.015 . . . . 0.0 110.329 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.403 -0.811 . . . . 0.0 109.838 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.823 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 27.1 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.065 0.459 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.899 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.1 pp -94.61 171.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.459 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.821 ' N ' HD12 ' A' ' 111' ' ' ILE . 27.9 t80 -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 181' ' ' CYS . 0.3 OUTLIER -147.14 160.79 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -144.17 168.76 26.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.603 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 90.01 17.15 54.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 140' ' ' LEU . 7.0 mt -44.81 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.361 -1.082 . . . . 0.0 110.032 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.471 ' HB3' ' OG1' ' A' ' 120' ' ' THR . 11.3 t -45.66 171.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -70.81 149.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.526 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 65.08 -42.24 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.438 0.637 . . . . 0.0 109.996 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' VAL . 6.1 m -38.76 120.91 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.572 . . . . 0.0 110.436 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 14.8 t -119.86 170.4 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.396 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 138' ' ' ALA . 1.9 t -38.48 -46.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.423 -0.798 . . . . 0.0 110.226 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.504 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 2.9 tt0 -40.95 -27.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.465 -0.772 . . . . 0.0 109.072 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 1.027 ' OD2' HG23 ' A' ' 174' ' ' ILE . 8.1 t70 -77.75 -59.41 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.356 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.784 HG21 HD21 ' A' ' 140' ' ' LEU . 1.4 t -62.74 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.798 . . . . 0.0 109.904 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 18.4 tttt -56.83 -56.72 17.91 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.62 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -64.0 -26.23 68.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.125 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 173' ' ' GLU . 19.8 t80 -79.4 -57.76 3.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 53.5 m-85 -77.38 -14.88 59.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.719 -1.238 . . . . 0.0 111.798 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -53.01 -41.68 64.91 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.152 -1.592 . . . . 0.0 108.859 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -70.49 -18.14 62.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.541 ' O ' HG21 ' A' ' 162' ' ' ILE . 25.3 m-85 -83.23 -31.04 27.23 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -165.13 156.52 28.54 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -39.22 -38.85 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.983 . . . . 0.0 110.5 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 45.24 91.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.87 -25.63 23.18 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.74 137.6 43.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB1' HG12 ' A' ' 125' ' ' VAL . . . -147.08 93.96 2.34 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.557 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.8 ttm -101.01 162.86 12.59 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.954 0.883 . . . . 0.0 111.949 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.997 HD23 ' HA3' ' A' ' 153' ' ' GLY . 13.1 mt -142.82 132.2 23.5 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 21.5 mmm -112.76 113.54 25.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.962 -1.086 . . . . 0.0 110.823 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 13.3 m-85 . . . . . 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 0.0 110.093 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.164 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 7.8 p90 -146.41 142.96 28.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 109.864 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.997 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -109.69 154.77 16.4 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.236 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 112' ' ' PHE . 21.5 m-85 -119.64 108.72 14.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -1.04 . . . . 0.0 109.262 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 1.3 t -104.76 178.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.06 . . . . 0.0 109.225 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.507 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 86.0 m -161.26 109.82 1.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.09 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.974 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -136.19 110.2 8.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -39.7 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.405 -0.809 . . . . 0.0 110.763 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.854 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -55.29 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -68.2 -38.53 82.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 109.094 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 8.0 t70 -43.02 -57.26 2.95 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.664 -0.647 . . . . 0.0 110.032 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.9 tp -64.01 -39.86 86.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.963 -1.085 . . . . 0.0 108.945 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.974 HG22 ' CE2' ' A' ' 157' ' ' PHE . 37.5 t -55.21 -39.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 2.7 tt0 -46.96 -59.45 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.798 -0.564 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 0.4 OUTLIER -90.96 -47.54 7.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.121 -0.987 . . . . 0.0 111.834 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 162' ' ' ILE . 3.6 p -50.37 -23.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.861 -1.15 . . . . 0.0 110.073 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.531 ' SG ' HG13 ' A' ' 163' ' ' VAL . 61.7 m -83.63 -0.64 51.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.758 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.489 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.428 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -155.24 108.24 2.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.554 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.027 HG23 ' OD2' ' A' ' 124' ' ' ASP . 1.6 mt -109.32 96.11 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.753 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 1.9 m-20 66.56 -55.91 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.436 -0.79 . . . . 0.0 110.429 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -164.86 21.49 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.701 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.597 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.4 tptt -122.11 159.14 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.58 43.2 1.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 109.877 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.791 HG21 ' CG1' ' A' ' 174' ' ' ILE . 33.6 m -53.98 -174.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -137.3 152.7 50.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 109.819 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.748 ' SG ' HD13 ' A' ' 111' ' ' ILE . 19.9 t -130.78 143.19 50.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 110.487 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 10.7 mtmt -134.93 178.01 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.813 . . . . 0.0 109.857 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -101.23 158.64 15.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 110.511 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.823 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 1.01 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 26.0 pttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.116 0.484 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.871 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.02 177.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.445 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.703 ' CD1' ' CE2' ' A' ' 154' ' ' PHE . 3.8 t80 -130.13 154.42 47.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 109.498 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.485 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -142.34 151.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.352 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.09 174.33 26.93 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.447 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 85.72 0.63 87.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.638 HD23 HG11 ' A' ' 179' ' ' VAL . 0.6 OUTLIER -80.33 95.91 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 110.33 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 116' ' ' LEU . 68.0 m -53.41 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.632 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -81.28 -154.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.785 -1.197 . . . . 0.0 110.196 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.633 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.45 -17.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.712 -0.617 . . . . 0.0 111.081 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.3 m -91.18 172.81 8.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.806 -1.183 . . . . 0.0 110.469 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.7 t -150.89 144.16 24.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.761 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 138' ' ' ALA . 1.5 t -37.57 -47.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.603 -0.686 . . . . 0.0 110.638 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 122' ' ' VAL . 1.4 tt0 -43.33 -26.05 0.17 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.216 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 24.7 m-20 -74.75 -56.23 5.01 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.404 0.621 . . . . 0.0 109.685 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 129' ' ' PHE . 2.0 t -63.05 -49.42 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 12.7 tttt -47.16 -65.71 0.52 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 110.058 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -58.93 -31.73 68.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 13.5 t80 -61.37 -68.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' A' ' 125' ' ' VAL . 73.1 m-85 -69.93 -15.87 63.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 110.911 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 23.0 tt0 -55.38 -37.82 68.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.75 -1.219 . . . . 0.0 108.124 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.561 ' CG ' ' CD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -73.5 -18.1 61.14 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.561 ' CD1' ' CG ' ' A' ' 131' ' ' GLN . 5.9 m-30 -89.98 -30.15 17.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.563 0.696 . . . . 0.0 109.442 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -160.45 161.93 32.98 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 15.1 ptpt -45.13 -41.05 7.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 49.92 92.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.944 0.878 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -90.36 -30.08 17.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 14.3 m-20 -132.66 136.67 46.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.772 ' HA ' HG13 ' A' ' 155' ' ' VAL . . . -144.94 92.32 2.26 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 5.0 ttm -91.85 165.79 13.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.883 0.849 . . . . 0.0 112.113 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.556 ' CB ' HG23 ' A' ' 122' ' ' VAL . 5.2 tp -154.73 161.28 41.59 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.609 ' HB2' ' CE1' ' A' ' 152' ' ' PHE . 7.5 mmt -143.12 158.23 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.009 -1.057 . . . . 0.0 110.576 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.532 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 54.7 m-85 . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.387 -0.821 . . . . 0.0 109.834 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 141' ' ' MET . 5.0 p90 -150.57 141.39 22.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -1.067 . . . . 0.0 109.115 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -135.07 178.01 18.89 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.771 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.703 ' CE2' ' CD1' ' A' ' 112' ' ' PHE . 88.0 m-85 -140.98 122.8 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.772 HG13 ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -110.65 -172.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.439 -1.304 . . . . 0.0 109.691 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.548 ' H ' HG12 ' A' ' 155' ' ' VAL . 18.6 m -158.54 102.62 1.72 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.006 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.871 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -126.12 111.55 14.79 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.281 177.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' GLU . 78.8 tt0 -41.69 -24.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 111.28 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.552 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -61.02 71.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.123 -0.986 . . . . 0.0 110.527 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.3 tt0 -51.86 -37.84 53.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.901 -1.124 . . . . 0.0 109.227 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -41.68 -59.66 1.58 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.965 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.789 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -58.56 -47.7 87.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.59 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 157' ' ' PHE . 42.7 t -45.91 -45.19 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -42.54 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 167' ' ' CYS . 25.2 tttt -90.28 -57.93 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 111.422 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.1 p -42.35 -23.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 111.082 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.661 ' SG ' HG13 ' A' ' 163' ' ' VAL . 84.6 m -87.27 -15.19 38.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 110.413 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.392 -179.916 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.673 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.197 0.522 . . . . 0.0 110.347 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.6 OUTLIER 61.89 77.5 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 174' ' ' ILE . 15.3 tt -96.46 98.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.273 -0.892 . . . . 0.0 110.002 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.2 m-20 65.33 -54.75 0.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 111.042 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -160.7 18.45 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.855 -179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.1 tptt -130.58 159.33 37.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.067 -1.02 . . . . 0.0 111.443 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.449 ' O ' ' C ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -102.22 29.69 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 108.897 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.638 HG11 HD23 ' A' ' 116' ' ' LEU . 6.6 m -35.27 152.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.489 0.661 . . . . 0.0 111.34 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.505 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 5.1 tt0 -106.0 148.47 27.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -0.773 . . . . 0.0 109.682 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.505 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 87.9 m -110.65 140.45 44.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.989 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.481 ' CG ' ' OE2' ' A' ' 180' ' ' GLU . 21.2 mmmt -128.57 167.32 17.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 109.855 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -92.73 152.64 19.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.422 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 1.01 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 110.128 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.923 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 3.5 pttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER -122.36 173.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 24.7 t80 -132.96 151.17 52.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.242 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -141.1 146.95 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.374 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.4 158.57 26.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 107.38 -6.8 36.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 174' ' ' ILE . 1.2 mp -68.28 96.24 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 110.037 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.01 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -89.53 -165.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.97 -1.081 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.697 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER 63.63 -11.54 0.1 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.681 -0.637 . . . . 0.0 110.509 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 121' ' ' THR . 3.4 m -90.43 -175.9 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.97 -1.081 . . . . 0.0 110.84 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.685 ' H ' HG22 ' A' ' 120' ' ' THR . 6.2 t -176.99 153.49 1.0 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.443 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -40.55 -51.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.522 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.9 -26.18 0.13 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.24 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.619 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 53.8 m-20 -77.27 -58.5 3.24 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.9 -48.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.38 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 3.2 tttt -49.03 -64.36 0.83 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.739 . . . . 0.0 110.523 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.619 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 6.1 p-80 -59.87 -32.26 70.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.112 -0.993 . . . . 0.0 110.013 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 63.6 t80 -62.93 -65.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.379 -0.826 . . . . 0.0 110.487 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 79.2 m-85 -72.77 -13.7 61.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 111.149 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.721 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 1.1 tp10 -57.55 -37.34 72.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.449 -1.407 . . . . 0.0 108.282 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.5 pt20 -76.43 -12.44 60.05 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.447 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.545 ' CA ' HD13 ' A' ' 162' ' ' ILE . 4.3 m-30 -88.26 -30.64 19.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.731 -0.606 . . . . 0.0 110.764 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -173.88 62.92 0.12 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 118.36 -1.876 . . . . 0.0 111.292 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 2.6 tptt 58.97 -68.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.458 -1.025 . . . . 0.0 111.521 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 63.99 91.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.88 -29.27 27.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -129.95 139.38 51.1 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.718 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -152.61 95.8 2.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 108.7 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.565 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.9 ttt -101.8 162.69 12.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.727 0.775 . . . . 0.0 111.462 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.527 ' CD1' HD22 ' A' ' 116' ' ' LEU . 53.7 tp -144.35 160.54 40.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.771 -0.581 . . . . 0.0 109.995 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -144.72 159.01 43.55 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.477 -0.764 . . . . 0.0 110.902 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.542 -0.724 . . . . 0.0 109.238 178.885 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 12.4 p90 -146.24 142.94 28.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 109.498 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.55 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -125.53 150.51 17.4 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.55 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 34.0 m-85 -112.48 113.43 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.459 -1.024 . . . . 0.0 108.41 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -110.77 -178.58 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -178.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.656 ' HA ' HD13 ' A' ' 111' ' ' ILE . 27.6 m -159.09 103.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.811 -1.18 . . . . 0.0 111.26 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.001 ' CE1' HG22 ' A' ' 163' ' ' VAL . 2.0 p90 -126.54 106.92 9.77 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.85 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.9 mt-10 -40.25 -37.7 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 0.0 111.187 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.959 ' O ' HG23 ' A' ' 163' ' ' VAL . 58.7 m -46.54 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -64.02 -37.98 89.42 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.08 -1.013 . . . . 0.0 109.492 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 4.9 t0 -40.57 -64.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.186 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.776 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.7 OUTLIER -60.34 -44.92 96.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.97 -1.081 . . . . 0.0 108.693 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.001 HG22 ' CE1' ' A' ' 157' ' ' PHE . 15.5 t -51.17 -41.7 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -48.25 -58.53 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 111.184 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 167' ' ' CYS . 12.0 tttt -90.47 -58.21 2.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.0 111.272 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 162' ' ' ILE . 2.0 p -39.83 -26.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.762 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 68.5 m -82.73 -31.96 28.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.954 -1.091 . . . . 0.0 110.15 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 . . . . . 0 N--CA 1.493 1.712 0 O-C-N 121.137 -0.977 . . . . 0.0 110.551 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.576 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.252 0.549 . . . . 0.0 110.35 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 174' ' ' ILE . 5.1 tt0 -153.95 107.0 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 110.061 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.877 HD13 ' CG2' ' A' ' 179' ' ' VAL . 1.3 mp -113.42 102.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER 67.56 -56.24 0.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.557 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -168.97 25.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.99 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.657 ' HB3' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -130.74 151.81 50.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 0.0 111.14 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.48 ' O ' ' O ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -90.36 46.9 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.54 -0.725 . . . . 0.0 109.607 179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.877 ' CG2' HD13 ' A' ' 174' ' ' ILE . 20.3 m -54.77 -160.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.74 . . . . 0.0 110.802 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -150.51 142.41 23.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.402 -0.811 . . . . 0.0 109.919 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.576 ' HA ' HG12 ' A' ' 113' ' ' VAL . 16.8 t -112.66 156.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.176 -0.953 . . . . 0.0 110.582 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' CYS . 51.2 mttt -138.78 -178.77 5.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 0.0 110.177 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -102.9 161.13 14.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 110.216 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.015 0.436 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.65 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.5 pt -110.3 169.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 7.9 t80 -125.01 158.39 33.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -150.16 142.84 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.383 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -134.43 150.84 20.15 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.716 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 103.34 2.0 47.59 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.707 HD12 ' CA ' ' A' ' 152' ' ' PHE . 2.5 mt -63.62 98.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -1.175 . . . . 0.0 110.022 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.509 ' HB2' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -39.61 156.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.63 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 119' ' ' ASN . 2.4 t -62.75 -62.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 110.383 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.563 ' N ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -44.58 -19.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.736 0.779 . . . . 0.0 108.914 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 142' ' ' PHE . 2.9 m -68.18 157.8 34.61 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.826 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 123' ' ' GLU . 7.8 t -148.44 150.47 33.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.097 -1.002 . . . . 0.0 110.405 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 140' ' ' LEU . 3.2 t -35.77 -53.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.764 -0.585 . . . . 0.0 111.097 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.536 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.5 mt-10 -41.02 -26.38 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.385 -0.822 . . . . 0.0 109.45 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.546 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 43.8 t0 -73.43 -59.44 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.526 0.679 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 140' ' ' LEU . 2.4 t -68.71 -52.91 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.773 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.8 ttmt -41.04 -60.98 1.07 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.711 -0.618 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.879 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.478 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -65.59 -64.31 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 111.011 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 28.2 m-85 -74.03 -16.75 61.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.657 -1.277 . . . . 0.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 4.5 tt0 -55.6 -37.98 68.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.036 -1.466 . . . . 0.0 108.173 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.3 pt20 -72.59 -18.06 61.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 162' ' ' ILE . 16.0 m-85 -84.84 -37.09 21.12 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -154.76 159.01 28.69 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -42.42 -43.25 3.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.16 . . . . 0.0 110.365 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 48.1 89.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 122.02 0.914 . . . . 0.0 110.94 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -89.18 -24.9 22.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -126.57 137.91 53.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.91 101.23 1.61 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.707 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -112.9 157.61 21.23 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.861 0.839 . . . . 0.0 112.758 -177.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 139' ' ' MET . 1.3 mp -138.12 142.45 40.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.885 -0.509 . . . . 0.0 110.258 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.508 ' HG3' ' CE2' ' A' ' 152' ' ' PHE . 2.2 mmt -118.5 145.78 45.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.647 ' HZ ' HD23 ' A' ' 140' ' ' LEU . 28.5 m-85 . . . . . 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 0.0 110.178 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.707 ' CA ' HD12 ' A' ' 116' ' ' LEU . 50.1 p90 -149.91 135.13 18.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -1.219 . . . . 0.0 109.855 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.6 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -128.0 166.92 20.45 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.148 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 139' ' ' MET . 64.6 m-85 -122.99 109.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -1.095 . . . . 0.0 109.03 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -99.81 177.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 120.948 -1.095 . . . . 0.0 109.172 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.561 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 91.5 m -165.03 109.86 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.127 -1.429 . . . . 0.0 112.461 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.75 ' HE1' HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -118.88 135.03 54.78 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.2 177.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -72.07 54.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.89 96.64 2.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 110.115 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 161' ' ' ASP . 10.5 tt0 -49.71 -38.33 32.74 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -41.95 -47.33 4.32 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.254 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.758 ' O ' HG12 ' A' ' 166' ' ' VAL . 20.1 mm -68.5 -42.6 83.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.75 HG22 ' HE1' ' A' ' 157' ' ' PHE . 11.8 t -63.28 -40.61 89.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLU . 52.5 mt-10 -56.29 -47.11 79.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 168' ' ' GLU . 19.2 ttmt -90.25 -65.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.356 -0.84 . . . . 0.0 111.167 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 162' ' ' ILE . 1.0 OUTLIER -41.42 -25.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 110.175 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 41.2 t -76.51 -36.15 57.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.374 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 87.3 mt-10 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.64 -0.663 . . . . 0.0 110.105 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 166' ' ' VAL . 34.3 m-70 . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.229 0.538 . . . . 0.0 110.646 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 46.47 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.699 ' O ' HG22 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -93.44 100.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.602 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 124' ' ' ASP . 2.6 m-20 65.58 -55.85 0.34 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.358 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.3 OUTLIER -168.66 28.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.414 -0.804 . . . . 0.0 109.537 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.5 tptt -132.51 158.02 43.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.483 -0.761 . . . . 0.0 110.769 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -100.78 55.17 0.86 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.859 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.716 HG12 ' C ' ' A' ' 115' ' ' GLY . 33.4 m -59.32 130.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.4 OUTLIER -70.65 148.01 48.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.328 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 166' ' ' VAL . 3.0 t -125.08 140.8 52.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.405 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 0.9 OUTLIER -149.04 -174.34 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -109.82 150.28 28.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.106 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.877 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.012 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 3.3 pt -110.81 167.93 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 111.138 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -119.29 155.01 32.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.278 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -148.39 146.97 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 110.556 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.41 -170.33 12.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.622 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 65.45 23.31 70.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' SER . 1.1 mt -84.15 93.91 8.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -1.109 . . . . 0.0 110.343 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.481 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 99.2 p -52.66 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.787 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.5 t -85.22 -165.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.718 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER 63.11 -10.28 0.1 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.626 -0.671 . . . . 0.0 110.358 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -88.7 -177.27 5.51 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.117 -0.99 . . . . 0.0 110.781 -178.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.546 HG22 ' OD1' ' A' ' 124' ' ' ASP . 12.1 t -178.8 153.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.878 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.628 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -38.42 -50.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.738 . . . . 0.0 110.735 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.477 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.67 -26.17 0.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.197 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.64 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.7 m-20 -76.58 -57.72 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 0.0 110.062 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.603 HG12 ' HB1' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -64.12 -47.83 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.549 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -51.13 -62.62 1.51 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 110.653 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.64 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -57.62 -26.53 61.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -78.48 -64.19 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 0.0 111.891 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 52.1 m-85 -70.91 -13.42 62.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.927 -1.108 . . . . 0.0 112.283 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.667 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -53.99 -41.39 67.86 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 119.893 -1.755 . . . . 0.0 109.115 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.9 pt20 -73.66 -14.86 61.23 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 16.2 m-85 -82.36 -31.11 29.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.725 -0.609 . . . . 0.0 110.051 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 157' ' ' PHE . . . -174.44 60.24 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.055 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 4.3 tptt 59.71 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.31 -1.112 . . . . 0.0 110.831 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 63.58 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 111.315 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -89.64 -23.15 21.98 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -133.29 137.67 46.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.502 0.668 . . . . 0.0 109.449 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.603 ' HB1' HG12 ' A' ' 125' ' ' VAL . . . -153.76 96.02 1.95 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.628 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 4.3 ttm -101.49 165.98 10.96 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.0 111.972 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.794 HD23 ' CZ ' ' A' ' 142' ' ' PHE . 2.6 tp -143.57 151.08 39.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.636 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 3.0 mmt -128.11 130.87 48.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.772 -1.205 . . . . 0.0 111.253 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.794 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 10.4 m-85 . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.515 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 25.0 p90 -145.62 136.0 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.924 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.737 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -120.82 158.12 15.76 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.68 107.38 12.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -1.017 . . . . 0.0 109.246 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -102.7 179.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.947 -1.096 . . . . 0.0 109.08 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.55 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 62.9 m -163.35 106.62 1.01 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.184 -1.406 . . . . 0.0 111.915 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.026 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -125.09 105.64 9.32 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.494 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -39.76 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.576 -0.703 . . . . 0.0 110.623 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -57.73 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.326 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -57.28 -39.08 74.97 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.651 -1.281 . . . . 0.0 109.559 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 3.7 m-20 -40.65 -64.88 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.791 ' O ' HG12 ' A' ' 166' ' ' VAL . 4.1 tp -57.25 -41.87 78.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.908 -1.12 . . . . 0.0 109.038 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.026 HG22 ' CE2' ' A' ' 157' ' ' PHE . 26.3 t -53.77 -37.56 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.7 OUTLIER -52.26 -56.72 12.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.809 -0.557 . . . . 0.0 110.975 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.9 tttp -85.87 -59.53 2.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.215 -0.928 . . . . 0.0 110.663 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 162' ' ' ILE . 3.9 p -40.94 -26.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.488 -0.758 . . . . 0.0 109.834 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 11.1 t -75.29 -38.34 60.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.872 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.487 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.7 tt0 . . . . . 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.537 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.623 ' NE2' HG23 ' A' ' 166' ' ' VAL . 1.2 m80 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.298 0.571 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 4.0 mt-10 -65.84 100.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.031 HD13 HG21 ' A' ' 179' ' ' VAL . 1.8 tp -78.1 -178.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.828 -1.17 . . . . 0.0 109.386 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.506 ' ND2' ' OD2' ' A' ' 124' ' ' ASP . 16.3 m-80 -34.56 -30.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.551 -0.718 . . . . 0.0 111.649 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.2 p30 -164.93 30.02 0.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 tptp -145.99 -166.25 2.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 110.967 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.451 ' O ' ' C ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -131.22 38.9 3.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 1.031 HG21 HD13 ' A' ' 174' ' ' ILE . 27.6 m -35.6 153.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.461 0.648 . . . . 0.0 111.257 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -98.03 156.06 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 6.8 p -134.56 153.78 51.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 4.2 mtpt -152.97 168.43 25.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.345 -0.847 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.15 154.63 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.373 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.187 0.518 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.907 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.1 pt -125.87 176.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 3.9 t80 -127.11 160.63 30.59 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.532 -0.73 . . . . 0.0 109.2 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -144.73 140.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.86 157.89 23.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 94.78 -23.06 34.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.822 HD21 ' HA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -49.45 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 115' ' ' GLY . 11.7 p -54.52 163.3 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 110.697 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.568 ' O ' ' N ' ' A' ' 120' ' ' THR . 18.9 m -62.81 -153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -0.865 . . . . 0.0 110.441 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.18 -41.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.649 0.738 . . . . 0.0 110.382 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' VAL . 30.8 m -70.92 156.52 39.5 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.087 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.62 148.1 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.2 t -40.12 -51.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.424 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -42.94 -25.89 0.12 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.432 -0.793 . . . . 0.0 109.087 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.498 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 32.9 m-20 -72.28 -56.71 5.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.432 0.634 . . . . 0.0 109.503 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.796 ' CG2' HD11 ' A' ' 174' ' ' ILE . 2.4 t -65.66 -53.45 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.564 0.697 . . . . 0.0 109.144 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -41.23 -63.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.725 -0.609 . . . . 0.0 109.901 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.516 ' ND1' ' C ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -60.07 -30.12 69.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.955 . . . . 0.0 109.07 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.514 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . 0.2 OUTLIER -60.9 -69.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.622 -0.674 . . . . 0.0 110.315 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 74.3 m-85 -70.4 -15.26 62.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -0.967 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 8.8 tt0 -57.17 -37.35 71.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.191 -1.568 . . . . 0.0 107.825 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.2 pt20 -72.51 -16.66 61.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.685 ' HB3' HD12 ' A' ' 162' ' ' ILE . 3.6 m-30 -83.42 -28.78 28.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.752 -0.593 . . . . 0.0 109.446 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 159' ' ' SER . . . -161.73 -139.42 2.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HD2' ' HG3' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -94.14 -33.83 13.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -1.05 . . . . 0.0 109.658 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 39.08 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.109 0.957 . . . . 0.0 111.456 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -25.3 18.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.36 140.04 49.62 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.676 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -157.17 100.16 1.84 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.575 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 1.6 ptp -116.66 165.99 12.64 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.876 0.846 . . . . 0.0 112.216 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.715 HD23 ' HA3' ' A' ' 153' ' ' GLY . 89.3 mt -142.92 146.48 34.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.85 -0.531 . . . . 0.0 109.579 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -120.64 110.12 16.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.0 -1.063 . . . . 0.0 110.337 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.837 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.822 ' HA ' HD21 ' A' ' 116' ' ' LEU . 17.7 p90 -144.85 138.83 27.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -1.103 . . . . 0.0 109.726 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.715 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -127.99 168.93 19.78 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.395 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 139' ' ' MET . 76.0 m-85 -126.82 115.94 20.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -1.134 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -108.79 -177.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.082 -1.011 . . . . 0.0 109.044 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 16.3 m -163.75 104.73 0.93 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.907 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.9 p90 -129.92 116.65 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.97 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.2 mm-40 -44.34 -32.58 1.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.387 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.543 ' HB3' ' CG1' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -51.77 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 110.544 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -56.57 -40.0 74.45 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.176 -0.952 . . . . 0.0 109.042 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -44.78 -38.05 4.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.943 ' O ' HG22 ' A' ' 166' ' ' VAL . 41.3 mm -69.61 -49.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 20.0 t -58.25 -36.82 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.8 mm-40 -56.89 -44.39 82.25 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.627 -0.67 . . . . 0.0 110.715 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 161' ' ' ASP . 3.1 mttt -90.14 -64.96 1.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 162' ' ' ILE . 6.3 m -42.9 -24.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.856 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 8.4 t -71.73 -38.15 70.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.725 -1.235 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 165' ' ' LYS . 8.0 mt-10 . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 110.49 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.873 ' O ' HG22 ' A' ' 179' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.347 0.594 . . . . 0.0 109.865 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.535 ' HG3' ' N ' ' A' ' 177' ' ' LYS . 3.6 tt0 -80.89 141.73 34.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 110.589 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.796 HD11 ' CG2' ' A' ' 125' ' ' VAL . 4.7 tt -114.58 115.43 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.186 -0.947 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 2.5 t-20 68.07 -55.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.631 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.561 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -174.22 24.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.863 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.627 ' HD2' HG12 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -139.49 129.14 24.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.785 -1.197 . . . . 0.0 110.179 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.512 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -68.3 119.63 13.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.817 -1.177 . . . . 0.0 110.596 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 172' ' ' HIS . 4.4 m -120.08 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.646 ' N ' HG23 ' A' ' 179' ' ' VAL . 57.1 tt0 -138.83 143.6 38.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 86.8 m -129.2 138.14 51.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.306 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.9 mttt -133.91 175.67 9.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.29 -0.882 . . . . 0.0 109.816 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.511 ' CD ' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -75.25 163.74 27.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.264 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.293 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.978 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.25 0.548 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.146 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -105.2 165.84 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -124.51 136.69 54.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -131.34 142.65 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 110.075 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -146.87 168.46 28.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.3 -29.4 8.93 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -53.67 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 116' ' ' LEU . 4.3 p -52.47 -173.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.577 ' O ' ' HB3' ' A' ' 119' ' ' ASN . 1.3 t -75.12 -149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 109.467 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER 64.06 -14.84 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.642 . . . . 0.0 111.398 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -89.87 -167.13 1.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.684 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 120' ' ' THR . 14.4 t -173.21 139.44 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -35.07 -49.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.633 -0.667 . . . . 0.0 111.303 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 122' ' ' VAL . 10.2 mt-10 -43.35 -25.88 0.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 128' ' ' TYR . 66.2 m-20 -73.42 -47.64 40.11 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.421 0.629 . . . . 0.0 110.209 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -73.86 -44.56 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.663 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.2 ttpp -50.02 -65.2 0.6 Allowed 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.454 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -64.42 -32.32 73.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.025 -1.047 . . . . 0.0 110.681 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 4.5 t80 -66.1 -54.06 30.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 111.212 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.762 ' CD2' HG12 ' A' ' 125' ' ' VAL . 46.2 m-85 -83.98 -16.53 43.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.164 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 40.2 tt0 -57.42 -36.89 71.93 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.053 -1.654 . . . . 0.0 107.73 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 13.2 pt20 -74.6 -15.93 60.82 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.704 ' O ' HD13 ' A' ' 162' ' ' ILE . 3.1 m-30 -83.36 -28.24 29.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -164.07 -143.45 3.71 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CG ' ' N ' ' A' ' 135' ' ' VAL . 2.0 ptmt -88.45 -42.19 12.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.325 -1.103 . . . . 0.0 109.7 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 46.24 90.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.484 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -92.42 -25.63 18.39 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.63 145.73 50.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.057 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.35 101.66 1.72 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.59 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -112.58 163.81 14.06 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.937 0.875 . . . . 0.0 112.216 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 125' ' ' VAL . 4.8 tp -138.03 154.79 49.27 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.644 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 66.0 mmm -131.19 135.8 47.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.767 -1.208 . . . . 0.0 110.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 118' ' ' VAL . 9.4 m-85 . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.696 . . . . 0.0 109.973 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 14.9 p90 -150.13 139.37 21.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.109 -1.23 . . . . 0.0 110.158 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -129.58 167.2 21.54 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.965 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.536 ' O ' ' HG3' ' A' ' 139' ' ' MET . 63.0 m-85 -123.5 117.8 25.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 108.879 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.543 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -109.2 -178.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 109.036 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 72.3 m -162.87 105.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.874 -1.53 . . . . 0.0 112.433 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.146 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -126.6 102.34 7.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.441 -0.787 . . . . 0.0 108.993 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -39.18 -29.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.503 -0.748 . . . . 0.0 110.962 -178.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.804 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -56.23 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 110.235 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -58.09 -38.32 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.078 -1.014 . . . . 0.0 109.701 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.7 m-20 -39.24 -64.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.771 -0.581 . . . . 0.0 110.259 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.704 HD13 ' O ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -61.84 -38.0 79.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.091 -1.006 . . . . 0.0 109.122 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.096 HG22 ' CE2' ' A' ' 157' ' ' PHE . 16.7 t -58.41 -33.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -58.77 -47.15 85.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.426 0.631 . . . . 0.0 110.079 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 167' ' ' CYS . 10.4 tttt -87.4 -63.82 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 110.499 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 163' ' ' VAL . 1.4 p -42.31 -24.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.876 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 9.3 t -73.36 -47.02 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.075 -1.016 . . . . 0.0 109.458 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.55 -0.719 . . . . 0.0 110.23 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 1.1 t60 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.281 0.562 . . . . 0.0 110.133 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -100.72 88.76 3.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 110.266 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 174' ' ' ILE . 1.3 mp -81.34 91.96 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.387 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER 68.56 -56.99 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.419 -0.801 . . . . 0.0 110.1 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -161.55 19.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.807 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.824 ' HB3' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.68 148.39 46.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.118 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -92.02 41.56 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 177' ' ' LYS . 10.3 m -70.47 -165.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.5 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 2.3 tm-20 -125.54 152.46 45.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.792 . . . . 0.0 110.103 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.5 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 37.9 t -141.41 103.02 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.417 ' HG3' ' OE2' ' A' ' 180' ' ' GLU . 6.1 mtmm -99.21 -175.56 3.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 109.886 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -100.32 -175.99 3.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.784 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.978 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 110.598 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.949 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.72 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -99.7 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 110.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -118.57 153.74 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 109.675 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -146.94 152.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -145.93 162.91 28.35 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 100.29 9.52 47.53 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.695 ' HG ' HD22 ' A' ' 140' ' ' LEU . 2.7 mm? -57.67 97.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -1.09 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.3 168.21 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.105 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 120' ' ' THR . 19.5 m -63.19 169.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.272 -0.892 . . . . 0.0 110.988 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 61.95 -39.13 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.976 -0.452 . . . . 0.0 111.018 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 118' ' ' VAL . 91.8 m -42.3 153.74 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.483 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 142' ' ' PHE . 15.2 t -149.66 146.77 27.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.718 ' HA ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -32.39 -47.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.81 -0.556 . . . . 0.0 111.396 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -41.94 -27.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.095 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.515 ' OD2' ' N ' ' A' ' 175' ' ' ASN . 15.6 t0 -72.24 -58.44 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.555 0.693 . . . . 0.0 109.966 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.658 ' CG2' HD11 ' A' ' 174' ' ' ILE . 2.1 t -67.07 -52.9 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.7 tttt -42.44 -59.82 1.73 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.649 -0.657 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.579 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -62.44 -27.74 69.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.441 -0.787 . . . . 0.0 110.196 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 18.7 t80 -76.29 -53.77 7.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 112.479 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.546 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 14.6 m-85 -82.32 -17.41 45.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.0 112.638 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -52.7 -41.76 64.19 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 119.969 -1.707 . . . . 0.0 109.263 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 17.6 pt20 -73.72 -15.78 61.21 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.502 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 15.8 m-85 -84.27 -33.97 23.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -159.35 162.29 32.71 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -44.6 -34.01 2.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 38.05 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.967 0.889 . . . . 0.0 111.342 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -25.06 18.0 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -130.9 142.01 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' HG11 ' A' ' 122' ' ' VAL . . . -157.4 102.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.418 ' HA ' HG11 ' A' ' 122' ' ' VAL . 3.2 tpp -110.39 160.21 16.78 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.775 0.797 . . . . 0.0 111.308 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.93 HD23 ' HA3' ' A' ' 153' ' ' GLY . 9.4 mt -147.04 145.42 29.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.774 -0.579 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.585 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 1.6 mmm -123.25 126.77 47.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.024 -1.047 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 42.2 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.865 . . . . 0.0 110.711 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.376 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.585 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.1 p90 -150.03 146.19 26.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -1.202 . . . . 0.0 109.977 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.93 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -138.16 174.62 21.84 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.174 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.96 118.26 18.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.495 -1.003 . . . . 0.0 109.246 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 156' ' ' THR . 1.5 t -109.21 -174.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.514 ' H ' HG12 ' A' ' 155' ' ' VAL . 96.3 m -163.98 106.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.002 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.181 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -132.12 109.96 10.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.199 -0.938 . . . . 0.0 109.722 177.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.19 -32.06 1.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.431 -0.793 . . . . 0.0 111.507 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.892 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -56.04 82.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -56.7 -38.61 72.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 110.086 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.4 OUTLIER -39.06 -69.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.815 -0.553 . . . . 0.0 110.426 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.778 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.8 OUTLIER -57.57 -42.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.927 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.181 HG22 ' CE2' ' A' ' 157' ' ' PHE . 14.7 t -51.76 -38.95 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 3.1 tt0 -48.4 -55.95 9.46 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.359 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.3 tttm -90.52 -59.6 2.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.257 -0.902 . . . . 0.0 111.316 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.24 -25.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.247 -0.908 . . . . 0.0 110.859 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 163' ' ' VAL . 71.2 m -90.21 -20.34 23.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.882 -1.137 . . . . 0.0 110.071 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 165' ' ' LYS . 19.6 mm-40 . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 110.186 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.666 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.371 0.605 . . . . 0.0 110.039 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 57.21 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 110.894 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.782 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.9 OUTLIER -113.83 116.15 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.632 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.535 ' HB2' HG23 ' A' ' 120' ' ' THR . 1.4 t-20 69.41 -56.49 0.55 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 174' ' ' ILE . 6.3 p30 -177.14 29.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.633 -0.667 . . . . 0.0 109.813 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.623 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -143.72 123.89 13.71 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.059 -1.025 . . . . 0.0 110.432 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.557 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.6 OUTLIER -54.02 116.31 2.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.782 HG21 ' HB ' ' A' ' 174' ' ' ILE . 16.0 m -119.09 -161.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 0.0 110.6 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 10.3 tt0 -130.1 146.45 51.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 71.3 m -117.42 152.32 35.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.52 -0.737 . . . . 0.0 109.917 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -110.03 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.949 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.699 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.223 0.535 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.962 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.8 pt -101.46 169.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.519 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.9 t80 -118.11 156.49 28.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.409 -0.807 . . . . 0.0 109.184 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.541 HG23 ' CA ' ' A' ' 153' ' ' GLY . 1.2 m -148.32 163.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.064 -1.022 . . . . 0.0 110.85 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.39 171.05 32.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 97.93 -22.39 41.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.661 HD11 ' O ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -41.43 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -1.06 . . . . 0.0 109.981 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' GLY . 38.7 m -96.19 -162.58 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.816 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' THR . 12.7 m -52.25 162.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 111.188 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 61.93 -38.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.872 -0.517 . . . . 0.0 110.984 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.585 HG23 ' OD2' ' A' ' 124' ' ' ASP . 55.6 m -61.76 123.92 19.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 0.0 110.507 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.0 t -136.53 166.14 24.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 0.0 109.688 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -41.36 -55.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -0.989 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.31 -24.67 0.1 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.406 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.609 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 62.4 t0 -75.24 -59.28 2.81 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.682 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.666 HG21 HD21 ' A' ' 140' ' ' LEU . 1.8 t -64.3 -49.0 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.287 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 53.4 tttm -47.72 -63.47 1.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.522 -0.736 . . . . 0.0 110.057 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.609 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -61.14 -31.95 71.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -0.985 . . . . 0.0 109.861 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 21.4 t80 -61.97 -60.6 3.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.469 -0.769 . . . . 0.0 110.883 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 82.9 m-85 -79.7 -18.8 50.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.042 -1.036 . . . . 0.0 111.518 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 1.1 tp10 -54.45 -36.03 63.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.366 -1.459 . . . . 0.0 108.699 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -74.77 -20.62 59.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 1.066 ' O ' HD13 ' A' ' 162' ' ' ILE . 7.5 m-85 -82.24 -28.9 31.61 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.823 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -163.06 -157.72 9.3 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.893 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -72.24 -50.12 29.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.586 -0.95 . . . . 0.0 110.129 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.5 t 51.19 87.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.121 0.962 . . . . 0.0 110.353 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -87.79 -28.64 21.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 79.8 m-20 -134.49 137.99 44.35 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.127 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.824 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -147.18 93.93 2.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.661 ' HA ' HG22 ' A' ' 122' ' ' VAL . 9.1 ttm -105.62 167.05 10.02 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.833 0.825 . . . . 0.0 111.875 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.948 HD23 ' HA3' ' A' ' 153' ' ' GLY . 31.0 mt -146.03 132.51 19.71 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.661 ' O ' HD11 ' A' ' 116' ' ' LEU . 9.7 mmt -107.79 133.73 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.88 -1.137 . . . . 0.0 110.792 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 17.4 m-85 . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.534 -0.728 . . . . 0.0 109.642 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.581 ' CA ' HD21 ' A' ' 116' ' ' LEU . 24.0 p90 -144.9 135.01 23.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -1.17 . . . . 0.0 110.022 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.948 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -114.62 164.87 12.04 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.332 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -127.78 113.12 15.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -1.106 . . . . 0.0 109.648 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -109.0 -178.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.909 . . . . 0.0 108.938 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.699 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 79.8 m -164.07 106.32 0.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.169 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.962 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -126.32 113.06 16.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 109.511 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 4.0 tt0 -39.74 -26.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.435 -0.79 . . . . 0.0 111.123 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.534 ' O ' HG22 ' A' ' 162' ' ' ILE . 80.9 p -63.5 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 110.587 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -52.13 -38.9 58.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.864 -1.148 . . . . 0.0 109.17 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 160' ' ' GLU . 38.1 t70 -43.07 -53.54 4.83 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.778 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 1.066 HD13 ' O ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -60.66 -49.22 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.441 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' CE2' ' A' ' 157' ' ' PHE . 47.0 t -44.72 -46.78 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -52.21 12.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 167' ' ' CYS . 11.3 ttpt -90.02 -62.37 1.48 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.131 -0.98 . . . . 0.0 111.065 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 162' ' ' ILE . 8.5 p -40.01 -25.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.71 . . . . 0.0 110.637 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 23.3 m -76.3 -40.44 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.024 -1.047 . . . . 0.0 109.676 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.438 ' N ' ' O ' ' A' ' 165' ' ' LYS . 1.2 mt-10 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 173' ' ' GLU . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 121.287 0.565 . . . . 0.0 110.128 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 68.59 101.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.092 -1.005 . . . . 0.0 110.914 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 125' ' ' VAL . 3.4 tt -122.25 118.74 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 29.1 m-20 64.19 -53.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.66 -0.65 . . . . 0.0 110.644 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -175.48 27.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.001 -1.062 . . . . 0.0 110.699 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.536 ' HD3' ' C ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -143.49 137.06 28.26 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.065 -1.022 . . . . 0.0 109.488 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.5 ' O ' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -77.87 88.05 4.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.326 -1.483 . . . . 0.0 110.097 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 174' ' ' ILE . 28.7 m -76.46 -178.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 110.379 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CD ' ' HE3' ' A' ' 182' ' ' LYS . 26.0 tt0 -128.78 140.65 51.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.752 . . . . 0.0 109.549 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 167' ' ' CYS . 1.5 t -122.68 142.65 50.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 110.811 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.42 ' C ' ' SG ' ' A' ' 167' ' ' CYS . 7.5 mttp -138.64 178.91 6.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.497 ' HD3' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -111.65 142.37 44.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.069 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.268 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 1.7 ptmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.972 0.415 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.93 HD12 ' N ' ' A' ' 112' ' ' PHE . 1.2 pp -123.26 178.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.795 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.93 ' N ' HD12 ' A' ' 111' ' ' ILE . 56.6 t80 -125.03 162.31 24.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.593 -0.692 . . . . 0.0 109.15 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.596 HG13 HD11 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -146.84 135.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -130.17 162.28 23.11 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.446 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 92.92 -26.04 16.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.003 HD21 ' HA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -44.1 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -1.092 . . . . 0.0 109.607 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -43.19 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.734 0.778 . . . . 0.0 111.018 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.825 HG12 ' N ' ' A' ' 119' ' ' ASN . 0.9 OUTLIER -74.44 -64.14 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.409 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.825 ' N ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -43.44 -21.98 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.75 HG21 HG12 ' A' ' 174' ' ' ILE . 23.6 m -72.71 142.21 48.2 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.778 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.0 158.98 36.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 110.563 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.722 HG23 ' HB2' ' A' ' 140' ' ' LEU . 2.7 t -37.56 -52.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -40.65 -27.06 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 122' ' ' VAL . 1.7 m-20 -72.79 -57.67 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.469 0.652 . . . . 0.0 109.567 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.72 HG21 HD11 ' A' ' 140' ' ' LEU . 2.1 t -65.87 -50.1 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.615 0.721 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 23.9 tttt -46.58 -61.77 1.67 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -59.52 -33.14 71.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -66.44 -64.89 0.76 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 110.832 -179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.645 ' CD2' HG13 ' A' ' 125' ' ' VAL . 78.3 m-85 -70.68 -18.54 62.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.9 -1.125 . . . . 0.0 111.541 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 38.4 tt0 -55.96 -36.7 68.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.912 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 6.5 pt20 -73.47 -18.15 61.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 16.9 m-85 -86.55 -32.85 20.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -160.74 165.61 35.18 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -41.71 -55.13 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 110.336 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 58.79 89.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.01 0.91 . . . . 0.0 110.747 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.456 ' OD2' ' HE2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -92.84 -26.23 17.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -129.43 138.67 51.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -155.91 99.97 2.02 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.788 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -111.18 158.97 18.31 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.097 0.951 . . . . 0.0 112.854 -177.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 139' ' ' MET . 1.8 mp -137.82 148.55 45.57 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.559 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 1.4 mmt -125.28 147.54 49.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.729 -1.232 . . . . 0.0 110.927 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 141' ' ' MET . 16.1 m-85 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.647 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.598 ' C ' HD11 ' A' ' 116' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.25 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 1.003 ' HA ' HD21 ' A' ' 116' ' ' LEU . 5.9 p90 -147.88 136.67 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -1.134 . . . . 0.0 109.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -128.91 172.54 19.57 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.367 -1.396 . . . . 0.0 110.463 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' A' ' 139' ' ' MET . 71.0 m-85 -128.74 108.18 10.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.546 -0.973 . . . . 0.0 108.594 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -93.94 -178.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.456 -1.403 . . . . 0.0 109.648 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.547 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 36.4 m -163.66 105.92 0.96 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.224 -1.39 . . . . 0.0 112.216 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -130.4 120.62 24.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -0.812 . . . . 0.0 109.505 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -49.29 -20.35 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.655 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 162' ' ' ILE . 1.6 m -66.03 60.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.122 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -47.27 -38.7 12.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 179.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 162' ' ' ILE . 1.6 p30 -44.01 -49.58 8.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.378 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.784 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.4 tp -62.88 -49.79 82.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.872 HG22 ' CE2' ' A' ' 157' ' ' PHE . 44.3 t -46.81 -46.43 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -44.9 -55.19 5.67 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.242 0.544 . . . . 0.0 111.181 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 167' ' ' CYS . 21.0 tttp -87.06 -61.88 1.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.213 -0.929 . . . . 0.0 110.921 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 162' ' ' ILE . 5.8 p -42.51 -24.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 40.8 t -82.98 -27.68 30.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 110.446 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 165' ' ' LYS . 9.0 mm-40 . . . . . 0 N--CA 1.494 1.758 0 O-C-N 121.145 -0.972 . . . . 0.0 111.018 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.721 ' CE1' HG23 ' A' ' 166' ' ' VAL . 34.4 m-70 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 174.25 119.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 110.201 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.781 HG23 ' O ' ' A' ' 174' ' ' ILE . 10.6 tp -98.27 78.64 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 49.0 m-80 63.84 -53.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 0.0 111.576 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -138.6 -0.67 1.93 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.987 -1.071 . . . . 0.0 111.383 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.9 OUTLIER -125.04 -175.53 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.913 -1.117 . . . . 0.0 111.079 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.438 ' N ' ' SD ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -121.72 79.03 1.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.627 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 174' ' ' ILE . 5.2 m -79.09 130.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -80.17 163.0 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.818 ' SG ' HD13 ' A' ' 111' ' ' ILE . 43.1 t -133.07 110.51 10.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.49 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 8.0 mmtm -105.29 163.42 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.55 ' HG3' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -76.32 154.95 34.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.022 . . . . 0.0 110.229 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.373 -0.829 . . . . 0.0 110.418 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.037 0.446 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 1.045 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pt -133.6 175.13 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 110.721 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 15.9 t80 -138.21 145.39 41.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.492 -0.755 . . . . 0.0 109.267 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.449 ' C ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -130.13 148.43 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.51 166.07 25.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.514 ' O ' ' HE2' ' A' ' 177' ' ' LYS . . . 86.31 -13.61 57.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -54.23 97.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -1.111 . . . . 0.0 110.648 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -54.85 175.9 0.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.092 -1.005 . . . . 0.0 108.656 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -79.51 -155.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.658 -1.276 . . . . 0.0 110.115 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.625 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER 75.44 -32.85 0.22 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' A' ' 121' ' ' THR . 1.8 m -81.47 172.14 13.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.606 0.717 . . . . 0.0 111.313 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 120' ' ' THR . 10.8 t -149.25 154.93 39.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 109.38 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.586 ' HA ' HD12 ' A' ' 140' ' ' LEU . 2.4 t -39.3 -50.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.465 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.64 -24.77 0.13 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.402 -0.812 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.617 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 25.5 t0 -74.95 -59.76 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.736 . . . . 0.0 109.696 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.706 HG21 HD21 ' A' ' 140' ' ' LEU . 1.1 t -63.66 -48.92 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.541 -0.724 . . . . 0.0 109.388 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 12.5 tttp -48.47 -60.94 2.29 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.255 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.617 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -63.9 -36.29 83.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.012 -1.055 . . . . 0.0 110.255 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 35.8 t80 -58.39 -57.7 11.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.38 -0.825 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.521 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 72.5 m-85 -83.0 -16.36 47.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.025 . . . . 0.0 111.485 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 83.3 tt0 -55.89 -37.59 69.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.45 -1.406 . . . . 0.0 108.244 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.4 pt20 -74.41 -16.6 60.88 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 162' ' ' ILE . 4.3 m-30 -87.72 -32.32 19.22 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 109.127 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.9 35.75 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HD3' ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -50.81 -41.38 57.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.607 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 47.62 91.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.195 0.998 . . . . 0.0 111.074 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -25.39 17.59 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.45 144.24 51.27 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -160.41 100.97 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.204 -0.935 . . . . 0.0 108.59 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.56 ' HA ' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -114.92 165.4 12.9 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.813 0.816 . . . . 0.0 112.239 -178.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 125' ' ' VAL . 34.2 mt -140.12 139.87 35.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.554 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -114.17 132.7 56.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.026 -1.046 . . . . 0.0 110.912 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 141' ' ' MET . 30.2 m-85 . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 13.5 p90 -150.14 140.25 22.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -1.088 . . . . 0.0 109.387 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.46 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -123.54 165.57 16.25 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.249 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' CG ' ' A' ' 139' ' ' MET . 22.8 m-85 -120.37 112.18 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 0.0 109.162 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.6 t -108.31 -179.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.68 -1.262 . . . . 0.0 109.008 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 110' ' ' LYS . 32.3 m -161.08 105.14 1.32 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.765 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.045 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.1 p90 -127.28 102.47 6.93 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.222 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.27 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 111.195 -178.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.872 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -54.74 86.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -54.91 -38.24 67.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.657 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.6 OUTLIER -39.39 -68.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.486 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 1.038 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -58.61 -45.63 90.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.956 -1.09 . . . . 0.0 108.875 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.978 HG22 ' CE1' ' A' ' 157' ' ' PHE . 9.9 t -47.29 -34.31 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -61.01 -42.81 99.18 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.617 0.722 . . . . 0.0 109.742 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.2 tptt -86.25 -62.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.56 -0.713 . . . . 0.0 110.81 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 1.038 HG22 ' O ' ' A' ' 162' ' ' ILE . 4.9 m -46.63 -24.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 108.908 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 1.7 t -65.89 -31.27 72.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.039 -1.038 . . . . 0.0 108.457 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 121.193 0.52 . . . . 0.0 110.717 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.843 ' NE2' HG12 ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.224 0.535 . . . . 0.0 110.456 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.2 tt0 66.42 105.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.372 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.744 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -112.43 118.03 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.271 179.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.486 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.4 m-20 67.45 -55.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.9 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -170.37 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 111.278 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.713 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -140.96 125.9 18.2 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.564 -1.335 . . . . 0.0 110.649 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -60.72 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.121 -0.987 . . . . 0.0 110.631 179.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.744 HG21 ' HB ' ' A' ' 174' ' ' ILE . 21.1 m -72.23 170.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 0.0 110.63 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.23 140.5 45.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 81.3 m -114.79 151.94 32.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 0.1 OUTLIER -159.84 147.11 16.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 110.255 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.631 ' HG3' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -58.31 166.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.385 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.991 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.842 HD11 ' CG2' ' A' ' 155' ' ' VAL . 1.3 pp -92.79 163.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.679 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.0 t80 -116.8 152.58 34.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.08 -1.013 . . . . 0.0 109.429 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 182' ' ' LYS . 2.3 m -143.38 155.63 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -140.03 -179.03 17.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.562 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 74.37 22.0 78.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.03 ' CD1' HD22 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -42.43 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLY . 14.3 t -46.88 161.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 120' ' ' THR . 3.0 t -73.17 151.69 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.87 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.508 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 64.71 -44.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.459 0.647 . . . . 0.0 109.761 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 118' ' ' VAL . 2.6 m -41.16 132.26 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.993 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.511 ' N ' ' OD2' ' A' ' 124' ' ' ASP . 2.0 m -118.84 165.43 14.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 110.536 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -39.36 -52.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 111.038 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' VAL . 7.3 mt-10 -42.52 -25.37 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.382 -0.823 . . . . 0.0 109.477 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.563 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 82.6 m-20 -74.51 -54.04 8.3 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.452 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 140' ' ' LEU . 2.0 t -65.77 -48.51 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 109.2 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 14.4 ttpt -47.65 -61.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.563 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -64.14 -32.32 73.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 109.599 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.576 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 31.8 t80 -59.6 -57.99 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.406 -0.809 . . . . 0.0 110.384 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.576 ' CE1' ' CE2' ' A' ' 128' ' ' TYR . 61.1 m-85 -82.59 -14.59 54.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.0 111.038 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 78.7 tt0 -55.0 -38.92 68.48 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.195 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.6 pt20 -73.12 -17.44 61.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 4.2 m-85 -91.66 -30.15 16.48 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -158.96 155.22 26.29 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HE3' ' HG2' ' A' ' 158' ' ' GLU . 1.9 ptpt -41.34 -40.6 1.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -1.129 . . . . 0.0 110.535 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 45.15 94.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 111.17 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.84 -25.74 19.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.17 144.47 48.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.534 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.801 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -153.83 99.03 2.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 4.9 tpp -99.66 164.61 11.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.897 0.856 . . . . 0.0 111.481 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.03 HD22 ' CD1' ' A' ' 116' ' ' LEU . 11.5 mt -149.78 133.56 16.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 15.9 mmm -111.26 122.03 46.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.833 -1.167 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.462 ' CE1' HD12 ' A' ' 116' ' ' LEU . 15.5 m-85 . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.419 -0.801 . . . . 0.0 109.86 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.399 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 14.7 p90 -150.44 140.0 21.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -1.106 . . . . 0.0 109.596 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.78 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -124.81 177.81 16.72 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.408 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.679 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 61.0 m-85 -138.37 117.41 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.929 . . . . 0.0 109.102 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.842 ' CG2' HD11 ' A' ' 111' ' ' ILE . 1.7 t -109.07 -174.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 155' ' ' VAL . 88.5 m -162.93 103.81 1.01 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.909 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.958 ' CE2' HG22 ' A' ' 163' ' ' VAL . 2.3 p90 -135.6 107.45 7.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.9 -22.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.434 -0.791 . . . . 0.0 111.118 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.853 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -56.36 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.421 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -61.63 -38.03 86.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.051 -1.031 . . . . 0.0 109.827 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 160' ' ' GLU . 10.1 t70 -39.27 -67.61 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.366 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.686 ' O ' HG12 ' A' ' 166' ' ' VAL . 5.6 tp -58.49 -42.68 85.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 108.79 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.958 HG22 ' CE2' ' A' ' 157' ' ' PHE . 38.2 t -50.94 -44.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.03 -46.51 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.7 tttt -90.26 -64.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -0.922 . . . . 0.0 111.202 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.866 HG13 ' HD3' ' A' ' 183' ' ' LYS . 6.0 p -45.31 -21.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.722 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 43.5 t -79.86 -22.87 42.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.931 -1.106 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 -179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 10.6 tp10 -158.91 86.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.904 -1.123 . . . . 0.0 111.012 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.754 HD11 HG23 ' A' ' 125' ' ' VAL . 1.5 tt -102.98 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.941 -1.099 . . . . 0.0 109.854 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 4.8 m120 67.36 -56.75 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -170.93 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 110.174 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.8 tptt -128.19 163.98 23.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 111.018 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.594 ' C ' HG22 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -94.28 -18.63 21.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -0.785 . . . . 0.0 109.32 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.594 HG22 ' C ' ' A' ' 178' ' ' MET . 34.5 m 37.25 -160.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.44 140.1 21.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 26.2 p -81.39 132.47 35.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.438 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -129.5 11.02 5.75 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.235 1.017 . . . . 0.0 109.175 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.866 ' HD3' HG13 ' A' ' 166' ' ' VAL . 1.4 mptt -41.01 158.09 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.586 -0.696 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 -179.894 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 9.8 pttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.03 0.443 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.955 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 5.4 pt -103.55 169.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.968 -1.083 . . . . 0.0 111.16 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 21.4 t80 -123.69 144.73 49.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.706 -0.621 . . . . 0.0 109.647 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -140.14 138.65 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 110.33 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -127.98 165.48 20.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.664 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 89.68 17.04 55.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.599 HD13 ' HG ' ' A' ' 140' ' ' LEU . 38.5 mt -39.54 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 110.278 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 177' ' ' LYS . 0.2 OUTLIER -43.87 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.884 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 120' ' ' THR . 10.6 m -67.71 157.6 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.766 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.22 -38.95 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.911 -0.493 . . . . 0.0 110.779 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 118' ' ' VAL . 54.9 m -47.68 150.23 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.947 -1.095 . . . . 0.0 109.994 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.801 ' C ' HD22 ' A' ' 140' ' ' LEU . 7.5 t -147.63 -167.28 2.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -60.21 -56.15 19.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 109.852 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -44.1 -24.62 0.16 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 109.604 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.719 ' OD2' HG22 ' A' ' 121' ' ' THR . 40.7 m-20 -78.2 -58.98 2.97 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.746 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.837 HG23 HD11 ' A' ' 174' ' ' ILE . 1.5 t -62.15 -47.79 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 108.943 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 6.0 ttmt -46.66 -61.98 1.59 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.485 -0.76 . . . . 0.0 109.992 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.541 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -64.76 -34.55 78.6 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.439 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 29.7 t80 -55.6 -58.21 8.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.575 -0.703 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 94.0 m-85 -81.29 -15.81 54.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.7 tt0 -55.41 -38.12 68.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 4.2 pt20 -74.59 -15.82 60.82 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.298 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 18.5 m-85 -86.85 -30.67 21.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.445 0.64 . . . . 0.0 109.341 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -162.03 -174.59 32.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -56.15 24.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 56.07 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.208 1.004 . . . . 0.0 111.135 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -24.91 16.36 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -130.71 140.01 50.33 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.753 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -153.8 101.69 2.47 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.873 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.3 ptm -113.16 168.79 9.43 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.92 0.867 . . . . 0.0 113.117 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.873 HD12 ' O ' ' A' ' 139' ' ' MET . 2.6 mp -139.1 139.18 37.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.851 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.583 ' HB3' ' O ' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -109.56 132.6 53.98 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.755 -1.215 . . . . 0.0 109.75 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 95.7 m-85 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.78 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . . . . . . 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.583 ' O ' ' HB3' ' A' ' 141' ' ' MET . 5.4 p90 -151.02 139.5 20.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.01 -1.288 . . . . 0.0 109.999 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -104.56 158.3 16.5 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.18 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 139' ' ' MET . 89.4 m-85 -114.3 103.4 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -97.0 -179.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.485 -178.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.627 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 73.7 m -163.95 104.52 0.9 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.782 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.955 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -125.99 106.55 9.7 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.45 177.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.553 -0.717 . . . . 0.0 111.529 -178.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -56.95 83.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 110.487 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -61.12 -38.43 86.32 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.774 -1.204 . . . . 0.0 109.478 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.8 m-20 -41.53 -62.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.788 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.1 tp -57.52 -47.14 85.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.033 -1.042 . . . . 0.0 108.564 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.949 HG22 ' CE2' ' A' ' 157' ' ' PHE . 43.2 t -47.67 -49.07 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.433 ' O ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -41.53 -52.28 3.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.674 -0.641 . . . . 0.0 111.386 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 167' ' ' CYS . 58.1 tttt -90.5 -61.79 1.6 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -0.999 . . . . 0.0 110.855 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 162' ' ' ILE . 7.1 p -42.36 -24.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 181' ' ' CYS . 13.9 p -81.2 -30.59 34.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.874 -1.141 . . . . 0.0 110.268 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.605 -179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.517 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.274 0.559 . . . . 0.0 110.166 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.7 tt0 -90.09 96.74 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.148 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.837 HD11 HG23 ' A' ' 125' ' ' VAL . 2.0 tt -97.71 97.26 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 110.034 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.472 ' OD1' ' CG1' ' A' ' 174' ' ' ILE . 3.8 m120 67.78 -56.89 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 110.009 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.543 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -166.0 23.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 110.192 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.557 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.4 OUTLIER -127.22 166.03 18.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 111.031 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -109.3 40.24 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.492 -0.755 . . . . 0.0 109.44 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.664 HG12 ' C ' ' A' ' 115' ' ' GLY . 19.0 m -47.76 167.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.5 -0.75 . . . . 0.0 111.332 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 1.8 tt0 -107.78 150.12 27.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.614 -0.679 . . . . 0.0 109.823 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 167' ' ' CYS . 3.1 p -131.0 90.6 2.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -89.66 143.24 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -79.99 163.87 23.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.296 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.318 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.861 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.359 0.599 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.687 HG21 ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.99 174.19 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.753 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 41.0 t80 -123.53 156.76 35.04 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.947 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 1.4 m -145.0 154.38 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 179' ' ' VAL . . . -144.12 174.0 24.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.813 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 77.85 12.84 84.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.763 HD11 ' N ' ' A' ' 153' ' ' GLY . 39.5 mt -53.48 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -1.171 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.519 ' HB2' ' CD ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -42.25 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.504 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 120' ' ' THR . 14.8 m -65.99 161.84 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 110.792 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 62.57 -38.6 0.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 110.67 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 118' ' ' VAL . 21.8 m -42.58 139.48 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 109.921 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.757 ' C ' HD12 ' A' ' 140' ' ' LEU . 8.7 t -127.0 168.93 13.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.08 -1.013 . . . . 0.0 111.079 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.792 ' N ' HD12 ' A' ' 140' ' ' LEU . 1.5 t -39.3 -47.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.679 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -44.38 -25.66 0.27 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 108.968 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.605 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 15.7 t0 -69.51 -46.31 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.699 . . . . 0.0 109.665 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.818 HG22 HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -76.66 -44.17 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.807 0.813 . . . . 0.0 109.17 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 9.6 ttmt -59.38 -48.82 80.19 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.691 -0.63 . . . . 0.0 111.078 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.605 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.9 -28.63 63.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 110.123 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.477 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 67.4 t80 -79.13 -50.0 11.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 112.167 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 125' ' ' VAL . 68.6 m-85 -88.43 -16.91 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.814 -1.179 . . . . 0.0 112.118 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 1.5 pp20? -53.73 -42.49 68.19 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.247 -1.781 . . . . 0.0 108.432 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -70.57 -17.04 62.92 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.802 179.527 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.745 ' O ' HD13 ' A' ' 162' ' ' ILE . 7.7 m-85 -79.99 -27.77 39.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.35 -132.6 1.36 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 158' ' ' GLU . 1.5 ptpp? -101.13 -37.48 8.55 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.516 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 42.45 89.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.11 0.957 . . . . 0.0 110.934 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.12 -27.2 23.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.72 136.92 37.8 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.377 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -143.2 91.1 2.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.558 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 6.3 ttp -96.32 162.94 13.29 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.098 0.951 . . . . 0.0 112.166 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.818 HD11 HG22 ' A' ' 125' ' ' VAL . 22.5 mt -139.35 129.95 25.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 35.2 mmm -103.68 111.46 23.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.011 -1.056 . . . . 0.0 110.616 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 110.034 179.724 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.426 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.7 p90 -147.46 140.4 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -1.054 . . . . 0.0 109.287 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.79 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -111.05 161.55 12.77 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.375 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.428 ' HB2' ' HE3' ' A' ' 139' ' ' MET . 28.3 m-85 -123.82 109.85 14.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -1.013 . . . . 0.0 109.128 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -105.24 -178.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 109.372 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.623 ' HA ' HD13 ' A' ' 111' ' ' ILE . 78.7 m -159.7 104.25 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.58 -1.325 . . . . 0.0 112.149 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.065 ' CE1' HG22 ' A' ' 163' ' ' VAL . 1.6 p90 -127.73 97.23 4.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 0.0 108.748 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLU . 1.0 OUTLIER -39.05 -31.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.755 . . . . 0.0 111.483 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -52.49 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -55.76 -38.11 69.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.091 -1.006 . . . . 0.0 109.755 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.9 OUTLIER -39.85 -64.46 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.305 -179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.847 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -61.36 -46.28 96.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.853 -1.154 . . . . 0.0 108.815 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.065 HG22 ' CE1' ' A' ' 157' ' ' PHE . 4.4 t -49.77 -35.3 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -50.1 -63.07 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.66 -0.65 . . . . 0.0 111.217 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 10.7 ptpt -90.43 -45.02 9.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.144 -0.973 . . . . 0.0 111.484 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -51.9 -22.05 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.517 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.536 ' CB ' ' HG2' ' A' ' 183' ' ' LYS . 89.5 m -89.61 -23.31 21.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.003 -1.061 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.592 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 178' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.246 0.545 . . . . 0.0 110.231 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.3 pt-20 -96.78 109.89 22.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.003 HD13 HG21 ' A' ' 179' ' ' VAL . 4.7 pt -118.91 119.62 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.133 . . . . 0.0 109.789 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.7 OUTLIER 68.22 -56.69 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.933 . . . . 0.0 109.702 -179.133 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -179.07 31.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 109.401 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.59 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.4 tptp -139.14 136.7 35.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 111.352 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.523 ' HA ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER -82.29 45.44 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.837 . . . . 0.0 109.588 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 1.003 HG21 HD13 ' A' ' 174' ' ' ILE . 6.8 m -46.77 176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.676 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 38.7 tt0 -129.19 150.89 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 109.821 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -117.91 160.25 21.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.461 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -159.06 150.31 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.769 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.536 ' HG2' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -66.52 158.94 28.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.0 110.276 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 110.261 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.902 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.03 0.443 . . . . 0.0 110.126 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.987 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 6.1 pt -106.7 170.89 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.099 -1.001 . . . . 0.0 110.822 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 54.2 t80 -125.57 150.66 47.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.507 -0.746 . . . . 0.0 109.893 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -142.54 159.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.917 . . . . 0.0 110.297 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -151.15 168.66 30.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.14 48.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 140' ' ' LEU . 2.6 mm? -63.89 93.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -1.196 . . . . 0.0 109.543 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 177' ' ' LYS . 4.9 t -64.6 -146.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 111.118 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' THR . 8.9 t -90.41 166.97 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 111.223 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 61.59 -40.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.285 0.564 . . . . 0.0 110.476 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' VAL . 24.2 m -51.22 134.51 27.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.045 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.6 t -138.57 159.18 42.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.574 HG23 ' CB ' ' A' ' 140' ' ' LEU . 2.6 t -39.74 -52.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.818 . . . . 0.0 110.556 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 122' ' ' VAL . 5.5 tt0 -39.68 -28.22 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.548 -0.72 . . . . 0.0 109.294 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 122' ' ' VAL . 28.0 m-20 -75.17 -59.79 2.58 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.004 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 129' ' ' PHE . 1.6 t -63.84 -48.86 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.25 -0.906 . . . . 0.0 108.99 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 5.2 ttpt -45.19 -70.14 0.11 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.413 -0.804 . . . . 0.0 109.495 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.545 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -55.99 -37.58 69.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.186 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 26.2 t80 -58.69 -47.4 84.63 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.59 -0.694 . . . . 0.0 111.409 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.614 ' CD2' HG13 ' A' ' 125' ' ' VAL . 69.2 m-85 -87.19 -15.11 39.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.05 -1.031 . . . . 0.0 113.425 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.792 ' HG2' HG11 ' A' ' 135' ' ' VAL . 3.2 mt-10 -56.53 -34.58 67.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.632 -1.917 . . . . 0.0 108.618 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.58 ' HG3' ' CD1' ' A' ' 132' ' ' PHE . 20.3 pt20 -74.87 -17.39 60.59 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.411 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.58 ' CD1' ' HG3' ' A' ' 131' ' ' GLN . 28.1 m-85 -83.79 -31.82 25.71 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -163.55 169.48 38.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.469 ' HD2' ' HG2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -42.39 -57.01 2.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -1.128 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.792 HG11 ' HG2' ' A' ' 130' ' ' GLU . 1.2 t 61.11 90.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.202 1.001 . . . . 0.0 111.268 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.13 -26.98 14.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.73 140.9 50.98 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.771 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -154.17 99.31 2.22 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 154' ' ' PHE . 2.5 ptm -110.31 167.61 10.07 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.064 0.935 . . . . 0.0 112.265 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 116' ' ' LEU . 5.1 tp -146.47 155.04 42.25 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 140' ' ' LEU . 75.5 mmm -142.22 144.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 23.3 m-85 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.615 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.8 p90 -149.0 146.87 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 109.641 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -123.71 152.84 17.2 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.883 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' HG3' ' A' ' 139' ' ' MET . 30.6 m-85 -119.26 109.28 15.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.059 -1.259 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -103.92 179.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.758 -1.214 . . . . 0.0 109.042 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.579 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 61.0 m -162.74 107.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.944 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.987 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -127.62 127.21 43.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -52.83 -17.25 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 110.952 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.7 m -72.53 81.1 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -59.28 -39.09 81.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.76 -1.213 . . . . 0.0 109.25 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 1.5 m-20 -40.2 -58.72 1.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.766 -0.584 . . . . 0.0 110.344 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.855 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -61.65 -47.5 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.614 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.911 HG22 ' CE2' ' A' ' 157' ' ' PHE . 36.1 t -47.07 -39.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 10.0 tt0 -46.13 -64.18 0.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.79 -0.569 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 3.9 pttm -90.5 -46.86 8.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.22 -0.925 . . . . 0.0 111.64 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.9 p -48.68 -23.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.075 . . . . 0.0 110.27 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 163' ' ' VAL . 91.3 m -89.93 -27.32 19.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.353 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.864 . . . . 0.0 110.705 -179.565 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.603 ' O ' HG22 ' A' ' 179' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.343 0.592 . . . . 0.0 110.348 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -84.17 104.4 14.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 1.001 ' CD1' HG21 ' A' ' 179' ' ' VAL . 3.8 mt -103.59 100.88 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 0.0 109.655 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.0 m-20 66.25 -55.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.301 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 174' ' ' ILE . 6.6 p30 -168.01 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.49 -0.756 . . . . 0.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.592 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.3 tptt -131.85 152.17 51.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -92.99 44.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.858 179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 1.001 HG21 ' CD1' ' A' ' 174' ' ' ILE . 33.5 m -48.06 170.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.354 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 30.5 tt0 -122.87 146.51 47.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.706 ' SG ' HD12 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -114.75 165.51 12.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.358 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -161.05 175.82 12.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.074 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -93.84 144.52 25.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.093 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.961 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.315 0.578 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.841 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 2.0 pt -104.92 176.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -0.806 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -124.55 159.81 29.79 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.223 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -149.3 161.66 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 0.0 110.483 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -150.86 152.69 24.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.773 ' HA3' HG12 ' A' ' 179' ' ' VAL . . . 114.3 -17.13 19.4 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.917 HD22 HD22 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -49.81 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -1.148 . . . . 0.0 110.097 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 118' ' ' VAL . 30.4 t -101.64 -167.57 1.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.747 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 120' ' ' THR . 16.4 m -42.25 168.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 111.081 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.556 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 62.69 -41.75 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.155 0.502 . . . . 0.0 110.33 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 118' ' ' VAL . 1.3 m -61.4 133.16 55.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.932 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLU . 10.2 t -149.27 60.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.091 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.89 ' H ' HD12 ' A' ' 140' ' ' LEU . 3.1 t 63.97 -56.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.173 0.511 . . . . 0.0 110.425 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.563 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.4 mm-40 -44.57 -23.71 0.14 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.442 -0.786 . . . . 0.0 108.946 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.595 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-20 -70.23 -58.04 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.718 . . . . 0.0 109.686 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.76 HG22 ' HE2' ' A' ' 129' ' ' PHE . 2.0 t -68.38 -50.48 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.703 . . . . 0.0 109.326 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 15.8 tttt -49.01 -59.76 3.34 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.386 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.628 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 0.4 OUTLIER -58.21 -29.53 65.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.477 ' O ' ' NE2' ' A' ' 131' ' ' GLN . 49.2 t80 -74.96 -62.41 1.56 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 111.827 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.76 ' HE2' HG22 ' A' ' 125' ' ' VAL . 67.8 m-85 -74.09 -15.09 61.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.902 -1.123 . . . . 0.0 112.668 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -52.41 -41.29 63.07 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 117.702 -1.599 . . . . 0.0 109.113 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.477 ' NE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -72.17 -16.97 61.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.648 -0.821 . . . . 0.0 108.874 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.531 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 2.8 m-85 -88.66 -25.36 22.43 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.564 0.697 . . . . 0.0 109.164 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -166.23 153.42 23.26 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 158' ' ' GLU . 12.3 ptpt -38.49 -41.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.599 -0.942 . . . . 0.0 110.727 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.2 t 47.52 90.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.099 0.952 . . . . 0.0 110.604 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.1 -26.06 19.31 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -127.92 140.23 52.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.739 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -157.77 98.93 1.68 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.682 ' HA ' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.95 169.37 9.7 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.971 0.891 . . . . 0.0 112.505 -177.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 1.029 HD23 ' HA3' ' A' ' 153' ' ' GLY . 18.0 mt -144.59 132.41 21.29 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.488 ' O ' HD11 ' A' ' 116' ' ' LEU . 1.9 mmt -103.16 112.27 25.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.179 -0.951 . . . . 0.0 110.784 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 140' ' ' LEU . 77.2 m-85 . . . . . 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.392 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.529 ' CA ' HD21 ' A' ' 116' ' ' LEU . 29.4 p90 -141.58 134.5 28.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -1.205 . . . . 0.0 110.248 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 1.029 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -117.0 165.15 12.35 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.52 ' O ' ' HG3' ' A' ' 139' ' ' MET . 46.6 m-85 -125.96 109.6 12.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.594 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -101.63 -177.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.973 -1.079 . . . . 0.0 108.922 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 88.6 m -164.07 105.48 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.277 -1.369 . . . . 0.0 112.242 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.841 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.3 p90 -132.41 108.36 9.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.02 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 160' ' ' GLU . 5.3 tt0 -39.56 -27.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 0.0 110.847 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.703 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -53.58 88.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 110.427 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.0 tm-20 -66.35 -38.58 87.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.1 OUTLIER -40.84 -60.73 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.995 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.942 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -59.88 -48.86 86.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.772 178.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.815 HG22 ' CE2' ' A' ' 157' ' ' PHE . 42.1 t -46.98 -41.95 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 4.9 tt0 -51.09 -42.92 60.93 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.512 0.673 . . . . 0.0 110.259 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -88.86 -63.59 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.372 -0.83 . . . . 0.0 110.947 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.942 HG22 ' O ' ' A' ' 162' ' ' ILE . 12.4 m -47.25 -23.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.489 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 13.9 t -73.63 -24.41 60.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 108.983 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 165' ' ' LYS . 42.2 tp10 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.842 -0.536 . . . . 0.0 110.418 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.808 ' NE2' HG12 ' A' ' 166' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.304 0.574 . . . . 0.0 110.272 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 13.1 tt0 70.48 79.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 0.0 110.824 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.669 HG22 ' CB ' ' A' ' 177' ' ' LYS . 2.8 tt -78.29 -175.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.97 -1.081 . . . . 0.0 109.726 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' ILE . 48.0 m-80 -30.28 -57.36 0.19 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.8 -0.562 . . . . 0.0 111.819 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.7 OUTLIER -138.86 28.9 2.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.213 -0.929 . . . . 0.0 110.27 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.669 ' CB ' HG22 ' A' ' 174' ' ' ILE . 0.2 OUTLIER -142.88 -166.63 2.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.729 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.465 ' O ' ' O ' ' A' ' 179' ' ' VAL . 0.0 OUTLIER -135.39 33.61 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.773 HG12 ' HA3' ' A' ' 115' ' ' GLY . 33.3 m -36.9 159.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.518 0.675 . . . . 0.0 111.375 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -114.57 153.72 29.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.78 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 166' ' ' VAL . 20.2 m -121.97 122.02 38.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 110.588 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -124.22 137.65 54.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.565 ' HD3' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -56.08 164.91 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 0.0 110.8 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.961 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.715 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.109 0.481 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.975 HD12 ' N ' ' A' ' 112' ' ' PHE . 1.2 pp -119.25 -179.15 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.853 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.975 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.6 t80 -131.43 159.49 37.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 109.563 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.443 HG23 ' CA ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -145.78 155.4 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.291 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 179' ' ' VAL . . . -156.63 140.62 7.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 121.62 -10.1 9.82 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.792 HD11 ' O ' ' A' ' 141' ' ' MET . 0.4 OUTLIER -50.89 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -1.12 . . . . 0.0 109.929 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' GLY . 53.7 p -65.49 -167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.782 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 120' ' ' THR . 23.1 m -58.84 171.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 0.0 111.225 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.3 OUTLIER 62.2 -39.87 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.914 -0.491 . . . . 0.0 110.775 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.672 HG23 ' OD2' ' A' ' 124' ' ' ASP . 36.8 m -55.56 148.74 15.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.006 -1.059 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.7 t -158.28 166.88 31.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.623 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -41.6 -53.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 110.558 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.08 -25.8 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.672 ' OD2' HG23 ' A' ' 120' ' ' THR . 50.5 t0 -72.24 -49.94 31.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.769 ' CG2' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -69.37 -44.85 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.09 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 8.2 tttm -52.16 -63.99 0.96 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.518 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -62.85 -30.79 71.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.144 -0.972 . . . . 0.0 110.95 -179.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 84.9 t80 -70.59 -50.92 32.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.19 -0.944 . . . . 0.0 111.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.721 ' CE2' HG12 ' A' ' 125' ' ' VAL . 56.0 m-85 -89.48 -12.29 40.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 111.941 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.695 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 26.0 tt0 -56.31 -38.29 71.08 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.357 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 24.6 pt20 -74.65 -14.46 60.76 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.565 ' O ' HD13 ' A' ' 162' ' ' ILE . 14.0 m-85 -86.8 -32.16 20.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.712 -0.617 . . . . 0.0 110.424 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -170.3 54.69 0.19 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.346 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER 60.15 -67.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.722 -0.869 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 135' ' ' VAL . 0.9 OUTLIER 62.44 94.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.083 . . . . 0.0 110.903 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.41 -25.0 25.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.51 136.55 39.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.5 0.667 . . . . 0.0 109.793 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.843 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -145.18 92.51 2.26 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.505 ' SD ' ' CE ' ' A' ' 141' ' ' MET . 6.8 tpp -90.17 163.06 14.97 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.834 0.826 . . . . 0.0 111.328 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.776 HD12 ' HA3' ' A' ' 153' ' ' GLY . 5.0 tp -151.11 154.71 37.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.774 -0.579 . . . . 0.0 109.711 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.792 ' O ' HD11 ' A' ' 116' ' ' LEU . 8.8 mmt -138.88 157.62 45.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.177 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.915 . . . . 0.0 110.062 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 6.6 p90 -149.7 141.84 24.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.994 . . . . 0.0 109.252 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.776 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -123.58 160.07 18.15 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.574 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -123.89 113.33 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.976 . . . . 0.0 108.748 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -104.42 178.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.879 -1.138 . . . . 0.0 109.543 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 45.8 m -160.6 104.92 1.41 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.178 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.018 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -128.83 112.31 14.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 177.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.444 ' CA ' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -39.48 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.499 -0.751 . . . . 0.0 110.585 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.865 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.4 m -59.92 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.499 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.271 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.463 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -43.24 -61.13 1.42 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.892 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.4 OUTLIER -58.1 -46.41 88.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.39 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.018 HG22 ' CE2' ' A' ' 157' ' ' PHE . 44.5 t -48.96 -51.3 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 161' ' ' ASP . 2.9 mt-10 -42.7 -43.97 4.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.612 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -90.92 -66.21 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 111.107 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.641 HG23 ' NE2' ' A' ' 172' ' ' HIS . 6.0 p -45.44 -20.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 0.0 110.936 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 183' ' ' LYS . 3.5 p -88.19 -29.19 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 109.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.896 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.641 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 121.357 0.599 . . . . 0.0 110.446 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 178' ' ' MET . 14.3 tt0 -153.65 127.74 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.812 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -116.3 102.82 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.01 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.468 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.9 OUTLIER 66.88 -58.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.188 . . . . 0.0 109.842 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.8 p30 -149.5 -31.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 110.587 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -76.72 -170.05 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.41 -0.806 . . . . 0.0 110.099 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.639 ' C ' HG23 ' A' ' 179' ' ' VAL . 21.8 mmt -100.63 -70.6 0.73 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.812 HG21 ' HB ' ' A' ' 174' ' ' ILE . 2.6 t 70.48 160.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.551 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -120.75 152.77 37.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 172' ' ' HIS . 35.4 m -126.39 158.84 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 181' ' ' CYS . 15.4 mtmt -157.53 155.47 30.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.832 . . . . 0.0 109.961 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -67.12 160.88 25.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.034 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.822 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.648 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -122.39 176.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.99 . . . . 0.0 110.389 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 56.4 t80 -126.08 160.22 30.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.812 . . . . 0.0 109.926 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.1 OUTLIER -147.42 149.25 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.037 -1.039 . . . . 0.0 110.667 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.22 174.2 22.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 89.59 13.19 61.64 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.889 HD21 ' HG ' ' A' ' 140' ' ' LEU . 1.7 mp -40.81 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -1.051 . . . . 0.0 110.167 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 115' ' ' GLY . 22.7 t -64.92 178.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.731 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -72.33 150.23 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 0.0 110.454 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.25 -38.85 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.99 -0.444 . . . . 0.0 110.598 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.642 HG23 ' OD2' ' A' ' 124' ' ' ASP . 18.0 m -41.4 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.304 -0.873 . . . . 0.0 110.015 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 124' ' ' ASP . 10.3 t -164.52 172.51 13.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 140' ' ' LEU . 3.1 t -39.01 -54.54 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.682 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.474 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -41.98 -25.91 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 109.155 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.642 ' OD2' HG23 ' A' ' 120' ' ' THR . 58.1 t0 -72.81 -55.56 6.52 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.493 0.663 . . . . 0.0 109.909 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' VAL . . . . . 0.848 HG12 ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -68.4 -54.75 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.1 tttt -39.29 -63.47 0.55 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.154 0.502 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.527 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 2.1 p-80 -61.87 -29.5 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.073 -1.017 . . . . 0.0 110.897 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -73.36 -55.29 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 0.0 111.707 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PHE . . . . . 0.848 ' CD2' HG12 ' A' ' 125' ' ' VAL . 38.6 m-85 -84.13 -17.53 39.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.104 . . . . 0.0 111.895 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.659 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 70.0 tt0 -57.2 -36.0 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.114 -1.616 . . . . 0.0 108.262 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLN . . . . . 0.479 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.9 pt20 -76.71 -13.56 60.03 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.651 ' CD2' HD11 ' A' ' 162' ' ' ILE . 4.1 m-30 -86.95 -35.11 19.07 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.806 -0.559 . . . . 0.0 111.101 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -169.45 65.01 0.18 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.273 -1.918 . . . . 0.0 111.181 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.86 -70.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.933 . . . . 0.0 111.591 178.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 64.95 92.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.09 0.948 . . . . 0.0 110.732 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -87.19 -21.61 25.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.06 137.9 41.59 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -155.9 98.17 1.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' MET . . . . . 0.577 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -113.61 171.79 7.36 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.145 0.974 . . . . 0.0 112.555 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.889 ' HG ' HD21 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -145.62 148.43 33.1 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.498 179.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . 0.448 ' O ' ' HA3' ' A' ' 151' ' ' GLY . 3.1 mmt -130.45 116.99 19.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.023 -1.048 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 116' ' ' LEU . 45.1 m-85 . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 109.997 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PHE . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 4.7 p90 -145.35 153.32 41.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -1.158 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -118.85 158.34 14.88 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.432 -1.366 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 139' ' ' MET . 11.9 m-85 -116.93 110.95 18.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -1.061 . . . . 0.0 109.352 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -107.65 179.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.638 -1.289 . . . . 0.0 109.392 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . 0.822 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 97.2 m -163.49 104.75 0.96 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.293 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 1.055 ' CE1' HG22 ' A' ' 163' ' ' VAL . 1.4 p90 -127.83 99.2 5.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.866 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -38.89 -31.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.757 -0.59 . . . . 0.0 111.381 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 163' ' ' VAL . 35.7 m -53.37 86.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.3 tt0 -54.36 -38.42 66.06 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.831 -1.168 . . . . 0.0 109.75 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.2 OUTLIER -38.42 -67.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -60.46 -38.23 77.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.325 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.055 HG22 ' CE1' ' A' ' 157' ' ' PHE . 7.7 t -58.2 -32.94 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.7 tm-20 -58.02 -49.59 76.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.478 -0.764 . . . . 0.0 110.604 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 168' ' ' GLU . 18.9 tttp -89.71 -60.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.577 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 162' ' ' ILE . 2.5 p -42.34 -25.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.452 -0.78 . . . . 0.0 109.805 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' CYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.7 t -76.28 -34.52 59.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.894 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.484 ' N ' ' O ' ' A' ' 165' ' ' LYS . 23.3 tt0 . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 110.703 -179.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 173' ' ' GLU . 6.7 m80 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.406 0.622 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 57.7 tt0 59.04 114.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . 0.633 ' CG2' HG11 ' A' ' 179' ' ' VAL . 0.4 OUTLIER -111.61 114.55 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.926 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.49 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.8 OUTLIER 68.84 -56.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.0 109.467 -178.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -174.24 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.571 -0.706 . . . . 0.0 110.312 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.628 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -139.92 122.31 16.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 110.138 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' MET . . . . . 0.476 ' HG2' ' O ' ' A' ' 178' ' ' MET . 0.0 OUTLIER -54.53 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.856 -1.153 . . . . 0.0 110.504 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' VAL . . . . . 0.633 HG11 ' CG2' ' A' ' 174' ' ' ILE . 23.3 m -97.01 -161.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -134.88 157.12 47.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.975 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.0 t -145.01 141.37 28.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.918 . . . . 0.0 110.48 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 13.6 mtpp -138.02 -171.15 2.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 109.886 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.639 ' HA ' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -106.28 164.31 12.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.214 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.565 ' N ' ' CD ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.987 -1.071 . . . . 0.0 110.962 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.821 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.173 0.511 . . . . 0.0 110.133 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.964 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.5 pt -114.77 174.84 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.123 -0.986 . . . . 0.0 110.881 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.483 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.7 t80 -121.93 157.7 30.65 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.495 -0.753 . . . . 0.0 109.422 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -149.72 153.75 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.085 -1.009 . . . . 0.0 110.479 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.49 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -141.1 176.37 21.68 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.394 -1.482 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.499 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 87.1 15.38 62.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.65 HD22 HD22 ' A' ' 140' ' ' LEU . 15.4 mt -47.63 97.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.882 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.426 ' N ' ' O ' ' A' ' 115' ' ' GLY . 2.2 t -57.52 -168.19 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.279 -0.888 . . . . 0.0 110.66 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.602 HG12 ' HA ' ' A' ' 148' ' ' ARG . 15.6 m -89.06 154.46 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.496 -0.753 . . . . 0.0 110.867 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.518 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 62.26 -35.28 0.12 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.739 -0.601 . . . . 0.0 111.082 179.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 118' ' ' VAL . 62.2 m -43.63 128.65 5.28 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.936 -1.102 . . . . 0.0 110.13 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 15.3 t -117.69 158.58 24.44 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.294 -0.878 . . . . 0.0 110.248 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.725 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.4 t -37.5 -51.82 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.57 -0.706 . . . . 0.0 110.848 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.464 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -41.11 -26.15 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.556 -0.715 . . . . 0.0 109.441 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.553 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 1.6 m-20 -74.14 -55.76 5.71 Favored 'General case' 0 N--CA 1.491 1.621 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.728 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 1.007 HG21 HD21 ' A' ' 140' ' ' LEU . 1.0 OUTLIER -66.6 -48.06 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.328 -0.857 . . . . 0.0 109.241 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.554 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 8.6 ttpp -47.53 -60.77 2.3 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.448 -0.783 . . . . 0.0 109.673 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -63.94 -33.51 75.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.945 . . . . 0.0 109.463 179.773 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 125' ' ' VAL . 7.1 t80 -57.77 -60.7 3.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.56 -0.712 . . . . 0.0 110.439 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.511 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 97.3 m-85 -80.43 -16.4 54.49 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.132 -0.98 . . . . 0.0 111.308 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.8 tt0 -56.64 -36.45 69.52 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.382 -1.449 . . . . 0.0 107.957 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.2 pt20 -73.75 -17.21 61.13 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.511 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 3.6 m-30 -86.31 -28.29 23.8 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.426 0.632 . . . . 0.0 109.608 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -165.83 -165.73 23.66 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -52.41 59.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.298 -1.119 . . . . 0.0 110.104 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.76 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 55.34 90.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 122.087 0.946 . . . . 0.0 110.913 -179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -92.83 -26.57 17.61 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 177.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -130.73 140.61 50.34 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.007 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.725 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -154.91 98.78 2.07 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.701 ' HA ' HG22 ' A' ' 122' ' ' VAL . 4.2 ptp -116.57 163.47 16.05 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 121.948 0.88 . . . . 0.0 112.461 -177.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.007 HD21 HG21 ' A' ' 125' ' ' VAL . 89.2 mt -137.26 133.01 34.56 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.614 ' O ' HD12 ' A' ' 116' ' ' LEU . 2.6 mmt -107.19 125.05 50.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.933 -1.105 . . . . 0.0 110.577 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.553 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 27.0 m-85 -111.91 -133.22 0.34 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.454 -0.778 . . . . 0.0 109.478 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 146' ' ' THR . 38.6 t0 -134.99 130.66 36.1 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.893 -1.13 . . . . 0.0 110.004 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -42.48 125.81 3.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.233 -0.917 . . . . 0.0 110.56 -179.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 7.8 p 44.37 31.75 0.62 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.426 -0.796 . . . . 0.0 110.516 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 143' ' ' ASP . 0.8 OUTLIER -150.0 53.33 0.92 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.887 . . . . 0.0 109.71 179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -76.01 53.34 0.77 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.555 -0.716 . . . . 0.0 110.382 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.602 ' HA ' HG12 ' A' ' 118' ' ' VAL . 9.9 mtt180 -126.39 -45.87 1.65 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.138 -0.976 . . . . 0.0 110.642 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -67.65 -174.62 0.44 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.124 -0.985 . . . . 0.0 110.205 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -86.18 160.56 19.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.206 -0.934 . . . . 0.0 110.121 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -148.26 -160.19 8.87 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.555 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.3 p90 -147.02 137.29 23.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.273 -1.134 . . . . 0.0 109.992 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.687 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -114.71 159.56 13.66 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 110.062 -1.215 . . . . 0.0 110.062 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.542 ' O ' ' CG ' ' A' ' 139' ' ' MET . 30.8 m-85 -115.04 109.85 18.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.331 -1.1 . . . . 0.0 109.372 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.49 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -104.66 -178.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.892 -1.13 . . . . 0.0 109.008 -179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.477 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 30.8 m -164.81 104.74 0.8 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.295 -1.362 . . . . 0.0 112.038 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.964 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 2.0 p90 -128.37 107.81 10.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.397 -0.815 . . . . 0.0 109.23 177.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.526 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -39.31 -26.58 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.432 -0.793 . . . . 0.0 111.138 -179.118 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 163' ' ' VAL . 2.3 m -56.48 81.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.183 -0.948 . . . . 0.0 110.777 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.526 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.6 tt0 -58.32 -38.61 77.45 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.693 -1.255 . . . . 0.0 109.463 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 6.6 t0 -40.37 -63.09 0.67 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.571 -0.705 . . . . 0.0 110.389 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.715 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.3 tp -57.99 -45.06 88.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 120.98 -1.075 . . . . 0.0 108.82 179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.779 HG22 ' CE2' ' A' ' 157' ' ' PHE . 35.5 t -47.42 -39.82 6.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -51.17 -56.58 12.08 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.203 -0.599 . . . . 0.0 110.716 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' A' ' 167' ' ' CYS . 5.9 tttp -84.8 -60.83 1.94 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.285 -0.884 . . . . 0.0 110.863 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.715 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.3 p -41.34 -25.7 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.453 -0.779 . . . . 0.0 110.097 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.555 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.9 t -75.62 -38.3 59.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.152 -0.968 . . . . 0.0 110.074 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.577 ' O ' ' CD2' ' A' ' 170' ' ' HIS . 4.4 mt-10 -77.18 -22.64 52.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.512 -179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.677 HG21 ' ND1' ' A' ' 172' ' ' HIS . 12.6 mm -54.08 132.55 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 0.0 110.169 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 168' ' ' GLU . 89.9 m-70 -112.86 26.75 10.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.212 -0.93 . . . . 0.0 110.058 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.62 ' CG ' ' HB3' ' A' ' 178' ' ' MET . 0.2 OUTLIER -177.98 59.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.291 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.677 ' ND1' HG21 ' A' ' 169' ' ' ILE . 18.6 m-70 -58.18 -159.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 109.921 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -141.32 99.41 3.57 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.161 -0.962 . . . . 0.0 109.988 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.804 HG23 ' O ' ' A' ' 174' ' ' ILE . 0.5 OUTLIER -92.06 81.82 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 120.958 -1.089 . . . . 0.0 110.159 179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 69.4 m-80 64.47 -53.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.612 -0.68 . . . . 0.0 111.287 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.507 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.1 p30 -147.75 7.45 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.05 -1.031 . . . . 0.0 111.191 -179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.593 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.3 OUTLIER -124.64 172.17 9.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.797 -1.19 . . . . 0.0 111.415 -179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.62 ' HB3' ' CG ' ' A' ' 171' ' ' PHE . 23.7 mmt -113.05 57.69 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.65 -0.656 . . . . 0.0 109.894 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.499 HG12 ' C ' ' A' ' 115' ' ' GLY . 15.4 m -56.88 -166.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.335 -0.853 . . . . 0.0 110.822 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -136.34 162.88 31.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.715 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.587 ' HB3' ' CD2' ' A' ' 172' ' ' HIS . 41.4 t -144.1 130.81 20.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.935 -1.103 . . . . 0.0 110.52 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -126.72 173.38 9.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.294 -0.879 . . . . 0.0 109.945 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.445 ' H ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -95.59 156.23 16.41 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.003 . . . . 0.0 110.275 -179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.821 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 110.58 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.926 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 5.7 ptpt . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.152 0.501 . . . . 0.0 110.108 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.036 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 5.1 pt -102.33 163.76 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.19 -0.944 . . . . 0.0 110.473 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.581 ' CD1' ' CZ ' ' A' ' 154' ' ' PHE . 64.7 t80 -125.73 137.22 53.81 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.328 -0.857 . . . . 0.0 109.854 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.437 HG23 ' H ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -130.06 149.41 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.265 -0.897 . . . . 0.0 110.332 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.27 177.43 25.56 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.518 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 75.83 11.1 84.86 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 116' ' ' LEU . 1.1 pp -87.53 97.19 10.71 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.196 -1.179 . . . . 0.0 110.458 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 116' ' ' LEU . 9.0 t -52.91 -169.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 147' ' ' ASN . 1.3 t -78.28 -153.72 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.865 -1.147 . . . . 0.0 110.403 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.607 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.65 -17.34 0.08 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.776 -0.577 . . . . 0.0 111.169 -178.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.505 ' H ' ' C ' ' A' ' 118' ' ' VAL . 40.7 m -91.41 143.62 26.43 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.735 -1.228 . . . . 0.0 110.695 -178.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.592 HG22 ' CG ' ' A' ' 124' ' ' ASP . 11.8 t -127.98 151.16 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.0 109.682 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.61 ' N ' HD12 ' A' ' 140' ' ' LEU . 2.4 t -41.75 -51.78 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.158 -0.964 . . . . 0.0 110.178 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.526 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.6 mt-10 -42.79 -26.01 0.11 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.279 -0.888 . . . . 0.0 109.342 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.629 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 66.0 m-20 -76.37 -57.37 3.9 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.545 -0.722 . . . . 0.0 110.094 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.733 HG21 HD21 ' A' ' 140' ' ' LEU . 1.3 t -67.34 -47.53 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.298 -0.876 . . . . 0.0 109.359 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.525 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 6.0 ttpp -48.4 -58.23 4.92 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.45 -0.781 . . . . 0.0 109.818 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.629 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.7 OUTLIER -66.83 -32.49 73.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.15 -0.969 . . . . 0.0 109.697 179.877 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.526 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -59.21 -55.96 28.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.495 -0.753 . . . . 0.0 110.05 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.549 ' HZ ' ' HG ' ' A' ' 181' ' ' CYS . 66.9 m-85 -83.66 -15.94 46.96 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.122 -1.031 . . . . 0.0 111.06 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 46.0 tt0 -56.41 -37.76 70.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.423 -1.423 . . . . 0.0 108.163 178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.526 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -74.59 -15.93 60.82 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 4.9 m-30 -88.16 -32.79 18.45 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -161.44 168.18 36.56 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.527 ' CE ' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -46.87 -40.02 13.21 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.21 -1.17 . . . . 0.0 111.118 -179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 44.59 92.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.0 110.863 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.22 -25.06 21.95 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -138.27 141.25 39.86 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.425 0.631 . . . . 0.0 109.604 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -149.45 95.21 2.32 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.437 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 6.4 ttp -101.07 164.78 11.64 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.873 0.844 . . . . 0.0 111.823 -177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.91 HD23 ' HA3' ' A' ' 153' ' ' GLY . 72.8 mt -143.93 133.59 23.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.7 OUTLIER -108.27 99.09 8.54 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.855 -1.153 . . . . 0.0 110.8 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.623 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -150.09 -167.35 2.8 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.379 -0.826 . . . . 0.0 109.984 178.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 145' ' ' THR . 0.1 OUTLIER 59.31 -162.4 0.25 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.148 -0.97 . . . . 0.0 110.007 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.438 ' HB3' ' O ' ' A' ' 143' ' ' ASP . 15.4 tttt 56.5 -83.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.288 -0.882 . . . . 0.0 110.227 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.518 ' N ' ' O ' ' A' ' 143' ' ' ASP . 15.3 t -151.12 15.61 0.73 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.032 -1.043 . . . . 0.0 110.473 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 150' ' ' ARG . 9.6 p -128.47 2.3 5.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.18 -0.95 . . . . 0.0 110.196 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.693 ' HB2' HG22 ' A' ' 118' ' ' VAL . 6.0 p30 -50.17 -42.84 51.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.225 -0.922 . . . . 0.0 110.528 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.502 ' N ' ' OD1' ' A' ' 147' ' ' ASN . 5.0 mtt180 -111.26 -24.79 10.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -0.895 . . . . 0.0 110.512 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -76.99 0.1 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.251 -0.905 . . . . 0.0 110.113 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.406 ' O ' ' HB ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -133.8 92.99 3.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 109.935 179.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -98.95 122.73 7.66 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.562 ' HB2' ' CE1' ' A' ' 112' ' ' PHE . 38.2 p90 -146.68 136.56 23.3 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.379 -1.071 . . . . 0.0 109.77 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.91 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -111.25 157.34 15.02 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.645 -1.265 . . . . 0.0 110.26 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.581 ' CZ ' ' CD1' ' A' ' 112' ' ' PHE . 24.4 m-85 -121.83 109.41 14.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.385 -1.068 . . . . 0.0 109.363 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.518 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 1.2 t -104.59 179.5 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.024 -1.047 . . . . 0.0 109.342 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.525 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 98.8 m -161.94 107.28 1.26 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 117.984 -1.486 . . . . 0.0 112.535 -179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.05 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -131.32 106.24 8.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.421 -0.8 . . . . 0.0 108.915 177.346 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.527 ' HB2' ' CE ' ' A' ' 134' ' ' LYS . 5.0 mm-40 -39.33 -27.69 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.471 -0.768 . . . . 0.0 110.822 -179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.944 ' O ' HG23 ' A' ' 163' ' ' VAL . 3.4 m -55.58 85.91 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 0.0 110.129 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.508 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -62.94 -38.33 90.59 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.129 -0.982 . . . . 0.0 109.738 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.57 -67.38 0.23 Allowed 'General case' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 110.137 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.781 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.7 OUTLIER -58.17 -40.23 76.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.228 -0.92 . . . . 0.0 109.119 179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.05 HG22 ' CE2' ' A' ' 157' ' ' PHE . 18.2 t -57.23 -34.52 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 160' ' ' GLU . 1.4 tt0 -55.34 -53.08 60.62 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.255 0.55 . . . . 0.0 110.777 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.463 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.6 tttt -88.59 -59.51 2.21 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.267 -0.896 . . . . 0.0 110.829 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.781 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.82 -26.51 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.333 -0.854 . . . . 0.0 109.631 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 7.9 t -73.64 -45.67 51.43 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.279 -0.888 . . . . 0.0 109.591 179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 169' ' ' ILE . 29.1 tt0 -61.16 -67.69 0.38 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.556 -0.715 . . . . 0.0 110.4 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.42 ' C ' ' O ' ' A' ' 168' ' ' GLU . 93.2 mt -42.83 111.82 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.283 -0.886 . . . . 0.0 110.272 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.524 ' O ' ' N ' ' A' ' 172' ' ' HIS . 95.8 m-70 -83.73 -55.01 4.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 110.349 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.625 ' CZ ' ' HB3' ' A' ' 178' ' ' MET . 10.3 t80 -61.16 76.72 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 110.14 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 170' ' ' HIS . 0.1 OUTLIER -91.56 121.02 32.87 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.243 -0.91 . . . . 0.0 110.03 -179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.593 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 1.1 pt-20 -72.36 89.64 1.24 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 110.58 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 174' ' ' ILE . 16.4 tt -89.27 91.75 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 120.986 -1.071 . . . . 0.0 109.909 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 3.4 m-20 65.73 -55.32 0.35 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.791 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.466 ' N ' ' O ' ' A' ' 174' ' ' ILE . 2.3 p30 -158.19 18.74 0.24 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.273 -0.892 . . . . 0.0 110.648 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.593 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.2 tptt -131.66 169.24 16.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.138 -0.976 . . . . 0.0 110.664 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.625 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 0.8 OUTLIER -112.4 33.57 4.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.057 -1.027 . . . . 0.0 109.267 178.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.518 HG12 ' C ' ' A' ' 115' ' ' GLY . 18.0 m -37.96 159.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 121.514 0.673 . . . . 0.0 111.315 -179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 170' ' ' HIS . 0.0 OUTLIER -99.06 141.37 31.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.558 -0.714 . . . . 0.0 109.761 179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.549 ' HG ' ' HZ ' ' A' ' 129' ' ' PHE . 38.5 m -113.33 127.8 56.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.895 . . . . 0.0 110.759 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.467 ' HG3' ' OE1' ' A' ' 180' ' ' GLU . 1.4 mmmt -125.77 170.32 11.7 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.347 -0.846 . . . . 0.0 109.678 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -108.52 169.79 8.43 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.076 -1.015 . . . . 0.0 110.329 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.926 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.403 -0.811 . . . . 0.0 109.838 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.823 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 27.1 pttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.065 0.459 . . . . 0.0 109.917 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.899 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.1 pp -94.61 171.59 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.459 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.821 ' N ' HD12 ' A' ' 111' ' ' ILE . 27.9 t80 -123.38 152.97 41.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.415 -0.803 . . . . 0.0 110.08 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 181' ' ' CYS . 0.3 OUTLIER -147.14 160.79 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.917 . . . . 0.0 110.394 -179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -144.17 168.76 26.49 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.603 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 90.01 17.15 54.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.59 HD22 HD22 ' A' ' 140' ' ' LEU . 7.0 mt -44.81 97.46 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.361 -1.082 . . . . 0.0 110.032 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.471 ' HB3' ' OG1' ' A' ' 120' ' ' THR . 11.3 t -45.66 171.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.397 -0.814 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.575 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -70.81 149.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.531 -0.731 . . . . 0.0 110.168 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.526 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 65.08 -42.24 0.32 Allowed 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.438 0.637 . . . . 0.0 109.996 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 118' ' ' VAL . 6.1 m -38.76 120.91 1.0 Allowed 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 121.3 0.572 . . . . 0.0 110.436 -178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.494 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 14.8 t -119.86 170.4 9.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.321 -0.862 . . . . 0.0 110.396 -179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 138' ' ' ALA . 1.9 t -38.48 -46.75 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.423 -0.798 . . . . 0.0 110.226 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.504 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 2.9 tt0 -40.95 -27.23 0.05 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.465 -0.772 . . . . 0.0 109.072 179.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 1.027 ' OD2' HG23 ' A' ' 174' ' ' ILE . 8.1 t70 -77.75 -59.41 2.79 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.356 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.784 HG21 HD21 ' A' ' 140' ' ' LEU . 1.4 t -62.74 -45.99 97.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.424 -0.798 . . . . 0.0 109.904 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.501 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 18.4 tttt -56.83 -56.72 17.91 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.52 -0.737 . . . . 0.0 110.667 -179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.62 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -64.0 -26.23 68.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.319 -0.863 . . . . 0.0 110.125 -179.298 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.571 ' CZ ' ' O ' ' A' ' 173' ' ' GLU . 19.8 t80 -79.4 -57.76 3.54 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.511 -0.743 . . . . 0.0 112.435 -178.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.522 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 53.5 m-85 -77.38 -14.88 59.62 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.719 -1.238 . . . . 0.0 111.798 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.609 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -53.01 -41.68 64.91 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.152 -1.592 . . . . 0.0 108.859 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.515 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.7 pt20 -70.49 -18.14 62.96 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.541 ' O ' HG21 ' A' ' 162' ' ' ILE . 25.3 m-85 -83.23 -31.04 27.23 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.458 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -165.13 156.52 28.54 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.743 -1.743 . . . . 0.0 108.743 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.458 ' C ' ' O ' ' A' ' 133' ' ' GLY . 0.0 OUTLIER -39.22 -38.85 0.54 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.529 -0.983 . . . . 0.0 110.5 -179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.756 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 45.24 91.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -87.87 -25.63 23.18 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.74 137.6 43.61 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB1' HG12 ' A' ' 125' ' ' VAL . . . -147.08 93.96 2.34 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.557 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.8 ttm -101.01 162.86 12.59 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.954 0.883 . . . . 0.0 111.949 -177.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.997 HD23 ' HA3' ' A' ' 153' ' ' GLY . 13.1 mt -142.82 132.2 23.5 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.458 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 21.5 mmm -112.76 113.54 25.68 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.962 -1.086 . . . . 0.0 110.823 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.592 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 13.3 m-85 -100.4 162.99 12.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 0.0 110.093 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 174.42 6.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.247 -0.908 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -92.06 -41.24 10.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.209 -0.932 . . . . 0.0 110.324 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 10.9 m -123.97 -4.43 8.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.21 -0.931 . . . . 0.0 110.224 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 12.4 p -128.87 42.3 3.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.298 -0.877 . . . . 0.0 109.726 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -74.63 52.03 0.49 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.408 -0.808 . . . . 0.0 110.554 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.497 ' HA ' ' CG2' ' A' ' 118' ' ' VAL . 0.9 OUTLIER -106.38 -68.84 0.86 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.792 179.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -121.85 21.64 10.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.887 . . . . 0.0 109.976 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -124.25 159.56 29.93 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.843 . . . . 0.0 110.059 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.71 162.87 11.88 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.748 -1.341 . . . . 0.0 109.748 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.618 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 7.8 p90 -146.41 142.96 28.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.294 -1.121 . . . . 0.0 109.864 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.997 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -109.69 154.77 16.4 Favored Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.539 -1.315 . . . . 0.0 110.236 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 112' ' ' PHE . 21.5 m-85 -119.64 108.72 14.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.432 -1.04 . . . . 0.0 109.262 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 110' ' ' LYS . 1.3 t -104.76 178.27 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.004 -1.06 . . . . 0.0 109.225 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.507 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 86.0 m -161.26 109.82 1.55 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 118.356 -1.337 . . . . 0.0 112.09 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.974 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -136.19 110.2 8.26 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.05 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -39.7 -27.91 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.405 -0.809 . . . . 0.0 110.763 -178.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.854 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -55.29 85.95 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 110.322 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -68.2 -38.53 82.06 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.871 -1.143 . . . . 0.0 109.094 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 8.0 t70 -43.02 -57.26 2.95 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.664 -0.647 . . . . 0.0 110.032 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.769 ' O ' HG12 ' A' ' 166' ' ' VAL . 3.9 tp -64.01 -39.86 86.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 120.963 -1.085 . . . . 0.0 108.945 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.974 HG22 ' CE2' ' A' ' 157' ' ' PHE . 37.5 t -55.21 -39.33 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 2.7 tt0 -46.96 -59.45 3.09 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.798 -0.564 . . . . 0.0 111.043 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.449 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 0.4 OUTLIER -90.96 -47.54 7.52 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.121 -0.987 . . . . 0.0 111.834 -178.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.769 HG12 ' O ' ' A' ' 162' ' ' ILE . 3.6 p -50.37 -23.37 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.861 -1.15 . . . . 0.0 110.073 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.531 ' SG ' HG13 ' A' ' 163' ' ' VAL . 61.7 m -83.63 -0.64 51.45 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.969 . . . . 0.0 109.758 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 169' ' ' ILE . 0.5 OUTLIER -130.47 125.29 34.04 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 110.489 -179.389 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 0.2 OUTLIER 175.08 -29.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.323 -0.861 . . . . 0.0 109.964 179.816 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 66.03 20.75 11.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.286 -0.884 . . . . 0.0 110.798 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER 175.89 57.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.921 -1.112 . . . . 0.0 110.767 179.759 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.434 ' O ' ' O ' ' A' ' 171' ' ' PHE . 0.3 OUTLIER -61.72 -145.84 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 109.527 179.361 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.571 ' O ' ' CZ ' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -155.24 108.24 2.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.007 -1.058 . . . . 0.0 110.554 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.027 HG23 ' OD2' ' A' ' 124' ' ' ASP . 1.6 mt -109.32 96.11 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.188 -0.945 . . . . 0.0 109.753 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 1.9 m-20 66.56 -55.91 0.41 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.436 -0.79 . . . . 0.0 110.429 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -164.86 21.49 0.05 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.343 -0.848 . . . . 0.0 110.701 179.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.597 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.4 tptt -122.11 159.14 27.76 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.077 -1.015 . . . . 0.0 110.672 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -96.58 43.2 1.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.386 -0.821 . . . . 0.0 109.877 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.791 HG21 ' CG1' ' A' ' 174' ' ' ILE . 33.6 m -53.98 -174.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -137.3 152.7 50.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.858 . . . . 0.0 109.819 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.748 ' SG ' HD13 ' A' ' 111' ' ' ILE . 19.9 t -130.78 143.19 50.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.115 -0.991 . . . . 0.0 110.487 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.513 ' O ' ' HB ' ' A' ' 111' ' ' ILE . 10.7 mtmt -134.93 178.01 7.35 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.398 -0.813 . . . . 0.0 109.857 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -101.23 158.64 15.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.087 -1.008 . . . . 0.0 110.511 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.823 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.172 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 1.01 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 26.0 pttt . . . . . 0 N--CA 1.489 1.514 0 CA-C-O 121.116 0.484 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.871 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -116.02 177.47 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.445 -179.279 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.703 ' CD1' ' CE2' ' A' ' 154' ' ' PHE . 3.8 t80 -130.13 154.42 47.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.58 -0.7 . . . . 0.0 109.498 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.485 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.4 OUTLIER -142.34 151.1 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.26 -0.9 . . . . 0.0 110.352 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.09 174.33 26.93 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.447 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 85.72 0.63 87.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.638 HD23 HG11 ' A' ' 179' ' ' VAL . 0.6 OUTLIER -80.33 95.91 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -1.153 . . . . 0.0 110.33 -179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 116' ' ' LEU . 68.0 m -53.41 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.143 -0.973 . . . . 0.0 109.632 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.633 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -81.28 -154.35 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.785 -1.197 . . . . 0.0 110.196 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.633 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.2 OUTLIER 64.45 -17.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.712 -0.617 . . . . 0.0 111.081 -178.775 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.3 m -91.18 172.81 8.29 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.806 -1.183 . . . . 0.0 110.469 -178.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.7 t -150.89 144.16 24.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.761 179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.748 HG13 ' O ' ' A' ' 138' ' ' ALA . 1.5 t -37.57 -47.86 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.603 -0.686 . . . . 0.0 110.638 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.447 ' C ' ' O ' ' A' ' 122' ' ' VAL . 1.4 tt0 -43.33 -26.05 0.17 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.356 -0.84 . . . . 0.0 109.216 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 24.7 m-20 -74.75 -56.23 5.01 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.404 0.621 . . . . 0.0 109.685 179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.513 HG13 ' CD2' ' A' ' 129' ' ' PHE . 2.0 t -63.05 -49.42 83.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.43 -0.794 . . . . 0.0 109.076 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.705 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 12.7 tttt -47.16 -65.71 0.52 Allowed 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.609 -0.682 . . . . 0.0 110.058 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -58.93 -31.73 68.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.944 . . . . 0.0 109.867 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.482 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 13.5 t80 -61.37 -68.26 0.33 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 0.0 110.368 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.513 ' CD2' HG13 ' A' ' 125' ' ' VAL . 73.1 m-85 -69.93 -15.87 63.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.011 -1.056 . . . . 0.0 110.911 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.529 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 23.0 tt0 -55.38 -37.82 68.04 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.75 -1.219 . . . . 0.0 108.124 178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.561 ' CG ' ' CD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -73.5 -18.1 61.14 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 178.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.561 ' CD1' ' CG ' ' A' ' 131' ' ' GLN . 5.9 m-30 -89.98 -30.15 17.98 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.563 0.696 . . . . 0.0 109.442 179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.534 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -160.45 161.93 32.98 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.445 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 15.1 ptpt -45.13 -41.05 7.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.187 -1.184 . . . . 0.0 110.38 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 49.92 92.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-O 121.944 0.878 . . . . 0.0 111.075 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' C ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -90.36 -30.08 17.66 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.579 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.435 ' OD1' ' C ' ' A' ' 136' ' ' ASP . 14.3 m-20 -132.66 136.67 46.61 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.772 ' HA ' HG13 ' A' ' 155' ' ' VAL . . . -144.94 92.32 2.26 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.454 ' CG ' ' N ' ' A' ' 140' ' ' LEU . 5.0 ttm -91.85 165.79 13.07 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 121.883 0.849 . . . . 0.0 112.113 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.556 ' CB ' HG23 ' A' ' 122' ' ' VAL . 5.2 tp -154.73 161.28 41.59 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.609 ' HB2' ' CE1' ' A' ' 152' ' ' PHE . 7.5 mmt -143.12 158.23 43.8 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.009 -1.057 . . . . 0.0 110.576 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.532 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 54.7 m-85 -125.87 -154.37 0.62 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.387 -0.821 . . . . 0.0 109.834 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.49 ' HB2' ' OD1' ' A' ' 147' ' ' ASN . 1.0 OUTLIER -45.32 159.04 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.2 -0.937 . . . . 0.0 110.265 179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.29 -47.17 75.94 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -0.889 . . . . 0.0 110.198 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.438 HG22 ' N ' ' A' ' 146' ' ' THR . 47.3 m -111.52 -86.14 0.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.35 -0.844 . . . . 0.0 110.249 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 145' ' ' THR . 4.7 p -146.8 24.64 1.19 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.297 -0.877 . . . . 0.0 110.149 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 143' ' ' ASP . 2.7 p30 -90.28 -106.16 0.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.39 -0.819 . . . . 0.0 110.323 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -150.42 -70.96 0.18 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.773 -1.204 . . . . 0.0 110.037 -179.78 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 42.52 -157.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.397 -0.815 . . . . 0.0 110.227 -179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -102.13 144.07 31.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.308 -179.903 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 116' ' ' LEU . . . -99.32 152.46 19.55 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 141' ' ' MET . 5.0 p90 -150.57 141.39 22.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.386 -1.067 . . . . 0.0 109.115 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 140' ' ' LEU . . . -135.07 178.01 18.89 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.985 -1.578 . . . . 0.0 110.771 -179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.703 ' CE2' ' CD1' ' A' ' 112' ' ' PHE . 88.0 m-85 -140.98 122.8 15.35 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.772 HG13 ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -110.65 -172.32 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.439 -1.304 . . . . 0.0 109.691 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.548 ' H ' HG12 ' A' ' 155' ' ' VAL . 18.6 m -158.54 102.62 1.72 Allowed 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 118.495 -1.282 . . . . 0.0 112.006 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.871 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -126.12 111.55 14.79 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.281 177.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.557 ' O ' ' N ' ' A' ' 160' ' ' GLU . 78.8 tt0 -41.69 -24.12 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.312 -0.867 . . . . 0.0 111.28 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.552 ' O ' HG22 ' A' ' 162' ' ' ILE . 0.5 OUTLIER -61.02 71.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.123 -0.986 . . . . 0.0 110.527 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.557 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.3 tt0 -51.86 -37.84 53.66 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.901 -1.124 . . . . 0.0 109.227 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -41.68 -59.66 1.58 Allowed 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 120.02 -0.672 . . . . 0.0 109.965 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.789 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -58.56 -47.7 87.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 C-N-CA 119.174 -1.01 . . . . 0.0 108.59 179.179 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 157' ' ' PHE . 42.7 t -45.91 -45.19 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -42.54 -59.51 1.86 Allowed 'General case' 0 N--CA 1.491 1.608 0 CA-C-O 121.327 0.584 . . . . 0.0 110.992 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.451 ' O ' ' N ' ' A' ' 167' ' ' CYS . 25.2 tttt -90.28 -57.93 2.67 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.304 -0.873 . . . . 0.0 111.422 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.789 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.1 p -42.35 -23.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.314 -0.866 . . . . 0.0 111.082 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.661 ' SG ' HG13 ' A' ' 163' ' ' VAL . 84.6 m -87.27 -15.19 38.83 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.827 -1.171 . . . . 0.0 110.413 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 62.2 mt-10 -105.87 36.07 2.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.857 . . . . 0.0 110.392 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.494 HG21 ' ND1' ' A' ' 172' ' ' HIS . 1.6 tt -113.79 157.69 14.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.085 -1.01 . . . . 0.0 110.268 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -116.56 -9.64 11.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.197 -0.939 . . . . 0.0 110.112 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.3 OUTLIER -140.8 90.66 2.35 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 0.0 110.307 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.673 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -90.37 -16.67 28.7 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.321 -0.862 . . . . 0.0 110.347 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.6 OUTLIER 61.89 77.5 0.33 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 0.0 110.159 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.767 HG23 ' O ' ' A' ' 174' ' ' ILE . 15.3 tt -96.46 98.04 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.273 -0.892 . . . . 0.0 110.002 179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.2 m-20 65.33 -54.75 0.33 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.534 -0.729 . . . . 0.0 111.042 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.495 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -160.7 18.45 0.13 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.257 -0.902 . . . . 0.0 110.855 -179.342 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.546 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.1 tptt -130.58 159.33 37.48 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.067 -1.02 . . . . 0.0 111.443 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -102.22 29.69 4.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.418 -0.801 . . . . 0.0 108.897 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.638 HG11 HD23 ' A' ' 116' ' ' LEU . 6.6 m -35.27 152.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-O 121.489 0.661 . . . . 0.0 111.34 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.505 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 5.1 tt0 -106.0 148.47 27.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.464 -0.773 . . . . 0.0 109.682 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.505 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 87.9 m -110.65 140.45 44.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.117 -0.989 . . . . 0.0 110.418 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.481 ' CG ' ' OE2' ' A' ' 180' ' ' GLU . 21.2 mmmt -128.57 167.32 17.31 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.0 109.855 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.494 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -92.73 152.64 19.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.185 -0.947 . . . . 0.0 110.422 -179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 1.01 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.285 -0.885 . . . . 0.0 110.128 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.923 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 3.5 pttp . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.085 0.469 . . . . 0.0 110.182 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.656 HD13 ' HA ' ' A' ' 156' ' ' THR . 0.0 OUTLIER -122.36 173.46 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.323 -0.861 . . . . 0.0 110.106 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 24.7 t80 -132.96 151.17 52.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 110.242 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.576 HG12 ' HA ' ' A' ' 181' ' ' CYS . 0.1 OUTLIER -141.1 146.95 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.238 -0.914 . . . . 0.0 110.374 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.4 158.57 26.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.541 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 107.38 -6.8 36.55 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.577 HD23 HG21 ' A' ' 174' ' ' ILE . 1.2 mp -68.28 96.24 0.64 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 110.037 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.2 OUTLIER -58.3 -152.61 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.256 -0.903 . . . . 0.0 110.01 -179.949 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.697 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -89.53 -165.09 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.97 -1.081 . . . . 0.0 110.416 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.697 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER 63.63 -11.54 0.1 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.681 -0.637 . . . . 0.0 110.509 -178.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.685 HG22 ' H ' ' A' ' 121' ' ' THR . 3.4 m -90.43 -175.9 4.61 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 120.97 -1.081 . . . . 0.0 110.84 -178.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.685 ' H ' HG22 ' A' ' 120' ' ' THR . 6.2 t -176.99 153.49 1.0 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.46 -0.775 . . . . 0.0 109.443 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.718 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -40.55 -51.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 0.0 110.554 -179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.522 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.9 -26.18 0.13 Allowed 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.397 -0.815 . . . . 0.0 109.24 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.619 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 53.8 m-20 -77.27 -58.5 3.24 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.215 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 t -64.9 -48.08 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.023 -1.048 . . . . 0.0 109.38 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 3.2 tttt -49.03 -64.36 0.83 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.518 -0.739 . . . . 0.0 110.523 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.619 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 6.1 p-80 -59.87 -32.26 70.55 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.112 -0.993 . . . . 0.0 110.013 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 63.6 t80 -62.93 -65.0 0.75 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.379 -0.826 . . . . 0.0 110.487 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 79.2 m-85 -72.77 -13.7 61.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.946 -1.096 . . . . 0.0 111.149 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.721 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 1.1 tp10 -57.55 -37.34 72.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 120.449 -1.407 . . . . 0.0 108.282 179.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.5 pt20 -76.43 -12.44 60.05 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.245 -0.982 . . . . 0.0 108.447 178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.545 ' CA ' HD13 ' A' ' 162' ' ' ILE . 4.3 m-30 -88.26 -30.64 19.5 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.731 -0.606 . . . . 0.0 110.764 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.569 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -173.88 62.92 0.12 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 118.36 -1.876 . . . . 0.0 111.292 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.515 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 2.6 tptt 58.97 -68.06 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.458 -1.025 . . . . 0.0 111.521 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.1 t 63.99 91.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.173 -0.954 . . . . 0.0 110.722 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.88 -29.27 27.34 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -129.95 139.38 51.1 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.358 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.718 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -152.61 95.8 2.06 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.242 -0.911 . . . . 0.0 108.7 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.565 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 2.9 ttt -101.8 162.69 12.72 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.727 0.775 . . . . 0.0 111.462 -178.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.527 ' CD1' HD22 ' A' ' 116' ' ' LEU . 53.7 tp -144.35 160.54 40.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.771 -0.581 . . . . 0.0 109.995 179.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.514 ' HG2' ' O ' ' A' ' 140' ' ' LEU . 0.0 OUTLIER -144.72 159.01 43.55 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.477 -0.764 . . . . 0.0 110.902 -179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 143' ' ' ASP . 89.9 m-85 -130.23 -160.12 1.01 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.542 -0.724 . . . . 0.0 109.238 178.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 148' ' ' ARG . 26.5 t0 58.94 120.01 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.08 . . . . 0.0 110.325 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.446 ' HB3' ' HB3' ' A' ' 149' ' ' HIS . 7.9 tptt -131.7 -48.64 0.96 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.209 -0.932 . . . . 0.0 110.196 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 146' ' ' THR . 5.3 t -119.49 -40.55 2.77 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.23 -0.919 . . . . 0.0 110.582 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 145' ' ' THR . 24.3 p -140.73 -80.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.152 -0.968 . . . . 0.0 110.091 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.51 ' O ' ' CZ ' ' A' ' 148' ' ' ARG . 5.5 p30 -91.21 -49.17 6.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.512 -0.743 . . . . 0.0 110.704 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.51 ' CZ ' ' O ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -150.18 -89.38 0.07 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.283 -0.886 . . . . 0.0 109.976 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.449 ' O ' ' O ' ' A' ' 150' ' ' ARG . 0.1 OUTLIER 62.55 74.22 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.181 179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 149' ' ' HIS . 6.2 mtt180 58.87 147.54 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.323 -0.861 . . . . 0.0 110.792 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -132.9 -170.27 12.43 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.603 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 12.4 p90 -146.24 142.94 28.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.018 -1.284 . . . . 0.0 109.498 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.55 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -125.53 150.51 17.4 Favored Glycine 0 N--CA 1.488 2.156 0 C-N-CA 118.951 -1.595 . . . . 0.0 110.55 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 34.0 m-85 -112.48 113.43 25.6 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.459 -1.024 . . . . 0.0 108.41 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -110.77 -178.58 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.086 -1.009 . . . . 0.0 109.506 -178.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.656 ' HA ' HD13 ' A' ' 111' ' ' ILE . 27.6 m -159.09 103.6 1.66 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.811 -1.18 . . . . 0.0 111.26 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.001 ' CE1' HG22 ' A' ' 163' ' ' VAL . 2.0 p90 -126.54 106.92 9.77 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.85 178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.9 mt-10 -40.25 -37.7 0.68 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.65 -0.656 . . . . 0.0 111.187 -179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.959 ' O ' HG23 ' A' ' 163' ' ' VAL . 58.7 m -46.54 92.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.22 -0.925 . . . . 0.0 110.215 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -64.02 -37.98 89.42 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.08 -1.013 . . . . 0.0 109.492 179.551 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.503 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 4.9 t0 -40.57 -64.36 0.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.186 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.776 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.7 OUTLIER -60.34 -44.92 96.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.97 -1.081 . . . . 0.0 108.693 179.205 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.001 HG22 ' CE1' ' A' ' 157' ' ' PHE . 15.5 t -51.17 -41.7 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -48.25 -58.53 4.43 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.375 -0.828 . . . . 0.0 111.184 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.496 ' O ' ' N ' ' A' ' 167' ' ' CYS . 12.0 tttt -90.47 -58.21 2.57 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.939 -1.101 . . . . 0.0 111.272 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 162' ' ' ILE . 2.0 p -39.83 -26.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.455 -0.778 . . . . 0.0 110.762 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 163' ' ' VAL . 68.5 m -82.73 -31.96 28.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.954 -1.091 . . . . 0.0 110.15 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.478 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 -54.38 154.87 4.25 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.137 -0.977 . . . . 0.0 110.551 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.458 HG12 ' OE2' ' A' ' 180' ' ' GLU . 6.6 mt -67.34 124.16 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.359 -0.838 . . . . 0.0 110.202 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -165.88 -168.62 1.32 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.101 -1.0 . . . . 0.0 110.634 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.658 ' CE1' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER -100.66 89.11 3.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.382 -0.824 . . . . 0.0 110.052 -179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.576 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.1 OUTLIER -78.45 -158.14 0.13 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -0.915 . . . . 0.0 110.35 -179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 174' ' ' ILE . 5.1 tt0 -153.95 107.0 2.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 110.061 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.877 HD13 ' CG2' ' A' ' 179' ' ' VAL . 1.3 mp -113.42 102.37 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.994 -1.066 . . . . 0.0 110.007 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.449 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER 67.56 -56.24 0.46 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.309 -0.87 . . . . 0.0 110.292 179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.557 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -168.97 25.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.526 -0.734 . . . . 0.0 109.99 -179.776 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.657 ' HB3' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -130.74 151.81 50.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.182 -0.949 . . . . 0.0 111.14 -179.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.658 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -90.36 46.9 1.38 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.54 -0.725 . . . . 0.0 109.607 179.388 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.877 ' CG2' HD13 ' A' ' 174' ' ' ILE . 20.3 m -54.77 -160.21 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.517 -0.74 . . . . 0.0 110.802 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.458 ' OE2' HG12 ' A' ' 169' ' ' ILE . 15.6 tt0 -150.51 142.41 23.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.402 -0.811 . . . . 0.0 109.919 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.576 ' HA ' HG12 ' A' ' 113' ' ' VAL . 16.8 t -112.66 156.95 21.87 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.176 -0.953 . . . . 0.0 110.582 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 167' ' ' CYS . 51.2 mttt -138.78 -178.77 5.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.347 -0.846 . . . . 0.0 110.177 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.485 ' C ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -102.9 161.13 14.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.253 -0.904 . . . . 0.0 110.179 179.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.923 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.913 . . . . 0.0 110.216 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.015 0.436 . . . . 0.0 110.11 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.65 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.5 pt -110.3 169.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.105 -0.997 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 7.9 t80 -125.01 158.39 33.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.23 -0.919 . . . . 0.0 110.113 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.2 OUTLIER -150.16 142.84 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 0.0 110.383 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -134.43 150.84 20.15 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.716 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 103.34 2.0 47.59 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.707 HD12 ' CA ' ' A' ' 152' ' ' PHE . 2.5 mt -63.62 98.98 0.2 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.203 -1.175 . . . . 0.0 110.022 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.509 ' HB2' ' HE2' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -39.61 156.94 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.553 -0.717 . . . . 0.0 110.63 -179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.563 HG12 ' N ' ' A' ' 119' ' ' ASN . 2.4 t -62.75 -62.68 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.475 -0.766 . . . . 0.0 110.383 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.563 ' N ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -44.58 -19.88 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 121.736 0.779 . . . . 0.0 108.914 179.718 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.578 ' O ' ' CE2' ' A' ' 142' ' ' PHE . 2.9 m -68.18 157.8 34.61 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.826 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 123' ' ' GLU . 7.8 t -148.44 150.47 33.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.097 -1.002 . . . . 0.0 110.405 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.648 HG23 ' HB2' ' A' ' 140' ' ' LEU . 3.2 t -35.77 -53.93 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.764 -0.585 . . . . 0.0 111.097 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.536 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.5 mt-10 -41.02 -26.38 0.04 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.385 -0.822 . . . . 0.0 109.45 179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.546 ' O ' ' CE1' ' A' ' 127' ' ' HIS . 43.8 t0 -73.43 -59.44 2.71 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.526 0.679 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.506 HG21 HD11 ' A' ' 140' ' ' LEU . 2.4 t -68.71 -52.91 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.773 . . . . 0.0 109.066 179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.508 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.8 ttmt -41.04 -60.98 1.07 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.711 -0.618 . . . . 0.0 109.857 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.551 ' C ' ' CD2' ' A' ' 127' ' ' HIS . 1.0 OUTLIER -61.01 -31.73 71.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.185 -0.947 . . . . 0.0 109.879 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.478 ' N ' ' CD2' ' A' ' 127' ' ' HIS . 0.2 OUTLIER -65.59 -64.31 0.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.455 -0.778 . . . . 0.0 111.011 -179.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 28.2 m-85 -74.03 -16.75 61.04 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.657 -1.277 . . . . 0.0 111.303 -179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 4.5 tt0 -55.6 -37.98 68.84 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.036 -1.466 . . . . 0.0 108.173 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.3 pt20 -72.59 -18.06 61.64 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.537 ' O ' ' CD1' ' A' ' 162' ' ' ILE . 16.0 m-85 -84.84 -37.09 21.12 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -154.76 159.01 28.69 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.649 -1.78 . . . . 0.0 108.649 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' HD2' ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -42.42 -43.25 3.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.227 -1.16 . . . . 0.0 110.365 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 48.1 89.98 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 122.02 0.914 . . . . 0.0 110.94 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -89.18 -24.9 22.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -126.57 137.91 53.39 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.91 101.23 1.61 Allowed 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.707 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -112.9 157.61 21.23 Favored 'General case' 0 N--CA 1.504 2.25 0 CA-C-O 121.861 0.839 . . . . 0.0 112.758 -177.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 139' ' ' MET . 1.3 mp -138.12 142.45 40.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.885 -0.509 . . . . 0.0 110.258 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.508 ' HG3' ' CE2' ' A' ' 152' ' ' PHE . 2.2 mmt -118.5 145.78 45.03 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.13 -0.981 . . . . 0.0 110.012 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.647 ' HZ ' HD23 ' A' ' 140' ' ' LEU . 28.5 m-85 -136.21 -163.38 1.4 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.155 -0.966 . . . . 0.0 110.178 179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.413 ' HB2' ' HG2' ' A' ' 148' ' ' ARG . 5.5 t0 -94.92 -142.31 0.25 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.108 -0.995 . . . . 0.0 110.321 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -90.5 -60.33 1.95 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.256 -0.903 . . . . 0.0 110.437 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.442 ' O ' HG11 ' A' ' 118' ' ' VAL . 70.8 p -132.01 -71.2 0.55 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 0.0 110.202 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.1 t -149.02 48.48 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.341 -0.85 . . . . 0.0 110.001 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -85.22 -59.53 2.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.421 -0.799 . . . . 0.0 110.22 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.413 ' HG2' ' HB2' ' A' ' 143' ' ' ASP . 40.8 ptt180 -112.24 141.24 46.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.339 -0.85 . . . . 0.0 110.141 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.402 ' O ' ' HA ' ' A' ' 117' ' ' SER . 2.2 m170 -90.24 29.83 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 110.517 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -140.28 152.18 45.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.156 -0.965 . . . . 0.0 110.337 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 115' ' ' GLY . . . -152.2 -169.06 17.17 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.707 ' CA ' HD12 ' A' ' 116' ' ' LEU . 50.1 p90 -149.91 135.13 18.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.127 -1.219 . . . . 0.0 109.855 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.6 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -128.0 166.92 20.45 Favored Glycine 0 N--CA 1.49 2.25 0 C-N-CA 119.53 -1.319 . . . . 0.0 110.148 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.51 ' O ' ' CG ' ' A' ' 139' ' ' MET . 64.6 m-85 -122.99 109.93 14.73 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -1.095 . . . . 0.0 109.03 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.2 t -99.81 177.45 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 O-C-N 120.948 -1.095 . . . . 0.0 109.172 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.561 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 91.5 m -165.03 109.86 0.91 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 118.127 -1.429 . . . . 0.0 112.461 -179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.75 ' HE1' HG22 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -118.88 135.03 54.78 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.542 -0.863 . . . . 0.0 109.2 177.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.404 ' HB2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -72.07 54.18 0.28 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.19 -0.944 . . . . 0.0 110.475 -179.475 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -152.89 96.64 2.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.352 -0.842 . . . . 0.0 110.115 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 161' ' ' ASP . 10.5 tt0 -49.71 -38.33 32.74 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 108.729 179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 160' ' ' GLU . 0.5 OUTLIER -41.95 -47.33 4.32 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.254 179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.758 ' O ' HG12 ' A' ' 166' ' ' VAL . 20.1 mm -68.5 -42.6 83.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.75 HG22 ' HE1' ' A' ' 157' ' ' PHE . 11.8 t -63.28 -40.61 89.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 160' ' ' GLU . 52.5 mt-10 -56.29 -47.11 79.31 Favored 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.495 -0.753 . . . . 0.0 110.621 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 168' ' ' GLU . 19.2 ttmt -90.25 -65.63 1.0 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.356 -0.84 . . . . 0.0 111.167 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.758 HG12 ' O ' ' A' ' 162' ' ' ILE . 1.0 OUTLIER -41.42 -25.45 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.335 -0.853 . . . . 0.0 110.175 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.583 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 41.2 t -76.51 -36.15 57.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.091 -1.005 . . . . 0.0 109.374 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 87.3 mt-10 -83.72 -160.99 0.48 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.64 -0.663 . . . . 0.0 110.105 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.481 ' O ' ' O ' ' A' ' 168' ' ' GLU . 44.0 mt 57.32 152.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.471 -0.768 . . . . 0.0 110.173 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.506 ' HB3' ' CD1' ' A' ' 171' ' ' PHE . 77.1 m-70 -53.17 -98.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.071 -1.018 . . . . 0.0 110.115 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.66 ' CZ ' ' HB3' ' A' ' 178' ' ' MET . 2.2 p90 -127.39 170.32 12.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.039 -1.038 . . . . 0.0 110.228 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.555 ' CE1' HG23 ' A' ' 166' ' ' VAL . 34.3 m-70 -102.83 24.94 9.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.243 -0.911 . . . . 0.0 110.646 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.544 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 46.47 95.74 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.153 -0.967 . . . . 0.0 110.054 -179.836 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.699 ' O ' HG22 ' A' ' 174' ' ' ILE . 1.0 OUTLIER -93.44 100.52 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.118 -0.989 . . . . 0.0 109.602 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.52 ' ND2' ' OD2' ' A' ' 124' ' ' ASP . 2.6 m-20 65.58 -55.85 0.34 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.292 -0.88 . . . . 0.0 110.358 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.3 OUTLIER -168.66 28.05 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.414 -0.804 . . . . 0.0 109.537 179.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 3.5 tptt -132.51 158.02 43.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.483 -0.761 . . . . 0.0 110.769 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.66 ' HB3' ' CZ ' ' A' ' 171' ' ' PHE . 1.0 OUTLIER -100.78 55.17 0.86 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.341 -0.849 . . . . 0.0 109.859 179.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.716 HG12 ' C ' ' A' ' 115' ' ' GLY . 33.4 m -59.32 130.26 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.527 -0.733 . . . . 0.0 110.713 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.4 OUTLIER -70.65 148.01 48.53 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.333 -0.855 . . . . 0.0 110.328 179.763 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.548 ' SG ' HG22 ' A' ' 166' ' ' VAL . 3.0 t -125.08 140.8 52.57 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 110.037 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.405 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 0.9 OUTLIER -149.04 -174.34 4.61 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -0.957 . . . . 0.0 110.293 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.471 ' N ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -109.82 150.28 28.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.341 -179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.647 0 O-C-N 121.299 -0.876 . . . . 0.0 110.106 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.877 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.15 0.5 . . . . 0.0 110.29 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.012 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 3.3 pt -110.81 167.93 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.242 -0.911 . . . . 0.0 111.138 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -119.29 155.01 32.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.59 -0.694 . . . . 0.0 109.278 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -148.39 146.97 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.082 -1.011 . . . . 0.0 110.556 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.41 -170.33 12.26 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.622 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 65.45 23.31 70.18 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' A' ' 117' ' ' SER . 1.1 mt -84.15 93.91 8.26 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.314 -1.109 . . . . 0.0 110.343 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.481 ' HB3' ' HE3' ' A' ' 177' ' ' LYS . 99.2 p -52.66 -172.6 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 109.787 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.718 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.5 t -85.22 -165.96 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.974 -1.079 . . . . 0.0 110.159 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.718 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER 63.11 -10.28 0.1 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.626 -0.671 . . . . 0.0 110.358 -178.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.524 ' H ' ' C ' ' A' ' 118' ' ' VAL . 0.7 OUTLIER -88.7 -177.27 5.51 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.117 -0.99 . . . . 0.0 110.781 -178.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.546 HG22 ' OD1' ' A' ' 124' ' ' ASP . 12.1 t -178.8 153.7 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.474 -0.766 . . . . 0.0 109.878 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.628 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -38.42 -50.81 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.52 -0.738 . . . . 0.0 110.735 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.477 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -42.67 -26.17 0.11 Allowed 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.344 -0.848 . . . . 0.0 109.197 179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.64 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.7 m-20 -76.58 -57.72 3.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 0.0 110.062 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.603 HG12 ' HB1' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -64.12 -47.83 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.46 -0.775 . . . . 0.0 109.549 179.559 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -51.13 -62.62 1.51 Allowed 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.59 -0.694 . . . . 0.0 110.653 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.64 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 0.6 OUTLIER -57.62 -26.53 61.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.383 -0.823 . . . . 0.0 110.549 -179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.2 OUTLIER -78.48 -64.19 1.23 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.385 -0.822 . . . . 0.0 111.891 -178.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 52.1 m-85 -70.91 -13.42 62.01 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.927 -1.108 . . . . 0.0 112.283 -178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.667 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -53.99 -41.39 67.86 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 119.893 -1.755 . . . . 0.0 109.115 179.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.9 pt20 -73.66 -14.86 61.23 Favored 'General case' 0 C--N 1.295 -1.793 0 C-N-CA 119.349 -0.94 . . . . 0.0 108.554 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.531 ' HB2' ' O ' ' A' ' 129' ' ' PHE . 16.2 m-85 -82.36 -31.11 29.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.725 -0.609 . . . . 0.0 110.051 179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.554 ' O ' ' CB ' ' A' ' 157' ' ' PHE . . . -174.44 60.24 0.12 Allowed Glycine 0 N--CA 1.492 2.418 0 C-N-CA 118.503 -1.808 . . . . 0.0 111.055 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 135' ' ' VAL . 4.3 tptt 59.71 -70.1 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.31 -1.112 . . . . 0.0 110.831 178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.735 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 63.58 94.01 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.004 . . . . 0.0 111.315 -179.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -89.64 -23.15 21.98 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -133.29 137.67 46.1 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.502 0.668 . . . . 0.0 109.449 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.603 ' HB1' HG12 ' A' ' 125' ' ' VAL . . . -153.76 96.02 1.95 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.628 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 4.3 ttm -101.49 165.98 10.96 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.907 0.861 . . . . 0.0 111.972 -177.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.794 HD23 ' CZ ' ' A' ' 142' ' ' PHE . 2.6 tp -143.57 151.08 39.76 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.636 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 3.0 mmt -128.11 130.87 48.84 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.772 -1.205 . . . . 0.0 111.253 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.794 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 10.4 m-85 -126.72 -174.56 3.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.604 -0.685 . . . . 0.0 109.515 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 142' ' ' PHE . 7.6 t0 66.54 -162.25 0.24 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.106 -0.996 . . . . 0.0 110.487 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' CB ' ' O ' ' A' ' 143' ' ' ASP . 0.1 OUTLIER 63.16 53.98 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.176 -0.952 . . . . 0.0 109.817 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 62.26 11.63 4.6 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.126 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -128.33 5.89 5.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.002 179.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.693 ' O ' HG22 ' A' ' 118' ' ' VAL . 13.0 p-10 -47.18 -23.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.221 -0.925 . . . . 0.0 109.917 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.05 -31.57 3.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.394 -0.816 . . . . 0.0 110.264 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 150' ' ' ARG . 0.2 OUTLIER -80.75 47.57 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.25 -0.906 . . . . 0.0 110.175 179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.556 ' O ' HG22 ' A' ' 146' ' ' THR . 1.4 mpt_? 57.09 157.89 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 0.0 110.062 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -129.41 -149.69 6.87 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.636 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 25.0 p90 -145.62 136.0 24.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.924 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.737 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -120.82 158.12 15.76 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -121.68 107.38 12.29 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.472 -1.017 . . . . 0.0 109.246 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -102.7 179.44 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.947 -1.096 . . . . 0.0 109.08 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.55 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 62.9 m -163.35 106.62 1.01 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 118.184 -1.406 . . . . 0.0 111.915 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.026 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -125.09 105.64 9.32 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.494 177.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.512 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -39.76 -28.07 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.576 -0.703 . . . . 0.0 110.623 -179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.677 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -57.73 82.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.297 -0.877 . . . . 0.0 110.326 179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -57.28 -39.08 74.97 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.651 -1.281 . . . . 0.0 109.559 179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.462 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 3.7 m-20 -40.65 -64.88 0.47 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.51 -0.744 . . . . 0.0 110.541 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.791 ' O ' HG12 ' A' ' 166' ' ' VAL . 4.1 tp -57.25 -41.87 78.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 120.908 -1.12 . . . . 0.0 109.038 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.026 HG22 ' CE2' ' A' ' 157' ' ' PHE . 26.3 t -53.77 -37.56 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.7 OUTLIER -52.26 -56.72 12.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.809 -0.557 . . . . 0.0 110.975 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.487 ' O ' ' N ' ' A' ' 168' ' ' GLU . 25.9 tttp -85.87 -59.53 2.28 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.215 -0.928 . . . . 0.0 110.663 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.791 HG12 ' O ' ' A' ' 162' ' ' ILE . 3.9 p -40.94 -26.62 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.488 -0.758 . . . . 0.0 109.834 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 11.1 t -75.29 -38.34 60.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.261 -0.899 . . . . 0.0 109.872 179.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.53 ' O ' ' CE1' ' A' ' 170' ' ' HIS . 2.7 tt0 -60.2 -82.18 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.418 -0.801 . . . . 0.0 110.537 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.432 ' C ' ' O ' ' A' ' 168' ' ' GLU . 7.0 pt -39.31 125.73 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.523 -0.736 . . . . 0.0 110.382 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.53 ' CE1' ' O ' ' A' ' 168' ' ' GLU . 70.0 m80 -106.66 35.69 2.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.198 -0.939 . . . . 0.0 110.667 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.663 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 2.8 t80 -140.38 61.53 1.52 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.043 -1.035 . . . . 0.0 110.522 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.623 ' NE2' HG23 ' A' ' 166' ' ' VAL . 1.2 m80 -74.0 115.89 14.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.316 -0.865 . . . . 0.0 109.677 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 4.0 mt-10 -65.84 100.37 0.55 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 110.876 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.031 HD13 HG21 ' A' ' 179' ' ' VAL . 1.8 tp -78.1 -178.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.828 -1.17 . . . . 0.0 109.386 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.506 ' ND2' ' OD2' ' A' ' 124' ' ' ASP . 16.3 m-80 -34.56 -30.91 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.551 -0.718 . . . . 0.0 111.649 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.524 ' N ' ' O ' ' A' ' 174' ' ' ILE . 1.2 p30 -164.93 30.02 0.06 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.96 -1.088 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.3 tptp -145.99 -166.25 2.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.463 -0.773 . . . . 0.0 110.967 -179.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.663 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -131.22 38.9 3.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 1.031 HG21 HD13 ' A' ' 174' ' ' ILE . 27.6 m -35.6 153.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.461 0.648 . . . . 0.0 111.257 -179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -98.03 156.06 16.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.5 -0.75 . . . . 0.0 109.844 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 6.8 p -134.56 153.78 51.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.187 -0.946 . . . . 0.0 110.527 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 4.2 mtpt -152.97 168.43 25.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.345 -0.847 . . . . 0.0 109.94 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.15 154.63 17.98 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.187 -0.945 . . . . 0.0 110.101 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.877 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.206 -0.934 . . . . 0.0 110.373 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.598 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.187 0.518 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.907 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.1 pt -125.87 176.13 6.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 110.454 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.509 ' CD1' ' N ' ' A' ' 113' ' ' VAL . 3.9 t80 -127.11 160.63 30.59 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.532 -0.73 . . . . 0.0 109.2 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.509 ' N ' ' CD1' ' A' ' 112' ' ' PHE . 0.7 OUTLIER -144.73 140.12 23.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.159 -0.963 . . . . 0.0 110.419 -179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -136.86 157.89 23.93 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.476 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 94.78 -23.06 34.49 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.822 HD21 ' HA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -49.45 94.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.267 -1.137 . . . . 0.0 109.84 179.796 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.477 ' HA ' ' N ' ' A' ' 150' ' ' ARG . 11.7 p -54.52 163.3 0.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.262 -0.899 . . . . 0.0 110.697 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.977 HG13 ' HA ' ' A' ' 149' ' ' HIS . 18.9 m -62.81 -153.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.316 -0.865 . . . . 0.0 110.441 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.525 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.18 -41.95 0.16 Allowed 'General case' 0 N--CA 1.498 1.973 0 CA-C-O 121.649 0.738 . . . . 0.0 110.382 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 118' ' ' VAL . 30.8 m -70.92 156.52 39.5 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 121.532 -0.73 . . . . 0.0 110.087 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.475 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.62 148.1 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.108 -0.995 . . . . 0.0 109.992 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.676 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.2 t -40.12 -51.21 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.417 -0.802 . . . . 0.0 110.424 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.2 OUTLIER -42.94 -25.89 0.12 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.432 -0.793 . . . . 0.0 109.087 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.498 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 32.9 m-20 -72.28 -56.71 5.05 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.432 0.634 . . . . 0.0 109.503 179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.796 ' CG2' HD11 ' A' ' 174' ' ' ILE . 2.4 t -65.66 -53.45 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 121.564 0.697 . . . . 0.0 109.144 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -41.23 -63.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.725 -0.609 . . . . 0.0 109.901 179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.516 ' ND1' ' C ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -60.07 -30.12 69.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.955 . . . . 0.0 109.07 179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.514 ' HB2' ' HA ' ' A' ' 125' ' ' VAL . 0.2 OUTLIER -60.9 -69.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.622 -0.674 . . . . 0.0 110.315 179.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 74.3 m-85 -70.4 -15.26 62.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -0.967 . . . . 0.0 111.061 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 8.8 tt0 -57.17 -37.35 71.99 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.191 -1.568 . . . . 0.0 107.825 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 3.2 pt20 -72.51 -16.66 61.78 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.685 ' HB3' HD12 ' A' ' 162' ' ' ILE . 3.6 m-30 -83.42 -28.78 28.61 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.752 -0.593 . . . . 0.0 109.446 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 159' ' ' SER . . . -161.73 -139.42 2.64 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.478 ' HD2' ' HG3' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -94.14 -33.83 13.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.414 -1.05 . . . . 0.0 109.658 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.746 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 39.08 91.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 CA-C-O 122.109 0.957 . . . . 0.0 111.456 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.66 -25.3 18.33 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -131.36 140.04 49.62 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.676 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -157.17 100.16 1.84 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.575 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 1.6 ptp -116.66 165.99 12.64 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 121.876 0.846 . . . . 0.0 112.216 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.715 HD23 ' HA3' ' A' ' 153' ' ' GLY . 89.3 mt -142.92 146.48 34.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.85 -0.531 . . . . 0.0 109.579 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -120.64 110.12 16.04 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.0 -1.063 . . . . 0.0 110.337 -179.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -94.43 -166.34 1.47 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.244 -0.91 . . . . 0.0 109.869 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.476 ' O ' ' CB ' ' A' ' 144' ' ' LYS . 11.7 p-10 -86.92 -27.71 23.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.108 -0.995 . . . . 0.0 110.202 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' A' ' 143' ' ' ASP . 0.0 OUTLIER 170.6 -45.95 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 0.0 110.11 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -170.28 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 0.0 110.048 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -143.16 44.66 1.55 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 110.351 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.439 ' HB2' ' OD2' ' A' ' 143' ' ' ASP . 0.3 OUTLIER -90.43 -61.86 1.59 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.268 -0.895 . . . . 0.0 110.379 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' A' ' 149' ' ' HIS . 3.2 ptp180 -120.63 -132.15 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.431 -0.793 . . . . 0.0 110.116 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.977 ' HA ' HG13 ' A' ' 118' ' ' VAL . 54.5 p-80 -152.4 -143.49 0.13 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.12 -0.987 . . . . 0.0 109.848 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.477 ' N ' ' HA ' ' A' ' 117' ' ' SER . 0.0 OUTLIER 55.13 -156.47 0.24 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.105 -0.997 . . . . 0.0 110.112 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 122.77 175.84 14.75 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.822 ' HA ' HD21 ' A' ' 116' ' ' LEU . 17.7 p90 -144.85 138.83 27.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -1.103 . . . . 0.0 109.726 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.715 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -127.99 168.93 19.78 Favored Glycine 0 N--CA 1.492 2.409 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.395 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 139' ' ' MET . 76.0 m-85 -126.82 115.94 20.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.272 -1.134 . . . . 0.0 109.662 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -108.79 -177.1 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.082 -1.011 . . . . 0.0 109.044 -179.922 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 135' ' ' VAL . 16.3 m -163.75 104.73 0.93 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 118.441 -1.304 . . . . 0.0 111.591 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.907 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.9 p90 -129.92 116.65 18.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.307 -0.871 . . . . 0.0 109.97 178.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 160' ' ' GLU . 3.2 mm-40 -44.34 -32.58 1.36 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.305 -0.872 . . . . 0.0 110.387 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.543 ' HB3' ' CG1' ' A' ' 162' ' ' ILE . 0.1 OUTLIER -51.77 89.15 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.295 -0.878 . . . . 0.0 110.544 -179.841 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.498 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -56.57 -40.0 74.45 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.176 -0.952 . . . . 0.0 109.042 179.424 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -44.78 -38.05 4.22 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.943 ' O ' HG22 ' A' ' 166' ' ' VAL . 41.3 mm -69.61 -49.29 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.565 ' O ' ' CB ' ' A' ' 167' ' ' CYS . 20.0 t -58.25 -36.82 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 178.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.8 mm-40 -56.89 -44.39 82.25 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.627 -0.67 . . . . 0.0 110.715 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 161' ' ' ASP . 3.1 mttt -90.14 -64.96 1.06 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.176 -0.953 . . . . 0.0 110.449 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.943 HG22 ' O ' ' A' ' 162' ' ' ILE . 6.3 m -42.9 -24.52 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 119.618 -0.833 . . . . 0.0 109.856 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.565 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 8.4 t -71.73 -38.15 70.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.725 -1.235 . . . . 0.0 109.391 179.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 165' ' ' LYS . 8.0 mt-10 -64.67 173.1 2.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.537 -0.727 . . . . 0.0 110.49 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.458 ' O ' HG22 ' A' ' 169' ' ' ILE . 2.6 mp -97.09 78.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.273 -0.892 . . . . 0.0 110.166 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -106.65 -162.03 0.83 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.182 -0.949 . . . . 0.0 110.46 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.65 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 2.2 t80 -94.55 54.35 1.79 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.352 -0.843 . . . . 0.0 110.242 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.873 ' O ' HG22 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -67.86 100.71 0.98 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.123 -0.986 . . . . 0.0 109.865 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.535 ' HG3' ' N ' ' A' ' 177' ' ' LYS . 3.6 tt0 -80.89 141.73 34.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 0.0 110.589 -179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.796 HD11 ' CG2' ' A' ' 125' ' ' VAL . 4.7 tt -114.58 115.43 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.186 -0.947 . . . . 0.0 108.702 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 2.5 t-20 68.07 -55.77 0.5 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.058 -1.026 . . . . 0.0 109.631 -178.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.561 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -174.22 24.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.35 -0.844 . . . . 0.0 110.863 179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.627 ' HD2' HG12 ' A' ' 179' ' ' VAL . 0.1 OUTLIER -139.49 129.14 24.52 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.785 -1.197 . . . . 0.0 110.179 -179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.65 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -68.3 119.63 13.15 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.817 -1.177 . . . . 0.0 110.596 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.873 HG22 ' O ' ' A' ' 172' ' ' HIS . 4.4 m -120.08 -146.21 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 O-C-N 121.031 -1.043 . . . . 0.0 110.6 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.646 ' N ' HG23 ' A' ' 179' ' ' VAL . 57.1 tt0 -138.83 143.6 38.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.436 -0.79 . . . . 0.0 109.81 179.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.544 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 86.8 m -129.2 138.14 51.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.159 -0.963 . . . . 0.0 110.306 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 7.9 mttt -133.91 175.67 9.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.29 -0.882 . . . . 0.0 109.816 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.511 ' CD ' ' SG ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -75.25 163.74 27.18 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.062 -1.024 . . . . 0.0 110.264 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 110.293 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.978 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.25 0.548 . . . . 0.0 110.237 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.146 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -105.2 165.84 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.132 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -124.51 136.69 54.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 110.125 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -131.34 142.65 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 110.075 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.441 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -146.87 168.46 28.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.3 -29.4 8.93 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.129 -1.588 . . . . 0.0 109.129 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -53.67 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.349 -1.089 . . . . 0.0 110.153 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.449 ' O ' ' O ' ' A' ' 116' ' ' LEU . 4.3 p -52.47 -173.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.305 -0.872 . . . . 0.0 109.854 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.741 HG21 ' HD3' ' A' ' 148' ' ' ARG . 1.3 t -75.12 -149.83 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.034 -1.041 . . . . 0.0 109.467 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.577 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.1 OUTLIER 64.06 -14.84 0.08 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.673 -0.642 . . . . 0.0 111.398 -179.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 121' ' ' THR . 0.2 OUTLIER -89.87 -167.13 1.76 Allowed 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.721 -1.237 . . . . 0.0 110.684 -178.108 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.498 ' H ' HG22 ' A' ' 120' ' ' THR . 14.4 t -173.21 139.44 0.79 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.637 -0.664 . . . . 0.0 109.389 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.59 ' CG2' ' HA ' ' A' ' 139' ' ' MET . 2.3 t -35.07 -49.92 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.633 -0.667 . . . . 0.0 111.303 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 122' ' ' VAL . 10.2 mt-10 -43.35 -25.88 0.16 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.293 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.497 ' O ' ' HB2' ' A' ' 128' ' ' TYR . 66.2 m-20 -73.42 -47.64 40.11 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.421 0.629 . . . . 0.0 110.209 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.795 HG21 HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -73.86 -44.56 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 C-N-CA 119.295 -0.962 . . . . 0.0 108.663 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.2 ttpp -50.02 -65.2 0.6 Allowed 'General case' 0 C--N 1.293 -1.849 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.454 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -64.42 -32.32 73.89 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.025 -1.047 . . . . 0.0 110.681 -179.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.497 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 4.5 t80 -66.1 -54.06 30.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.301 -0.874 . . . . 0.0 111.212 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.762 ' CD2' HG12 ' A' ' 125' ' ' VAL . 46.2 m-85 -83.98 -16.53 43.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 111.164 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 40.2 tt0 -57.42 -36.89 71.93 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 120.053 -1.654 . . . . 0.0 107.73 178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 13.2 pt20 -74.6 -15.93 60.82 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.704 ' O ' HD13 ' A' ' 162' ' ' ILE . 3.1 m-30 -83.36 -28.24 29.11 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.444 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -164.07 -143.45 3.71 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.52 ' CG ' ' N ' ' A' ' 135' ' ' VAL . 2.0 ptmt -88.45 -42.19 12.29 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.325 -1.103 . . . . 0.0 109.7 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 46.24 90.78 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.619 0 CA-C-O 122.111 0.958 . . . . 0.0 111.064 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.484 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -92.42 -25.63 18.39 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 177.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -133.63 145.73 50.25 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.057 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -158.35 101.66 1.72 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.59 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.9 OUTLIER -112.58 163.81 14.06 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.937 0.875 . . . . 0.0 112.216 -177.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.795 HD13 HG21 ' A' ' 125' ' ' VAL . 4.8 tp -138.03 154.79 49.27 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.644 ' CB ' ' CE1' ' A' ' 152' ' ' PHE . 66.0 mmm -131.19 135.8 47.73 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.767 -1.208 . . . . 0.0 110.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 118' ' ' VAL . 9.4 m-85 -136.7 -173.13 3.34 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.587 -0.696 . . . . 0.0 109.973 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 147' ' ' ASN . 36.8 m-20 -142.12 -127.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.987 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 0.9 OUTLIER -110.78 -131.68 0.32 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.956 -1.09 . . . . 0.0 110.302 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.46 ' O ' ' CG ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER -79.85 -60.52 2.31 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 110.582 -179.663 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.8 m -94.36 -20.94 19.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.379 -0.826 . . . . 0.0 110.504 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' A' ' 143' ' ' ASP . 86.8 m-20 -73.94 -1.75 21.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.192 -0.942 . . . . 0.0 110.542 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.741 ' HD3' HG21 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -90.45 -112.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.106 -0.996 . . . . 0.0 109.95 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 148' ' ' ARG . 0.0 OUTLIER 65.8 -76.82 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.862 -1.149 . . . . 0.0 110.58 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.475 ' NH1' ' HG3' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -51.82 -69.18 0.12 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.215 -0.928 . . . . 0.0 110.741 -179.718 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.451 ' O ' ' HG ' ' A' ' 116' ' ' LEU . . . 62.94 120.12 0.01 OUTLIER Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.944 -1.662 . . . . 0.0 108.944 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.644 ' CE1' ' CB ' ' A' ' 141' ' ' MET . 14.9 p90 -150.13 139.37 21.26 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.109 -1.23 . . . . 0.0 110.158 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.53 ' O ' ' CG2' ' A' ' 113' ' ' VAL . . . -129.58 167.2 21.54 Favored Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.515 -1.326 . . . . 0.0 109.965 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.536 ' O ' ' HG3' ' A' ' 139' ' ' MET . 63.0 m-85 -123.5 117.8 25.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 108.879 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.543 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.8 OUTLIER -109.2 -178.6 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 O-C-N 120.965 -1.085 . . . . 0.0 109.036 -179.181 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.517 ' OG1' ' CB ' ' A' ' 110' ' ' LYS . 72.3 m -162.87 105.13 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 117.874 -1.53 . . . . 0.0 112.433 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.146 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -126.6 102.34 7.05 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.441 -0.787 . . . . 0.0 108.993 177.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -39.18 -29.03 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.503 -0.748 . . . . 0.0 110.962 -178.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.804 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -56.23 85.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 110.235 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -58.09 -38.32 76.18 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.078 -1.014 . . . . 0.0 109.701 179.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.461 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.7 m-20 -39.24 -64.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.771 -0.581 . . . . 0.0 110.259 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.704 HD13 ' O ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -61.84 -38.0 79.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.091 -1.006 . . . . 0.0 109.122 179.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.096 HG22 ' CE2' ' A' ' 157' ' ' PHE . 16.7 t -58.41 -33.56 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 160' ' ' GLU . 0.0 OUTLIER -58.77 -47.15 85.71 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.426 0.631 . . . . 0.0 110.079 179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.465 ' O ' ' N ' ' A' ' 167' ' ' CYS . 10.4 tttt -87.4 -63.82 1.24 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.47 -0.769 . . . . 0.0 110.499 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 163' ' ' VAL . 1.4 p -42.31 -24.64 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.322 -0.861 . . . . 0.0 109.876 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.574 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 9.3 t -73.36 -47.02 45.67 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.075 -1.016 . . . . 0.0 109.458 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -42.86 130.84 4.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.55 -0.719 . . . . 0.0 110.23 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 170' ' ' HIS . 2.9 mp -73.84 133.75 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.193 -0.942 . . . . 0.0 110.099 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 3.3 t-160 -177.73 62.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.207 -0.933 . . . . 0.0 110.216 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.64 ' CE1' ' CB ' ' A' ' 178' ' ' MET . 0.1 OUTLIER 43.98 61.12 2.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.168 -0.958 . . . . 0.0 109.899 -179.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 1.1 t60 -60.83 145.03 51.43 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.288 -0.883 . . . . 0.0 110.133 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.514 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -100.72 88.76 3.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 110.266 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 174' ' ' ILE . 1.3 mp -81.34 91.96 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.144 -0.972 . . . . 0.0 109.387 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.487 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER 68.56 -56.99 0.5 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.419 -0.801 . . . . 0.0 110.1 -179.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.1 OUTLIER -161.55 19.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.41 -0.807 . . . . 0.0 110.416 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.824 ' HB3' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -123.68 148.39 46.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.222 -0.924 . . . . 0.0 111.118 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.64 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -92.02 41.56 1.07 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.824 HG13 ' HB3' ' A' ' 177' ' ' LYS . 10.3 m -70.47 -165.3 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.638 -0.664 . . . . 0.0 110.788 -178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.5 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 2.3 tm-20 -125.54 152.46 45.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.432 -0.792 . . . . 0.0 110.103 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.5 ' N ' ' HG2' ' A' ' 180' ' ' GLU . 37.9 t -141.41 103.02 4.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.318 -0.864 . . . . 0.0 110.314 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.417 ' HG3' ' OE2' ' A' ' 180' ' ' GLU . 6.1 mtmm -99.21 -175.56 3.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.267 -0.895 . . . . 0.0 109.886 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -100.32 -175.99 3.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.174 -0.954 . . . . 0.0 109.784 179.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.978 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.688 0 O-C-N 121.064 -1.022 . . . . 0.0 110.598 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.949 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.339 0.59 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.72 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.7 pt -99.7 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.311 -0.868 . . . . 0.0 110.462 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -118.57 153.74 33.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.863 . . . . 0.0 109.675 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.9 OUTLIER -146.94 152.07 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.154 -0.966 . . . . 0.0 110.492 -179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -145.93 162.91 28.35 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 100.29 9.52 47.53 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.695 ' HG ' HD22 ' A' ' 140' ' ' LEU . 2.7 mm? -57.67 97.08 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.346 -1.09 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.3 168.21 0.26 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.237 -0.914 . . . . 0.0 110.105 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.581 ' O ' ' N ' ' A' ' 120' ' ' THR . 19.5 m -63.19 169.05 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.272 -0.892 . . . . 0.0 110.988 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 61.95 -39.13 0.13 Allowed 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.976 -0.452 . . . . 0.0 111.018 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 118' ' ' VAL . 91.8 m -42.3 153.74 0.07 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.118 -0.989 . . . . 0.0 110.483 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.564 ' HA ' ' CZ ' ' A' ' 142' ' ' PHE . 15.2 t -149.66 146.77 27.45 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.198 -0.939 . . . . 0.0 110.388 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.718 ' HA ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -32.39 -47.03 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 121.81 -0.556 . . . . 0.0 111.396 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -41.94 -27.41 0.12 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 0.0 109.095 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' OD2' ' N ' ' A' ' 175' ' ' ASN . 15.6 t0 -72.24 -58.44 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.555 0.693 . . . . 0.0 109.966 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.658 ' CG2' HD11 ' A' ' 174' ' ' ILE . 2.1 t -67.07 -52.9 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.498 -0.751 . . . . 0.0 109.438 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.533 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 1.7 tttt -42.44 -59.82 1.73 Allowed 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.649 -0.657 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.579 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -62.44 -27.74 69.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.441 -0.787 . . . . 0.0 110.196 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 18.7 t80 -76.29 -53.77 7.74 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.511 -0.743 . . . . 0.0 112.479 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.546 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 14.6 m-85 -82.32 -17.41 45.86 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.552 -1.343 . . . . 0.0 112.638 -177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.579 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -52.7 -41.76 64.19 Favored 'General case' 0 C--N 1.295 -1.793 0 O-C-N 119.969 -1.707 . . . . 0.0 109.263 179.682 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 17.6 pt20 -73.72 -15.78 61.21 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.265 -0.974 . . . . 0.0 108.502 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.546 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 15.8 m-85 -84.27 -33.97 23.91 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -159.35 162.29 32.71 Favored Glycine 0 N--CA 1.487 2.04 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER -44.6 -34.01 2.0 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.314 -1.11 . . . . 0.0 110.286 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.762 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.3 t 38.05 91.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 CA-C-O 121.967 0.889 . . . . 0.0 111.342 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.18 -25.06 18.0 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 177.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -130.9 142.01 50.34 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.542 ' O ' HG11 ' A' ' 122' ' ' VAL . . . -157.4 102.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.418 ' HA ' HG11 ' A' ' 122' ' ' VAL . 3.2 tpp -110.39 160.21 16.78 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.775 0.797 . . . . 0.0 111.308 -178.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.93 HD23 ' HA3' ' A' ' 153' ' ' GLY . 9.4 mt -147.04 145.42 29.68 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.774 -0.579 . . . . 0.0 109.499 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.585 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 1.6 mmm -123.25 126.77 47.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.024 -1.047 . . . . 0.0 110.396 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 140' ' ' LEU . 42.2 m-85 -120.37 170.87 8.96 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.315 -0.865 . . . . 0.0 110.711 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 19.2 t70 43.43 -92.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.496 -0.752 . . . . 0.0 111.317 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 143' ' ' ASP . 1.1 mttm 57.47 23.36 9.02 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 109.751 -179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 11.1 p 50.31 19.37 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.428 -0.795 . . . . 0.0 110.482 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 145' ' ' THR . 7.7 p -151.04 -65.15 0.19 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.23 -0.919 . . . . 0.0 109.923 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -86.68 54.7 3.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.47 -0.769 . . . . 0.0 110.286 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.414 ' HB2' ' HA ' ' A' ' 143' ' ' ASP . 0.9 OUTLIER -89.56 -28.15 19.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.238 -0.914 . . . . 0.0 109.957 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.402 ' C ' ' HG2' ' A' ' 150' ' ' ARG . 1.2 t-80 -87.1 -14.99 39.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.17 -0.956 . . . . 0.0 110.048 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 116' ' ' LEU . 11.9 mmt180 -126.62 -65.25 0.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 110.3 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.63 151.32 11.44 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.585 ' CE1' ' HG3' ' A' ' 141' ' ' MET . 14.1 p90 -150.03 146.19 26.83 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.157 -1.202 . . . . 0.0 109.977 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.93 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -138.16 174.62 21.84 Favored Glycine 0 N--CA 1.489 2.223 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.174 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -132.96 118.26 18.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.495 -1.003 . . . . 0.0 109.246 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.514 HG12 ' H ' ' A' ' 156' ' ' THR . 1.5 t -109.21 -174.54 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 0.0 109.751 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.514 ' H ' HG12 ' A' ' 155' ' ' VAL . 96.3 m -163.98 106.97 0.94 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.498 -1.281 . . . . 0.0 112.002 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.181 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -132.12 109.96 10.35 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.199 -0.938 . . . . 0.0 109.722 177.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.19 -32.06 1.15 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.431 -0.793 . . . . 0.0 111.507 -179.184 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.892 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -56.04 82.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.127 -0.983 . . . . 0.0 110.51 -179.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -56.7 -38.61 72.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.0 -1.062 . . . . 0.0 110.086 179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.4 OUTLIER -39.06 -69.1 0.13 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.815 -0.553 . . . . 0.0 110.426 -179.534 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.778 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.8 OUTLIER -57.57 -42.98 82.35 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.927 179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.181 HG22 ' CE2' ' A' ' 157' ' ' PHE . 14.7 t -51.76 -38.95 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 3.1 tt0 -48.4 -55.95 9.46 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.359 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.3 tttm -90.52 -59.6 2.14 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.257 -0.902 . . . . 0.0 111.316 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.778 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -41.24 -25.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.247 -0.908 . . . . 0.0 110.859 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.589 ' SG ' HG13 ' A' ' 163' ' ' VAL . 71.2 m -90.21 -20.34 23.13 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.882 -1.137 . . . . 0.0 110.071 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.54 ' N ' ' O ' ' A' ' 165' ' ' LYS . 19.6 mm-40 -103.98 -30.03 10.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.387 -0.821 . . . . 0.0 110.186 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.684 HG21 ' CE1' ' A' ' 172' ' ' HIS . 18.0 tt -54.92 155.08 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -115.31 164.3 14.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.117 -0.99 . . . . 0.0 110.448 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.612 ' CD2' ' HB2' ' A' ' 178' ' ' MET . 0.3 OUTLIER 58.0 55.99 4.93 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.454 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.684 ' CE1' HG21 ' A' ' 169' ' ' ILE . 0.7 OUTLIER -81.36 -8.06 59.68 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.317 -0.864 . . . . 0.0 110.039 179.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.438 ' O ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 57.21 115.1 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.337 -0.852 . . . . 0.0 110.894 179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.782 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.9 OUTLIER -113.83 116.15 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.092 -1.005 . . . . 0.0 108.632 178.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.535 ' HB2' HG23 ' A' ' 120' ' ' THR . 1.4 t-20 69.41 -56.49 0.55 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.007 -1.058 . . . . 0.0 109.095 -178.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 174' ' ' ILE . 6.3 p30 -177.14 29.12 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.633 -0.667 . . . . 0.0 109.813 179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.623 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -143.72 123.89 13.71 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.059 -1.025 . . . . 0.0 110.432 -178.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.612 ' HB2' ' CD2' ' A' ' 171' ' ' PHE . 0.6 OUTLIER -54.02 116.31 2.5 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.894 -1.129 . . . . 0.0 110.778 -179.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.782 HG21 ' HB ' ' A' ' 174' ' ' ILE . 16.0 m -119.09 -161.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.718 -1.239 . . . . 0.0 110.6 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.439 ' HG2' ' N ' ' A' ' 181' ' ' CYS . 10.3 tt0 -130.1 146.45 51.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.479 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 71.3 m -117.42 152.32 35.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.252 -0.905 . . . . 0.0 110.574 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 181' ' ' CYS . 0.0 OUTLIER -146.39 157.82 43.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.52 -0.737 . . . . 0.0 109.917 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -110.03 173.67 6.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.144 -0.973 . . . . 0.0 110.425 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.949 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.34 -0.85 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.699 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.223 0.535 . . . . 0.0 110.217 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.962 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.8 pt -101.46 169.51 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.209 -0.932 . . . . 0.0 110.417 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.519 ' C ' ' CD1' ' A' ' 112' ' ' PHE . 1.9 t80 -118.11 156.49 28.57 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.409 -0.807 . . . . 0.0 109.184 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.541 HG23 ' CA ' ' A' ' 153' ' ' GLY . 1.2 m -148.32 163.16 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.064 -1.022 . . . . 0.0 110.85 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.39 171.05 32.89 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.47 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 97.93 -22.39 41.08 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.661 HD11 ' O ' ' A' ' 141' ' ' MET . 0.3 OUTLIER -41.43 97.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.398 -1.06 . . . . 0.0 109.981 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.47 ' N ' ' O ' ' A' ' 115' ' ' GLY . 38.7 m -96.19 -162.58 0.97 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 110.816 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 120' ' ' THR . 12.7 m -52.25 162.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.491 -0.756 . . . . 0.0 111.188 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.52 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 61.93 -38.86 0.13 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.872 -0.517 . . . . 0.0 110.984 179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.585 HG23 ' OD2' ' A' ' 124' ' ' ASP . 55.6 m -61.76 123.92 19.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.989 -1.069 . . . . 0.0 110.507 -179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.531 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.0 t -136.53 166.14 24.21 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 0.0 109.688 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.824 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -41.36 -55.71 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.118 -0.989 . . . . 0.0 110.511 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.492 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.31 -24.67 0.1 Allowed 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.406 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.609 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 62.4 t0 -75.24 -59.28 2.81 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.682 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.666 HG21 HD21 ' A' ' 140' ' ' LEU . 1.8 t -64.3 -49.0 83.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.287 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 53.4 tttm -47.72 -63.47 1.05 Allowed 'General case' 0 C--N 1.296 -1.751 0 O-C-N 121.522 -0.736 . . . . 0.0 110.057 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.609 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -61.14 -31.95 71.67 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.124 -0.985 . . . . 0.0 109.861 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 21.4 t80 -61.97 -60.6 3.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.469 -0.769 . . . . 0.0 110.883 -179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 132' ' ' PHE . 82.9 m-85 -79.7 -18.8 50.43 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.042 -1.036 . . . . 0.0 111.518 -179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.5 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 1.1 tp10 -54.45 -36.03 63.63 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 120.366 -1.459 . . . . 0.0 108.699 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -74.77 -20.62 59.73 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 1.066 ' O ' HD13 ' A' ' 162' ' ' ILE . 7.5 m-85 -82.24 -28.9 31.61 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.823 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.449 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -163.06 -157.72 9.3 Favored Glycine 0 N--CA 1.487 2.07 0 C-N-CA 119.404 -1.379 . . . . 0.0 109.893 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.404 ' O ' ' OE2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -72.24 -50.12 29.77 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.586 -0.95 . . . . 0.0 110.129 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.5 t 51.19 87.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 122.121 0.962 . . . . 0.0 110.353 -179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' O ' ' OD1' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -87.79 -28.64 21.55 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 136' ' ' ASP . 79.8 m-20 -134.49 137.99 44.35 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.127 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.824 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -147.18 93.93 2.32 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.661 ' HA ' HG22 ' A' ' 122' ' ' VAL . 9.1 ttm -105.62 167.05 10.02 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.833 0.825 . . . . 0.0 111.875 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.948 HD23 ' HA3' ' A' ' 153' ' ' GLY . 31.0 mt -146.03 132.51 19.71 Favored 'General case' 0 N--CA 1.494 1.725 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.661 ' O ' HD11 ' A' ' 116' ' ' LEU . 9.7 mmt -107.79 133.73 51.76 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.88 -1.137 . . . . 0.0 110.792 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 17.4 m-85 -120.84 -135.51 0.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.534 -0.728 . . . . 0.0 109.642 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 146' ' ' THR . 6.4 m-20 -133.55 174.39 10.47 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.036 -1.04 . . . . 0.0 110.11 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 0.2 OUTLIER -78.03 118.99 20.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 110.141 179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 25.6 p 42.59 26.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.886 . . . . 0.0 110.234 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 143' ' ' ASP . 30.7 p -150.35 52.98 0.9 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.005 . . . . 0.0 110.008 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.516 ' N ' ' OD1' ' A' ' 147' ' ' ASN . 14.9 p-10 -72.13 52.29 0.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 110.81 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.46 -15.14 3.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.106 -0.996 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.497 ' O ' ' HG2' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -104.85 144.35 31.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.014 -1.054 . . . . 0.0 110.108 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 149' ' ' HIS . 0.0 OUTLIER 31.68 -147.5 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.319 0.581 . . . . 0.0 111.39 179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.444 ' N ' ' CG ' ' A' ' 150' ' ' ARG . . . 127.71 134.01 3.85 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.581 ' CA ' HD21 ' A' ' 116' ' ' LEU . 24.0 p90 -144.9 135.01 23.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.212 -1.17 . . . . 0.0 110.022 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.948 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -114.62 164.87 12.04 Favored Glycine 0 N--CA 1.492 2.372 0 C-N-CA 119.69 -1.243 . . . . 0.0 110.332 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -127.78 113.12 15.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.32 -1.106 . . . . 0.0 109.648 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.514 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -109.0 -178.98 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.246 -0.909 . . . . 0.0 108.938 -179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.699 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 79.8 m -164.07 106.32 0.92 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 118.214 -1.394 . . . . 0.0 112.169 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.962 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -126.32 113.06 16.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.324 -0.86 . . . . 0.0 109.511 177.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 4.0 tt0 -39.74 -26.26 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.435 -0.79 . . . . 0.0 111.123 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.534 ' O ' HG22 ' A' ' 162' ' ' ILE . 80.9 p -63.5 67.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.117 -0.989 . . . . 0.0 110.587 -179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -52.13 -38.9 58.96 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.864 -1.148 . . . . 0.0 109.17 179.557 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 160' ' ' GLU . 38.1 t70 -43.07 -53.54 4.83 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.945 -0.702 . . . . 0.0 109.778 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 1.066 HD13 ' O ' ' A' ' 132' ' ' PHE . 0.6 OUTLIER -60.66 -49.22 85.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 C-N-CA 119.077 -1.049 . . . . 0.0 108.441 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.87 HG22 ' CE2' ' A' ' 157' ' ' PHE . 47.0 t -44.72 -46.78 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -46.15 -52.21 12.65 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.644 -0.66 . . . . 0.0 110.948 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 167' ' ' CYS . 11.3 ttpt -90.02 -62.37 1.48 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.131 -0.98 . . . . 0.0 111.065 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 162' ' ' ILE . 8.5 p -40.01 -25.69 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.563 -0.71 . . . . 0.0 110.637 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.499 ' N ' ' O ' ' A' ' 165' ' ' LYS . 23.3 m -76.3 -40.44 51.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.024 -1.047 . . . . 0.0 109.676 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.49 ' O ' HG13 ' A' ' 169' ' ' ILE . 1.2 mt-10 -68.67 -161.1 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.556 -0.715 . . . . 0.0 110.24 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 168' ' ' GLU . 20.9 pt 35.82 91.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.558 -0.714 . . . . 0.0 110.755 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.498 ' CD2' ' N ' ' A' ' 170' ' ' HIS . 11.2 m170 -60.5 -166.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 110.144 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 178' ' ' MET . 1.4 t80 54.62 69.04 0.77 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.303 -0.873 . . . . 0.0 110.27 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -82.15 -26.27 33.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.195 -0.94 . . . . 0.0 110.128 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 172' ' ' HIS . 0.0 OUTLIER 68.59 101.47 0.05 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.092 -1.005 . . . . 0.0 110.914 179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.594 HD11 HG23 ' A' ' 125' ' ' VAL . 3.4 tt -122.25 118.74 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.076 -1.015 . . . . 0.0 108.996 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.55 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 29.1 m-20 64.19 -53.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.66 -0.65 . . . . 0.0 110.644 -178.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -175.48 27.25 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.001 -1.062 . . . . 0.0 110.699 179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.536 ' HD3' ' C ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER -143.49 137.06 28.26 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.065 -1.022 . . . . 0.0 109.488 -179.127 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.64 ' CG ' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -77.87 88.05 4.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.326 -1.483 . . . . 0.0 110.097 179.429 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.499 HG11 HG21 ' A' ' 174' ' ' ILE . 28.7 m -76.46 -178.16 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.22 -0.925 . . . . 0.0 110.379 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.407 ' CD ' ' HE3' ' A' ' 182' ' ' LYS . 26.0 tt0 -128.78 140.65 51.62 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.498 -0.752 . . . . 0.0 109.549 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 167' ' ' CYS . 1.5 t -122.68 142.65 50.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.049 -1.032 . . . . 0.0 110.811 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.42 ' C ' ' SG ' ' A' ' 167' ' ' CYS . 7.5 mttp -138.64 178.91 6.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.468 -0.77 . . . . 0.0 109.779 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.497 ' HD3' ' HB3' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -111.65 142.37 44.05 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.17 -0.956 . . . . 0.0 110.069 179.607 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.268 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.547 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 1.7 ptmt . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 120.972 0.415 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.93 HD12 ' N ' ' A' ' 112' ' ' PHE . 1.2 pp -123.26 178.78 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -0.999 . . . . 0.0 110.795 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.93 ' N ' HD12 ' A' ' 111' ' ' ILE . 56.6 t80 -125.03 162.31 24.81 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.593 -0.692 . . . . 0.0 109.15 179.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.596 HG13 HD11 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -146.84 135.41 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.783 -1.198 . . . . 0.0 111.266 -179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 179' ' ' VAL . . . -130.17 162.28 23.11 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.446 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 92.92 -26.04 16.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.179 -1.568 . . . . 0.0 109.179 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.003 HD21 ' HA ' ' A' ' 152' ' ' PHE . 0.4 OUTLIER -44.1 99.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -1.092 . . . . 0.0 109.607 179.747 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 116' ' ' LEU . 0.0 OUTLIER -43.19 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 CA-C-O 121.734 0.778 . . . . 0.0 111.018 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.825 HG12 ' N ' ' A' ' 119' ' ' ASN . 0.9 OUTLIER -74.44 -64.14 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.418 -0.801 . . . . 0.0 110.409 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.825 ' N ' HG12 ' A' ' 118' ' ' VAL . 0.1 OUTLIER -43.44 -21.98 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.75 HG21 HG12 ' A' ' 174' ' ' ILE . 23.6 m -72.71 142.21 48.2 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 119.403 -0.919 . . . . 0.0 109.778 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.455 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 1.3 m -128.0 158.98 36.42 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.023 -1.048 . . . . 0.0 110.563 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.722 HG23 ' HB2' ' A' ' 140' ' ' LEU . 2.7 t -37.56 -52.92 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.698 -0.626 . . . . 0.0 110.862 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.476 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -40.65 -27.06 0.05 OUTLIER 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.492 -0.755 . . . . 0.0 109.171 179.703 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 122' ' ' VAL . 1.7 m-20 -72.79 -57.67 3.92 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 121.469 0.652 . . . . 0.0 109.567 179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.72 HG21 HD11 ' A' ' 140' ' ' LEU . 2.1 t -65.87 -50.1 72.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.615 0.721 . . . . 0.0 109.62 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 23.9 tttt -46.58 -61.77 1.67 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.465 -0.772 . . . . 0.0 110.416 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.504 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -59.52 -33.14 71.01 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.114 -0.991 . . . . 0.0 110.316 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 0.3 OUTLIER -66.44 -64.89 0.76 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.3 -0.875 . . . . 0.0 110.832 -179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.645 ' CD2' HG13 ' A' ' 125' ' ' VAL . 78.3 m-85 -70.68 -18.54 62.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.9 -1.125 . . . . 0.0 111.541 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.517 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 38.4 tt0 -55.96 -36.7 68.1 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.023 -1.471 . . . . 0.0 107.912 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 6.5 pt20 -73.47 -18.15 61.15 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.528 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 16.9 m-85 -86.55 -32.85 20.48 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -160.74 165.61 35.18 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.456 ' HE2' ' OD2' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -41.71 -55.13 3.08 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.367 -1.078 . . . . 0.0 110.336 -179.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 58.79 89.74 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 CA-C-O 122.01 0.91 . . . . 0.0 110.747 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.456 ' OD2' ' HE2' ' A' ' 134' ' ' LYS . 0.7 OUTLIER -92.84 -26.23 17.75 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -129.43 138.67 51.59 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.557 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -155.91 99.97 2.02 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.788 ' O ' HD12 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -111.18 158.97 18.31 Favored 'General case' 0 N--CA 1.503 2.218 0 CA-C-O 122.097 0.951 . . . . 0.0 112.854 -177.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.788 HD12 ' O ' ' A' ' 139' ' ' MET . 1.8 mp -137.82 148.55 45.57 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.559 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 1.4 mmt -125.28 147.54 49.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.729 -1.232 . . . . 0.0 110.927 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.559 ' CD1' ' O ' ' A' ' 141' ' ' MET . 16.1 m-85 -133.6 -177.63 4.63 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.422 -0.798 . . . . 0.0 109.647 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.481 ' HB3' ' HG2' ' A' ' 148' ' ' ARG . 12.0 p30 -70.49 -176.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.099 -1.001 . . . . 0.0 110.049 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' O ' ' OG1' ' A' ' 145' ' ' THR . 4.5 pttt -65.62 -24.17 66.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.944 . . . . 0.0 110.083 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 144' ' ' LYS . 88.6 m -164.12 -79.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.889 . . . . 0.0 110.312 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 146' ' ' THR . 7.7 t -146.17 40.75 1.15 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.203 -0.935 . . . . 0.0 110.248 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -76.01 -18.5 59.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.235 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.481 ' HG2' ' HB3' ' A' ' 143' ' ' ASP . 3.2 ptp180 -149.11 -149.08 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.149 -0.969 . . . . 0.0 110.303 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.499 ' C ' ' CD2' ' A' ' 149' ' ' HIS . 3.6 p-80 -149.18 14.07 0.88 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.145 -0.972 . . . . 0.0 110.511 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -114.53 -162.9 0.84 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.202 -0.936 . . . . 0.0 110.311 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.598 ' C ' HD11 ' A' ' 116' ' ' LEU . . . 169.14 176.37 39.12 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 1.003 ' HA ' HD21 ' A' ' 116' ' ' LEU . 5.9 p90 -147.88 136.67 21.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -1.134 . . . . 0.0 109.709 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.554 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -128.91 172.54 19.57 Favored Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.367 -1.396 . . . . 0.0 110.463 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.551 ' O ' ' HG2' ' A' ' 139' ' ' MET . 71.0 m-85 -128.74 108.18 10.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.546 -0.973 . . . . 0.0 108.594 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -93.94 -178.23 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.456 -1.403 . . . . 0.0 109.648 -178.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.547 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 36.4 m -163.66 105.92 0.96 Allowed 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.224 -1.39 . . . . 0.0 112.216 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.916 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -130.4 120.62 24.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -0.812 . . . . 0.0 109.505 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -49.29 -20.35 0.63 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.655 -179.679 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.483 ' O ' HG22 ' A' ' 162' ' ' ILE . 1.6 m -66.03 60.93 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.216 -0.927 . . . . 0.0 110.122 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.534 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -47.27 -38.7 12.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.979 -1.076 . . . . 0.0 108.887 179.713 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 162' ' ' ILE . 1.6 p30 -44.01 -49.58 8.62 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.378 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.784 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.4 tp -62.88 -49.79 82.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.872 HG22 ' CE2' ' A' ' 157' ' ' PHE . 44.3 t -46.81 -46.43 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -44.9 -55.19 5.67 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 121.242 0.544 . . . . 0.0 111.181 -179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.47 ' O ' ' N ' ' A' ' 167' ' ' CYS . 21.0 tttp -87.06 -61.88 1.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.213 -0.929 . . . . 0.0 110.921 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.784 HG12 ' O ' ' A' ' 162' ' ' ILE . 5.8 p -42.51 -24.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.318 -0.864 . . . . 0.0 110.38 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 40.8 t -82.98 -27.68 30.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.055 -1.028 . . . . 0.0 110.446 -179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.496 ' O ' ' HB ' ' A' ' 169' ' ' ILE . 9.0 mm-40 -91.56 -175.57 4.24 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.145 -0.972 . . . . 0.0 111.018 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 168' ' ' GLU . 22.1 mt 62.1 161.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.574 -0.704 . . . . 0.0 110.57 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -42.92 167.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 109.899 179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.642 ' CZ ' ' HB2' ' A' ' 178' ' ' MET . 0.1 OUTLIER -59.03 -172.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.959 -1.088 . . . . 0.0 110.189 -179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.721 ' CE1' HG23 ' A' ' 166' ' ' VAL . 34.4 m-70 -105.01 -95.77 0.33 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.908 . . . . 0.0 109.511 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.557 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.0 OUTLIER 174.25 119.14 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.155 -0.965 . . . . 0.0 110.201 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.781 HG23 ' O ' ' A' ' 174' ' ' ILE . 10.6 tp -98.27 78.64 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.121 -0.987 . . . . 0.0 110.34 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 49.0 m-80 63.84 -53.13 0.24 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.684 -0.635 . . . . 0.0 111.576 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.471 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.6 OUTLIER -138.6 -0.67 1.93 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.987 -1.071 . . . . 0.0 111.383 -179.17 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.623 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.9 OUTLIER -125.04 -175.53 3.32 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.913 -1.117 . . . . 0.0 111.079 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.642 ' HB2' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -121.72 79.03 1.51 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.703 -0.623 . . . . 0.0 109.627 179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.552 ' CG1' ' HB ' ' A' ' 174' ' ' ILE . 5.2 m -79.09 130.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.085 -1.009 . . . . 0.0 110.492 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.405 ' HA ' ' HB3' ' A' ' 171' ' ' PHE . 59.3 tt0 -80.17 163.0 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.856 . . . . 0.0 110.074 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.818 ' SG ' HD13 ' A' ' 111' ' ' ILE . 43.1 t -133.07 110.51 10.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.333 -0.854 . . . . 0.0 110.424 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.49 ' HA ' ' SG ' ' A' ' 167' ' ' CYS . 8.0 mmtm -105.29 163.42 12.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.925 . . . . 0.0 109.72 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.55 ' HG3' ' CG1' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -76.32 154.95 34.62 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.064 -1.022 . . . . 0.0 110.229 -179.721 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.373 -0.829 . . . . 0.0 110.418 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.037 0.446 . . . . 0.0 110.091 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 1.045 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 1.2 pt -133.6 175.13 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.073 -1.017 . . . . 0.0 110.721 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.53 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 15.9 t80 -138.21 145.39 41.37 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.492 -0.755 . . . . 0.0 109.267 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.449 ' C ' HD11 ' A' ' 116' ' ' LEU . 0.1 OUTLIER -130.13 148.43 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.242 -0.911 . . . . 0.0 110.333 -179.704 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -139.51 166.07 25.64 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.514 ' O ' ' HE2' ' A' ' 177' ' ' LYS . . . 86.31 -13.61 57.09 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -54.23 97.32 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.311 -1.111 . . . . 0.0 110.648 -179.751 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.7 t -54.85 175.9 0.05 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.092 -1.005 . . . . 0.0 108.656 178.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 119' ' ' ASN . 1.4 t -79.51 -155.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.658 -1.276 . . . . 0.0 110.115 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.625 ' H ' HG12 ' A' ' 118' ' ' VAL . 0.0 OUTLIER 75.44 -32.85 0.22 Allowed 'General case' 0 N--CA 1.497 1.886 0 CA-C-O 121.755 0.788 . . . . 0.0 109.691 -178.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.557 ' CG2' ' N ' ' A' ' 121' ' ' THR . 1.8 m -81.47 172.14 13.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 121.606 0.717 . . . . 0.0 111.313 -177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.557 ' N ' ' CG2' ' A' ' 120' ' ' THR . 10.8 t -149.25 154.93 39.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.617 -0.677 . . . . 0.0 109.38 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.586 ' HA ' HD12 ' A' ' 140' ' ' LEU . 2.4 t -39.3 -50.9 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.182 -0.949 . . . . 0.0 110.583 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.465 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -43.64 -24.77 0.13 Allowed 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.402 -0.812 . . . . 0.0 109.239 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.617 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 25.5 t0 -74.95 -59.76 2.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.736 . . . . 0.0 109.696 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.706 HG21 HD21 ' A' ' 140' ' ' LEU . 1.1 t -63.66 -48.92 84.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.541 -0.724 . . . . 0.0 109.388 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 12.5 tttp -48.47 -60.94 2.29 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.255 179.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.617 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 1.9 p-80 -63.9 -36.29 83.46 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.012 -1.055 . . . . 0.0 110.255 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 35.8 t80 -58.39 -57.7 11.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.38 -0.825 . . . . 0.0 110.564 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.521 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 72.5 m-85 -83.0 -16.36 47.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.061 -1.025 . . . . 0.0 111.485 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 83.3 tt0 -55.89 -37.59 69.06 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.45 -1.406 . . . . 0.0 108.244 179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.509 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.4 pt20 -74.41 -16.6 60.88 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 162' ' ' ILE . 4.3 m-30 -87.72 -32.32 19.22 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.573 0.701 . . . . 0.0 109.127 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -159.37 170.9 35.75 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.412 ' HD3' ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -50.81 -41.38 57.31 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.31 -1.112 . . . . 0.0 110.607 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.734 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 47.62 91.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 122.195 0.998 . . . . 0.0 111.074 -179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.55 -25.39 17.59 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 107.161 -1.422 . . . . 0.0 107.161 177.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -130.45 144.24 51.27 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 178.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -160.41 100.97 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.204 -0.935 . . . . 0.0 108.59 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.56 ' HA ' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -114.92 165.4 12.9 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.813 0.816 . . . . 0.0 112.239 -178.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 125' ' ' VAL . 34.2 mt -140.12 139.87 35.9 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.554 ' O ' ' CD1' ' A' ' 142' ' ' PHE . 0.0 OUTLIER -114.17 132.7 56.0 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.026 -1.046 . . . . 0.0 110.912 -179.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 141' ' ' MET . 30.2 m-85 -142.72 -173.74 3.96 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.441 -0.787 . . . . 0.0 109.965 179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.478 ' HA ' ' OD1' ' A' ' 147' ' ' ASN . 58.4 m-20 53.34 -166.28 0.07 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.137 -0.977 . . . . 0.0 110.33 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.521 ' O ' ' ND2' ' A' ' 147' ' ' ASN . 0.1 OUTLIER 62.97 -142.96 0.37 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.342 -0.849 . . . . 0.0 110.407 179.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.16 10.45 8.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.356 -0.84 . . . . 0.0 110.067 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.653 HG22 ' HB3' ' A' ' 150' ' ' ARG . 17.2 p -139.32 41.68 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -0.865 . . . . 0.0 109.997 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.521 ' ND2' ' O ' ' A' ' 144' ' ' LYS . 21.9 m-80 -47.05 -87.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 110.416 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.46 ' O ' ' N ' ' A' ' 150' ' ' ARG . 3.7 mtt180 -97.26 161.99 13.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.438 -0.789 . . . . 0.0 110.192 -179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.445 ' CB ' ' O ' ' A' ' 148' ' ' ARG . 0.2 OUTLIER 64.69 -75.09 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.162 -0.961 . . . . 0.0 110.44 179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.653 ' HB3' HG22 ' A' ' 146' ' ' THR . 8.0 mpt_? -53.75 -17.27 2.18 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.478 -0.764 . . . . 0.0 110.7 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 150' ' ' ARG . . . -41.87 133.91 3.74 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.6 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 13.5 p90 -150.14 140.25 22.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.351 -1.088 . . . . 0.0 109.387 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.46 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -123.54 165.57 16.25 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.249 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' CG ' ' A' ' 139' ' ' MET . 22.8 m-85 -120.37 112.18 18.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.376 -1.073 . . . . 0.0 109.162 179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 1.6 t -108.31 -179.34 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.68 -1.262 . . . . 0.0 109.008 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 110' ' ' LYS . 32.3 m -161.08 105.14 1.32 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.058 -1.457 . . . . 0.0 111.765 -179.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.045 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.1 p90 -127.28 102.47 6.93 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.571 -0.852 . . . . 0.0 109.222 178.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -39.27 -28.08 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.503 -0.748 . . . . 0.0 111.195 -178.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.872 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.8 OUTLIER -54.74 86.32 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.167 -0.958 . . . . 0.0 110.055 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.9 OUTLIER -54.91 -38.24 67.37 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.05 -1.031 . . . . 0.0 109.657 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.6 OUTLIER -39.39 -68.21 0.18 Allowed 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 120.36 -0.536 . . . . 0.0 110.486 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 1.038 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -58.61 -45.63 90.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 120.956 -1.09 . . . . 0.0 108.875 179.417 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.978 HG22 ' CE1' ' A' ' 157' ' ' PHE . 9.9 t -47.29 -34.31 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.2 OUTLIER -61.01 -42.81 99.18 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.617 0.722 . . . . 0.0 109.742 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.483 ' O ' ' N ' ' A' ' 168' ' ' GLU . 1.2 tptt -86.25 -62.98 1.39 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.56 -0.713 . . . . 0.0 110.81 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 1.038 HG22 ' O ' ' A' ' 162' ' ' ILE . 4.9 m -46.63 -24.26 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.076 -1.015 . . . . 0.0 108.908 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.572 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 1.7 t -65.89 -31.27 72.11 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.039 -1.038 . . . . 0.0 108.457 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.3 OUTLIER -71.88 158.68 35.6 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 121.193 0.52 . . . . 0.0 110.717 -179.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.584 ' O ' HD12 ' A' ' 169' ' ' ILE . 1.2 pp -90.57 85.5 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.424 -0.798 . . . . 0.0 110.091 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.501 ' O ' ' N ' ' A' ' 172' ' ' HIS . 0.7 OUTLIER -126.79 139.61 52.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.248 -0.907 . . . . 0.0 110.373 -179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.615 ' CE1' ' HG3' ' A' ' 178' ' ' MET . 0.1 OUTLIER -42.54 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.284 -0.885 . . . . 0.0 110.058 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.843 ' NE2' HG12 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -87.05 -41.24 14.0 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.045 -1.034 . . . . 0.0 110.456 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.562 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.2 tt0 66.42 105.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.144 -0.972 . . . . 0.0 110.372 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.744 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -112.43 118.03 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.271 179.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.486 ' ND2' ' CG ' ' A' ' 124' ' ' ASP . 1.4 m-20 67.45 -55.34 0.47 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.9 -178.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -170.37 20.66 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.199 -0.938 . . . . 0.0 111.278 179.773 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.713 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -140.96 125.9 18.2 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.564 -1.335 . . . . 0.0 110.649 -179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.615 ' HG3' ' CE1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -60.72 75.92 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.121 -0.987 . . . . 0.0 110.631 179.125 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.744 HG21 ' HB ' ' A' ' 174' ' ' ILE . 21.1 m -72.23 170.56 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 120.992 -1.068 . . . . 0.0 110.63 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -111.23 140.5 45.74 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.446 -0.784 . . . . 0.0 110.04 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 81.3 m -114.79 151.94 32.96 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 0.0 110.42 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 0.1 OUTLIER -159.84 147.11 16.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.195 -0.941 . . . . 0.0 110.255 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.631 ' HG3' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -58.31 166.07 1.81 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.172 -0.955 . . . . 0.0 110.385 179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.991 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.457 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.245 0.545 . . . . 0.0 110.215 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.842 HD11 ' CG2' ' A' ' 155' ' ' VAL . 1.3 pp -92.79 163.52 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 110.523 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.679 ' CD1' ' CE1' ' A' ' 154' ' ' PHE . 12.0 t80 -116.8 152.58 34.1 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.08 -1.013 . . . . 0.0 109.429 179.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 182' ' ' LYS . 2.3 m -143.38 155.63 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.146 -0.971 . . . . 0.0 110.323 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -140.03 -179.03 17.45 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.562 ' O ' HG12 ' A' ' 179' ' ' VAL . . . 74.37 22.0 78.11 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.03 ' CD1' HD22 ' A' ' 140' ' ' LEU . 0.8 OUTLIER -42.43 96.34 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.351 -1.088 . . . . 0.0 110.203 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.484 ' N ' ' O ' ' A' ' 115' ' ' GLY . 14.3 t -46.88 161.82 0.06 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 110.282 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.893 HG23 ' HE ' ' A' ' 148' ' ' ARG . 3.0 t -73.17 151.69 7.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.87 . . . . 0.0 110.426 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.508 ' C ' ' ND2' ' A' ' 119' ' ' ASN . 0.0 OUTLIER 64.71 -44.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 121.459 0.647 . . . . 0.0 109.761 179.65 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 118' ' ' VAL . 2.6 m -41.16 132.26 2.53 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.064 -0.655 . . . . 0.0 109.993 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.511 ' N ' ' OD2' ' A' ' 124' ' ' ASP . 2.0 m -118.84 165.43 14.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.126 -0.984 . . . . 0.0 110.536 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.801 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -39.36 -52.79 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.465 -0.772 . . . . 0.0 111.038 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 122' ' ' VAL . 7.3 mt-10 -42.52 -25.37 0.08 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.382 -0.823 . . . . 0.0 109.477 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.563 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 82.6 m-20 -74.51 -54.04 8.3 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.717 -0.793 . . . . 0.0 109.452 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.758 HG21 HD21 ' A' ' 140' ' ' LEU . 2.0 t -65.77 -48.51 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.423 -0.798 . . . . 0.0 109.2 179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 14.4 ttpt -47.65 -61.54 1.89 Allowed 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 109.842 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.563 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -64.14 -32.32 73.85 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.17 -0.956 . . . . 0.0 109.599 179.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.576 ' CE2' ' CE1' ' A' ' 129' ' ' PHE . 31.8 t80 -59.6 -57.99 10.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.406 -0.809 . . . . 0.0 110.384 -179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.576 ' CE1' ' CE2' ' A' ' 128' ' ' TYR . 61.1 m-85 -82.59 -14.59 54.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.0 111.038 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.505 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 78.7 tt0 -55.0 -38.92 68.48 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.35 -1.34 . . . . 0.0 108.195 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 7.6 pt20 -73.12 -17.44 61.4 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.537 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 4.2 m-85 -91.66 -30.15 16.48 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.443 ' O ' ' C ' ' A' ' 134' ' ' LYS . . . -158.96 155.22 26.29 Favored Glycine 0 N--CA 1.487 2.051 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.454 ' HE3' ' HG2' ' A' ' 158' ' ' GLU . 1.9 ptpt -41.34 -40.6 1.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.281 -1.129 . . . . 0.0 110.535 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 45.15 94.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.931 . . . . 0.0 111.17 -179.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.84 -25.74 19.73 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -134.17 144.47 48.52 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.534 179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.801 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -153.83 99.03 2.25 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' A' ' 140' ' ' LEU . 4.9 tpp -99.66 164.61 11.98 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.897 0.856 . . . . 0.0 111.481 -177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.03 HD22 ' CD1' ' A' ' 116' ' ' LEU . 11.5 mt -149.78 133.56 16.87 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 152' ' ' PHE . 15.9 mmm -111.26 122.03 46.8 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.833 -1.167 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.462 ' CE1' HD12 ' A' ' 116' ' ' LEU . 15.5 m-85 -106.92 -168.03 1.35 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.419 -0.801 . . . . 0.0 109.86 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.426 ' O ' ' C ' ' A' ' 144' ' ' LYS . 8.8 t0 -109.19 -162.72 0.82 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.99 . . . . 0.0 110.068 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 143' ' ' ASP . 0.2 OUTLIER -42.93 -55.2 3.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.248 -0.907 . . . . 0.0 110.007 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 146' ' ' THR . 53.2 m -148.86 -87.98 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.432 -0.792 . . . . 0.0 109.961 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.487 HG22 HG13 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -111.56 3.39 17.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.363 -0.835 . . . . 0.0 110.102 179.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -89.87 59.14 4.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.27 -0.894 . . . . 0.0 109.807 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.893 ' HE ' HG23 ' A' ' 118' ' ' VAL . 0.0 OUTLIER -89.6 -56.5 3.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.347 -0.846 . . . . 0.0 111.282 -179.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 53.34 18.2 1.24 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.595 -1.316 . . . . 0.0 110.152 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.473 ' O ' ' O ' ' A' ' 151' ' ' GLY . 0.1 OUTLIER -178.19 -81.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 0.0 109.656 -179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.473 ' O ' ' O ' ' A' ' 150' ' ' ARG . . . 58.39 150.73 0.01 OUTLIER Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.576 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 14.7 p90 -150.44 140.0 21.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.319 -1.106 . . . . 0.0 109.596 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.78 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -124.81 177.81 16.72 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 119.258 -1.449 . . . . 0.0 110.408 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.679 ' CE1' ' CD1' ' A' ' 112' ' ' PHE . 61.0 m-85 -138.37 117.41 12.53 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.62 -0.929 . . . . 0.0 109.102 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.842 ' CG2' HD11 ' A' ' 111' ' ' ILE . 1.7 t -109.07 -174.27 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.042 -1.036 . . . . 0.0 109.159 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.541 ' H ' HG12 ' A' ' 155' ' ' VAL . 88.5 m -162.93 103.81 1.01 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 118.206 -1.397 . . . . 0.0 111.909 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.958 ' CE2' HG22 ' A' ' 163' ' ' VAL . 2.3 p90 -135.6 107.45 7.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.367 -0.833 . . . . 0.0 109.339 177.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.531 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.1 OUTLIER -44.9 -22.7 0.1 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.434 -0.791 . . . . 0.0 111.118 -179.109 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.853 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.4 OUTLIER -56.36 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.195 -0.941 . . . . 0.0 110.421 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 158' ' ' GLU . 1.0 OUTLIER -61.63 -38.03 86.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.051 -1.031 . . . . 0.0 109.827 179.676 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.464 ' C ' ' O ' ' A' ' 160' ' ' GLU . 10.1 t70 -39.27 -67.61 0.21 Allowed 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.18 -0.608 . . . . 0.0 110.366 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.686 ' O ' HG12 ' A' ' 166' ' ' VAL . 5.6 tp -58.49 -42.68 85.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.134 -0.979 . . . . 0.0 108.79 179.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.958 HG22 ' CE2' ' A' ' 157' ' ' PHE . 38.2 t -50.94 -44.3 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 N-CA-C 107.739 -1.208 . . . . 0.0 107.739 178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.03 -46.51 33.19 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.694 -0.629 . . . . 0.0 110.824 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' A' ' 167' ' ' CYS . 2.7 tttt -90.26 -64.72 1.1 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.225 -0.922 . . . . 0.0 111.202 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.866 HG13 ' HD3' ' A' ' 183' ' ' LYS . 6.0 p -45.31 -21.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.296 -0.877 . . . . 0.0 110.722 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 43.5 t -79.86 -22.87 42.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.931 -1.106 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.421 ' N ' ' O ' ' A' ' 165' ' ' LYS . 2.4 tt0 -68.26 156.43 37.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.5 -0.75 . . . . 0.0 110.449 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.78 113.83 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.33 -0.856 . . . . 0.0 110.111 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.447 ' O ' ' O ' ' A' ' 171' ' ' PHE . 0.9 OUTLIER -163.23 32.36 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.308 -0.87 . . . . 0.0 110.331 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.659 ' CE2' ' CB ' ' A' ' 178' ' ' MET . 0.0 OUTLIER 55.88 165.03 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.856 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.53 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -143.85 -156.96 0.74 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 179.686 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.532 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 10.6 tp10 -158.91 86.63 0.84 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.904 -1.123 . . . . 0.0 111.012 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.754 HD11 HG23 ' A' ' 125' ' ' VAL . 1.5 tt -102.98 104.89 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.941 -1.099 . . . . 0.0 109.854 179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 4.8 m120 67.36 -56.75 0.45 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.874 -1.141 . . . . 0.0 110.185 -179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.522 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -170.93 25.97 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.516 -0.74 . . . . 0.0 110.174 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 2.8 tptt -128.19 163.98 23.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 111.018 -179.299 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.659 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -94.28 -18.63 21.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.444 -0.785 . . . . 0.0 109.32 178.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.594 HG22 ' C ' ' A' ' 178' ' ' MET . 34.5 m 37.25 -160.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-O 121.374 0.607 . . . . 0.0 110.796 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -150.44 140.1 21.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.31 -0.869 . . . . 0.0 110.024 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 181' ' ' CYS . 26.2 p -81.39 132.47 35.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 110.438 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -129.5 11.02 5.75 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-O 122.235 1.017 . . . . 0.0 109.175 179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.866 ' HD3' HG13 ' A' ' 166' ' ' VAL . 1.4 mptt -41.01 158.09 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.586 -0.696 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.892 . . . . 0.0 110.338 -179.894 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.786 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 9.8 pttt . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.03 0.443 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.955 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 5.4 pt -103.55 169.2 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 120.968 -1.083 . . . . 0.0 111.16 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 21.4 t80 -123.69 144.73 49.46 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.706 -0.621 . . . . 0.0 109.647 179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.474 HG23 ' H ' ' A' ' 153' ' ' GLY . 0.3 OUTLIER -140.14 138.65 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.201 -0.937 . . . . 0.0 110.33 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -127.98 165.48 20.97 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.664 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 89.68 17.04 55.66 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.599 HD13 ' HG ' ' A' ' 140' ' ' LEU . 38.5 mt -39.54 95.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.467 -1.019 . . . . 0.0 110.278 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.49 ' CB ' ' HB2' ' A' ' 177' ' ' LYS . 0.2 OUTLIER -43.87 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 110.884 -179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.571 ' O ' ' N ' ' A' ' 120' ' ' THR . 10.6 m -67.71 157.6 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.597 -0.689 . . . . 0.0 110.766 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.534 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.22 -38.95 0.14 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.911 -0.493 . . . . 0.0 110.779 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.571 ' N ' ' O ' ' A' ' 118' ' ' VAL . 54.9 m -47.68 150.23 1.07 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.947 -1.095 . . . . 0.0 109.994 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.801 ' C ' HD22 ' A' ' 140' ' ' LEU . 7.5 t -147.63 -167.28 2.75 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.308 -0.87 . . . . 0.0 109.891 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.753 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.9 t -60.21 -56.15 19.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 O-C-N 120.815 -1.178 . . . . 0.0 109.852 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.8 OUTLIER -44.1 -24.62 0.16 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 109.604 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.719 ' OD2' HG22 ' A' ' 121' ' ' THR . 40.7 m-20 -78.2 -58.98 2.97 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.413 -0.915 . . . . 0.0 109.746 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.837 HG23 HD11 ' A' ' 174' ' ' ILE . 1.5 t -62.15 -47.79 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.0 108.943 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.597 ' HB2' ' HB3' ' A' ' 138' ' ' ALA . 6.0 ttmt -46.66 -61.98 1.59 Allowed 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.485 -0.76 . . . . 0.0 109.992 179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.541 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.1 OUTLIER -64.76 -34.55 78.6 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.165 -1.014 . . . . 0.0 109.439 179.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 29.7 t80 -55.6 -58.21 8.73 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.575 -0.703 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 132' ' ' PHE . 94.0 m-85 -81.29 -15.81 54.38 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.151 -0.968 . . . . 0.0 111.115 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 126' ' ' LYS . 35.7 tt0 -55.41 -38.12 68.52 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 118.29 -1.364 . . . . 0.0 108.584 179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 4.2 pt20 -74.59 -15.82 60.82 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.156 -1.018 . . . . 0.0 108.298 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 18.5 m-85 -86.85 -30.67 21.28 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.445 0.64 . . . . 0.0 109.341 178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 130' ' ' GLU . . . -162.03 -174.59 32.1 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.07 -56.15 24.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.363 -1.081 . . . . 0.0 110.449 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 56.07 89.4 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-O 122.208 1.004 . . . . 0.0 111.135 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -95.63 -24.91 16.36 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 106.387 -1.709 . . . . 0.0 106.387 176.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -130.71 140.01 50.33 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.753 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -153.8 101.69 2.47 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.873 ' O ' HD12 ' A' ' 140' ' ' LEU . 1.3 ptm -113.16 168.79 9.43 Favored 'General case' 0 N--CA 1.505 2.312 0 CA-C-O 121.92 0.867 . . . . 0.0 113.117 -177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.873 HD12 ' O ' ' A' ' 139' ' ' MET . 2.6 mp -139.1 139.18 37.61 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.851 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.583 ' HB3' ' O ' ' A' ' 152' ' ' PHE . 0.0 OUTLIER -109.56 132.6 53.98 Favored 'General case' 0 C--N 1.309 -1.163 0 O-C-N 120.755 -1.215 . . . . 0.0 109.75 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 140' ' ' LEU . 95.7 m-85 -122.66 -156.18 0.68 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.638 -0.664 . . . . 0.0 109.78 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 146' ' ' THR . 0.4 OUTLIER 61.26 -177.95 0.11 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.175 -0.953 . . . . 0.0 110.182 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.695 ' O ' HG22 ' A' ' 145' ' ' THR . 0.2 OUTLIER 61.34 100.15 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.2 -0.938 . . . . 0.0 109.93 -179.736 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 144' ' ' LYS . 10.5 t 39.6 26.76 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.481 -0.762 . . . . 0.0 110.382 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.83 ' O ' HG22 ' A' ' 146' ' ' THR . 2.3 m -151.08 56.46 0.89 Allowed 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 122.115 0.959 . . . . 0.0 108.575 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.507 ' OD1' ' N ' ' A' ' 147' ' ' ASN . 2.2 m120 -59.32 -10.97 3.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.903 -1.123 . . . . 0.0 110.898 -179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.72 -144.87 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.907 -1.121 . . . . 0.0 110.196 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -103.68 34.66 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.149 -0.97 . . . . 0.0 110.485 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.619 ' HB3' HG23 ' A' ' 146' ' ' THR . 0.2 OUTLIER -95.41 -158.2 0.63 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 110.305 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . 108.03 -147.46 16.5 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.583 ' O ' ' HB3' ' A' ' 141' ' ' MET . 5.4 p90 -151.02 139.5 20.5 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.01 -1.288 . . . . 0.0 109.999 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -104.56 158.3 16.5 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.037 -1.554 . . . . 0.0 111.18 -179.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.509 ' O ' ' HG3' ' A' ' 139' ' ' MET . 89.4 m-85 -114.3 103.4 11.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.7 OUTLIER -97.0 -179.07 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 119.076 -1.05 . . . . 0.0 109.485 -178.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.627 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 73.7 m -163.95 104.52 0.9 Allowed 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.435 -1.306 . . . . 0.0 111.782 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.955 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -125.99 106.55 9.7 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.45 177.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.52 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.6 OUTLIER -38.78 -29.09 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.553 -0.717 . . . . 0.0 111.529 -178.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.3 OUTLIER -56.95 83.03 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.967 -1.083 . . . . 0.0 110.487 -179.467 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -61.12 -38.43 86.32 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.774 -1.204 . . . . 0.0 109.478 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 160' ' ' GLU . 1.8 m-20 -41.53 -62.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.788 ' O ' HG12 ' A' ' 166' ' ' VAL . 1.1 tp -57.52 -47.14 85.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.033 -1.042 . . . . 0.0 108.564 179.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.949 HG22 ' CE2' ' A' ' 157' ' ' PHE . 43.2 t -47.67 -49.07 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.433 ' O ' ' SG ' ' A' ' 167' ' ' CYS . 0.4 OUTLIER -41.53 -52.28 3.72 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.674 -0.641 . . . . 0.0 111.386 -179.854 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' O ' ' N ' ' A' ' 167' ' ' CYS . 58.1 tttt -90.5 -61.79 1.6 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.101 -0.999 . . . . 0.0 110.855 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.788 HG12 ' O ' ' A' ' 162' ' ' ILE . 7.1 p -42.36 -24.11 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.405 -0.809 . . . . 0.0 110.556 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 181' ' ' CYS . 13.9 p -81.2 -30.59 34.26 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.874 -1.141 . . . . 0.0 110.268 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.446 ' N ' ' O ' ' A' ' 165' ' ' LYS . 0.7 OUTLIER -67.82 -56.07 10.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 110.605 -179.53 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 171' ' ' PHE . 2.4 mt -43.74 136.36 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.152 -0.968 . . . . 0.0 110.217 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -110.73 17.52 20.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 0.0 110.013 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 1.3 t80 -140.23 64.26 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.906 . . . . 0.0 110.426 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.517 ' NE2' ' CG2' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -71.11 138.88 50.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.019 -1.051 . . . . 0.0 110.166 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.7 tt0 -90.09 96.74 10.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.148 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.837 HD11 HG23 ' A' ' 125' ' ' VAL . 2.0 tt -97.71 97.26 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.949 -1.094 . . . . 0.0 110.034 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.472 ' OD1' ' CG1' ' A' ' 174' ' ' ILE . 3.8 m120 67.78 -56.89 0.47 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.11 -0.994 . . . . 0.0 110.009 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.543 ' N ' ' ND2' ' A' ' 176' ' ' ASN . 0.1 OUTLIER -166.0 23.71 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.479 -0.763 . . . . 0.0 110.192 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.557 ' HB3' HG22 ' A' ' 174' ' ' ILE . 0.4 OUTLIER -127.22 166.03 18.5 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.316 -0.865 . . . . 0.0 111.031 -179.459 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -109.3 40.24 1.89 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.492 -0.755 . . . . 0.0 109.44 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.664 HG12 ' C ' ' A' ' 115' ' ' GLY . 19.0 m -47.76 167.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.5 -0.75 . . . . 0.0 111.332 -179.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 1.8 tt0 -107.78 150.12 27.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.614 -0.679 . . . . 0.0 109.823 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 167' ' ' CYS . 3.1 p -131.0 90.6 2.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.286 -0.884 . . . . 0.0 110.419 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -89.66 143.24 26.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.26 -0.9 . . . . 0.0 110.096 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.423 ' HB3' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -79.99 163.87 23.9 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.165 -0.959 . . . . 0.0 110.296 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.786 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 110.318 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.861 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.359 0.599 . . . . 0.0 110.431 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.687 HG21 ' CE1' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -123.99 174.19 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.753 179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 41.0 t80 -123.53 156.76 35.04 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.252 -0.905 . . . . 0.0 109.947 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 1.4 m -145.0 154.38 14.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.233 -0.917 . . . . 0.0 110.583 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.447 ' O ' ' CB ' ' A' ' 179' ' ' VAL . . . -144.12 174.0 24.63 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.813 ' C ' HG12 ' A' ' 179' ' ' VAL . . . 77.85 12.84 84.04 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.763 HD11 ' N ' ' A' ' 153' ' ' GLY . 39.5 mt -53.48 97.38 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -1.171 . . . . 0.0 110.351 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.519 ' HB2' ' CD ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -42.25 162.99 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.406 -0.809 . . . . 0.0 110.504 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 120' ' ' THR . 14.8 m -65.99 161.84 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.386 -0.821 . . . . 0.0 110.792 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.2 OUTLIER 62.57 -38.6 0.15 Allowed 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.791 -0.568 . . . . 0.0 110.67 179.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.565 ' N ' ' O ' ' A' ' 118' ' ' VAL . 21.8 m -42.58 139.48 1.54 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.064 -1.023 . . . . 0.0 109.921 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.757 ' C ' HD12 ' A' ' 140' ' ' LEU . 8.7 t -127.0 168.93 13.89 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.08 -1.013 . . . . 0.0 111.079 -179.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.792 ' N ' HD12 ' A' ' 140' ' ' LEU . 1.5 t -39.3 -47.04 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.614 -0.679 . . . . 0.0 110.561 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.445 ' O ' ' CD2' ' A' ' 127' ' ' HIS . 0.6 OUTLIER -44.38 -25.66 0.27 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 108.968 179.569 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.605 ' HA ' ' CD2' ' A' ' 127' ' ' HIS . 15.7 t0 -69.51 -46.31 66.84 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 121.569 0.699 . . . . 0.0 109.665 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.818 HG22 HD11 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -76.66 -44.17 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 CA-C-O 121.807 0.813 . . . . 0.0 109.17 179.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 9.6 ttmt -59.38 -48.82 80.19 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.691 -0.63 . . . . 0.0 111.078 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.605 ' CD2' ' HA ' ' A' ' 124' ' ' ASP . 0.0 OUTLIER -71.9 -28.63 63.63 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.078 -1.014 . . . . 0.0 110.123 -179.393 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.477 ' O ' ' HG2' ' A' ' 131' ' ' GLN . 67.4 t80 -79.13 -50.0 11.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.465 -0.772 . . . . 0.0 112.167 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.571 ' CD2' HG12 ' A' ' 125' ' ' VAL . 68.6 m-85 -88.43 -16.91 31.6 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.814 -1.179 . . . . 0.0 112.118 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 1.5 pp20? -53.73 -42.49 68.19 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 117.247 -1.781 . . . . 0.0 108.432 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -70.57 -17.04 62.92 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 119.536 -0.866 . . . . 0.0 108.802 179.527 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.745 ' O ' HD13 ' A' ' 162' ' ' ILE . 7.7 m-85 -79.99 -27.77 39.56 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 179.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -162.35 -132.6 1.36 Allowed Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 179.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.538 ' HD2' ' CB ' ' A' ' 158' ' ' GLU . 1.5 ptpp? -101.13 -37.48 8.55 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.349 -1.089 . . . . 0.0 109.516 179.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.776 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.4 t 42.45 89.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.11 0.957 . . . . 0.0 110.934 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.12 -27.2 23.23 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 177.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -137.72 136.92 37.8 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.377 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.687 ' O ' HG22 ' A' ' 122' ' ' VAL . . . -143.2 91.1 2.24 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.558 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 6.3 ttp -96.32 162.94 13.29 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 122.098 0.951 . . . . 0.0 112.166 -177.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.818 HD11 HG22 ' A' ' 125' ' ' VAL . 22.5 mt -139.35 129.95 25.85 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.492 ' HG3' ' CE1' ' A' ' 152' ' ' PHE . 35.2 mmm -103.68 111.46 23.96 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.011 -1.056 . . . . 0.0 110.616 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -92.29 -136.2 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.341 -0.849 . . . . 0.0 110.034 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -142.72 95.98 2.86 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.003 -1.06 . . . . 0.0 110.471 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.44 ' HG3' ' N ' ' A' ' 145' ' ' THR . 10.7 tptt 51.5 -109.77 0.45 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.132 -0.98 . . . . 0.0 110.117 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.543 HG22 HG22 ' A' ' 146' ' ' THR . 32.9 m -87.7 -90.39 0.12 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.799 -1.188 . . . . 0.0 110.043 179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 HG22 ' A' ' 145' ' ' THR . 6.9 t -132.94 8.77 4.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.195 -0.941 . . . . 0.0 110.427 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -79.33 52.83 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.194 -0.941 . . . . 0.0 109.945 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -109.4 155.31 21.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.306 -0.871 . . . . 0.0 110.616 -179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 15.0 m80 -121.62 -21.19 6.27 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 0.0 109.916 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.4 mtt180 -156.68 -55.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.392 -0.817 . . . . 0.0 109.627 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 63.4 179.03 5.01 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 21.7 p90 -147.46 140.4 25.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.408 -1.054 . . . . 0.0 109.287 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.79 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -111.05 161.55 12.77 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.353 -1.403 . . . . 0.0 110.375 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.428 ' HB2' ' HE3' ' A' ' 139' ' ' MET . 28.3 m-85 -123.82 109.85 14.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.478 -1.013 . . . . 0.0 109.128 179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -105.24 -178.91 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.088 -1.007 . . . . 0.0 109.372 -179.379 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.623 ' HA ' HD13 ' A' ' 111' ' ' ILE . 78.7 m -159.7 104.25 1.57 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.58 -1.325 . . . . 0.0 112.149 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.065 ' CE1' HG22 ' A' ' 163' ' ' VAL . 1.6 p90 -127.73 97.23 4.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.256 -0.902 . . . . 0.0 108.748 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.545 ' O ' ' N ' ' A' ' 160' ' ' GLU . 1.0 OUTLIER -39.05 -31.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.491 -0.755 . . . . 0.0 111.483 -178.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.839 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.5 OUTLIER -52.49 86.7 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.18 -0.95 . . . . 0.0 110.168 -179.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.545 ' N ' ' O ' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -55.76 -38.11 69.41 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.091 -1.006 . . . . 0.0 109.755 179.794 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.9 OUTLIER -39.85 -64.46 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.305 -179.646 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.847 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -61.36 -46.28 96.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 O-C-N 120.853 -1.154 . . . . 0.0 108.815 179.249 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.065 HG22 ' CE1' ' A' ' 157' ' ' PHE . 4.4 t -49.77 -35.3 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 0.0 OUTLIER -50.1 -63.07 1.23 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.66 -0.65 . . . . 0.0 111.217 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 10.7 ptpt -90.43 -45.02 9.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.144 -0.973 . . . . 0.0 111.484 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.847 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.0 p -51.9 -22.05 2.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.159 -0.963 . . . . 0.0 110.517 -179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.536 ' CB ' ' HG2' ' A' ' 183' ' ' LYS . 89.5 m -89.61 -23.31 21.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.003 -1.061 . . . . 0.0 109.992 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.97 169.83 0.15 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.0 110.592 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.7 mt -78.41 121.29 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.422 -0.799 . . . . 0.0 110.186 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.52 -152.27 0.25 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.126 -0.984 . . . . 0.0 110.314 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.635 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 1.1 t80 -122.02 81.52 1.84 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.259 -0.901 . . . . 0.0 110.083 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.523 ' O ' ' HA ' ' A' ' 178' ' ' MET . 0.1 OUTLIER -74.75 115.53 14.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 0.0 110.231 -179.976 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 2.3 pt-20 -96.78 109.89 22.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.3 -0.875 . . . . 0.0 110.331 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.003 HD13 HG21 ' A' ' 179' ' ' VAL . 4.7 pt -118.91 119.62 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.886 -1.133 . . . . 0.0 109.789 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.479 ' CB ' ' O ' ' A' ' 174' ' ' ILE . 0.7 OUTLIER 68.22 -56.69 0.49 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.933 . . . . 0.0 109.702 -179.133 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.4 OUTLIER -179.07 31.06 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.718 -0.614 . . . . 0.0 109.401 179.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.59 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.4 tptp -139.14 136.7 35.4 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.295 -0.878 . . . . 0.0 111.352 -178.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.635 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -82.29 45.44 0.95 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.837 . . . . 0.0 109.588 178.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 1.003 HG21 HD13 ' A' ' 174' ' ' ILE . 6.8 m -46.77 176.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.299 -0.876 . . . . 0.0 110.676 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 38.7 tt0 -129.19 150.89 50.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.382 -0.824 . . . . 0.0 109.821 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 166' ' ' VAL . 0.0 OUTLIER -117.91 160.25 21.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 110.461 -179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -159.06 150.31 20.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.0 109.769 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.536 ' HG2' ' CB ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -66.52 158.94 28.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.766 -1.209 . . . . 0.0 110.276 -179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.861 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.537 -0.727 . . . . 0.0 110.261 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.902 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.03 0.443 . . . . 0.0 110.126 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.987 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 6.1 pt -106.7 170.89 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.099 -1.001 . . . . 0.0 110.822 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.593 ' CE1' ' HB2' ' A' ' 152' ' ' PHE . 54.2 t80 -125.57 150.66 47.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.507 -0.746 . . . . 0.0 109.893 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.2 OUTLIER -142.54 159.77 19.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.232 -0.917 . . . . 0.0 110.297 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 152' ' ' PHE . . . -151.15 168.66 30.79 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 94.5 15.14 48.12 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 140' ' ' LEU . 2.6 mm? -63.89 93.56 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -1.196 . . . . 0.0 109.543 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.564 ' CB ' ' CE ' ' A' ' 177' ' ' LYS . 4.9 t -64.6 -146.51 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.441 -0.787 . . . . 0.0 111.118 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.58 ' O ' ' N ' ' A' ' 120' ' ' THR . 8.9 t -90.41 166.97 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.569 -0.707 . . . . 0.0 111.223 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.569 ' N ' ' CG1' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 61.59 -40.52 0.13 Allowed 'General case' 0 N--CA 1.496 1.867 0 CA-C-O 121.285 0.564 . . . . 0.0 110.476 178.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 118' ' ' VAL . 24.2 m -51.22 134.51 27.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.241 -0.912 . . . . 0.0 110.045 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.46 ' O ' ' HB2' ' A' ' 124' ' ' ASP . 14.6 t -138.57 159.18 42.73 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.233 -0.917 . . . . 0.0 110.317 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.574 HG23 ' CB ' ' A' ' 140' ' ' LEU . 2.6 t -39.74 -52.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.392 -0.818 . . . . 0.0 110.556 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.483 ' C ' ' O ' ' A' ' 122' ' ' VAL . 5.5 tt0 -39.68 -28.22 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.548 -0.72 . . . . 0.0 109.294 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 122' ' ' VAL . 28.0 m-20 -75.17 -59.79 2.58 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.197 -0.601 . . . . 0.0 110.004 179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.614 HG13 ' CD2' ' A' ' 129' ' ' PHE . 1.6 t -63.84 -48.86 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.25 -0.906 . . . . 0.0 108.99 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.594 ' O ' ' CG ' ' A' ' 130' ' ' GLU . 5.2 ttpt -45.19 -70.14 0.11 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.413 -0.804 . . . . 0.0 109.495 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.545 ' HA ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -55.99 -37.58 69.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.56 -0.712 . . . . 0.0 110.186 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 26.2 t80 -58.69 -47.4 84.63 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.59 -0.694 . . . . 0.0 111.409 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.614 ' CD2' HG13 ' A' ' 125' ' ' VAL . 69.2 m-85 -87.19 -15.11 39.26 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.05 -1.031 . . . . 0.0 113.425 -178.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.792 ' HG2' HG11 ' A' ' 135' ' ' VAL . 3.2 mt-10 -56.53 -34.58 67.17 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 119.632 -1.917 . . . . 0.0 108.618 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.58 ' HG3' ' CD1' ' A' ' 132' ' ' PHE . 20.3 pt20 -74.87 -17.39 60.59 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.262 -0.975 . . . . 0.0 108.411 177.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.58 ' CD1' ' HG3' ' A' ' 131' ' ' GLN . 28.1 m-85 -83.79 -31.82 25.71 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -163.55 169.48 38.59 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.006 -1.637 . . . . 0.0 109.006 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.469 ' HD2' ' HG2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -42.39 -57.01 2.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.282 -1.128 . . . . 0.0 110.103 -179.974 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.792 HG11 ' HG2' ' A' ' 130' ' ' GLU . 1.2 t 61.11 90.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-O 122.202 1.001 . . . . 0.0 111.268 -179.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.13 -26.98 14.77 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 176.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -129.73 140.9 50.98 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.771 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -154.17 99.31 2.22 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.547 ' HG3' ' O ' ' A' ' 154' ' ' PHE . 2.5 ptm -110.31 167.61 10.07 Favored 'General case' 0 N--CA 1.501 2.099 0 CA-C-O 122.064 0.935 . . . . 0.0 112.265 -178.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 116' ' ' LEU . 5.1 tp -146.47 155.04 42.25 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.46 ' SD ' ' O ' ' A' ' 140' ' ' LEU . 75.5 mmm -142.22 144.2 33.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.554 ' CZ ' HD23 ' A' ' 140' ' ' LEU . 23.3 m-85 -114.94 -143.85 0.39 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.222 -0.924 . . . . 0.0 110.283 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.447 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 0.6 OUTLIER -114.59 -10.83 12.47 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.503 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.452 ' HB3' ' OD1' ' A' ' 147' ' ' ASN . 0.3 OUTLIER 179.36 -148.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 110.162 -179.786 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.1 m -105.5 -23.66 12.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.371 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.77 -51.22 0.79 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.145 -0.972 . . . . 0.0 110.122 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 144' ' ' LYS . 19.4 p-10 -80.45 49.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' A' ' 142' ' ' PHE . 0.1 OUTLIER -94.07 156.78 16.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 0.0 110.43 -179.756 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.465 ' HB3' ' HD2' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -159.63 -74.12 0.07 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 0.0 110.148 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' A' ' 149' ' ' HIS . 0.0 OUTLIER -98.41 113.23 25.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.352 -0.843 . . . . 0.0 110.173 179.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -131.61 -164.05 11.01 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.615 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 10.8 p90 -149.0 146.87 27.98 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.259 -1.142 . . . . 0.0 109.641 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.626 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -123.71 152.84 17.2 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.547 -1.311 . . . . 0.0 109.883 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.547 ' O ' ' HG3' ' A' ' 139' ' ' MET . 30.6 m-85 -119.26 109.28 15.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.059 -1.259 . . . . 0.0 109.953 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.496 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -103.92 179.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.758 -1.214 . . . . 0.0 109.042 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.579 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 61.0 m -162.74 107.22 1.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.192 -1.403 . . . . 0.0 111.944 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.987 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 0.2 OUTLIER -127.62 127.21 43.42 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.404 -0.81 . . . . 0.0 109.929 178.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.469 ' HG2' ' HD2' ' A' ' 134' ' ' LYS . 0.9 OUTLIER -52.83 -17.25 1.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.481 -0.762 . . . . 0.0 110.952 -179.502 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.548 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.7 m -72.53 81.1 1.08 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.129 -0.982 . . . . 0.0 110.578 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.439 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.8 OUTLIER -59.28 -39.09 81.85 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.76 -1.213 . . . . 0.0 109.25 179.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 1.5 m-20 -40.2 -58.72 1.42 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.766 -0.584 . . . . 0.0 110.344 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.855 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.5 OUTLIER -61.65 -47.5 93.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.867 -1.133 . . . . 0.0 108.614 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.911 HG22 ' CE2' ' A' ' 157' ' ' PHE . 36.1 t -47.07 -39.48 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 177.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.51 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 10.0 tt0 -46.13 -64.18 0.81 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.79 -0.569 . . . . 0.0 111.146 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.467 ' CG ' ' N ' ' A' ' 166' ' ' VAL . 3.9 pttm -90.5 -46.86 8.06 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.22 -0.925 . . . . 0.0 111.64 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.855 HG12 ' O ' ' A' ' 162' ' ' ILE . 4.9 p -48.68 -23.51 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.981 -1.075 . . . . 0.0 110.27 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.548 ' SG ' HG13 ' A' ' 163' ' ' VAL . 91.3 m -89.93 -27.32 19.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 110.353 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.431 ' O ' ' C ' ' A' ' 169' ' ' ILE . 39.1 tt0 -74.89 -35.72 62.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.317 -0.864 . . . . 0.0 110.705 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.672 HG21 ' ND1' ' A' ' 172' ' ' HIS . 1.2 tt -42.42 145.09 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.194 -0.941 . . . . 0.0 110.441 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.568 ' CD2' ' OE1' ' A' ' 180' ' ' GLU . 1.8 t60 -114.8 28.53 8.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -0.889 . . . . 0.0 110.035 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.656 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.9 OUTLIER -171.21 56.35 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.277 -0.889 . . . . 0.0 110.317 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.672 ' ND1' HG21 ' A' ' 169' ' ' ILE . 0.1 OUTLIER -64.93 128.54 36.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.247 -0.908 . . . . 0.0 110.348 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.546 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 0.3 OUTLIER -84.17 104.4 14.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 110.241 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 1.001 ' CD1' HG21 ' A' ' 179' ' ' VAL . 3.8 mt -103.59 100.88 11.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.145 -0.972 . . . . 0.0 109.655 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 174' ' ' ILE . 2.0 m-20 66.25 -55.73 0.39 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.498 -0.751 . . . . 0.0 110.301 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.499 ' N ' ' O ' ' A' ' 174' ' ' ILE . 6.6 p30 -168.01 26.44 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.49 -0.756 . . . . 0.0 109.89 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.592 ' HB3' HG13 ' A' ' 179' ' ' VAL . 1.3 tptt -131.85 152.17 51.19 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.225 -0.922 . . . . 0.0 110.839 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.656 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -92.99 44.22 1.14 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.287 -0.883 . . . . 0.0 109.858 179.379 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 1.001 HG21 ' CD1' ' A' ' 174' ' ' ILE . 33.5 m -48.06 170.45 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 110.354 -179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.568 ' OE1' ' CD2' ' A' ' 170' ' ' HIS . 30.5 tt0 -122.87 146.51 47.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.045 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.706 ' SG ' HD12 ' A' ' 111' ' ' ILE . 0.5 OUTLIER -114.75 165.51 12.74 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 0.0 110.358 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 13.3 mtmt -161.05 175.82 12.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.268 -0.895 . . . . 0.0 110.074 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -93.84 144.52 25.36 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.256 -0.903 . . . . 0.0 110.093 179.823 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.646 0 O-C-N 121.246 -0.909 . . . . 0.0 110.224 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.961 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.315 0.578 . . . . 0.0 110.493 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.841 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 2.0 pt -104.92 176.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.41 -0.806 . . . . 0.0 110.36 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.499 ' CE2' ' HB2' ' A' ' 152' ' ' PHE . 0.9 OUTLIER -124.55 159.81 29.79 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.476 -0.765 . . . . 0.0 109.223 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 152' ' ' PHE . 0.3 OUTLIER -149.3 161.66 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 0.0 110.483 -179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 179' ' ' VAL . . . -150.86 152.69 24.48 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.773 ' HA3' HG12 ' A' ' 179' ' ' VAL . . . 114.3 -17.13 19.4 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.917 HD22 HD22 ' A' ' 140' ' ' LEU . 0.3 OUTLIER -49.81 97.82 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -1.148 . . . . 0.0 110.097 179.845 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 118' ' ' VAL . 30.4 t -101.64 -167.57 1.43 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.257 -0.902 . . . . 0.0 110.747 -179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 120' ' ' THR . 16.4 m -42.25 168.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.523 -0.736 . . . . 0.0 111.081 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.556 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.4 OUTLIER 62.69 -41.75 0.18 Allowed 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.155 0.502 . . . . 0.0 110.33 179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.582 ' N ' ' O ' ' A' ' 118' ' ' VAL . 1.3 m -61.4 133.16 55.49 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.148 -0.97 . . . . 0.0 109.932 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.554 ' O ' ' N ' ' A' ' 123' ' ' GLU . 10.2 t -149.27 60.03 1.03 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.21 -0.931 . . . . 0.0 110.091 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.89 ' H ' HD12 ' A' ' 140' ' ' LEU . 3.1 t 63.97 -56.05 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 121.173 0.511 . . . . 0.0 110.425 -179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.563 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 1.4 mm-40 -44.57 -23.71 0.14 Allowed 'General case' 0 C--N 1.295 -1.791 0 O-C-N 121.442 -0.786 . . . . 0.0 108.946 179.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.595 ' HA ' ' CE1' ' A' ' 127' ' ' HIS . 2.4 m-20 -70.23 -58.04 4.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.55 -0.718 . . . . 0.0 109.686 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.76 HG22 ' HE2' ' A' ' 129' ' ' PHE . 2.0 t -68.38 -50.48 56.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.575 -0.703 . . . . 0.0 109.326 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.529 ' O ' ' HG2' ' A' ' 130' ' ' GLU . 15.8 tttt -49.01 -59.76 3.34 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.386 -0.821 . . . . 0.0 110.386 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.628 ' HA ' ' HG2' ' A' ' 130' ' ' GLU . 0.4 OUTLIER -58.21 -29.53 65.76 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.494 -0.754 . . . . 0.0 110.301 -179.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.477 ' O ' ' NE2' ' A' ' 131' ' ' GLN . 49.2 t80 -74.96 -62.41 1.56 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.512 -0.742 . . . . 0.0 111.827 -178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.76 ' HE2' HG22 ' A' ' 125' ' ' VAL . 67.8 m-85 -74.09 -15.09 61.07 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.902 -1.123 . . . . 0.0 112.668 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.628 ' HG2' ' HA ' ' A' ' 127' ' ' HIS . 0.0 OUTLIER -52.41 -41.29 63.07 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 117.702 -1.599 . . . . 0.0 109.113 179.525 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.477 ' NE2' ' O ' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -72.17 -16.97 61.98 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.648 -0.821 . . . . 0.0 108.874 179.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.531 ' HB2' ' HA ' ' A' ' 129' ' ' PHE . 2.8 m-85 -88.66 -25.36 22.43 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.564 0.697 . . . . 0.0 109.164 178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 157' ' ' PHE . . . -166.23 153.42 23.26 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.483 ' NZ ' ' HB3' ' A' ' 158' ' ' GLU . 12.3 ptpt -38.49 -41.64 0.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.599 -0.942 . . . . 0.0 110.727 -179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.754 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.2 t 47.52 90.03 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 122.099 0.952 . . . . 0.0 110.604 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -91.1 -26.06 19.31 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 177.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -127.92 140.23 52.12 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.739 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -157.77 98.93 1.68 Allowed 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.682 ' HA ' HG22 ' A' ' 122' ' ' VAL . 0.3 OUTLIER -117.95 169.37 9.7 Favored 'General case' 0 N--CA 1.499 1.975 0 CA-C-O 121.971 0.891 . . . . 0.0 112.505 -177.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 1.029 HD23 ' HA3' ' A' ' 153' ' ' GLY . 18.0 mt -144.59 132.41 21.29 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.488 ' O ' HD11 ' A' ' 116' ' ' LEU . 1.9 mmt -103.16 112.27 25.05 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.179 -0.951 . . . . 0.0 110.784 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.468 ' CE1' ' HB3' ' A' ' 140' ' ' LEU . 77.2 m-85 -99.98 154.96 17.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.326 -0.859 . . . . 0.0 110.242 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 147' ' ' ASN . 0.4 OUTLIER -101.77 90.16 3.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 0.0 109.946 179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 143' ' ' ASP . 14.4 mttt -41.1 -32.38 0.25 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.247 -0.908 . . . . 0.0 110.541 -179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 65.9 p -74.1 -42.76 59.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.127 -0.983 . . . . 0.0 110.191 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 1.9 t -150.45 53.71 0.9 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 110.111 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.523 ' N ' ' O ' ' A' ' 143' ' ' ASP . 47.5 p30 -73.91 52.53 0.43 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.307 -0.871 . . . . 0.0 110.563 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.19 -38.45 1.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 109.805 179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -101.25 -31.74 10.85 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.295 -0.878 . . . . 0.0 109.723 179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 5.9 ttm105 -110.66 171.18 7.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.37 -0.831 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 148.07 129.15 1.84 Allowed Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.529 ' CA ' HD21 ' A' ' 116' ' ' LEU . 29.4 p90 -141.58 134.5 28.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -1.205 . . . . 0.0 110.248 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 1.029 ' HA3' HD23 ' A' ' 140' ' ' LEU . . . -117.0 165.15 12.35 Favored Glycine 0 N--CA 1.489 2.192 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.016 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.52 ' O ' ' HG3' ' A' ' 139' ' ' MET . 46.6 m-85 -125.96 109.6 12.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.292 -1.123 . . . . 0.0 109.594 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.535 ' HB ' ' CG1' ' A' ' 111' ' ' ILE . 0.9 OUTLIER -101.63 -177.74 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.973 -1.079 . . . . 0.0 108.922 -179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 88.6 m -164.07 105.48 0.9 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.277 -1.369 . . . . 0.0 112.242 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.841 ' CZ ' HG21 ' A' ' 111' ' ' ILE . 1.3 p90 -132.41 108.36 9.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.512 -0.742 . . . . 0.0 109.02 177.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.493 ' O ' ' N ' ' A' ' 160' ' ' GLU . 5.3 tt0 -39.56 -27.99 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 0.0 110.847 -179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.703 ' O ' HG23 ' A' ' 163' ' ' VAL . 0.7 OUTLIER -53.58 88.31 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 110.427 -179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.493 ' N ' ' O ' ' A' ' 158' ' ' GLU . 2.0 tm-20 -66.35 -38.58 87.93 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.03 -1.044 . . . . 0.0 109.326 179.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.1 OUTLIER -40.84 -60.73 1.1 Allowed 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.995 179.796 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.942 ' O ' HG22 ' A' ' 166' ' ' VAL . 0.0 OUTLIER -59.88 -48.86 86.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.194 -1.003 . . . . 0.0 108.772 178.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.815 HG22 ' CE2' ' A' ' 157' ' ' PHE . 42.1 t -46.98 -41.95 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 4.9 tt0 -51.09 -42.92 60.93 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.512 0.673 . . . . 0.0 110.259 179.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.474 ' O ' ' N ' ' A' ' 168' ' ' GLU . 0.0 OUTLIER -88.86 -63.59 1.27 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.372 -0.83 . . . . 0.0 110.947 -179.207 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.942 HG22 ' O ' ' A' ' 162' ' ' ILE . 12.4 m -47.25 -23.09 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 118.956 -1.098 . . . . 0.0 109.489 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 13.9 t -73.63 -24.41 60.01 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.186 -0.947 . . . . 0.0 108.983 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' ' O ' ' A' ' 165' ' ' LYS . 42.2 tp10 -105.64 -49.76 3.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.842 -0.536 . . . . 0.0 110.418 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 43.4 mt -52.77 111.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.242 -0.911 . . . . 0.0 110.449 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.447 ' NE2' ' OE1' ' A' ' 180' ' ' GLU . 0.4 OUTLIER -88.22 176.74 7.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.277 -0.889 . . . . 0.0 110.234 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.617 ' CD1' ' HB2' ' A' ' 178' ' ' MET . 2.8 t80 43.66 65.91 0.91 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.168 -0.958 . . . . 0.0 110.004 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.808 ' NE2' HG12 ' A' ' 166' ' ' VAL . 0.1 OUTLIER -66.5 -22.47 66.18 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.148 -0.97 . . . . 0.0 110.272 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 13.1 tt0 70.48 79.78 0.18 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 0.0 110.824 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.669 HG22 ' CB ' ' A' ' 177' ' ' LYS . 2.8 tt -78.29 -175.32 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.97 -1.081 . . . . 0.0 109.726 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.478 ' C ' ' O ' ' A' ' 174' ' ' ILE . 48.0 m-80 -30.28 -57.36 0.19 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.8 -0.562 . . . . 0.0 111.819 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.502 ' O ' ' HD3' ' A' ' 177' ' ' LYS . 0.7 OUTLIER -138.86 28.9 2.34 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.213 -0.929 . . . . 0.0 110.27 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.669 ' CB ' HG22 ' A' ' 174' ' ' ILE . 0.2 OUTLIER -142.88 -166.63 2.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 110.729 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.617 ' HB2' ' CD1' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -135.39 33.61 3.04 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.773 HG12 ' HA3' ' A' ' 115' ' ' GLY . 33.3 m -36.9 159.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.518 0.675 . . . . 0.0 111.375 -179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.447 ' OE1' ' NE2' ' A' ' 170' ' ' HIS . 28.4 tt0 -114.57 153.72 29.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.404 -0.81 . . . . 0.0 109.78 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 166' ' ' VAL . 20.2 m -121.97 122.02 38.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 110.588 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.5 mmtt -124.22 137.65 54.5 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.227 -0.921 . . . . 0.0 109.86 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.565 ' HD3' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -56.08 164.91 1.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.111 -0.993 . . . . 0.0 110.8 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.961 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.501 -0.749 . . . . 0.0 109.956 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.715 ' O ' ' HB3' ' A' ' 184' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 121.109 0.481 . . . . 0.0 110.216 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.975 HD12 ' N ' ' A' ' 112' ' ' PHE . 1.2 pp -119.25 -179.15 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.225 -0.922 . . . . 0.0 110.853 -179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.975 ' N ' HD12 ' A' ' 111' ' ' ILE . 1.6 t80 -131.43 159.49 37.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.576 -0.703 . . . . 0.0 109.563 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.443 HG23 ' CA ' ' A' ' 153' ' ' GLY . 0.4 OUTLIER -145.78 155.4 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.291 -0.881 . . . . 0.0 110.291 -179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.523 ' O ' ' CG1' ' A' ' 179' ' ' VAL . . . -156.63 140.62 7.32 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 121.62 -10.1 9.82 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.792 HD11 ' O ' ' A' ' 141' ' ' MET . 0.4 OUTLIER -50.89 95.97 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.296 -1.12 . . . . 0.0 109.929 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 115' ' ' GLY . 53.7 p -65.49 -167.87 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.368 -0.832 . . . . 0.0 110.782 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 120' ' ' THR . 23.1 m -58.84 171.69 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 0.0 111.225 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.529 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.3 OUTLIER 62.2 -39.87 0.15 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.914 -0.491 . . . . 0.0 110.775 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.672 HG23 ' OD2' ' A' ' 124' ' ' ASP . 36.8 m -55.56 148.74 15.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.006 -1.059 . . . . 0.0 110.182 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.488 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 10.7 t -158.28 166.88 31.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.146 -0.971 . . . . 0.0 110.623 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.843 HG13 ' O ' ' A' ' 138' ' ' ALA . 2.3 t -41.6 -53.26 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.252 -0.905 . . . . 0.0 110.558 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 122' ' ' VAL . 0.1 OUTLIER -43.08 -25.8 0.12 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.672 ' OD2' HG23 ' A' ' 120' ' ' THR . 50.5 t0 -72.24 -49.94 31.19 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.769 ' CG2' HD13 ' A' ' 140' ' ' LEU . 0.0 OUTLIER -69.37 -44.85 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 C-N-CA 119.716 -0.793 . . . . 0.0 109.09 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 8.2 tttm -52.16 -63.99 0.96 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.495 -0.753 . . . . 0.0 110.64 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.518 ' C ' ' ND1' ' A' ' 127' ' ' HIS . 0.1 OUTLIER -62.85 -30.79 71.77 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.144 -0.972 . . . . 0.0 110.95 -179.256 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HB2' ' O ' ' A' ' 124' ' ' ASP . 84.9 t80 -70.59 -50.92 32.09 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.19 -0.944 . . . . 0.0 111.673 -178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.721 ' CE2' HG12 ' A' ' 125' ' ' VAL . 56.0 m-85 -89.48 -12.29 40.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.965 -1.084 . . . . 0.0 111.941 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.695 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 26.0 tt0 -56.31 -38.29 71.08 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 117.9 -1.52 . . . . 0.0 108.357 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.442 ' HG2' ' O ' ' A' ' 128' ' ' TYR . 24.6 pt20 -74.65 -14.46 60.76 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.565 ' O ' HD13 ' A' ' 162' ' ' ILE . 14.0 m-85 -86.8 -32.16 20.48 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.712 -0.617 . . . . 0.0 110.424 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.563 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -170.3 54.69 0.19 Allowed Glycine 0 N--CA 1.491 2.305 0 C-N-CA 118.918 -1.611 . . . . 0.0 110.346 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 130' ' ' GLU . 0.0 OUTLIER 60.15 -67.34 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.722 -0.869 . . . . 0.0 111.001 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.739 HG12 ' O ' ' A' ' 135' ' ' VAL . 0.9 OUTLIER 62.44 94.62 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.967 -1.083 . . . . 0.0 110.903 -179.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -86.41 -25.0 25.52 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -136.51 136.55 39.47 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 121.5 0.667 . . . . 0.0 109.793 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.843 ' O ' HG13 ' A' ' 122' ' ' VAL . . . -145.18 92.51 2.26 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 179.329 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.505 ' SD ' ' CE ' ' A' ' 141' ' ' MET . 6.8 tpp -90.17 163.06 14.97 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 121.834 0.826 . . . . 0.0 111.328 -177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.776 HD12 ' HA3' ' A' ' 153' ' ' GLY . 5.0 tp -151.11 154.71 37.48 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.774 -0.579 . . . . 0.0 109.711 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.792 ' O ' HD11 ' A' ' 116' ' ' LEU . 8.8 mmt -138.88 157.62 45.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.885 . . . . 0.0 110.177 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 142' ' ' PHE . 22.8 m-85 -124.69 -146.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.235 -0.915 . . . . 0.0 110.062 180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.8 132.94 55.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 110.116 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 25.1 tttt -83.13 48.05 1.32 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.17 -0.956 . . . . 0.0 110.344 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 3.7 m -94.36 -57.11 2.59 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.975 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.646 HG23 ' H ' ' A' ' 147' ' ' ASN . 0.0 OUTLIER -149.5 -74.04 0.17 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.574 -0.704 . . . . 0.0 109.925 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.646 ' H ' HG23 ' A' ' 146' ' ' THR . 9.0 m-20 -90.27 -82.82 0.27 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.864 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.487 ' O ' ' HB3' ' A' ' 142' ' ' PHE . 4.4 ptt180 -150.33 -49.01 0.13 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.415 -0.803 . . . . 0.0 110.104 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 150' ' ' ARG . 12.8 m170 54.76 177.41 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -0.937 . . . . 0.0 110.657 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 149' ' ' HIS . 5.9 mtm180 -52.0 -174.47 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.384 -0.822 . . . . 0.0 110.217 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.472 ' HA3' ' HA ' ' A' ' 142' ' ' PHE . . . 173.89 -149.26 10.71 Favored Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.707 -1.235 . . . . 0.0 110.165 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.558 ' CD1' ' O ' ' A' ' 152' ' ' PHE . 6.6 p90 -149.7 141.84 24.02 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.51 -0.994 . . . . 0.0 109.252 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.776 ' HA3' HD12 ' A' ' 140' ' ' LEU . . . -123.58 160.07 18.15 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.574 -179.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -123.89 113.33 18.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.54 -0.976 . . . . 0.0 108.748 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.8 OUTLIER -104.42 178.91 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.879 -1.138 . . . . 0.0 109.543 -179.207 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 45.8 m -160.6 104.92 1.41 Allowed 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.316 -1.354 . . . . 0.0 112.178 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.018 ' CE2' HG22 ' A' ' 163' ' ' VAL . 0.2 OUTLIER -128.83 112.31 14.01 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.374 -0.829 . . . . 0.0 109.338 177.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.444 ' CA ' ' OE1' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -39.48 -28.44 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.499 -0.751 . . . . 0.0 110.585 -179.281 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.865 ' O ' HG23 ' A' ' 163' ' ' VAL . 1.4 m -59.92 86.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.226 -0.921 . . . . 0.0 110.13 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.499 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 1.0 OUTLIER -69.22 -37.98 78.33 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.86 -1.15 . . . . 0.0 109.271 179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.463 ' HA ' ' HG3' ' A' ' 164' ' ' GLU . 0.8 OUTLIER -43.24 -61.13 1.42 Allowed 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.799 -0.76 . . . . 0.0 109.892 179.905 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.4 OUTLIER -58.1 -46.41 88.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.139 -1.024 . . . . 0.0 108.39 178.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.018 HG22 ' CE2' ' A' ' 157' ' ' PHE . 44.5 t -48.96 -51.3 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.463 ' HG3' ' HA ' ' A' ' 161' ' ' ASP . 2.9 mt-10 -42.7 -43.97 4.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.612 179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.423 ' O ' ' N ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -90.92 -66.21 0.95 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.315 -0.866 . . . . 0.0 111.107 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.641 HG23 ' NE2' ' A' ' 172' ' ' HIS . 6.0 p -45.44 -20.16 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.465 -0.772 . . . . 0.0 110.936 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.524 ' HB2' ' N ' ' A' ' 183' ' ' LYS . 3.5 p -88.19 -29.19 20.68 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.885 -1.134 . . . . 0.0 109.921 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.456 ' O ' ' O ' ' A' ' 167' ' ' CYS . 0.0 OUTLIER -44.44 172.33 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.896 -179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -80.71 109.23 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.373 -0.83 . . . . 0.0 110.163 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.41 ' O ' ' C ' ' A' ' 171' ' ' PHE . 18.4 t-160 -168.24 120.42 0.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 110.069 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.61 ' CD1' ' HB3' ' A' ' 178' ' ' MET . 0.1 OUTLIER -42.71 101.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.275 -0.89 . . . . 0.0 110.144 -179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.641 ' NE2' HG23 ' A' ' 166' ' ' VAL . 0.3 OUTLIER -79.79 -153.02 0.08 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.182 -0.949 . . . . 0.0 110.446 -179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 178' ' ' MET . 14.3 tt0 -153.65 127.74 9.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.278 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.812 ' HB ' HG21 ' A' ' 179' ' ' VAL . 0.5 OUTLIER -116.3 102.82 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.214 -0.929 . . . . 0.0 110.01 179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.468 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.9 OUTLIER 66.88 -58.59 0.39 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.188 . . . . 0.0 109.842 -179.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 174' ' ' ILE . 7.8 p30 -149.5 -31.1 0.23 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.557 -0.714 . . . . 0.0 110.587 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 0.1 OUTLIER -76.72 -170.05 1.45 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.41 -0.806 . . . . 0.0 110.099 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.639 ' C ' HG23 ' A' ' 179' ' ' VAL . 21.8 mmt -100.63 -70.6 0.73 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.238 -0.914 . . . . 0.0 110.307 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.812 HG21 ' HB ' ' A' ' 174' ' ' ILE . 2.6 t 70.48 160.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.541 -0.724 . . . . 0.0 110.551 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -120.75 152.77 37.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.287 -0.883 . . . . 0.0 110.013 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . 0.551 ' SG ' ' CD2' ' A' ' 172' ' ' HIS . 35.4 m -126.39 158.84 34.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 0.0 110.286 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.476 ' CG ' ' O ' ' A' ' 181' ' ' CYS . 15.4 mtmt -157.53 155.47 30.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.368 -0.832 . . . . 0.0 109.961 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.538 ' HD2' HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -67.12 160.88 25.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.146 -0.971 . . . . 0.0 110.034 -179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.715 ' HB3' ' O ' ' A' ' 110' ' ' LYS . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.926 . . . . 0.0 110.548 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.822 ' HB2' ' HG1' ' A' ' 156' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.301 0.572 . . . . 0.0 110.086 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.648 HG21 ' CZ ' ' A' ' 157' ' ' PHE . 0.0 OUTLIER -122.39 176.88 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.117 -0.99 . . . . 0.0 110.389 179.914 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 152' ' ' PHE . 56.4 t80 -126.08 160.22 30.71 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.402 -0.812 . . . . 0.0 109.926 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 153' ' ' GLY . 0.1 OUTLIER -147.42 149.25 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.037 -1.039 . . . . 0.0 110.667 -179.601 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.22 174.2 22.94 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 117' ' ' SER . . . 89.59 13.19 61.64 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.889 HD21 ' HG ' ' A' ' 140' ' ' LEU . 1.7 mp -40.81 97.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -1.051 . . . . 0.0 110.167 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 115' ' ' GLY . 22.7 t -64.92 178.99 0.73 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.358 -0.839 . . . . 0.0 110.731 -179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.572 ' O ' ' N ' ' A' ' 120' ' ' THR . 2.7 t -72.33 150.23 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 0.0 110.454 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.541 ' HB3' ' O ' ' A' ' 118' ' ' VAL . 0.5 OUTLIER 62.25 -38.85 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.99 -0.444 . . . . 0.0 110.598 179.577 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.642 HG23 ' OD2' ' A' ' 124' ' ' ASP . 18.0 m -41.4 159.09 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.304 -0.873 . . . . 0.0 110.015 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.441 ' O ' ' CB ' ' A' ' 124' ' ' ASP . 10.3 t -164.52 172.51 13.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.947 -1.096 . . . . 0.0 111.127 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 140' ' ' LEU . 3.1 t -39.01 -54.54 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.608 -0.682 . . . . 0.0 110.842 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.474 ' O ' ' ND1' ' A' ' 127' ' ' HIS . 0.3 OUTLIER -41.98 -25.91 0.08 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 109.155 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.642 ' OD2' HG23 ' A' ' 120' ' ' THR . 58.1 t0 -72.81 -55.56 6.52 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 121.493 0.663 . . . . 0.0 109.909 179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.848 HG12 ' CD2' ' A' ' 129' ' ' PHE . 0.0 OUTLIER -68.4 -54.75 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . 0.528 ' O ' ' HB2' ' A' ' 130' ' ' GLU . 1.1 tttt -39.29 -63.47 0.55 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.154 0.502 . . . . 0.0 110.555 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.527 ' CE1' ' HA ' ' A' ' 124' ' ' ASP . 2.1 p-80 -61.87 -29.5 70.23 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.073 -1.017 . . . . 0.0 110.897 -179.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.479 ' O ' ' CG ' ' A' ' 131' ' ' GLN . 10.0 t80 -73.36 -55.29 6.58 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.322 -0.861 . . . . 0.0 111.707 -178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PHE . . . . . 0.848 ' CD2' HG12 ' A' ' 125' ' ' VAL . 38.6 m-85 -84.13 -17.53 39.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.933 -1.104 . . . . 0.0 111.895 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.659 ' HA ' ' HB ' ' A' ' 135' ' ' VAL . 70.0 tt0 -57.2 -36.0 70.32 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.114 -1.616 . . . . 0.0 108.262 179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . 0.479 ' CG ' ' O ' ' A' ' 128' ' ' TYR . 4.9 pt20 -76.71 -13.56 60.03 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.651 ' CD2' HD11 ' A' ' 162' ' ' ILE . 4.1 m-30 -86.95 -35.11 19.07 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.806 -0.559 . . . . 0.0 111.101 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.572 ' O ' ' N ' ' A' ' 135' ' ' VAL . . . -169.45 65.01 0.18 Allowed Glycine 0 N--CA 1.493 2.474 0 C-N-CA 118.273 -1.918 . . . . 0.0 111.181 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.507 ' O ' ' HB ' ' A' ' 135' ' ' VAL . 0.0 OUTLIER 57.86 -70.88 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.614 -0.933 . . . . 0.0 111.591 178.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.736 HG12 ' O ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER 64.95 92.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 CA-C-O 122.09 0.948 . . . . 0.0 110.732 -178.868 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.489 ' OD1' ' HE2' ' A' ' 134' ' ' LYS . 0.1 OUTLIER -87.19 -21.61 25.78 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 177.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -136.06 137.9 41.59 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 155' ' ' VAL . . . -155.9 98.17 1.88 Allowed 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' MET . . . . . 0.577 ' HA ' ' CG2' ' A' ' 122' ' ' VAL . 0.0 OUTLIER -113.61 171.79 7.36 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-O 122.145 0.974 . . . . 0.0 112.555 -177.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.889 ' HG ' HD21 ' A' ' 116' ' ' LEU . 1.0 OUTLIER -145.62 148.43 33.1 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.498 179.683 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . 0.448 ' O ' ' HA3' ' A' ' 151' ' ' GLY . 3.1 mmt -130.45 116.99 19.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.023 -1.048 . . . . 0.0 110.67 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.506 ' CD1' HD23 ' A' ' 116' ' ' LEU . 45.1 m-85 -92.64 -173.35 3.32 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 0.0 109.997 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -58.02 177.93 0.1 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.187 -0.945 . . . . 0.0 110.001 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.63 -20.66 65.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.167 -0.958 . . . . 0.0 110.146 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.517 HG22 ' N ' ' A' ' 146' ' ' THR . 85.0 m -130.48 -105.34 0.28 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.29 -0.881 . . . . 0.0 109.918 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.517 ' N ' HG22 ' A' ' 145' ' ' THR . 10.7 p -150.49 49.48 0.88 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.953 -1.092 . . . . 0.0 109.827 179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -53.48 -90.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.334 -0.854 . . . . 0.0 110.593 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.411 ' O ' ' HB3' ' A' ' 149' ' ' HIS . 1.1 tpp180 -150.23 -58.0 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.084 -1.01 . . . . 0.0 110.626 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.549 ' N ' ' ND1' ' A' ' 149' ' ' HIS . 0.0 OUTLIER 178.01 110.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 110.403 -179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -176.64 36.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.194 -0.941 . . . . 0.0 110.146 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.448 ' HA3' ' O ' ' A' ' 141' ' ' MET . . . -111.5 -160.14 16.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PHE . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 112' ' ' PHE . 4.7 p90 -145.35 153.32 41.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.231 -1.158 . . . . 0.0 109.625 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 140' ' ' LEU . . . -118.85 158.34 14.88 Favored Glycine 0 N--CA 1.489 2.228 0 C-N-CA 119.432 -1.366 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.533 ' O ' ' CG ' ' A' ' 139' ' ' MET . 11.9 m-85 -116.93 110.95 18.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -1.061 . . . . 0.0 109.352 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.544 ' HA ' ' HA ' ' A' ' 138' ' ' ALA . 0.9 OUTLIER -107.65 179.82 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 120.638 -1.289 . . . . 0.0 109.392 -179.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . 0.822 ' HG1' ' HB2' ' A' ' 110' ' ' LYS . 97.2 m -163.49 104.75 0.96 Allowed 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.187 -1.405 . . . . 0.0 112.293 -179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 1.055 ' CE1' HG22 ' A' ' 163' ' ' VAL . 1.4 p90 -127.83 99.2 5.44 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.866 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.523 ' O ' ' N ' ' A' ' 160' ' ' GLU . 0.2 OUTLIER -38.89 -31.04 0.05 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.757 -0.59 . . . . 0.0 111.381 -178.596 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 163' ' ' VAL . 35.7 m -53.37 86.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.055 -1.028 . . . . 0.0 110.243 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 158' ' ' GLU . 5.3 tt0 -54.36 -38.42 66.06 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.831 -1.168 . . . . 0.0 109.75 179.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 164' ' ' GLU . 0.2 OUTLIER -38.42 -67.76 0.19 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.258 -179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.694 ' O ' HG12 ' A' ' 166' ' ' VAL . 0.6 OUTLIER -60.46 -38.23 77.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.056 -1.027 . . . . 0.0 109.325 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.055 HG22 ' CE1' ' A' ' 157' ' ' PHE . 7.7 t -58.2 -32.94 45.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 161' ' ' ASP . 1.7 tm-20 -58.02 -49.59 76.33 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.478 -0.764 . . . . 0.0 110.604 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 168' ' ' GLU . 18.9 tttp -89.71 -60.33 1.97 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.297 -0.877 . . . . 0.0 110.577 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.694 HG12 ' O ' ' A' ' 162' ' ' ILE . 2.5 p -42.34 -25.93 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.452 -0.78 . . . . 0.0 109.805 179.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' CYS . . . . . 0.568 ' CB ' ' O ' ' A' ' 163' ' ' VAL . 10.7 t -76.28 -34.52 59.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 0.0 109.894 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.577 ' O ' ' CE1' ' A' ' 170' ' ' HIS . 23.3 tt0 -87.04 -86.86 0.15 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.556 -0.715 . . . . 0.0 110.703 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 168' ' ' GLU . 0.6 OUTLIER -41.44 138.0 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.349 -0.844 . . . . 0.0 110.424 -179.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 168' ' ' GLU . 21.9 m-70 -112.2 -154.35 0.54 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.361 -0.837 . . . . 0.0 110.117 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.664 ' CZ ' ' CB ' ' A' ' 178' ' ' MET . 0.4 OUTLIER 57.09 51.68 10.09 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.85 . . . . 0.0 110.038 179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.405 ' O ' ' O ' ' A' ' 173' ' ' GLU . 6.7 m80 -83.0 -5.94 59.29 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.431 -0.793 . . . . 0.0 109.775 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 177' ' ' LYS . 57.7 tt0 59.04 114.14 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.356 -0.84 . . . . 0.0 110.523 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . 0.633 ' CG2' HG11 ' A' ' 179' ' ' VAL . 0.4 OUTLIER -111.61 114.55 47.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 O-C-N 121.231 -0.918 . . . . 0.0 108.926 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.49 ' HB2' ' OD2' ' A' ' 124' ' ' ASP . 0.8 OUTLIER 68.84 -56.33 0.53 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.044 -1.035 . . . . 0.0 109.467 -178.448 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . 0.515 ' N ' ' O ' ' A' ' 174' ' ' ILE . 0.2 OUTLIER -174.24 26.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.571 -0.706 . . . . 0.0 110.312 179.864 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.628 ' HD2' HG13 ' A' ' 179' ' ' VAL . 0.0 OUTLIER -139.92 122.31 16.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.022 -1.049 . . . . 0.0 110.138 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' MET . . . . . 0.664 ' CB ' ' CZ ' ' A' ' 171' ' ' PHE . 0.0 OUTLIER -54.53 99.41 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.856 -1.153 . . . . 0.0 110.504 179.815 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' VAL . . . . . 0.633 HG11 ' CG2' ' A' ' 174' ' ' ILE . 23.3 m -97.01 -161.04 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.195 -0.941 . . . . 0.0 110.221 179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . 0.513 ' OE2' ' CD2' ' A' ' 170' ' ' HIS . 19.7 tt0 -134.88 157.12 47.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.265 -0.897 . . . . 0.0 109.975 179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' CYS . . . . . . . . . . . . . 6.0 t -145.01 141.37 28.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.232 -0.918 . . . . 0.0 110.48 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.556 ' HA ' ' HA ' ' A' ' 167' ' ' CYS . 13.6 mtpp -138.02 -171.15 2.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.418 -0.801 . . . . 0.0 109.886 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.639 ' HA ' HG22 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -106.28 164.31 12.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.179 -0.95 . . . . 0.0 109.214 179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.565 ' N ' ' CD ' ' A' ' 183' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.987 -1.071 . . . . 0.0 110.962 -179.698 . . . . . . . . 1 1 . 1 stop_ save_